cell_line_ac,cell_line_name,coriell_id,atcc_id,age,sex,population,cell_line_category,transformant_id_ncbi,transformant_name_ncbi,breed,cell,tissue,disease,seqvar,knockout
CVCL_0207,CCRF-CEM,GM03671,CCL-119,3Y11M,Female,Caucasian,Cancer cell line,,,,T-cell,UBERON_0000178,NCIt; C7953; Childhood T acute lymphoblastic leukemia," Gene fusion; HGNC; 13222; BCL11B + HGNC; 2488; NKX2-5; Name(s)=NKX2.5-BCL11B (PubMed=14500364; PubMed=17308084)., Mutation; HGNC; 3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (PubMed=17088437; Cosmic-CLP=905952; DepMap=ACH-001738)., Mutation; HGNC; 7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (PubMed=15472075)., Mutation; HGNC; 11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (PubMed=2144611; PubMed=10071127; PubMed=17088437; Cosmic-CLP=905952; DepMap=ACH-001738).",
CVCL_1859,CCRF-HSB-2,GM04155,CCL-120.1,11Y,Male,Caucasian,Cancer cell line,,,,T-cell,UBERON_0000178,NCIt; C7953; Childhood T acute lymphoblastic leukemia," Gene fusion; HGNC; 10879; STIL + HGNC; 11556; TAL1; Name(s)=STIL-TAL1, SIL-TAL1, SIL-SCL (PubMed=2255914)., Mutation; HGNC; 3690; FGFR3; Simple; p.Tyr226His (c.676T>C); Zygosity=Unspecified (PubMed=22675565)., Mutation; HGNC; 7881; NOTCH1; Simple; p.Leu1600Pro (c.4799T>C); Zygosity=Unspecified (PubMed=22675565)., Mutation; HGNC; 8979; PIK3R1; Simple; p.Thr454Ile (c.1361C>T); Zygosity=Unspecified (PubMed=22675565)., Mutation; HGNC; 11998; TP53; None_reported; -; Zygosity=- (PubMed=2144611).",
CVCL_1860,CCRF-SB,GM04154,CCL-120,11Y,Male,Caucasian,Cancer cell line,10376,Epstein-Barr virus (EBV).,,B-cell,UBERON_0000178,NCIt; C7953; Childhood T acute lymphoblastic leukemia,,
CVCL_5239,1205Lu,WC00058,CRL-2812,37Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002097,NCIt; C3510; Cutaneous melanoma, Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=16827748; PubMed=18632627; Wistar).,
CVCL_2270,143B,GM05887,CRL-8303,13Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000981,NCIt; C9145; Osteosarcoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (PubMed=19787792)., Mutation; HGNC; 6407; KRAS; Simple; p.Ala59Thr (c.175G>A); ClinVar=VCV000012581; Zygosity=Heterozygous (DepMap=ACH-001001).",
CVCL_0008,Daudi,GM03190,CCL-213,16Y,Male,African,Cancer cell line,10376,Epstein-Barr virus (EBV).,,B-cell,UBERON_0000178,NCIt; C27694; EBV-related Burkitt lymphoma," Gene fusion; HGNC; 5477; IGH + HGNC; 7553; MYC; Name(s)=MYC-IGH (PubMed=3116544; PubMed=6806672)., Mutation; HGNC; 2514; CTNNB1; Simple; p.Ala5_Ala80del (c.14_241del228); Zygosity=Homozygous (ATCC=CCL-213).",
CVCL_1185,EB3 [Human Burkitt lymphoma],GM04679,CCL-85,3Y,Male,African,Cancer cell line,10376,Epstein-Barr virus (EBV).,,B-cell,UBERON_0002397,NCIt; C27694; EBV-related Burkitt lymphoma," Mutation; HGNC; 11998; TP53; Simple; p.Tyr163Cys (c.488A>G); ClinVar=VCV000127814; Zygosity=Heterozygous (Cosmic-CLP=906847; DepMap=ACH-002236)., Mutation; HGNC; 11998; TP53; Simple; c.1101-2A>G; ClinVar=VCV000141332; Zygosity=Heterozygous; Note=Splice acceptor mutation (Cosmic-CLP=906847; DepMap=ACH-002236).",
CVCL_6357,451Lu,WC00059,CRL-2813,22Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002427,NCIt; C3510; Cutaneous melanoma," Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=17260012; PubMed=18632627; PubMed=21156289; PubMed=23851445; Cosmic-CLP=1287706; DepMap=ACH-001002; Wistar)., Mutation; HGNC; 11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (PubMed=17260012; PubMed=21156289; PubMed=23851445; Cosmic-CLP=1287706; DepMap=ACH-001002).",
CVCL_0346,IMR-32,AG03320,CCL-127,1Y1M,Male,Caucasian,Cancer cell line,,,,,UBERON_0000916,NCIt; C3270; Neuroblastoma,,
CVCL_1317,Jiyoye,GM04678,CCL-87,7Y,Male,African,Cancer cell line,10376,Epstein-Barr virus (EBV).,,B-cell,UBERON_0007795,NCIt; C27694; EBV-related Burkitt lymphoma, Mutation; HGNC; 11998; TP53; Simple; p.Lys132Gln (c.394A>C); ClinVar=VCV000376628; Zygosity=Unspecified (PubMed=1915267).,
CVCL_0004,K-562,GM05372,CCL-243,53Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000175,"NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive"," Gene fusion; HGNC; 76; ABL1 + HGNC; 1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (PubMed=10071072; PubMed=10071072; PubMed=12506034; PubMed=20809971).",
CVCL_0013,MOLT-4,GM02219,CRL-1582,19Y,Male,Caucasian,Cancer cell line,,,,T-cell,UBERON_0000178,NCIt; C9142; Adult T acute lymphoblastic leukemia," Mutation; HGNC; 7881; NOTCH1; Simple; p.Leu1600Pro (c.4799T>C); Zygosity=Heterozygous (PubMed=15472075)., Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000040468; Zygosity=Heterozygous (PubMed=12068308; PubMed=17088437)., Mutation; HGNC; 11389; STK11; Simple; p.Gln214Ter (c.640C>T); ClinVar=VCV000428759; Zygosity=Heterozygous (PubMed=17088437).",
CVCL_0511,Raji,GM04671,CCL-86,11Y,Male,African,Cancer cell line,10376,Epstein-Barr virus (EBV).,,B-cell,UBERON_0002397,NCIt; C27694; EBV-related Burkitt lymphoma," Gene fusion; HGNC; 5477; IGH + HGNC; 7553; MYC; Name(s)=MYC-IGH (PubMed=6306472; PubMed=6419122; PubMed=6806672)., Mutation; HGNC; 11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (PubMed=8344493; PubMed=15901131; Cosmic-CLP=909262; DepMap=ACH-000654).",
CVCL_0014,RPMI-8226,GM02132,CCL-155,61Y,Male,African American,Cancer cell line,,,,B-cell,UBERON_0000178,NCIt; C3242; Plasma cell myeloma," Gene fusion; HGNC; 5722; IGKJ4 + HGNC; 5783; IGKV2-28; Name(s)=IGKV2-28-IGKJ4 (CelloPub=CLPUB00604)., Mutation; HGNC; 3236; EGFR; Simple; p.Thr751Ile (c.2252C>T); ClinVar=VCV000177773; Zygosity=Heterozygous (PubMed=17088437)., Mutation; HGNC; 11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Homozygous; Note=Temperature-sensitive (PubMed=1373872; PubMed=17088437; PubMed=18277095; PubMed=21173094; CelloPub=CLPUB00604).",
CVCL_0040,WM115,WC00079,CRL-1675,55Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0001511,NCIt; C3224; Melanoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (Wistar)., Gene deletion; HGNC; 9588; PTEN; Zygosity=Hemizygous (Wistar).",
CVCL_2765,WM266-4,WC00097,CRL-1676,55Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0004262,NCIt; C3224; Melanoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (Wistar)., Gene deletion; HGNC; 9588; PTEN; Zygosity=Hemizygous (Wistar)., Mutation; HGNC; 11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).",
CVCL_6473,WM278,WC00054,CRL-2809,62Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002097,NCIt; C3510; Cutaneous melanoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (Wistar)., Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=16827748; PubMed=23851445; Cosmic-CLP=1240226; DepMap=ACH-002206; Wistar).",
CVCL_0580,WM35,WC00060,CRL-2807,24Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002097,NCIt; C3510; Cutaneous melanoma, Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=18632627; Cosmic-CLP=1299080; DepMap=ACH-002207; Wistar).,
CVCL_2240,WM39,WC00077,CRL-2811,Age unspecified,Male,,Cancer cell line,,,,,,NCIt; C3224; Melanoma," Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (PubMed=16827748; PubMed=18632627; PubMed=23851445; Wistar)., Mutation; HGNC; 2514; CTNNB1; Simple; p.Ser45ins4aa (c.134ins12bp); Zygosity=Unspecified (PubMed=23851445).",
CVCL_8787,WM793,WC00062,CRL-2806,37Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002097,NCIt; C3510; Cutaneous melanoma," Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=16827748; PubMed=18632627; PubMed=23851445; PubMed=24576830; Cosmic-CLP=1299081; DepMap=ACH-000827; Wistar)., Mutation; HGNC; 9588; PTEN; Simple; p.Trp274Ter (c.821G>A); ClinVar=VCV001762511; Zygosity=Heterozygous (PubMed=23851445; Cosmic-CLP=1299081; DepMap=ACH-000827).",
CVCL_1893,Y-79,GM01232,HTB-18,2Y6M,Female,Caucasian,Cancer cell line,,,,,UBERON_0010230,NCIt; C7541; Retinoblastoma, Mutation; HGNC; 9884; RB1; Unexplicit; Ex2-6del; Zygosity=Heterozygous (PubMed=3413073; PubMed=25326674).,
CVCL_1079,BC-1,,CRL-2230,46Y,Male,Caucasian,Cancer cell line,10376,Epstein-Barr virus (EBV).,,B-cell,UBERON_0007795,NCIt; C6915; Primary effusion lymphoma,,
CVCL_1856,BC-2,,CRL-2231,31Y,Male,,Cancer cell line,10376,Epstein-Barr virus (EBV).,,,UBERON_0000175,NCIt; C6915; Primary effusion lymphoma,,
CVCL_1080,BC-3,,CRL-2277,85Y,Male,Caucasian,Cancer cell line,37296,Human herpesvirus 8 (HHV-8/KSHV).,,,UBERON_0000175,NCIt; C6915; Primary effusion lymphoma, Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (PubMed=19608668).,
CVCL_U618,BCL2 (AAA) Jurkat,,CRL-2902,14Y,Male,Caucasian,Cancer cell line,,,,T-cell,UBERON_0000178,NCIt; C7953; Childhood T acute lymphoblastic leukemia," Mutation; HGNC; 959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).",
CVCL_U619,BCL2 (S70A) Jurkat,,CRL-2900,14Y,Male,Caucasian,Cancer cell line,,,,T-cell,UBERON_0000178,NCIt; C7953; Childhood T acute lymphoblastic leukemia," Mutation; HGNC; 959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).",
CVCL_U620,BCL2 (S87A) Jurkat,,CRL-2901,14Y,Male,Caucasian,Cancer cell line,,,,T-cell,UBERON_0000178,NCIt; C7953; Childhood T acute lymphoblastic leukemia," Mutation; HGNC; 959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).",
CVCL_U617,BCL2 Jurkat,,CRL-2899,14Y,Male,Caucasian,Cancer cell line,,,,T-cell,UBERON_0000178,NCIt; C7953; Childhood T acute lymphoblastic leukemia," Mutation; HGNC; 959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).",
CVCL_0107,BCP-1,,CRL-2294,94Y,Male,Caucasian,Cancer cell line,37296,Human herpesvirus 8 (HHV-8/KSHV).,,,UBERON_0000178,NCIt; C6915; Primary effusion lymphoma," Gene deletion; HGNC; 9588; PTEN; Zygosity=Homozygous (PubMed=19608668)., Mutation; HGNC; 11998; TP53; Simple; p.Asp259Asn (c.775G>A); Zygosity=Heterozygous (PubMed=19608668; DepMap=ACH-000923).",
CVCL_4613,BDCM,,CRL-2740,Age unspecified,Male,Caucasian,Cancer cell line,10376,Epstein-Barr virus (EBV).,,B-cell,UBERON_0000178,NCIt; C3171; Acute myeloid leukemia,,
CVCL_A4BJ,BECK-1,,CRL-3384,Age unspecified,Female,,Cancer cell line,,,,,UBERON_0002371,NCIt; C8644; B acute lymphoblastic leukemia," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Unspecified (ATCC=CRL-3384)., Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000177778; Zygosity=Unspecified (ATCC=CRL-3384).",
CVCL_0044,BeWo,,CCL-98,Fetus,Male,Caucasian,Cancer cell line,,,,,UBERON_0006237,NCIt; C4646; Gestational choriocarcinoma,,
CVCL_9727,BG01V,,SCRC-2002,Blastocyst stage,Male,,Embryonic stem cell,,,,Embryonic stem cell,UBERON_0000358,,,
CVCL_C137,BL-16,GM08686,,5Y,Female,Africans south of the Sahara,Cancer cell line,10376,Epstein-Barr virus (EBV).,,B-cell,UBERON_0007795,NCIt; C27694; EBV-related Burkitt lymphoma,,
CVCL_C139,BL-18,GM08687,,3Y,Male,Algerian,Cancer cell line,10376,Epstein-Barr virus (EBV).,,B-cell,UBERON_0007795,NCIt; C27694; EBV-related Burkitt lymphoma, Mutation; HGNC; 7553; MYC; Simple; p.Thr73Ala (c.217A>G); Zygosity=Unspecified (PubMed=8108117).,
CVCL_0178,BT-20,,CRL-7912,74Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000310,NCIt; C4194; Invasive breast carcinoma of no special type," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (PubMed=19593635; ATCC=HTB-19)., Mutation; HGNC; 8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (PubMed=19593635; PubMed=28889351; ATCC=HTB-19)., Mutation; HGNC; 9884; RB1; Simple; p.Pro515Leu (c.1544C>T); Zygosity=Heterozygous (PubMed=19593635).",
CVCL_0179,BT-474,,CRL-7913,60Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000310,NCIt; C4194; Invasive breast carcinoma of no special type," Gene fusion; HGNC; 24618; AHCTF1 + HGNC; 736; NAAA; Name(s)=AHCTF1-NAAA (PubMed=26865974)., Gene fusion; HGNC; 16173; DOK5 + HGNC; 17579; STARD3; Name(s)=STARD3-DOK5 (PubMed=21247443; PubMed=26865974)., Gene fusion; HGNC; 13178; IKZF3 + HGNC; 12649; VAPB; Name(s)=VAPB-IKZF3 (PubMed=21247443; PubMed=26865974)., Mutation; HGNC; 11621; HNF1A; Simple; p.Gln495Ter (c.1483C>T); ClinVar=VCV000586785; Zygosity=Heterozygous (PubMed=26865974; Cosmic-CLP=946359; DepMap=ACH-000927)., Mutation; HGNC; 8975; PIK3CA; Simple; p.Lys111Asn (c.333G>C); ClinVar=VCV000376483; Zygosity=Heterozygous (PubMed=19593635; PubMed=26865974; Cosmic-CLP=946359; DepMap=ACH-000927).",
CVCL_AQ07,BT-474 Clone 5,,CRL-3247,60Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000310,NCIt; C4194; Invasive breast carcinoma of no special type," Gene fusion; HGNC; 24618; AHCTF1 + HGNC; 736; NAAA; Name(s)=AHCTF1-NAAA (from parent cell line)., Gene fusion; HGNC; 16173; DOK5 + HGNC; 17579; STARD3; Name(s)=STARD3-DOK5 (from parent cell line)., Gene fusion; HGNC; 13178; IKZF3 + HGNC; 12649; VAPB; Name(s)=VAPB-IKZF3 (from parent cell line)., Mutation; HGNC; 11621; HNF1A; Simple; p.Gln495Ter (c.1483C>T); ClinVar=VCV000586785; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 8975; PIK3CA; Simple; p.Lys111Asn (c.333G>C); ClinVar=VCV000376483; Zygosity=Heterozygous (from parent cell line).",
CVCL_A4CL,BT-474 Ecadherin EmGFP,,HTB-20EMT,60Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000310,NCIt; C4194; Invasive breast carcinoma of no special type," Gene fusion; HGNC; 24618; AHCTF1 + HGNC; 736; NAAA; Name(s)=AHCTF1-NAAA (from parent cell line)., Gene fusion; HGNC; 16173; DOK5 + HGNC; 17579; STARD3; Name(s)=STARD3-DOK5 (from parent cell line)., Gene fusion; HGNC; 13178; IKZF3 + HGNC; 12649; VAPB; Name(s)=VAPB-IKZF3 (from parent cell line)., Mutation; HGNC; 11621; HNF1A; Simple; p.Gln495Ter (c.1483C>T); ClinVar=VCV000586785; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 8975; PIK3CA; Simple; p.Lys111Asn (c.333G>C); ClinVar=VCV000376483; Zygosity=Heterozygous (from parent cell line).",
CVCL_AR86,BT-474 Tam1,,CRL-3433,60Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000310,NCIt; C4194; Invasive breast carcinoma of no special type," Gene fusion; HGNC; 24618; AHCTF1 + HGNC; 736; NAAA; Name(s)=AHCTF1-NAAA (from parent cell line)., Gene fusion; HGNC; 16173; DOK5 + HGNC; 17579; STARD3; Name(s)=STARD3-DOK5 (from parent cell line)., Gene fusion; HGNC; 13178; IKZF3 + HGNC; 12649; VAPB; Name(s)=VAPB-IKZF3 (from parent cell line)., Mutation; HGNC; 11621; HNF1A; Simple; p.Gln495Ter (c.1483C>T); ClinVar=VCV000586785; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 8975; PIK3CA; Simple; p.Lys111Asn (c.333G>C); ClinVar=VCV000376483; Zygosity=Heterozygous (from parent cell line).",
CVCL_A4AK,BT-474 Tam2,,CRL-3434,60Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000310,NCIt; C4194; Invasive breast carcinoma of no special type," Gene fusion; HGNC; 24618; AHCTF1 + HGNC; 736; NAAA; Name(s)=AHCTF1-NAAA (from parent cell line)., Gene fusion; HGNC; 16173; DOK5 + HGNC; 17579; STARD3; Name(s)=STARD3-DOK5 (from parent cell line)., Gene fusion; HGNC; 13178; IKZF3 + HGNC; 12649; VAPB; Name(s)=VAPB-IKZF3 (from parent cell line)., Mutation; HGNC; 11621; HNF1A; Simple; p.Gln495Ter (c.1483C>T); ClinVar=VCV000586785; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 8975; PIK3CA; Simple; p.Lys111Asn (c.333G>C); ClinVar=VCV000376483; Zygosity=Heterozygous (from parent cell line).",
CVCL_C9CU,BT-474-Luc2,,HTB-20-LUC2,60Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000310,NCIt; C4194; Invasive breast carcinoma of no special type," Gene fusion; HGNC; 24618; AHCTF1 + HGNC; 736; NAAA; Name(s)=AHCTF1-NAAA (from parent cell line)., Gene fusion; HGNC; 16173; DOK5 + HGNC; 17579; STARD3; Name(s)=STARD3-DOK5 (from parent cell line)., Gene fusion; HGNC; 13178; IKZF3 + HGNC; 12649; VAPB; Name(s)=VAPB-IKZF3 (from parent cell line)., Mutation; HGNC; 11621; HNF1A; Simple; p.Gln495Ter (c.1483C>T); ClinVar=VCV000586785; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 8975; PIK3CA; Simple; p.Lys111Asn (c.333G>C); ClinVar=VCV000376483; Zygosity=Heterozygous (from parent cell line).",
CVCL_2319,BT-483,,HTB-121,23Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000310,NCIt; C4194; Invasive breast carcinoma of no special type, Mutation; HGNC; 8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Heterozygous (PubMed=19593635; DepMap=ACH-000818).,
CVCL_1092,BT-549,,HTB-122,72Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000310,NCIt; C4194; Invasive breast carcinoma of no special type," Gene fusion; HGNC; 2092; CLTC + HGNC; 29559; VMP1; Name(s)=CLTC-VMP1 (PubMed=23637631)., Mutation; HGNC; 9884; RB1; Simple; c.265_607del343; Zygosity=Homozygous (PubMed=19593635; ATCC=HTB-122).",
CVCL_UK38,BT050,,CRL-3408,61Y,Male,,Cancer cell line,,,,,UBERON_0000955,NCIt; C3058; Glioblastoma, Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (PubMed=26095605).,
CVCL_N707,BT054,,CRL-3416,49Y,Female,,Cancer cell line,,,,,UBERON_0000955,NCIt; C4326; Anaplastic oligodendroglioma, Mutation; HGNC; 5382; IDH1; Simple; p.Arg132His (c.395G>A); ClinVar=VCV000156444; Zygosity=Unspecified (PubMed=20388696).,
CVCL_UK39,BT067,,CRL-3409,44Y,Male,,Cancer cell line,,,,,UBERON_0000955,NCIt; C3058; Glioblastoma, Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (PubMed=26095605).,
CVCL_UK37,BT069,,CRL-3410,59Y,Male,,Cancer cell line,,,,,UBERON_0000955,NCIt; C3058; Glioblastoma,,
CVCL_N708,BT088,,CRL-3417,50Y,Male,,Cancer cell line,,,,,UBERON_0000955,NCIt; C4326; Anaplastic oligodendroglioma, Mutation; HGNC; 5382; IDH1; None_reported; -; Zygosity=- (PubMed=20388696).,
CVCL_UK40,BT089,,CRL-3411,60Y,Female,,Cancer cell line,,,,,UBERON_0000955,NCIt; C3058; Glioblastoma, Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (PubMed=26095605).,
CVCL_UK72,BT094,,CRL-3412,60Y,Female,,Cancer cell line,,,,,UBERON_0000955,NCIt; C3058; Glioblastoma,,
CVCL_X501,BT142 mut/-,,ACS-1018,38Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002811,NCIt; C4050; Oligoastrocytoma, Gene deletion; HGNC; 5382; IDH1; Zygosity=Heterozygous; Note=Spontaneous loss of heterozygosity (PubMed=23757293).,
CVCL_VV25,BT169,,CRL-3413,41Y,Male,,Cancer cell line,,,,,UBERON_0000955,NCIt; C3058; Glioblastoma,,
CVCL_A4AY,BT238,,CRL-3414,61Y,Male,,Cancer cell line,,,,,UBERON_0000955,NCIt; C3058; Glioblastoma,,
CVCL_A4AZ,BT301,,CRL-3415,48Y,Male,,Cancer cell line,,,,,UBERON_0000955,NCIt; C3058; Glioblastoma,,
CVCL_0186,BxPC-3,,CRL-1687,61Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0001264,NCIt; C9120; Pancreatic ductal adenocarcinoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (PubMed=11169959)., Mutation; HGNC; 1097; BRAF; Simple; p.Val487_Pro492delinsAla (c.1460_1474delGTGTAGGTGCTGTCA); Zygosity=Heterozygous (Cosmic-CLP=906693; DepMap=ACH-000535)., Mutation; HGNC; 11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (PubMed=1630814; PubMed=7961102; PubMed=8026879; PubMed=8194712; PubMed=8426738; PubMed=11115575; PubMed=15367885; PubMed=21607521; Cosmic-CLP=906693; DepMap=ACH-000535).",
CVCL_1094,C-33 A,,HTB-31,66Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000002,NCIt; C180841; Human papillomavirus-independent cervical squamous cell carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (PubMed=1648218).,
CVCL_1E27,C-33 B,,CRL-7716,66Y,Female,Caucasian,Cancer cell line,,,,,,NCIt; C180841; Human papillomavirus-independent cervical squamous cell carcinoma,,
CVCL_4J79,C-378,,CRL-2083,19Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000976,NCIt; C4817; Ewing sarcoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (from parent cell line).",
CVCL_U332,C-386,,CRL-2074,19Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000976,NCIt; C4817; Ewing sarcoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (from parent cell line).",
CVCL_2253,C-4-I,,CRL-1594,41Y,Female,Caucasian,Cancer cell line,333761,Human papillomavirus type 18 (HPV18).,,,UBERON_0000002,NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma,,
CVCL_1095,C-4-II,,CRL-1595,41Y,Female,Caucasian,Cancer cell line,333761,Human papillomavirus type 18 (HPV18).,,,UBERON_0000002,NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma,,
CVCL_4J80,C-430,,CRL-2084,19Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000976,NCIt; C4817; Ewing sarcoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (from parent cell line).",
CVCL_1969,C-433,,CRL-2085,19Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000976,NCIt; C4817; Ewing sarcoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (from parent cell line).",
CVCL_1096,C2BBe1,,CRL-2102,72Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4349; Colon adenocarcinoma," Mutation; HGNC; 583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (ATCC=CRL-2102; Cosmic-CLP=910700; DepMap=ACH-000009)., Mutation; HGNC; 6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (Cosmic-CLP=910700; DepMap=ACH-000009).",
CVCL_1097,C32 [Human melanoma],,CRL-1585,53Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002097,NCIt; C3802; Amelanotic melanoma," Gene deletion; HGNC; 9588; PTEN; Zygosity=Homozygous (PubMed=17363583)., Mutation; HGNC; 1787; CDKN2A; Simple; p.Ter157Serext*13 (c.470G>C); Zygosity=Homozygous (PubMed=9354451; DepMap=ACH-000580).",
CVCL_2324,C32TG,,CRL-1579,53Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002097,NCIt; C3802; Amelanotic melanoma," Gene deletion; HGNC; 9588; PTEN; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 1787; CDKN2A; Simple; p.Ter157Serext*13 (c.470G>C); Zygosity=Homozygous (from parent cell line).",
CVCL_1100,Ca Ski,,CRL-1550,40Y,Female,Caucasian,Cancer cell line,333760,Human papillomavirus type 16 (HPV16).,,,UBERON_0002108,NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma," Mutation; HGNC; 7133; KMT2D; Simple; p.Gln4079Ter (c.12235C>T); Zygosity=Heterozygous (Cosmic-CLP=906824; DepMap=ACH-001336)., Mutation; HGNC; 11998; TP53; None_reported; -; Zygosity=- (PubMed=9887230).",
CVCL_1101,CA46,,CRL-1648,Age unspecified,Male,,Cancer cell line,,,,B-cell,UBERON_0007795,NCIt; C2912; Burkitt lymphoma, Gene fusion; HGNC; 5477; IGH + HGNC; 7553; MYC; Name(s)=MYC-IGH (PubMed=3921823; PubMed=9643977; PubMed=11587216).,
CVCL_0025,Caco-2,,HTB-37,72Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4349; Colon adenocarcinoma," Mutation; HGNC; 583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (PubMed=24755471; DepMap=ACH-000003)., Mutation; HGNC; 6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (PubMed=24755471; DepMap=ACH-000003).",
CVCL_0234,Caki-1,,HTB-46,49Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002097,NCIt; C4033; Clear cell renal cell carcinoma, Mutation; HGNC; 9884; RB1; Simple; p.Leu98Pro (c.293T>C); ClinVar=VCV001502192; Zygosity=Heterozygous (Cosmic-CLP=905963; DepMap=ACH-000433).,
CVCL_0235,Caki-2,,HTB-47,69Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002113,NCIt; C6975; Papillary renal cell carcinoma,,
CVCL_1107,CAL-27,,CRL-2095,56Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001723,NCIt; C173807; Tongue adenosquamous carcinoma, Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).,
CVCL_RP61,Cali-1,,HTB-51,,,,Cancer cell line,,,,,,NCIt; C3099; Hepatocellular carcinoma,,
CVCL_0608,Calu-1,,HTB-54,47Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C3493; Lung squamous cell carcinoma," Gene deletion; HGNC; 11998; TP53; Zygosity=Homozygous (MSKCC)., Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).",
CVCL_0U29,Calu-1 W5-6,,CRL-9267,47Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C3493; Lung squamous cell carcinoma," Gene deletion; HGNC; 11998; TP53; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).",
CVCL_0609,Calu-3,,HTB-55,25Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C3512; Lung adenocarcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Met237Ile (c.711G>T); ClinVar=VCV000634770; Zygosity=Homozygous (PubMed=20557307; ATCC=HTB-55).,
CVCL_0236,Calu-6,,HTB-56,61Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C3512; Lung adenocarcinoma, Mutation; HGNC; 6407; KRAS; Simple; p.Gln61Lys (c.180_181TC>CA) (c.180_181delinsCA); Zygosity=Heterozygous (PubMed=1855224; PubMed=12068308; PubMed=12794755; ATCC=HTB-56; Cosmic-CLP=724859; DepMap=ACH-000264).,
CVCL_1115,CAMA-1,,HTB-21,51Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C5214; Breast adenocarcinoma," Mutation; HGNC; 1748; CDH1; Simple; c.1712-1G>A; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=19593635)., Mutation; HGNC; 11998; TP53; Simple; p.Arg280Thr (c.839G>C); ClinVar=VCV000012368; Zygosity=Homozygous (PubMed=16541312; ATCC=HTB-21; Cosmic-CLP=946382; DepMap=ACH-000783).",
CVCL_6861,Caov-2,,HTB-74,Age unspecified,Female,,Cancer cell line,,,,,UBERON_0007795,NCIt; C4908; Ovarian carcinoma,,
CVCL_0201,Caov-3,,HTB-75,54Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000992,NCIt; C105555; High grade ovarian serous adenocarcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Gln136Ter (c.406C>T); ClinVar=VCV001802458; Zygosity=Homozygous (PubMed=24023729; PubMed=25230021; ATCC=HTB-75).,
CVCL_0202,Caov-4,,HTB-76,45Y,Female,Caucasian,Cancer cell line,,,,,UBERON_8480037,NCIt; C105555; High grade ovarian serous adenocarcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Val147Asp (c.440T>A); ClinVar=VCV001351017; Zygosity=Homozygous (PubMed=25230021; ATCC=HTB-76).,
CVCL_0237,Capan-1,,HTB-79,40Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002107,NCIt; C9120; Pancreatic ductal adenocarcinoma," Mutation; HGNC; 1101; BRCA2; Simple; p.Ser1982Argfs*22 (c.5946delT) (6174delT); ClinVar=VCV000009325; Zygosity=Hemizygous (PubMed=8968085; PubMed=15162061; PubMed=21750719; Cosmic-CLP=753624; DepMap=ACH-000354)., Mutation; HGNC; 23671; GLT6D1; Simple; p.Trp198Ter (c.593G>A); Zygosity=Heterozygous (PubMed=21750719; Cosmic-CLP=753624; DepMap=ACH-000354)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (PubMed=8026879; PubMed=8426738; PubMed=15367885; PubMed=21750719; Cosmic-CLP=753624; DepMap=ACH-000354)., Mutation; HGNC; 6770; SMAD4; Simple; p.Ser343Ter (c.1028C>G); ClinVar=VCV000822036; Zygosity=Homozygous (PubMed=10408907; PubMed=21750719; Cosmic-CLP=753624; DepMap=ACH-000354)., Mutation; HGNC; 11998; TP53; Simple; p.Ala159Val (c.476C>T); ClinVar=VCV000458545; Zygosity=Homozygous (PubMed=8026879; PubMed=8426738; PubMed=15367885; Cosmic-CLP=753624; DepMap=ACH-000354).",
CVCL_0026,Capan-2,,HTB-80,56Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001264,NCIt; C9120; Pancreatic ductal adenocarcinoma," Mutation; HGNC; 1787; CDKN2A; Simple; p.Thr18_Ala19dup (c.52_57dupACGGCC); ClinVar=VCV000579466; Zygosity=Homozygous (PubMed=7972006; DepMap=ACH-000107)., Mutation; HGNC; 11998; TP53; Simple; p.Thr125Thr (c.375G>T); ClinVar=VCV000237948; Zygosity=Homozygous; Note=Impairs TP53 splicing dramatically (PubMed=7961102; PubMed=8026879; PubMed=24700732; DepMap=ACH-000107).",
CVCL_1E91,Casa-1,,HTB-42,61Y,Male,,Cancer cell line,,,,,UBERON_0002048,NCIt; C5977; Submandibular gland carcinoma ex pleomorphic adenoma,,
CVCL_3296,Cates-1B,,HTB-104,34Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C3752; Embryonal carcinoma,,
CVCL_1118,CCF-STTG1,,CRL-1718,68Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000955,NCIt; C60781; Astrocytoma, Mutation; HGNC; 5382; IDH1; None_reported; -; Zygosity=- (PubMed=19435942).,
CVCL_3930,CEM-CM3,,TIB-195,3Y11M,Female,Caucasian,Cancer cell line,,,,T-cell,UBERON_0000178,NCIt; C7953; Childhood T acute lymphoblastic leukemia," Gene fusion; HGNC; 13222; BCL11B + HGNC; 2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line)., Mutation; HGNC; 3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).",
CVCL_J395,CEM-ON,,CRL-8199,3Y11M,Female,Caucasian,Cancer cell line,,,,T-cell,UBERON_0000178,NCIt; C7953; Childhood T acute lymphoblastic leukemia," Gene fusion; HGNC; 13222; BCL11B + HGNC; 2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line)., Mutation; HGNC; 3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).",
CVCL_3496,CEM/C1,,CRL-2265,3Y11M,Female,Caucasian,Cancer cell line,,,,T-cell,UBERON_0000178,NCIt; C7953; Childhood T acute lymphoblastic leukemia," Gene fusion; HGNC; 13222; BCL11B + HGNC; 2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line)., Mutation; HGNC; 3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).",
CVCL_3497,CEM/C2,,CRL-2264,3Y11M,Female,Caucasian,Cancer cell line,,,,T-cell,UBERON_0000178,NCIt; C7953; Childhood T acute lymphoblastic leukemia," Gene fusion; HGNC; 13222; BCL11B + HGNC; 2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line)., Mutation; HGNC; 3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).",
CVCL_0U11,CEM/MX1,,CRL-2259,3Y11M,Female,Caucasian,Cancer cell line,,,,T-cell,UBERON_0000178,NCIt; C7953; Childhood T acute lymphoblastic leukemia," Gene fusion; HGNC; 13222; BCL11B + HGNC; 2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line)., Mutation; HGNC; 3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).",
CVCL_1119,CFPAC-1,,CRL-1918,26Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002107,"NCIt; C2975; Cystic fibrosis,ORDO; Orphanet_586; Cystic fibrosis"," Gene deletion; HGNC; 6770; SMAD4; Zygosity=Homozygous (PubMed=10408907; PubMed=11169959; PubMed=11787853; PubMed=15367885; PubMed=18380791)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous (PubMed=11169959; PubMed=11787853; PubMed=15367885; Cosmic-CLP=906821).",
CVCL_1121,ChaGo-K-1,,HTB-168,45Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002072,NCIt; C35875; Bronchogenic carcinoma," Mutation; HGNC; 11110; ARID1A; Simple; c.1921-2A>G; Zygosity=Heterozygous; Note=Splice acceptor mutation (Cosmic-CLP=687596; DepMap=ACH-000867)., Mutation; HGNC; 9884; RB1; Simple; p.Glu837Lys (c.2509G>A); Zygosity=Homozygous (Cosmic-CLP=687596; DepMap=ACH-000867).",
CVCL_0238,Chang Liver,,CCL-13,30Y6M,Female,African American,Cancer cell line,333761,Human papillomavirus type 18 (HPV18).,,,UBERON_0000002,NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma,,
CVCL_1122,CHL-1,,CRL-3619,36Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C3224; Melanoma," Gene fusion; HGNC; 2352; CREM + HGNC; 3508; EWSR1; Name(s)=EWSR1-CREM (PubMed=23637631)., Mutation; HGNC; 6877; MAPK3; Simple; p.Ile228Val (c.682A>G); Zygosity=Homozygous (ATCC=CRL-3619; Cosmic-CLP=910853; DepMap=ACH-001024)., Mutation; HGNC; 11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Homozygous (Cosmic-CLP=910853; DepMap=ACH-001024).",
CVCL_V643,CHL-2,,CRL-9451,36Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C3224; Melanoma," Gene fusion; HGNC; 2352; CREM + HGNC; 3508; EWSR1; Name(s)=EWSR1-CREM (from parent cell line)., Mutation; HGNC; 6877; MAPK3; Simple; p.Ile228Val (c.682A>G); Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Homozygous (from parent cell line).",
CVCL_B044,CHLA-01-MED,,CRL-3021,8Y,Male,,Cancer cell line,,,,,UBERON_0002037,"NCIt; C129446; Medulloblastoma, non-WNT/non-SHH, group 4", Mutation; HGNC; 1101; BRCA2; Simple; p.Ser1982Argfs*22 (c.5946delT) (6174delT); ClinVar=VCV000009325; Zygosity=Heterozygous (PubMed=26380221).,
CVCL_N534,CHLA-01R-MED,,CRL-3034,8Y,Male,,Cancer cell line,,,,,UBERON_0000175,"NCIt; C129446; Medulloblastoma, non-WNT/non-SHH, group 4", Mutation; HGNC; 1101; BRCA2; Simple; p.Ser1982Argfs*22 (c.5946delT) (6174delT); ClinVar=VCV000009325; Zygosity=Heterozygous (PubMed=26380221).,
CVCL_B045,CHLA-02-ATRT,,CRL-3020,1Y8M,Male,,Cancer cell line,,,,,UBERON_0000955,NCIt; C6906; Atypical teratoid/rhabdoid tumor,,
CVCL_U616,CHLA-03-AA,,CRL-3035,9Y,Female,,Cancer cell line,,,,,UBERON_0001871,NCIt; C9477; Anaplastic astrocytoma,,
CVCL_0F38,CHLA-04-ATRT,,CRL-3036,1Y8M,Male,,Cancer cell line,,,,,UBERON_0002286,NCIt; C6906; Atypical teratoid/rhabdoid tumor,,
CVCL_AQ41,CHLA-05-ATRT,,CRL-3037,2Y8M,Male,,Cancer cell line,,,,,UBERON_0016525,NCIt; C6906; Atypical teratoid/rhabdoid tumor,,
CVCL_AQ42,CHLA-06-ATRT,,CRL-3038,4M,Female,,Cancer cell line,,,,,UBERON_0002037,NCIt; C6906; Atypical teratoid/rhabdoid tumor, Mutation; HGNC; 11998; TP53; Simple; p.His178Asp (c.532C>G); ClinVar=VCV000482223; Zygosity=Unspecified (DepMap=ACH-001028).,
CVCL_1125,CHP-212,,CRL-2273,1Y8M,Male,Caucasian,Cancer cell line,,,,,UBERON_0000955,NCIt; C3270; Neuroblastoma, Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (PubMed=12068308; ATCC=CRL-2273; Cosmic-CLP=906820; DepMap=ACH-000120).,
CVCL_4359,CHP-234,,CRL-2272,3Y,Female,,Cancer cell line,,,,,UBERON_0002371,NCIt; C3270; Neuroblastoma,,
CVCL_1987,COLO 201,,CCL-224,70Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0007795,NCIt; C4349; Colon adenocarcinoma," Mutation; HGNC; 583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (PubMed=24755471; Cosmic-CLP; DepMap=ACH-000253)., Mutation; HGNC; 2514; CTNNB1; Simple; p.Asn287Ser (c.860A>G); ClinVar=VCV000133954; Zygosity=Homozygous (PubMed=9294210).",
CVCL_0218,COLO 205,,CCL-222,70Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0007795,NCIt; C4349; Colon adenocarcinoma," Mutation; HGNC; 583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Homozygous (PubMed=17088437; PubMed=24755471; ATCC=CCL-222; Cosmic-CLP=905961; DepMap=ACH-001039)., Mutation; HGNC; 2514; CTNNB1; Simple; p.Asn287Ser (c.860A>G); ClinVar=VCV000133954; Zygosity=Homozygous (PubMed=9294210).",
CVCL_0219,COLO 320DM,,CCL-220,55Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0001159,NCIt; C4349; Colon adenocarcinoma, Mutation; HGNC; 583; APC; Simple; p.Ser811Ter (c.2432C>G); ClinVar=VCV002203685; Zygosity=Unspecified (PubMed=24755471; PubMed=28179481).,
CVCL_0220,COLO 320HSR,,CCL-220.1,55Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0001159,NCIt; C4349; Colon adenocarcinoma, Mutation; HGNC; 583; APC; Simple; p.Ser811Ter (c.2432C>G); ClinVar=VCV002203685; Zygosity=Unspecified (from parent cell line).,
CVCL_F641,COLO 587,,CRL-2000,55Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0001159,NCIt; C4349; Colon adenocarcinoma, Mutation; HGNC; 583; APC; Simple; p.Ser811Ter (c.2432C>G); ClinVar=VCV002203685; Zygosity=Unspecified (from parent cell line).,
CVCL_1137,COLO 829,,CRL-1974,45Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002097,NCIt; C3510; Cutaneous melanoma," Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=12068308; PubMed=27094764; ATCC=CRL-1974; Cosmic-CLP=687448; DepMap=ACH-000644)., Mutation; HGNC; 9588; PTEN; Simple; c.493_634del142; Zygosity=Homozygous (ATCC=CRL-1974).",
CVCL_2260,1-5c-4,,CCL-20.2,30Y6M,Female,African American,Cancer cell line,333761,Human papillomavirus type 18 (HPV18).,,,UBERON_0000002,NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma,,
CVCL_3476,143.98.2,,CRL-11226,13Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000981,NCIt; C9145; Osteosarcoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 6407; KRAS; Simple; p.Ala59Thr (c.175G>A); ClinVar=VCV000012581; Zygosity=Heterozygous (from parent cell line).",
CVCL_3477,143B pML BK TK,,CRL-8304,13Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000981,NCIt; C9145; Osteosarcoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 6407; KRAS; Simple; p.Ala59Thr (c.175G>A); ClinVar=VCV000012581; Zygosity=Heterozygous (from parent cell line).",
CVCL_A324,201B7,,ACS-1023,36Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002067,,,
CVCL_1045,22Rv1,,CRL-2505,Adult,Male,Caucasian,Cancer cell line,,,,,UBERON_0002367,NCIt; C4863; Prostate carcinoma," Mutation; HGNC; 7133; KMT2D; Simple; p.Arg1252Ter (c.3754C>T); ClinVar=VCV000167228; Zygosity=Heterozygous (Cosmic-CLP=924100; DepMap=ACH-000956)., Mutation; HGNC; 8975; PIK3CA; Simple; p.Gln546Arg (c.1637A>G); ClinVar=VCV000045466; Zygosity=Heterozygous (Cosmic-CLP=924100; DepMap=ACH-000956).",
CVCL_1N86,CV-hIPS-B,GM25430,,62Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002427,,,
CVCL_4Q37,CW10001,CW10001,,24Y,Female,Asian,Induced pluripotent stem cell,,,,,,,,
CVCL_JH36,CW10002,CW10002,,24Y,Female,Asian,Induced pluripotent stem cell,,,,,,,,
CVCL_4Q38,CW10003,CW10003,,48Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_AN15,CW10004,CW10004,,50Y,Female,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C84444; Nonalcoholic fatty liver disease,,
CVCL_AN16,CW10005,CW10005,,49Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_4Q39,CW10007,CW10007,,43Y,Female,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C84444; Nonalcoholic fatty liver disease,,
CVCL_4Q40,CW10009,CW10009,,53Y,Female,,Induced pluripotent stem cell,,,,,,,,
CVCL_4Q41,CW10010,CW10010,,59Y,Male,Native North American,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_4Q42,CW10011,CW10011,,59Y,Female,Southeast Asian,Induced pluripotent stem cell,,,,,,NCIt; C84444; Nonalcoholic fatty liver disease,,
CVCL_4Q43,CW10012,CW10012,,56Y,Female,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C84444; Nonalcoholic fatty liver disease,,
CVCL_HG43,CW10013,CW10013,,65Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_4Q44,CW10014,CW10014,,50Y,Male,African American,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_DI66,CW10015,CW10015,,40Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C150596; Hepatic steatosis,,
CVCL_4Q45,CW10018,CW10018,,64Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_4Q46,CW10019,CW10019,,63Y,Female,,Induced pluripotent stem cell,,,,,,NCIt; C84444; Nonalcoholic fatty liver disease,,
CVCL_4Q47,CW10020,CW10020,,67Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C84444; Nonalcoholic fatty liver disease,,
CVCL_AN17,CW10021,CW10021,,32Y,Male,,Induced pluripotent stem cell,,,,,,,,
CVCL_4Q48,CW10022,CW10022,,,Female,,Induced pluripotent stem cell,,,,,,NCIt; C150596; Hepatic steatosis,,
CVCL_4Q49,CW10023,CW10023,,54Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_4Q50,CW10024,CW10024,,33Y,Female,Southeast Asian,Induced pluripotent stem cell,,,,,,,,
CVCL_HG44,CW10025,CW10025,,67Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_4Q51,CW10026,CW10026,,52Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_DI67,CW10027,CW10027,,59Y,Female,Caucasian,Induced pluripotent stem cell,,,,,,,,
CVCL_4Q52,CW10028,CW10028,,42Y,Male,,Induced pluripotent stem cell,,,,,,,,
CVCL_4Q53,CW10030,CW10030,,39Y,Male,Caucasian and Native North American,Induced pluripotent stem cell,,,,,,,,
CVCL_4Q54,CW10031,CW10031,,58Y,Female,,Induced pluripotent stem cell,,,,,,NCIt; C84444; Nonalcoholic fatty liver disease,,
CVCL_HG45,CW10033,CW10033,,58Y,Female,Caucasian,Induced pluripotent stem cell,,,,,,,,
CVCL_JH37,CW10034,CW10034,,46Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_4Q55,CW10035,CW10035,,63Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_4Q56,CW10036,CW10036,,35Y,Male,African American and Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_4Q57,CW10037,CW10037,,50Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,,,
CVCL_4Q58,CW10038,CW10038,,38Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_4Q59,CW10039,CW10039,,66Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_DI68,CW10040,CW10040,,61Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,,,
CVCL_4Q60,CW10041,CW10041,,51Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_DI69,CW10042,CW10042,,52Y,Female,Chinese,Induced pluripotent stem cell,,,,,,NCIt; C84444; Nonalcoholic fatty liver disease,,
CVCL_4Q61,CW10044,CW10044,,72Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_4Q62,CW10045,CW10045,,42Y,Female,Mongolian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84444; Nonalcoholic fatty liver disease,,
CVCL_4Q63,CW10046,CW10046,,46Y,Male,,Induced pluripotent stem cell,,,,,,NCIt; C3098; Hepatitis C infection,,
CVCL_AN18,CW10048,CW10048,,68Y,Male,,Induced pluripotent stem cell,,,,,,NCIt; C3098; Hepatitis C infection,,
CVCL_4Q64,CW10049,CW10049,,52Y,Male,,Induced pluripotent stem cell,,,,,,NCIt; C3098; Hepatitis C infection,,
CVCL_4Q65,CW10050,CW10050,,60Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_4Q66,CW10054,CW10054,,40Y,Female,African American,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DI70,CW10058,CW10058,,56Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_4Q67,CW10060,CW10060,,54Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_HG46,CW10061,CW10061,,27Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_HG47,CW10062,CW10062,,42Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_JH38,CW10063,CW10063,,60Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_HG48,CW10064,CW10064,,23Y,Female,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_HG49,CW10066,CW10066,,54Y,Female,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_4Q68,CW10067,CW10067,,59Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_JH39,CW10068,CW10068,,56Y,Male,African American,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_HG50,CW10069,CW10069,,64Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_DI71,CW10073,CW10073,,60Y,Female,African American,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_AN19,CW10074,CW10074,,61Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_DI72,CW10075,CW10075,,60Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_4Q69,CW10076,CW10076,,52Y,Female,Southeast Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84444; Nonalcoholic fatty liver disease,,
CVCL_4Q70,CW10077,CW10077,,58Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84444; Nonalcoholic fatty liver disease,,
CVCL_AN20,CW10078,CW10078,,56Y,Male,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_HG51,CW10079,CW10079,,59Y,Female,African American,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_JH40,CW10081,CW10081,,44Y,Female,African American,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_AN21,CW10083,CW10083,,50Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_HG52,CW10084,CW10084,,44Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_HG53,CW10085,CW10085,,56Y,Female,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_JH41,CW10086,CW10086,,55Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_HG54,CW10087,CW10087,,56Y,Female,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_HG55,CW10088,CW10088,,44Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_DI73,CW10089,CW10089,,69Y,Male,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_JH42,CW10090,CW10090,,65Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_HG56,CW10091,CW10091,,47Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_JH43,CW10093,CW10093,,58Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_AN22,CW10094,CW10094,,34Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_DI74,CW10095,CW10095,,56Y,Male,African American,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_DI75,CW10096,CW10096,,65Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_HG57,CW10097,CW10097,,52Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_DI76,CW10098,CW10098,,32Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84444; Nonalcoholic fatty liver disease,,
CVCL_DI77,CW10100,CW10100,,51Y,Male,African American,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_DI78,CW10101,CW10101,,41Y,Male,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_AN23,CW10102,CW10102,,63Y,Male,African American,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_HG58,CW10103,CW10103,,65Y,Male,African American,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_HG59,CW10104,CW10104,,62Y,Female,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_AN24,CW10107,CW10107,,52Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_HG60,CW10109,CW10109,,28Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_DI79,CW10110,CW10110,,43Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_HG61,CW10111,CW10111,,46Y,Female,African American,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_AN25,CW10114,CW10114,,52Y,Female,African American,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_AN26,CW10115,CW10115,,53Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_HG62,CW10116,CW10116,,48Y,Male,African American,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_DI80,CW10118,CW10118,,28Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_HG63,CW10120,CW10120,,54Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_JH44,CW10121,CW10121,,63Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_AN27,CW10122,CW10122,,62Y,Male,African American,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_JH45,CW10126,CW10126,,49Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_HG64,CW10127,CW10127,,63Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_DI81,CW10128,CW10128,,64Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84444; Nonalcoholic fatty liver disease,,
CVCL_DI82,CW10130,CW10130,,36Y,Male,Nepali,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84444; Nonalcoholic fatty liver disease,,
CVCL_HG65,CW10131,CW10131,,48Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84444; Nonalcoholic fatty liver disease,,
CVCL_JH46,CW10133,CW10133,,62Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_HG66,CW10135,CW10135,,54Y,Male,African American and Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_HG67,CW10136,CW10136,,54Y,Female,African American,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_JH47,CW10137,CW10137,,58Y,Male,African American,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_HG68,CW10139,CW10139,,56Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_HG69,CW10141,CW10141,,55Y,Male,African American,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_JH48,CW10142,CW10142,,64Y,Male,African American,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_HG70,CW10143,CW10143,,51Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_JH49,CW10144,CW10144,,59Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_HG71,CW10146,CW10146,,61Y,Male,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_JH50,CW10147,CW10147,,51Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_JH51,CW10148,CW10148,,50Y,Female,African American,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_DI83,CW10149,CW10149,,38Y,Male,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DI84,CW10150,CW10150,,45Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84444; Nonalcoholic fatty liver disease,,
CVCL_DI85,CW10151,CW10151,,71Y,Female,,Induced pluripotent stem cell,,,,,,NCIt; C84444; Nonalcoholic fatty liver disease,,
CVCL_DI86,CW10152,CW10152,,33Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84444; Nonalcoholic fatty liver disease,,
CVCL_HG72,CW10153,CW10153,,64Y,Male,African American,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_DI87,CW10154,CW10154,,61Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_HG73,CW10155,CW10155,,66Y,Female,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_AN28,CW10156,CW10156,,55Y,Male,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_HG74,CW10157,CW10157,,51Y,Male,African American,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_ER30,CW10158,CW10158,,56Y,Female,African American,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_AN29,CW10159,CW10159,,58Y,Male,African American,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_HG75,CW10160,CW10160,,58Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_JH52,CW10162,CW10162,,63Y,Male,African American,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_HG76,CW10163,CW10163,,60Y,Male,African American,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_ER31,CW10165,CW10165,,54Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84444; Nonalcoholic fatty liver disease,,
CVCL_HG77,CW10166,CW10166,,48Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84444; Nonalcoholic fatty liver disease,,
CVCL_DI88,CW10167,CW10167,,53Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84444; Nonalcoholic fatty liver disease,,
CVCL_HG78,CW10168,CW10168,,64Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_HG79,CW10169,CW10169,,32Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_DI89,CW10171,CW10171,,53Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84444; Nonalcoholic fatty liver disease,,
CVCL_HG80,CW10172,CW10172,,47Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84444; Nonalcoholic fatty liver disease,,
CVCL_HG81,CW10173,CW10173,,37Y,Female,African American,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DI90,CW10175,CW10175,,40Y,Male,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_HG82,CW10176,CW10176,,55Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84444; Nonalcoholic fatty liver disease,,
CVCL_HG83,CW10177,CW10177,,33Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84444; Nonalcoholic fatty liver disease,,
CVCL_ER32,CW10178,CW10178,,42Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_JH53,CW10181,CW10181,,34Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84444; Nonalcoholic fatty liver disease,,
CVCL_HG84,CW10182,CW10182,,38Y,Male,Indian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84444; Nonalcoholic fatty liver disease,,
CVCL_HG85,CW10183,CW10183,,42Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84444; Nonalcoholic fatty liver disease,,
CVCL_HG86,CW10184,CW10184,,45Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C150596; Hepatic steatosis,,
CVCL_HG87,CW10185,CW10185,,41Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84444; Nonalcoholic fatty liver disease,,
CVCL_RV42,CW10186,CW10186,,45Y,Male,Nepali,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84444; Nonalcoholic fatty liver disease,,
CVCL_HG88,CW10187,CW10187,,37Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84444; Nonalcoholic fatty liver disease,,
CVCL_HG89,CW10188,CW10188,,47Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84444; Nonalcoholic fatty liver disease,,
CVCL_HG90,CW10189,CW10189,,22Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84444; Nonalcoholic fatty liver disease,,
CVCL_RV43,CW10190,CW10190,,30Y,Female,,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_HG91,CW10191,CW10191,,68Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84444; Nonalcoholic fatty liver disease,,
CVCL_HG92,CW10192,CW10192,,31Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_HG93,CW10201,CW10201,,52Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84444; Nonalcoholic fatty liver disease,,
CVCL_DI91,CW10202,CW10202,,65Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84444; Nonalcoholic fatty liver disease,,
CVCL_HG94,CW10203,CW10203,,63Y,Male,African American,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_HG95,CW10205,CW10205,,52Y,Female,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3098; Hepatitis C infection,,
CVCL_ER33,CW10206,CW10206,,32Y,Male,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_RV44,CW10208,CW10208,,70Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84444; Nonalcoholic fatty liver disease,,
CVCL_D4Z7,CW1474,,CRL-3529,86Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001043,NCIt; C4025; Esophageal adenocarcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Gly279_Thr284del; Zygosity=Homozygous (Direct_author_submission).,
CVCL_DI92,CW20001,CW20001,,8Y,Female,African American,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_4Q71,CW20002,CW20002,,6Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_HG96,CW20004,CW20004,,8Y,Female,African American,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_4Q72,CW20006,CW20006,,7Y,Male,Indian,Induced pluripotent stem cell,,,,,,NCIt; C88412; Autism spectrum disorder,,
CVCL_4Q73,CW20008,CW20008,,5Y,Male,Asian,Induced pluripotent stem cell,,,,,,NCIt; C88412; Autism spectrum disorder,,
CVCL_HG97,CW20009,CW20009,,15Y,Female,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_AN30,CW20012,CW20012,,5Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_4Q74,CW20013,CW20013,,6Y,Male,,Induced pluripotent stem cell,,,,,,NCIt; C88412; Autism spectrum disorder,,
CVCL_HG98,CW20015,CW20015,,17Y,Male,Indian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_DI93,CW20016,CW20016,,11Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DI94,CW20020,CW20020,,14Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_HG99,CW20021,CW20021,,13Y,Female,Asian,Induced pluripotent stem cell,,,,,,NCIt; C88412; Autism spectrum disorder,,
CVCL_4Q75,CW20023,CW20023,,8Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_4Q76,CW20025,CW20025,,8Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_DI95,CW20026,CW20026,,10Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_4Q77,CW20027,CW20027,,16Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_HH00,CW20029,CW20029,,6Y,Female,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C88412; Autism spectrum disorder,,
CVCL_DI96,CW20030,CW20030,,10Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C88412; Autism spectrum disorder,,
CVCL_4Q78,CW20031,CW20031,,7Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_4Q79,CW20032,CW20032,,12Y,Female,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DI97,CW20033,CW20033,,18Y,Female,,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_4Q80,CW20034,CW20034,,12Y,Female,African American,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_4Q81,CW20035,CW20035,,5Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_HH01,CW20039,CW20039,,6Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_HH02,CW20041,CW20041,,9Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_4Q82,CW20042,CW20042,,6Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_DI98,CW20043,CW20043,,19Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DI99,CW20044,CW20044,,10Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_4Q83,CW20046,CW20046,,17Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_4Q84,CW20047,CW20047,,11Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DJ00,CW20048,CW20048,,18Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DJ01,CW20049,CW20049,,11Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_4Q85,CW20050,CW20050,,6Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_4Q86,CW20051,CW20051,,17Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DJ02,CW20052,CW20052,,26Y,Female,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_HH03,CW20053,CW20053,,5Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_HH04,CW20054,CW20054,,20Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_DJ03,CW20055,CW20055,,10Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_DJ04,CW20056,CW20056,,4Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DJ05,CW20057,CW20057,,19Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DJ06,CW20058,CW20058,,25Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_JH54,CW20061,CW20061,,18Y,Female,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DJ07,CW20062,CW20062,,19Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_JH55,CW20063,CW20063,,22Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DJ08,CW20065,CW20065,,10Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_DJ09,CW20068,CW20068,,27Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_HH05,CW20069,CW20069,,5Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_4Q87,CW20070,CW20070,,9Y,Male,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_DJ10,CW20072,CW20072,,18Y,Female,,Induced pluripotent stem cell,,,,,,NCIt; C88412; Autism spectrum disorder,,
CVCL_JH56,CW20073,CW20073,,19Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DJ11,CW20074,CW20074,,20Y,Female,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DJ12,CW20075,CW20075,,20Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DJ13,CW20076,CW20076,,17Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_DJ14,CW20077,CW20077,,22Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DJ15,CW20078,CW20078,,6Y,Male,Caucasian and Chinese,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_JH57,CW20079,CW20079,,27Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DJ16,CW20080,CW20080,,22Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DJ17,CW20081,CW20081,,15Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_DJ18,CW20083,CW20083,,22Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_DJ19,CW20084,CW20084,,17Y,Male,Indian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DJ20,CW20085,CW20085,,22Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_HH06,CW20087,CW20087,,23Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DJ21,CW20088,CW20088,,22Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DJ22,CW20090,CW20090,,18Y,Female,,Induced pluripotent stem cell,,,,,,NCIt; C88412; Autism spectrum disorder,,
CVCL_JH59,CW20091,CW20091,,21Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_JH60,CW20092,CW20092,,17Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_JH61,CW20094,CW20094,,20Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_RV45,CW20095,CW20095,,11Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_DJ23,CW20098,CW20098,,21Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DJ24,CW20099,CW20099,,21Y,Female,Indian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_RV46,CW20100,CW20100,,27Y,Male,African American,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_RV47,CW20101,CW20101,,19Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_HH07,CW20103,CW20103,,20Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_LI60,CW20104,CW20104,,10Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_HH08,CW20105,CW20105,,18Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DJ25,CW20106,CW20106,,20Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_JH62,CW20107,CW20107,,21Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_JH63,CW20108,CW20108,,9Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DJ26,CW20109,CW20109,,12Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DJ27,CW20110,CW20110,,21Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_HH09,CW20111,CW20111,,28Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_RV48,CW20112,CW20112,,27Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DJ28,CW20115,CW20115,,13Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_JH64,CW20116,CW20116,,15Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DJ29,CW20118,CW20118,,17Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_RV49,CW20121,CW20121,,9Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_DJ30,CW20122,CW20122,,19Y,Female,Chinese,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_JH65,CW20123,CW20123,,23Y,Male,Nepali,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_HH10,CW20124,CW20124,,19Y,Male,Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_RV50,CW20125,CW20125,,16Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_HH11,CW20126,CW20126,,16Y,Male,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DJ31,CW20128,CW20128,,13Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_HH12,CW20129,CW20129,,5Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_HH13,CW20131,CW20131,,24Y,Female,Indian,Induced pluripotent stem cell,,,,,,,,
CVCL_DJ32,CW20132,CW20132,,14Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_HH14,CW20133,CW20133,,18Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DJ33,CW20135,CW20135,,14Y,Male,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_HH15,CW20136,CW20136,,27Y,Male,Nepali,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DJ34,CW20137,CW20137,,23Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_JH66,CW20139,CW20139,,12Y,Male,African American,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_HH16,CW20140,CW20140,,20Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_HH17,CW20141,CW20141,,7Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_DJ35,CW20142,CW20142,,9Y,Male,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_JH67,CW20144,CW20144,,22Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DJ36,CW20146,CW20146,,12Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DJ37,CW20149,CW20149,,18Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_RV51,CW20150,CW20150,,19Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_DJ38,CW20151,CW20151,,11Y,Male,Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_HH18,CW20152,CW20152,,8Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_HH19,CW20153,CW20153,,16Y,Male,Japanese,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_RV52,CW20156,CW20156,,22Y,Male,African American,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_RV53,CW20158,CW20158,,20Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_JH68,CW20164,CW20164,,25Y,Male,Chinese,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_JH69,CW20166,CW20166,,13Y,Male,Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_JH70,CW20167,CW20167,,14Y,Male,Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_LI61,CW20170,CW20170,,17Y,Female,Chinese,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_JH71,CW20178,CW20178,,15Y,Male,Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_RV54,CW20179,CW20179,,19Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_RV55,CW20181,CW20181,,25Y,Male,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_HH20,CW20183,CW20183,,12Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_HH21,CW20184,CW20184,,24Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_RV56,CW20185,CW20185,,22Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_RV57,CW20186,CW20186,,13Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_RV58,CW20188,CW20188,,7Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_HH22,CW20192,CW20192,,6Y,Male,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_JH72,CW20193,CW20193,,7Y,Female,Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_RV59,CW20195,CW20195,,24Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_JH73,CW20196,CW20196,,15Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_JH74,CW20200,CW20200,,16Y,Female,Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_HH23,CW20201,CW20201,,7Y,Male,Indian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_RV60,CW20202,CW20202,,13Y,Male,Indian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_HH24,CW20203,CW20203,,13Y,Male,Indian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_HH25,CW20204,CW20204,,14Y,Male,Asian and Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_HH26,CW20206,CW20206,,7Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_RV61,CW20207,CW20207,,11Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_RV62,CW20209,CW20209,,18Y,Female,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_HH27,CW20210,CW20210,,11Y,Male,Indian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_RV63,CW20212,CW20212,,5Y,Male,East Indian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_HH28,CW20213,CW20213,,9Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_HH29,CW20214,CW20214,,15Y,Female,Southeast Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_HH30,CW20222,CW20222,,5Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_HH31,CW20225,CW20225,,13Y,Male,Southeast Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_HH32,CW20226,CW20226,,16Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_HH33,CW20231,CW20231,,10Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_RV64,CW20235,CW20235,,32Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_DJ39,CW20237,CW20237,,21Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_HH34,CW20239,CW20239,,15Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_RV65,CW20240,CW20240,,20Y,Female,African American,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_HH35,CW20242,CW20242,,8Y,Male,Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_JH75,CW20243,CW20243,,4Y,Male,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_RV66,CW20245,CW20245,,24Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_HH36,CW20249,CW20249,,25Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_JH77,CW20252,CW20252,,13Y,Female,African American,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_RV67,CW20273,CW20273,,17Y,Male,Caucasian and Chinese,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_RV68,CW20277,CW20277,,17Y,Male,Caucasian and Chinese,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_RV69,CW20278,CW20278,,12Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_LI62,CW20284,CW20284,,19Y,Male,African American and Chinese,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_JH78,CW20295,CW20295,,20Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_JH79,CW20296,CW20296,,12Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_LJ96,CW20299,CW20299,,9Y,Male,Asian and Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_LJ97,CW20300,CW20300,,10Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_RV70,CW20303,CW20303,,12Y,Male,Korean,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_RV71,CW20311,CW20311,,13Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_RV72,CW20320,CW20320,,7Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_JH80,CW20321,CW20321,,15Y,Female,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_RV74,CW20322,CW20322,,5Y,Male,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_RV75,CW20323,CW20323,,9Y,Female,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_RV76,CW20324,CW20324,,4Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_RV77,CW20325,CW20325,,5Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_RV78,CW20326,CW20326,,7Y,Male,Indian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_4Q88,CW30001,CW30001,,42Y,Female,Asian,Induced pluripotent stem cell,,,,,,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_4Q89,CW30002,CW30002,,47Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4Q90,CW30003,CW30003,,22Y,Female,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HH37,CW30004,CW30004,,54Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_JH81,CW30005,CW30005,,62Y,Female,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C34830; Cardiomyopathy,,
CVCL_DJ40,CW30006,CW30006,,71Y,Female,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_AN31,CW30007,CW30007,,53Y,Female,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C34830; Cardiomyopathy,,
CVCL_HH38,CW30008,CW30008,,37Y,Male,Asian,Induced pluripotent stem cell,,,,,,NCIt; C34830; Cardiomyopathy,,
CVCL_4Q91,CW30009,CW30009,,54Y,Male,Asian,Induced pluripotent stem cell,,,,,,NCIt; C34830; Cardiomyopathy,,
CVCL_4Q92,CW30010,CW30010,,60Y,Female,,Induced pluripotent stem cell,,,,,,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4Q93,CW30011,CW30011,,56Y,Female,African American,Induced pluripotent stem cell,,,,,,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_JH82,CW30012,CW30012,,46Y,Male,Latino or Hispanic,Induced pluripotent stem cell,,,,,,NCIt; C34830; Cardiomyopathy,,
CVCL_AN32,CW30013,CW30013,,57Y,Female,,Induced pluripotent stem cell,,,,,,NCIt; C34830; Cardiomyopathy,,
CVCL_4Q94,CW30014,CW30014,,58Y,Female,,Induced pluripotent stem cell,,,,,,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HH39,CW30015,CW30015,,61Y,Male,,Induced pluripotent stem cell,,,,,,NCIt; C34830; Cardiomyopathy,,
CVCL_4Q95,CW30016,CW30016,,50Y,Female,African American,Induced pluripotent stem cell,,,,,,NCIt; C34830; Cardiomyopathy,,
CVCL_AN33,CW30017,CW30017,,70Y,Female,,Induced pluripotent stem cell,,,,,,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_4Q96,CW30018,CW30018,,52Y,Female,Asian,Induced pluripotent stem cell,,,,,,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_JH83,CW30019,CW30019,,44Y,Female,African American,Induced pluripotent stem cell,,,,,,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_DJ41,CW30020,CW30020,,58Y,Female,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_DJ42,CW30022,CW30022,,55Y,Female,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C34830; Cardiomyopathy,,
CVCL_JH84,CW30024,CW30024,,46Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_AN34,CW30027,CW30027,,60Y,Male,Latino or Hispanic,Induced pluripotent stem cell,,,,,,NCIt; C34830; Cardiomyopathy,,
CVCL_4Q97,CW30028,CW30028,,61Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C34830; Cardiomyopathy,,
CVCL_4Q98,CW30029,CW30029,,83Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_JH85,CW30030,CW30030,,47Y,Female,,Induced pluripotent stem cell,,,,,,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_JH86,CW30031,CW30031,,48Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_ER34,CW30032,CW30032,,76Y,Female,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_AN35,CW30033,CW30033,,74Y,Female,,Induced pluripotent stem cell,,,,,,NCIt; C34830; Cardiomyopathy,,
CVCL_JH87,CW30035,CW30035,,65Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HH40,CW30036,CW30036,,49Y,Female,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HH41,CW30037,CW30037,,65Y,Male,African American,Induced pluripotent stem cell,,,,,,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AN36,CW30038,CW30038,,62Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_JH88,CW30040,CW30040,,53Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AN37,CW30042,CW30042,,43Y,Female,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34830; Cardiomyopathy,,
CVCL_AN38,CW30043,CW30043,,65Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4Q99,CW30044,CW30044,,25Y,Male,,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_HH42,CW30045,CW30045,,37Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R00,CW30046,CW30046,,71Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HH43,CW30048,CW30048,,44Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HH44,CW30049,CW30049,,50Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34830; Cardiomyopathy,,
CVCL_HH45,CW30050,CW30050,,47Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R01,CW30051,CW30051,,66Y,Male,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34830; Cardiomyopathy,,
CVCL_4R02,CW30052,CW30052,,53Y,Male,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34830; Cardiomyopathy,,
CVCL_HH46,CW30053,CW30053,,78Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_ER35,CW30054,CW30054,,79Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_HH47,CW30055,CW30055,,62Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_DJ43,CW30056,CW30056,,37Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34830; Cardiomyopathy,,
CVCL_AN39,CW30057,CW30057,,42Y,Female,,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34830; Cardiomyopathy,,
CVCL_4R03,CW30058,CW30058,,60Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34830; Cardiomyopathy,,
CVCL_4R04,CW30059,CW30059,,71Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R05,CW30060,CW30060,,68Y,Female,,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34830; Cardiomyopathy,,
CVCL_4R06,CW30061,CW30061,,65Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34830; Cardiomyopathy,,
CVCL_4R07,CW30062,CW30062,,42Y,Male,Pacific,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34830; Cardiomyopathy,,
CVCL_4R08,CW30063,CW30063,,59Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R09,CW30064,CW30064,,80Y,Female,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_4R10,CW30065,CW30065,,64Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34830; Cardiomyopathy,,
CVCL_4R11,CW30066,CW30066,,59Y,Male,,Induced pluripotent stem cell,,,,,,NCIt; C34830; Cardiomyopathy,,
CVCL_4R12,CW30067,CW30067,,21Y,Female,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_ER36,CW30068,CW30068,,60Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R13,CW30069,CW30069,,39Y,Male,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R14,CW30070,CW30070,,53Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R15,CW30071,CW30071,,83Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R16,CW30073,CW30073,,48Y,Male,,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_4R17,CW30074,CW30074,,40Y,Male,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R18,CW30075,CW30075,,59Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R19,CW30076,CW30076,,73Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34830; Cardiomyopathy,,
CVCL_JH89,CW30077,CW30077,,60Y,Male,,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_4R20,CW30078,CW30078,,80Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R21,CW30079,CW30079,,75Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_JH90,CW30080,CW30080,,78Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_HH48,CW30081,CW30081,,52Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34830; Cardiomyopathy,,
CVCL_4R22,CW30082,CW30082,,33Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R23,CW30083,CW30083,,39Y,Male,Pacific,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HH49,CW30084,CW30084,,71Y,Female,,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_4R24,CW30085,CW30085,,56Y,Male,,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R25,CW30086,CW30086,,65Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_4R26,CW30089,CW30089,,41Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_DJ44,CW30090,CW30090,,73Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HH50,CW30092,CW30092,,50Y,Female,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R27,CW30093,CW30093,,57Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C99544; Left ventricular non-compaction syndrome,,
CVCL_DJ45,CW30094,CW30094,,50Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_JH91,CW30095,CW30095,,44Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34830; Cardiomyopathy,,
CVCL_4R28,CW30096,CW30096,,63Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R29,CW30097,CW30097,,57Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R30,CW30098,CW30098,,63Y,Female,African American,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R31,CW30099,CW30099,,48Y,Male,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R32,CW30101,CW30101,,65Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R33,CW30102,CW30102,,66Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34830; Cardiomyopathy,,
CVCL_4R34,CW30103,CW30103,,42Y,Male,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AN40,CW30104,CW30104,,69Y,Female,African American,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R35,CW30105,CW30105,,57Y,Female,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AN41,CW30106,CW30106,,54Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_JH92,CW30107,CW30107,,55Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_4R36,CW30108,CW30108,,53Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34830; Cardiomyopathy,,
CVCL_AN42,CW30109,CW30109,,57Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AN43,CW30110,CW30110,,63Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R37,CW30111,CW30111,,27Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R38,CW30112,CW30112,,47Y,Female,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R39,CW30113,CW30113,,67Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HH51,CW30115,CW30115,,73Y,Female,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_AN44,CW30116,CW30116,,63Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34830; Cardiomyopathy,,
CVCL_4R40,CW30117,CW30117,,77Y,Male,,Induced pluripotent stem cell,,,,,,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R41,CW30118,CW30118,,25Y,Male,,Induced pluripotent stem cell,,,,,,NCIt; C99544; Left ventricular non-compaction syndrome,,
CVCL_AN45,CW30119,CW30119,,30Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34830; Cardiomyopathy,,
CVCL_4R42,CW30120,CW30120,,64Y,Male,African American,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R43,CW30121,CW30121,,56Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R44,CW30122,CW30122,,30Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R45,CW30123,CW30123,,57Y,Female,,Induced pluripotent stem cell,,,,,,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R46,CW30125,CW30125,,60Y,Male,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R47,CW30126,CW30126,,68Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34830; Cardiomyopathy,,
CVCL_4R48,CW30127,CW30127,,37Y,Male,,Induced pluripotent stem cell,,,,,,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R49,CW30128,CW30128,,76Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R50,CW30129,CW30129,,26Y,Female,,Induced pluripotent stem cell,,,,,,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R51,CW30130,CW30130,,53Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_JH93,CW30131,CW30131,,66Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R52,CW30132,CW30132,,70Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R53,CW30133,CW30133,,68Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_4R54,CW30134,CW30134,,61Y,Male,,Induced pluripotent stem cell,,,,,,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_4R55,CW30136,CW30136,,35Y,Male,,Induced pluripotent stem cell,,,,,,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R56,CW30137,CW30137,,62Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R57,CW30138,CW30138,,74Y,Male,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34830; Cardiomyopathy,,
CVCL_4R58,CW30139,CW30139,,24Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_4R59,CW30140,CW30140,,66Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34830; Cardiomyopathy,,
CVCL_4R60,CW30141,CW30141,,73Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R61,CW30142,CW30142,,36Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_JH94,CW30143,CW30143,,30Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R62,CW30144,CW30144,,52Y,Male,,Induced pluripotent stem cell,,,,,,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AN46,CW30145,CW30145,,52Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DJ46,CW30146,CW30146,,70Y,Female,,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R63,CW30147,CW30147,,73Y,Male,,Induced pluripotent stem cell,,,,,,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_AN47,CW30148,CW30148,,53Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34830; Cardiomyopathy,,
CVCL_AN48,CW30149,CW30149,,52Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C99544; Left ventricular non-compaction syndrome,,
CVCL_4R64,CW30150,CW30150,,66Y,Male,,Induced pluripotent stem cell,,,,,,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HH52,CW30151,CW30151,,39Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34830; Cardiomyopathy,,
CVCL_4R65,CW30152,CW30152,,41Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R66,CW30154,CW30154,,66Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R67,CW30155,CW30155,,71Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_JH95,CW30156,CW30156,,57Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_ER37,CW30157,CW30157,,36Y,Male,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_JH96,CW30158,CW30158,,47Y,Male,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AN49,CW30159,CW30159,,44Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AN50,CW30160,CW30160,,62Y,Female,,Induced pluripotent stem cell,,,,,,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AN51,CW30161,CW30161,,74Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AN52,CW30162,CW30162,,79Y,Female,,Induced pluripotent stem cell,,,,,,NCIt; C34830; Cardiomyopathy,,
CVCL_JH97,CW30163,CW30163,,50Y,Female,African American,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_DJ47,CW30164,CW30164,,70Y,Female,Pacific,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R68,CW30165,CW30165,,54Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AN53,CW30166,CW30166,,54Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34830; Cardiomyopathy,,
CVCL_AN54,CW30167,CW30167,,56Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_DJ48,CW30168,CW30168,,65Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_4R69,CW30169,CW30169,,53Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AN55,CW30170,CW30170,,49Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AN56,CW30171,CW30171,,37Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_JH98,CW30172,CW30172,,30Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_AN57,CW30173,CW30173,,46Y,Male,,Induced pluripotent stem cell,,,,,,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_LI63,CW30174,CW30174,,39Y,Male,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_DJ49,CW30175,CW30175,,72Y,Male,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34830; Cardiomyopathy,,
CVCL_JH99,CW30176,CW30176,,49Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R70,CW30177,CW30177,,78Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_AN58,CW30178,CW30178,,50Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_JI00,CW30179,CW30179,,62Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34830; Cardiomyopathy,,
CVCL_AN59,CW30180,CW30180,,79Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AN60,CW30181,CW30181,,67Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34830; Cardiomyopathy,,
CVCL_DJ50,CW30182,CW30182,,46Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R71,CW30184,CW30184,,71Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R72,CW30185,CW30185,,47Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R73,CW30186,CW30186,,72Y,Male,,Induced pluripotent stem cell,,,,,,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_4R74,CW30187,CW30187,,41Y,Female,,Induced pluripotent stem cell,,,,,,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R75,CW30188,CW30188,,47Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R76,CW30189,CW30189,,67Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34830; Cardiomyopathy,,
CVCL_JI01,CW30190,CW30190,,63Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_JI02,CW30191,CW30191,,62Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R77,CW30192,CW30192,,52Y,Male,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_JI03,CW30193,CW30193,,66Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_AN61,CW30194,CW30194,,71Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HH53,CW30195,CW30195,,51Y,Female,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R78,CW30196,CW30196,,48Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R79,CW30197,CW30197,,56Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R80,CW30198,CW30198,,46Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_DJ51,CW30199,CW30199,,41Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_LI64,CW30200,CW30200,,55Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HH54,CW30202,CW30202,,59Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AN62,CW30203,CW30203,,60Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_JI04,CW30204,CW30204,,48Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AN63,CW30205,CW30205,,52Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_AN64,CW30207,CW30207,,46Y,Female,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_JI05,CW30208,CW30208,,58Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HH55,CW30209,CW30209,,47Y,Female,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_JI06,CW30210,CW30210,,45Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C99544; Left ventricular non-compaction syndrome,,
CVCL_AN65,CW30211,CW30211,,76Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AN66,CW30212,CW30212,,49Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_JI07,CW30213,CW30213,,64Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AN67,CW30214,CW30214,,35Y,Male,African American,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AN68,CW30215,CW30215,,53Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_JI08,CW30216,CW30216,,75Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AN69,CW30217,CW30217,,49Y,Male,,Induced pluripotent stem cell,,,,,,NCIt; C99544; Left ventricular non-compaction syndrome,,
CVCL_AN70,CW30219,CW30219,,24Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_JI09,CW30220,CW30220,,41Y,Male,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_JI10,CW30221,CW30221,,63Y,Male,African American,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AN71,CW30222,CW30222,,73Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_DJ52,CW30223,CW30223,,47Y,Female,African American,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_JI11,CW30224,CW30224,,60Y,Male,African American,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_AN72,CW30225,CW30225,,41Y,Female,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C99544; Left ventricular non-compaction syndrome,,
CVCL_ER38,CW30226,CW30226,,48Y,Male,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_JI12,CW30227,CW30227,,62Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AN73,CW30228,CW30228,,35Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AN74,CW30229,CW30229,,34Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AN75,CW30230,CW30230,,52Y,Female,African American,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_JI13,CW30231,CW30231,,58Y,Male,,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AN76,CW30232,CW30232,,28Y,Male,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HH56,CW30233,CW30233,,58Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AN77,CW30234,CW30234,,72Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_JI14,CW30235,CW30235,,52Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_4R81,CW30236,CW30236,,26Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R82,CW30237,CW30237,,56Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AN78,CW30238,CW30238,,52Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AN79,CW30240,CW30240,,63Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_DJ53,CW30241,CW30241,,45Y,Male,,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AN80,CW30242,CW30242,,72Y,Female,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AN81,CW30243,CW30243,,41Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_ER39,CW30244,CW30244,,71Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AN82,CW30245,CW30245,,66Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_4R83,CW30246,CW30246,,44Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AN83,CW30247,CW30247,,42Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AN84,CW30248,CW30248,,84Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R84,CW30249,CW30249,,31Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_4R85,CW30251,CW30251,,68Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AN85,CW30253,CW30253,,42Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_DJ54,CW30254,CW30254,,48Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AN86,CW30255,CW30255,,39Y,Male,,Induced pluripotent stem cell,,,,,,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_DJ55,CW30256,CW30256,,25Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_JI15,CW30257,CW30257,,42Y,Male,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AN87,CW30258,CW30258,,34Y,Male,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AN88,CW30259,CW30259,,67Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_JI16,CW30260,CW30260,,66Y,Female,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HH57,CW30261,CW30261,,30Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HH58,CW30262,CW30262,,60Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HH59,CW30263,CW30263,,65Y,Female,African American,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_JI17,CW30264,CW30264,,69Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_DN40,CW30265,CW30265,,55Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HH60,CW30266,CW30266,,78Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_HH61,CW30267,CW30267,,26Y,Female,African American,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AN89,CW30268,CW30268,,44Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AN90,CW30269,CW30269,,52Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HH62,CW30270,CW30270,,31Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_JI18,CW30272,CW30272,,44Y,Male,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_JI19,CW30273,CW30273,,67Y,Male,African American,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AN91,CW30274,CW30274,,63Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_LI65,CW30275,CW30275,,44Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_DJ56,CW30276,CW30276,,60Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AN92,CW30277,CW30277,,70Y,Male,,Induced pluripotent stem cell,,,,,,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_DJ57,CW30279,CW30279,,55Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AN93,CW30280,CW30280,,28Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AN94,CW30282,CW30282,,28Y,Male,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AN95,CW30283,CW30283,,38Y,Male,Pacific,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_DJ58,CW30284,CW30284,,49Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AN96,CW30285,CW30285,,42Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_JI20,CW30286,CW30286,,55Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_JI21,CW30287,CW30287,,44Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_DJ59,CW30288,CW30288,,81Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_DJ60,CW30289,CW30289,,61Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84571; Arrhythmogenic right ventricular dysplasia,,
CVCL_DJ61,CW30290,CW30290,,35Y,Female,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_DJ62,CW30291,CW30291,,47Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_AN97,CW30292,CW30292,,17Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_HH63,CW30293,CW30293,,19Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_DJ63,CW30295,CW30295,,64Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_DJ64,CW30297,CW30297,,72Y,Male,African American,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34830; Cardiomyopathy,,
CVCL_HH64,CW30298,CW30298,,63Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AN98,CW30299,CW30299,,66Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_DJ65,CW30300,CW30300,,40Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AN99,CW30302,CW30302,,68Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AP00,CW30303,CW30303,,61Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_JI22,CW30305,CW30305,,44Y,Female,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AP01,CW30306,CW30306,,61Y,Female,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AP02,CW30307,CW30307,,18Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_DJ66,CW30309,CW30309,,21Y,Female,African American,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AP03,CW30310,CW30310,,60Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_AP04,CW30311,CW30311,,62Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_AP05,CW30312,CW30312,,51Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_AP06,CW30314,CW30314,,35Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_DJ67,CW30316,CW30316,,47Y,Male,African American,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_DJ68,CW30317,CW30317,,67Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_DJ69,CW30318,CW30318,,11Y,Female,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DJ70,CW30319,CW30319,,67Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_JI23,CW30320,CW30320,,41Y,Female,Pacific,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HH65,CW30321,CW30321,,65Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_DJ71,CW30322,CW30322,,54Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_DJ72,CW30323,CW30323,,73Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HH66,CW30324,CW30324,,71Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_DJ73,CW30325,CW30325,,34Y,Female,Pacific,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_DJ74,CW30326,CW30326,,50Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_DJ75,CW30327,CW30327,,68Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AP07,CW30328,CW30328,,66Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_DJ76,CW30329,CW30329,,63Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_AP08,CW30331,CW30331,,68Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_HH67,CW30332,CW30332,,43Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_ER40,CW30333,CW30333,,52Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_DJ77,CW30334,CW30334,,64Y,Female,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AP09,CW30335,CW30335,,43Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AP10,CW30336,CW30336,,78Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HH68,CW30337,CW30337,,55Y,Male,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AP11,CW30338,CW30338,,51Y,Male,Pacific,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_ER41,CW30339,CW30339,,62Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AP12,CW30340,CW30340,,67Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_ER42,CW30342,CW30342,,38Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HH69,CW30343,CW30343,,53Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_ER43,CW30344,CW30344,,29Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_ER44,CW30345,CW30345,,56Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_HH70,CW30346,CW30346,,43Y,Female,East Indian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_JI24,CW30348,CW30348,,41Y,Male,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HH71,CW30349,CW30349,,41Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HH72,CW30350,CW30350,,12Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HH73,CW30353,CW30353,,64Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_ER45,CW30354,CW30354,,34Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_HH74,CW30355,CW30355,,62Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HH75,CW30356,CW30356,,14Y,Male,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_HH76,CW30357,CW30357,,46Y,Male,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_ER46,CW30358,CW30358,,48Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_ER47,CW30359,CW30359,,14Y,Male,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C99544; Left ventricular non-compaction syndrome,,
CVCL_HH77,CW30360,CW30360,,21Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HH78,CW30361,CW30361,,44Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HH79,CW30362,CW30362,,66Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_HH80,CW30363,CW30363,,60Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HH81,CW30364,CW30364,,61Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_DJ78,CW30369,CW30369,,26Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_DJ79,CW30370,CW30370,,41Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_DJ80,CW30371,CW30371,,45Y,Male,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_LI66,CW30374,CW30374,,68Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HH82,CW30376,CW30376,,37Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_DJ81,CW30380,CW30380,,47Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_LI67,CW30382,CW30382,,57Y,Male,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DJ82,CW30383,CW30383,,17Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HH83,CW30386,CW30386,,48Y,Male,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_LI68,CW30387,CW30387,,56Y,Female,East Indian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_JI25,CW30389,CW30389,,64Y,Male,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_HH84,CW30390,CW30390,,16Y,Male,,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_HH85,CW30391,CW30391,,51Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DJ83,CW30392,CW30392,,36Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_DJ84,CW30393,CW30393,,59Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_HH86,CW30394,CW30394,,66Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HH87,CW30395,CW30395,,72Y,Male,African American,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_JI26,CW30397,CW30397,,56Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_HH88,CW30398,CW30398,,63Y,Male,African American,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HH89,CW30399,CW30399,,57Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HH90,CW30400,CW30400,,26Y,Male,Pacific,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_DJ85,CW30401,CW30401,,38Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HH91,CW30403,CW30403,,43Y,Male,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_DJ86,CW30404,CW30404,,63Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_ER48,CW30406,CW30406,,53Y,Male,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_DJ87,CW30408,CW30408,,24Y,Male,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_DJ88,CW30409,CW30409,,51Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_DJ89,CW30410,CW30410,,36Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_DJ90,CW30412,CW30412,,65Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_DJ91,CW30413,CW30413,,34Y,Male,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_DJ92,CW30414,CW30414,,47Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_DJ93,CW30415,CW30415,,44Y,Female,African American,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HH92,CW30417,CW30417,,58Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_HH93,CW30418,CW30418,,63Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_DJ94,CW30419,CW30419,,81Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HH94,CW30420,CW30420,,54Y,Male,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_HH95,CW30421,CW30421,,66Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_DJ95,CW30422,CW30422,,52Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_DJ96,CW30423,CW30423,,52Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_DJ97,CW30425,CW30425,,32Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_DJ98,CW30426,CW30426,,23Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_ER49,CW30427,CW30427,,56Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DJ99,CW30428,CW30428,,28Y,Male,African American,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_DK00,CW30429,CW30429,,75Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C99544; Left ventricular non-compaction syndrome,,
CVCL_DK01,CW30430,CW30430,,72Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_ER50,CW30431,CW30431,,48Y,Male,Pacific,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_ER51,CW30432,CW30432,,38Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_DK02,CW30433,CW30433,,61Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84571; Arrhythmogenic right ventricular dysplasia,,
CVCL_ER52,CW30434,CW30434,,19Y,Male,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_DK03,CW30435,CW30435,,61Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_DK04,CW30436,CW30436,,60Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_JI27,CW30437,CW30437,,48Y,Male,Pacific,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HH96,CW30438,CW30438,,69Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HH97,CW30439,CW30439,,62Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_JI28,CW30440,CW30440,,52Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_JI29,CW30441,CW30441,,61Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_DK05,CW30442,CW30442,,15Y,Male,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HH98,CW30443,CW30443,,70Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_JI30,CW30444,CW30444,,67Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HH99,CW30445,CW30445,,52Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_DK06,CW30446,CW30446,,58Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HI00,CW30447,CW30447,,53Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HI01,CW30448,CW30448,,37Y,Female,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HI02,CW30449,CW30449,,62Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HI03,CW30450,CW30450,,60Y,Male,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_JI31,CW30452,CW30452,,69Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HI04,CW30453,CW30453,,65Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HI05,CW30454,CW30454,,67Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HI06,CW30455,CW30455,,58Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HI07,CW30456,CW30456,,50Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HI08,CW30457,CW30457,,53Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HI09,CW30459,CW30459,,35Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HI10,CW30460,CW30460,,51Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HI11,CW30461,CW30461,,62Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_ER53,CW30462,CW30462,,48Y,Male,African American,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HI12,CW30463,CW30463,,40Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HI13,CW30464,CW30464,,40Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HI14,CW30465,CW30465,,59Y,Female,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HI15,CW30466,CW30466,,59Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HI16,CW30467,CW30467,,63Y,Female,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_HI17,CW30468,CW30468,,37Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HI18,CW30470,CW30470,,59Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HI19,CW30471,CW30471,,58Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_HI20,CW30472,CW30472,,45Y,Female,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HI21,CW30473,CW30473,,53Y,Male,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_JI32,CW30474,CW30474,,46Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HI22,CW30476,CW30476,,36Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HI23,CW30477,CW30477,,67Y,Male,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HI24,CW30478,CW30478,,78Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HI25,CW30479,CW30479,,66Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HI26,CW30480,CW30480,,33Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34449; Hypertrophic cardiomyopathy,,
CVCL_HI27,CW30481,CW30481,,61Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_JI33,CW30482,CW30482,,40Y,Female,African American,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_JI34,CW30483,CW30483,,54Y,Male,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HI28,CW30484,CW30484,,23Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C62798; Restrictive cardiomyopathy,,
CVCL_HI29,CW30485,CW30485,,61Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C99544; Left ventricular non-compaction syndrome,,
CVCL_HI30,CW30486,CW30486,,57Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HI31,CW30488,CW30488,,46Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HI32,CW30489,CW30489,,48Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HI33,CW30490,CW30490,,70Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HI34,CW30491,CW30491,,76Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HI35,CW30492,CW30492,,62Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_LI69,CW30494,CW30494,,31Y,Female,African American,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HI36,CW30495,CW30495,,40Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HI37,CW30496,CW30496,,69Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HI38,CW30497,CW30497,,68Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HI39,CW30499,CW30499,,71Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HI40,CW30500,CW30500,,66Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HI41,CW30501,CW30501,,51Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_JI35,CW30503,CW30503,,69Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HI42,CW30505,CW30505,,69Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HI43,CW30506,CW30506,,30Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HI44,CW30508,CW30508,,53Y,Female,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HI45,CW30509,CW30509,,51Y,Male,Pacific,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_HI46,CW30510,CW30510,,69Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_JI36,CW30512,CW30512,,67Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_JI37,CW30513,CW30513,,73Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_JI38,CW30515,CW30515,,55Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_JI39,CW30516,CW30516,,54Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_JI40,CW30519,CW30519,,43Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_JI41,CW30520,CW30520,,69Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34830; Cardiomyopathy,,
CVCL_JI42,CW30522,CW30522,,69Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_JI43,CW30523,CW30523,,62Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_JI44,CW30525,CW30525,,56Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_LJ98,CW30526,CW30526,,74Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_LJ99,CW30527,CW30527,,72Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_LK00,CW30528,CW30528,,45Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_LK01,CW30529,CW30529,,35Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84673; Dilated cardiomyopathy,,
CVCL_AP13,CW40001,CW40001,,68Y,Male,,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4R86,CW40002,CW40002,,79Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_AP14,CW40003,CW40003,,71Y,Male,,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4R87,CW40004,CW40004,,68Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_DK07,CW40005,CW40005,,69Y,Male,,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4R88,CW40006,CW40006,,66Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4R89,CW40007,CW40007,,65Y,Male,,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4R90,CW40008,CW40008,,59Y,Male,,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4R91,CW40009,CW40009,,61Y,Female,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_JI45,CW40010,CW40010,,70Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_AP15,CW40011,CW40011,,68Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_JI46,CW40012,CW40012,,71Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4R92,CW40013,CW40013,,74Y,Male,,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4R93,CW40014,CW40014,,64Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4R94,CW40015,CW40015,,62Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_HI47,CW40017,CW40017,,62Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_HI48,CW40018,CW40018,,73Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_HI49,CW40020,CW40020,,79Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_DK08,CW40021,CW40021,,71Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4R95,CW40022,CW40022,,61Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4R96,CW40023,CW40023,,73Y,Male,Asian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_DK09,CW40024,CW40024,,70Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4R97,CW40025,CW40025,,75Y,Female,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4R98,CW40026,CW40026,,69Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4R99,CW40027,CW40027,,74Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4S00,CW40028,CW40028,,68Y,Female,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4S01,CW40029,CW40029,,74Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_JI47,CW40030,CW40030,,69Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4S02,CW40031,CW40031,,65Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4S03,CW40032,CW40032,,85Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_DK10,CW40033,CW40033,,68Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_AP16,CW40034,CW40034,,59Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4S04,CW40035,CW40035,,71Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4S05,CW40036,CW40036,,67Y,Male,,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_AP17,CW40037,CW40037,,72Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_HI50,CW40038,CW40038,,75Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_AP18,CW40039,CW40039,,73Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_DK11,CW40040,CW40040,,68Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_HI51,CW40042,CW40042,,74Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_AP19,CW40043,CW40043,,58Y,Female,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_ER54,CW40044,CW40044,,68Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_AP20,CW40045,CW40045,,70Y,Male,,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_HI52,CW40046,CW40046,,72Y,Male,Asian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_HI53,CW40047,CW40047,,57Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4S06,CW40049,CW40049,,59Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4S07,CW40051,CW40051,,66Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_JI48,CW40052,CW40052,,65Y,Female,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_JI49,CW40053,CW40053,,66Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_HI54,CW40054,CW40054,,57Y,Male,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_AP21,CW40055,CW40055,,73Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_JI50,CW40057,CW40057,,48Y,Female,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_JI51,CW40061,CW40061,,73Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_JI52,CW40062,CW40062,,64Y,Female,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_JI53,CW40063,CW40063,,68Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_DK12,CW40064,CW40064,,70Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_AP22,CW40065,CW40065,,74Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_JI54,CW40066,CW40066,,59Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4S08,CW40067,CW40067,,76Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4S09,CW40068,CW40068,,63Y,Male,,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_JI55,CW40070,CW40070,,71Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_AP23,CW40071,CW40071,,65Y,Female,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_JI56,CW40073,CW40073,,68Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_DK13,CW40074,CW40074,,69Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_AP24,CW40075,CW40075,,52Y,Female,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_JI57,CW40077,CW40077,,54Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_DK14,CW40078,CW40078,,63Y,Female,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_HI55,CW40079,CW40079,,71Y,Female,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_AP25,CW40080,CW40080,,75Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_HI56,CW40081,CW40081,,68Y,Female,,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_AP26,CW40083,CW40083,,51Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4S10,CW40084,CW40084,,71Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4S11,CW40085,CW40085,,70Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4S12,CW40086,CW40086,,64Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_AP27,CW40087,CW40087,,62Y,Female,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_DK15,CW40088,CW40088,,73Y,Male,Asian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_AP28,CW40089,CW40089,,71Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_AP29,CW40090,CW40090,,62Y,Female,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4S13,CW40091,CW40091,,78Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_HI57,CW40092,CW40092,,72Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_JI58,CW40094,CW40094,,62Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_LI70,CW40096,CW40096,,58Y,Male,,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_AP30,CW40097,CW40097,,47Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_HI58,CW40100,CW40100,,63Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_JI59,CW40101,CW40101,,64Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4S14,CW40102,CW40102,,70Y,Male,,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4S15,CW40105,CW40105,,68Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4S16,CW40106,CW40106,,68Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_DK16,CW40107,CW40107,,71Y,Male,,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_AP31,CW40109,CW40109,,71Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_HJ46,CW40110,CW40110,,69Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4S17,CW40111,CW40111,,64Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4S18,CW40112,CW40112,,64Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4S19,CW40113,CW40113,,63Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4S20,CW40114,CW40114,,64Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4S21,CW40115,CW40115,,68Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4S22,CW40116,CW40116,,61Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4S23,CW40118,CW40118,,71Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4S24,CW40119,CW40119,,72Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4S25,CW40120,CW40120,,70Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4S26,CW40121,CW40121,,68Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_LI71,CW40122,CW40122,,68Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4S27,CW40123,CW40123,,82Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4S28,CW40124,CW40124,,70Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_LI72,CW40125,CW40125,,69Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4S29,CW40126,CW40126,,66Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_HI59,CW40127,CW40127,,67Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4S30,CW40128,CW40128,,75Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4S31,CW40129,CW40129,,69Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_DK17,CW40130,CW40130,,63Y,Female,,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4S32,CW40131,CW40131,,77Y,Male,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4S33,CW40132,CW40132,,83Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4S34,CW40135,CW40135,,70Y,Male,,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4S35,CW40136,CW40136,,63Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4S36,CW40137,CW40137,,72Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4S37,CW40139,CW40139,,66Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4S38,CW40142,CW40142,,54Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_HI60,CW40144,CW40144,,72Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_AP32,CW40145,CW40145,,70Y,Male,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4S39,CW40147,CW40147,,77Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_AP33,CW40148,CW40148,,65Y,Female,,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4S40,CW40149,CW40149,,85Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_HI61,CW40152,CW40152,,77Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_LI73,CW40153,CW40153,,68Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_AP34,CW40155,CW40155,,66Y,Male,,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_AP35,CW40157,CW40157,,60Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_AP36,CW40158,CW40158,,86Y,Female,,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_AP37,CW40159,CW40159,,74Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_AP38,CW40160,CW40160,,68Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_AP39,CW40161,CW40161,,74Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_DK18,CW40163,CW40163,,59Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_AP40,CW40164,CW40164,,66Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_AP41,CW40165,CW40165,,63Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_HI62,CW40167,CW40167,,85Y,Male,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_AP42,CW40169,CW40169,,70Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_LI74,CW40172,CW40172,,73Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_AP43,CW40174,CW40174,,77Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_AP44,CW40175,CW40175,,80Y,Male,,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_AP45,CW40176,CW40176,,64Y,Male,,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_AP46,CW40178,CW40178,,62Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_DK19,CW40179,CW40179,,77Y,Female,,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_LI75,CW40181,CW40181,,58Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_AP47,CW40182,CW40182,,80Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_AP48,CW40183,CW40183,,73Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_HI63,CW40185,CW40185,,62Y,Male,Southeast Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_AP49,CW40186,CW40186,,75Y,Female,,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_DK20,CW40187,CW40187,,71Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_AP50,CW40190,CW40190,,77Y,Male,,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_LK02,CW40191,CW40191,,67Y,Male,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_JI60,CW40192,CW40192,,63Y,Male,,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_ER55,CW40193,CW40193,,67Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_DK21,CW40194,CW40194,,73Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_DK22,CW40195,CW40195,,71Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_DK23,CW40196,CW40196,,68Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_DK24,CW40197,CW40197,,67Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_DK25,CW40198,CW40198,,73Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_DK26,CW40199,CW40199,,72Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_DK27,CW40200,CW40200,,69Y,Female,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_AP51,CW40201,CW40201,,76Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_HI64,CW40206,CW40206,,69Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_DK28,CW40207,CW40207,,67Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_AP52,CW40208,CW40208,,68Y,Female,,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_HI65,CW40209,CW40209,,62Y,Female,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_DK29,CW40210,CW40210,,83Y,Male,,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_HI66,CW40211,CW40211,,67Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_ER56,CW40212,CW40212,,69Y,Male,Japanese,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_ER57,CW40213,CW40213,,77Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_HI67,CW40214,CW40214,,70Y,Male,,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_JI61,CW40217,CW40217,,71Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_HI68,CW40218,CW40218,,67Y,Male,,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_DK30,CW40219,CW40219,,72Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_DK31,CW40220,CW40220,,76Y,Female,African American,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_DK32,CW40221,CW40221,,71Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_DK33,CW40222,CW40222,,63Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_LI76,CW40224,CW40224,,82Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_LK03,CW40225,CW40225,,68Y,Male,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_DK34,CW40226,CW40226,,68Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_DK35,CW40227,CW40227,,68Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_HI69,CW40228,CW40228,,72Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_HI70,CW40229,CW40229,,61Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_HI71,CW40230,CW40230,,72Y,Male,,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_DK36,CW40231,CW40231,,70Y,Male,,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_DK37,CW40232,CW40232,,72Y,Male,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_DK38,CW40233,CW40233,,68Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_HI72,CW40234,CW40234,,71Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_HI73,CW40235,CW40235,,69Y,Male,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_DK39,CW40236,CW40236,,61Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_DK40,CW40237,CW40237,,65Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_DK41,CW40239,CW40239,,70Y,Male,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_DK42,CW40240,CW40240,,,Male,,Induced pluripotent stem cell,,,,,,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_HI74,CW40243,CW40243,,63Y,Male,African American,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_DK43,CW40244,CW40244,,67Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_DK44,CW40245,CW40245,,78Y,Male,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_DK45,CW40246,CW40246,,66Y,Male,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_ER58,CW40247,CW40247,,75Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_DK46,CW40249,CW40249,,57Y,Male,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_LI77,CW40250,CW40250,,66Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_DK47,CW40251,CW40251,,72Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35716; Idiopathic pulmonary fibrosis,,
CVCL_4S41,CW50001,CW50001,,90Y,Male,,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_4S42,CW50002,CW50002,,75Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_4S43,CW50003,CW50003,,81Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_4S44,CW50004,CW50004,,73Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_4S45,CW50005,CW50005,,90Y,Male,,Induced pluripotent stem cell,,,,,,,,
CVCL_4S46,CW50006,CW50006,,90Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_4S47,CW50007,CW50007,,82Y,Female,,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_4S48,CW50008,CW50008,,90Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DK48,CW50009,CW50009,,77Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_4S49,CW50013,CW50013,,87Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DK49,CW50015,CW50015,,84Y,Male,,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DK50,CW50016,CW50016,,78Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DK51,CW50018,CW50018,,58Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_DK52,CW50019,CW50019,,83Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_HI75,CW50021,CW50021,,69Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DK53,CW50022,CW50022,,72Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_LI78,CW50023,CW50023,,69Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DK54,CW50024,CW50024,,63Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_DK55,CW50025,CW50025,,68Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_DK56,CW50026,CW50026,,71Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DK57,CW50027,CW50027,,75Y,Male,Chinese,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DK58,CW50028,CW50028,,68Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DK59,CW50029,CW50029,,81Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_LI79,CW50032,CW50032,,86Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DK60,CW50033,CW50033,,75Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DK61,CW50034,CW50034,,79Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DK62,CW50035,CW50035,,72Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DK63,CW50036,CW50036,,73Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DK64,CW50037,CW50037,,70Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DK65,CW50038,CW50038,,86Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_LI80,CW50039,CW50039,,70Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_HI76,CW50040,CW50040,,63Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_LI81,CW50041,CW50041,,84Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_DK66,CW50042,CW50042,,77Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DK67,CW50043,CW50043,,79Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_DK68,CW50044,CW50044,,75Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DK69,CW50045,CW50045,,83Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DK70,CW50046,CW50046,,79Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DK71,CW50047,CW50047,,77Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DK72,CW50050,CW50050,,81Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DK73,CW50051,CW50051,,76Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DK74,CW50052,CW50052,,87Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_DK75,CW50054,CW50054,,82Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DK76,CW50055,CW50055,,87Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DK77,CW50056,CW50056,,79Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DK78,CW50057,CW50057,,76Y,Female,,Induced pluripotent stem cell,,,,,,NCIt; C2866; Alzheimer's disease,,
CVCL_DK79,CW50058,CW50058,,78Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DK80,CW50059,CW50059,,70Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DK81,CW50060,CW50060,,87Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_DK82,CW50061,CW50061,,78Y,Male,,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DK83,CW50062,CW50062,,81Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DK84,CW50063,CW50063,,82Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DK85,CW50064,CW50064,,80Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DK86,CW50065,CW50065,,74Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DK87,CW50066,CW50066,,83Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DK88,CW50067,CW50067,,77Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_HI77,CW50068,CW50068,,72Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DK89,CW50069,CW50069,,66Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_DK90,CW50070,CW50070,,81Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DK91,CW50071,CW50071,,71Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_ER59,CW50072,CW50072,,83Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_HI78,CW50073,CW50073,,82Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_HI79,CW50074,CW50074,,75Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_HI80,CW50075,CW50075,,77Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_ER60,CW50076,CW50076,,84Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DK92,CW50078,CW50078,,81Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DK93,CW50079,CW50079,,74Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DK94,CW50082,CW50082,,68Y,Male,African American,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_DK95,CW50086,CW50086,,74Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_LI82,CW50093,CW50093,,72Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DK96,CW50094,CW50094,,70Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DK97,CW50095,CW50095,,79Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_LI83,CW50096,CW50096,,77Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_DK98,CW50097,CW50097,,78Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DK99,CW50099,CW50099,,70Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_HI81,CW50101,CW50101,,78Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DL00,CW50104,CW50104,,79Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_DL01,CW50106,CW50106,,67Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_DL02,CW50107,CW50107,,72Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_HI82,CW50108,CW50108,,72Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DL03,CW50109,CW50109,,73Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_DL04,CW50111,CW50111,,92Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_JI62,CW50112,CW50112,,80Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_HI83,CW50113,CW50113,,68Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_DL05,CW50114,CW50114,,72Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_HI84,CW50115,CW50115,,67Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_HI85,CW50117,CW50117,,81Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_DL06,CW50118,CW50118,,82Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_LK04,CW50119,CW50119,,84Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_DL07,CW50120,CW50120,,82Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_DL08,CW50121,CW50121,,68Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_DL09,CW50122,CW50122,,80Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_LI84,CW50123,CW50123,,70Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DL10,CW50126,CW50126,,65Y,Male,Native North American,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_DL11,CW50127,CW50127,,68Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_HI86,CW50128,CW50128,,83Y,Female,African American,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_HI87,CW50129,CW50129,,76Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_JI63,CW50130,CW50130,,77Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_HI88,CW50131,CW50131,,77Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_HI89,CW50132,CW50132,,79Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_HI90,CW50133,CW50133,,87Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_HI91,CW50134,CW50134,,75Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_ER61,CW50136,CW50136,,76Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_ER62,CW50137,CW50137,,70Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_HI92,CW50138,CW50138,,68Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_HI93,CW50139,CW50139,,70Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_HI94,CW50141,CW50141,,74Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_HI95,CW50142,CW50142,,75Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_HI96,CW50143,CW50143,,73Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_HI97,CW50144,CW50144,,81Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_HI98,CW50145,CW50145,,79Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_HI99,CW50147,CW50147,,71Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_HJ00,CW50148,CW50148,,69Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_HJ01,CW50149,CW50149,,73Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_HJ02,CW50150,CW50150,,65Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_HJ03,CW50152,CW50152,,86Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_HJ04,CW50153,CW50153,,70Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_LK05,CW50155,CW50155,,75Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_LK06,CW50156,CW50156,,72Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_LK07,CW50157,CW50157,,73Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_HJ05,CW50158,CW50158,,63Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_JI64,CW50159,CW50159,,85Y,Male,,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_JI65,CW50161,CW50161,,70Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_JI66,CW50162,CW50162,,77Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_JI67,CW50165,CW50165,,78Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_LK08,CW50166,CW50166,,69Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_JI68,CW50167,CW50167,,82Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_LK09,CW50168,CW50168,,68Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_LK10,CW50169,CW50169,,68Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_LK11,CW50170,CW50170,,64Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_LK12,CW50173,CW50173,,74Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_LK13,CW50174,CW50174,,76Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_LK14,CW50175,CW50175,,77Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_LK15,CW50176,CW50176,,74Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_LK16,CW50177,CW50177,,85Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2866; Alzheimer's disease,,
CVCL_DL12,CW60001,CW60001,,13Y,Female,Lybian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3020; Seizure disorder,,
CVCL_DL13,CW60002,CW60002,,,Female,,Induced pluripotent stem cell,,,,,,NCIt; C3020; Seizure disorder,,
CVCL_LI85,CW60011,CW60011,,35Y,Female,Arab,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_DL14,CW60013,CW60013,,34Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_DL15,CW60014,CW60014,,39Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_HJ06,CW60015,CW60015,,39Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_LI86,CW60017,CW60017,,8Y,Male,Pakistani,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3020; Seizure disorder,,
CVCL_DL16,CW60018,CW60018,,3Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C34460; Cerebral palsy,,
CVCL_4S50,CW60021,CW60021,,3Y,Male,Israeli,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C88412; Autism spectrum disorder,,
CVCL_DL17,CW60024,CW60024,,7Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C88412; Autism spectrum disorder,,
CVCL_4S51,CW60026,CW60026,,17Y,Female,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C34460; Cerebral palsy,,
CVCL_HJ07,CW60027,CW60027,,35Y,Male,Lybian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_DL18,CW60029,CW60029,,7Y,Female,,Induced pluripotent stem cell,,,,,,NCIt; C88412; Autism spectrum disorder,,
CVCL_LI87,CW60031,CW60031,,31Y,Female,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DL19,CW60034,CW60034,,15Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,,,
CVCL_RV79,CW60037,CW60037,,38Y,Male,,Induced pluripotent stem cell,,,,,,,,
CVCL_4S52,CW60039,CW60039,,5Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C88412; Autism spectrum disorder,,
CVCL_DL20,CW60040,CW60040,,5Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,,,
CVCL_DL21,CW60045,CW60045,,23Y,Female,Lybian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_DL22,CW60046,CW60046,,6Y,Female,Lybian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3020; Seizure disorder,,
CVCL_DL23,CW60048,CW60048,,4Y,Female,Lybian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_DL24,CW60049,CW60049,,6Y,Female,Lybian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_LI88,CW60051,CW60051,,16Y,Male,Lybian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_LI89,CW60053,CW60053,,25Y,Male,Lybian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_LI90,CW60054,CW60054,,54Y,Male,Lybian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_DL25,CW60055,CW60055,,8Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C88412; Autism spectrum disorder,,
CVCL_DL26,CW60056,CW60056,,11Y,Female,Arab,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_LI91,CW60057,CW60057,,41Y,Male,Lybian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_LK17,CW60058,CW60058,,16Y,Female,Pakistani,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_DL27,CW60060,CW60060,,37Y,Female,Caucasian,Induced pluripotent stem cell,,,,,,,,
CVCL_LI92,CW60065,CW60065,,23Y,Female,Lybian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_LI93,CW60066,CW60066,,9Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C88412; Autism spectrum disorder,,
CVCL_JI69,CW60070,CW60070,,9Y,Male,Lybian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3020; Seizure disorder,,
CVCL_LI94,CW60076,CW60076,,38Y,Female,Lybian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_RV80,CW60079,CW60079,,14Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_DL28,CW60083,CW60083,,2Y,Female,Lybian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_JI70,CW60084,CW60084,,14Y,Male,Pakistani,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_LI95,CW60085,CW60085,,46Y,Male,Pakistani,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_LI96,CW60086,CW60086,,2Y,Male,Lybian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3020; Seizure disorder,,
CVCL_LI97,CW60087,CW60087,,2Y,Male,Lybian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3020; Seizure disorder,,
CVCL_JI71,CW60088,CW60088,,20Y,Female,Lybian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_DL29,CW60089,CW60089,,9Y,Female,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C88412; Autism spectrum disorder,,
CVCL_JI72,CW60092,CW60092,,4Y,Female,Lybian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3020; Seizure disorder,,
CVCL_AP53,CW60094,CW60094,,11Y,Male,Pakistani,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C97250; Intellectual disability,,
CVCL_AP54,CW60095,CW60095,,51Y,Male,Pakistani,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DL30,CW60097,CW60097,,48Y,Female,Caucasian,Induced pluripotent stem cell,,,,,,,,
CVCL_DL31,CW60098,CW60098,,48Y,Male,Lybian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_HJ08,CW60104,CW60104,,6Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C88412; Autism spectrum disorder,,
CVCL_LI98,CW60105,CW60105,,10Y,Male,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_LI99,CW60106,CW60106,,7Y,Male,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_LJ00,CW60107,CW60107,,3Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_DL32,CW60108,CW60108,,5Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_4S53,CW60109,CW60109,,38Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DL33,CW60110,CW60110,,11Y,Male,,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_DL34,CW60111,CW60111,,7Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_4S54,CW60115,CW60115,,4Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_LJ01,CW60117,CW60117,,16Y,Male,Caucasian and Native North American,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C3020; Seizure disorder,,
CVCL_DL35,CW60118,CW60118,,6Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_DL36,CW60119,CW60119,,53Y,Male,Lybian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_DL37,CW60122,CW60122,,5Y,Male,Lybian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3020; Seizure disorder,,
CVCL_DL38,CW60123,CW60123,,9Y,Female,Lybian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3020; Seizure disorder,,
CVCL_LJ02,CW60124,CW60124,,29Y,Female,Lybian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_HJ09,CW60125,CW60125,,32Y,Female,Lybian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_DL39,CW60130,CW60130,,6Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C3020; Seizure disorder,,
CVCL_HJ10,CW60131,CW60131,,12Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_DL40,CW60132,CW60132,,32Y,Female,Arab,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DL41,CW60133,CW60133,,4Y,Female,Arab,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34460; Cerebral palsy,,
CVCL_DL42,CW60134,CW60134,,44Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_LJ03,CW60135,CW60135,,11Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_DL43,CW60136,CW60136,,15Y,Male,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_HJ11,CW60138,CW60138,,16Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_LJ04,CW60139,CW60139,,51Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_DL44,CW60141,CW60141,,21Y,Male,Lybian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_DL45,CW60142,CW60142,,6Y,Male,Lybian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3020; Seizure disorder,,
CVCL_JI73,CW60143,CW60143,,17Y,Female,Lybian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_LJ05,CW60144,CW60144,,15Y,Female,Lybian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_JI74,CW60145,CW60145,,14Y,Female,Lybian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_LJ06,CW60146,CW60146,,35Y,Male,Lybian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_HJ12,CW60155,CW60155,,40Y,Female,Pakistani,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_LJ07,CW60157,CW60157,,26Y,Female,Arab,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_HJ13,CW60159,CW60159,,35Y,Male,Pakistani,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_DL46,CW60161,CW60161,,14Y,Male,Pakistani,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_LJ08,CW60163,CW60163,,28Y,Female,Arab,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_DL47,CW60164,CW60164,,4Y,Female,Arab,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_LJ09,CW60166,CW60166,,26Y,Male,Arab,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_LJ10,CW60167,CW60167,,2Y,Male,Arab,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_LJ11,CW60168,CW60168,,40Y,Female,Pakistani,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_DL48,CW60171,CW60171,,7Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_HJ14,CW60172,CW60172,,10Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_JI75,CW60174,CW60174,,17Y,Male,Pakistani,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_JI76,CW60175,CW60175,,7Y,Female,Pakistani,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_LJ12,CW60181,CW60181,,4Y,Female,Pakistani,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3020; Seizure disorder,,
CVCL_JI77,CW60182,CW60182,,7Y,Female,Pakistani,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3020; Seizure disorder,,
CVCL_JI78,CW60184,CW60184,,26Y,Female,Lybian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_LJ13,CW60186,CW60186,,2Y,Female,Lybian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_DL49,CW60187,CW60187,,4Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_JI79,CW60188,CW60188,,15Y,Male,Lybian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C34460; Cerebral palsy,,
CVCL_VK77,CW60189,CW60189,,42Y,Male,Lybian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_LJ14,CW60190,CW60190,,35Y,Female,Lybian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_JI80,CW60193,CW60193,,5Y,Male,Lybian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3020; Seizure disorder,,
CVCL_LJ15,CW60195,CW60195,,28Y,Female,Lybian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_LJ16,CW60200,CW60200,,23Y,Female,Lybian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C34460; Cerebral palsy,,
CVCL_HJ15,CW60201,CW60201,,30Y,Female,Lybian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_JI81,CW60205,CW60205,,7Y,Male,Lybian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_LJ17,CW60207,CW60207,,27Y,Male,Lybian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_JI82,CW60208,CW60208,,6Y,Female,Lybian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3020; Seizure disorder,,
CVCL_JI83,CW60209,CW60209,,5Y,Male,Lybian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3020; Seizure disorder,,
CVCL_HJ16,CW60210,CW60210,,40Y,Male,Pakistani,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_LJ18,CW60213,CW60213,,28Y,Female,Lybian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_DL50,CW60214,CW60214,,3Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_DL51,CW60217,CW60217,,5Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_LJ19,CW60218,CW60218,,7Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_DL52,CW60219,CW60219,,13Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_DL53,CW60220,CW60220,,9Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DL54,CW60221,CW60221,,17Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C97250; Intellectual disability,,
CVCL_DL55,CW60222,CW60222,,15Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C97250; Intellectual disability,,
CVCL_HJ17,CW60223,CW60223,,13Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_4S55,CW60224,CW60224,,8Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34460; Cerebral palsy,,
CVCL_DL56,CW60226,CW60226,,21Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C3020; Seizure disorder,,
CVCL_LJ20,CW60227,CW60227,,19Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C3020; Seizure disorder,,
CVCL_LK18,CW60228,CW60228,,10Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_DL57,CW60230,CW60230,,4Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_LJ21,CW60231,CW60231,,6Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C3020; Seizure disorder,,
CVCL_DL58,CW60232,CW60232,,13Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_DL59,CW60234,CW60234,,15Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C3020; Seizure disorder,,
CVCL_DL60,CW60236,CW60236,,11Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C3020; Seizure disorder,,
CVCL_DL61,CW60237,CW60237,,9Y,Female,,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DL62,CW60239,CW60239,,20Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34460; Cerebral palsy,,
CVCL_JI84,CW60242,CW60242,,16Y,Female,Arab,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_JI85,CW60243,CW60243,,14Y,Male,Arab,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_JI86,CW60245,CW60245,,9Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_JI87,CW60247,CW60247,,7Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C34460; Cerebral palsy,,
CVCL_JI88,CW60252,CW60252,,8Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_JI89,CW60261,CW60261,,1Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3020; Seizure disorder,,
CVCL_LJ22,CW60263,CW60263,,7Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C97250; Intellectual disability,,
CVCL_DL63,CW60264,CW60264,,10Y,Female,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34460; Cerebral palsy,,
CVCL_LJ23,CW60267,CW60267,,8Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34460; Cerebral palsy,,
CVCL_DL64,CW60269,CW60269,,10Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_RV81,CW60270,CW60270,,13Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_DL65,CW60272,CW60272,,19Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34460; Cerebral palsy,,
CVCL_JI90,CW60277,CW60277,,17Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_JI91,CW60278,CW60278,,39Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_JI92,CW60279,CW60279,,32Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_JI93,CW60280,CW60280,,18Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_LJ24,CW60281,CW60281,,4Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_JI94,CW60286,CW60286,,26Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_LJ25,CW60288,CW60288,,3Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3020; Seizure disorder,,
CVCL_JI95,CW60289,CW60289,,39Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_JI96,CW60290,CW60290,,18Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_LK19,CW60291,CW60291,,8Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_LJ26,CW60296,CW60296,,6Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3020; Seizure disorder,,
CVCL_RV82,CW60297,CW60297,,5Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3020; Seizure disorder,,
CVCL_JI97,CW60298,CW60298,,2Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3020; Seizure disorder,,
CVCL_JI98,CW60302,CW60302,,24Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C34460; Cerebral palsy,,
CVCL_JI99,CW60303,CW60303,,51Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_JJ00,CW60304,CW60304,,40Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_LK20,CW60305,CW60305,,5Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_RV83,CW60308,CW60308,,30Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_RV84,CW60309,CW60309,,10Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_RV85,CW60310,CW60310,,36Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_RV86,CW60314,CW60314,,35Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_RV87,CW60319,CW60319,,5Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C88412; Autism spectrum disorder,,
CVCL_HJ18,CW60320,CW60320,,3Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3020; Seizure disorder,,
CVCL_JJ01,CW60325,CW60325,,2Y,Female,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_JJ02,CW60330,CW60330,,27Y,Female,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_JJ03,CW60331,CW60331,,8Y,Female,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_JJ04,CW60333,CW60333,,4Y,Male,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C34460; Cerebral palsy,,
CVCL_RV88,CW60334,CW60334,,38Y,Female,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_JJ05,CW60335,CW60335,,14Y,Female,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_RV89,CW60336,CW60336,,20Y,Female,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_RV90,CW60338,CW60338,,24Y,Female,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_JJ06,CW60342,CW60342,,35Y,Female,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_LK21,CW60350,CW60350,,3Y,Female,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_JJ07,CW60353,CW60353,,23Y,Female,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_RV91,CW60354,CW60354,,1Y,Female,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_JJ08,CW60355,CW60355,,30Y,Female,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_RV92,CW60359,CW60359,,1Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_RV93,CW60362,CW60362,,29Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_RV94,CW60365,CW60365,,32Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_HJ19,CW60383,CW60383,,40Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_HJ20,CW60384,CW60384,,5Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C97250; Intellectual disability,,
CVCL_LK22,CW60389,CW60389,,38Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_JJ09,CW60390,CW60390,,14Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_LK23,CW60391,CW60391,,12Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_RV95,CW60395,CW60395,,10Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3020; Seizure disorder,,
CVCL_JJ10,CW60403,CW60403,,5Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_JJ11,CW60404,CW60404,,28Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_LK24,CW60405,CW60405,,7Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_JJ12,CW60408,CW60408,,18Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_JJ13,CW60410,CW60410,,26Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_JJ14,CW60412,CW60412,,32Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_JJ15,CW60413,CW60413,,30Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_JJ16,CW60416,CW60416,,28Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_LK25,CW60417,CW60417,,5Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3020; Seizure disorder,,
CVCL_RV96,CW60418,CW60418,,29Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_RV97,CW60420,CW60420,,2Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_LJ27,CW60421,CW60421,,47Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_LK26,CW60427,CW60427,,10Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C34460; Cerebral palsy,,
CVCL_RV98,CW60428,CW60428,,22Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_RV99,CW60436,CW60436,,33Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_JJ17,CW60437,CW60437,,7Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_RW00,CW60441,CW60441,,30Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_JJ18,CW60447,CW60447,,9Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_LK27,CW60450,CW60450,,6Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_LK28,CW60453,CW60453,,32Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_JJ19,CW60456,CW60456,,7Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C34460; Cerebral palsy,,
CVCL_JJ20,CW60457,CW60457,,36Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_JJ21,CW60458,CW60458,,4Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C34460; Cerebral palsy,,
CVCL_RW01,CW60462,CW60462,,5Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_JJ22,CW60465,CW60465,,36Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_RW02,CW60469,CW60469,,6Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3020; Seizure disorder,,
CVCL_LK29,CW60470,CW60470,,31Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_JJ23,CW60473,CW60473,,2Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3020; Seizure disorder,,
CVCL_JJ24,CW60474,CW60474,,15Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_RW03,CW60477,CW60477,,9Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C34460; Cerebral palsy,,
CVCL_RW04,CW60480,CW60480,,1Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_RW05,CW60481,CW60481,,26Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_JJ25,CW60483,CW60483,,14Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_RW06,CW60498,CW60498,,33Y,Male,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_RW07,CW60499,CW60499,,25Y,Male,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_LJ28,CW60503,CW60503,,10Y,Female,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_JJ26,CW60504,CW60504,,7Y,Male,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_JJ27,CW60507,CW60507,,6Y,Male,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_RW08,CW60509,CW60509,,28Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_JJ28,CW60510,CW60510,,6Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3020; Seizure disorder,,
CVCL_JJ29,CW60517,CW60517,,66Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3020; Seizure disorder,,
CVCL_JJ30,CW60520,CW60520,,38Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_JJ31,CW60521,CW60521,,7Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_LK30,CW60548,CW60548,,22Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C34460; Cerebral palsy,,
CVCL_RW09,CW60569,CW60569,,7Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C97250; Intellectual disability,,
CVCL_RW10,CW60576,CW60576,,32Y,Female,Asian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_RW11,CW60594,CW60594,,1Y11M,Male,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3020; Seizure disorder,,
CVCL_4S56,CW70001,CW70001,,56Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,,,
CVCL_4S57,CW70002,CW70002,,56Y,Female,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_4S58,CW70004,CW70004,,65Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_4S59,CW70005,CW70005,,85Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C35394; Primary open angle glaucoma,,
CVCL_4S60,CW70006,CW70006,,86Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C84391; Age-related macular degeneration,,
CVCL_4S61,CW70007,CW70007,,80Y,Female,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C84391; Age-related macular degeneration,,
CVCL_4S62,CW70008,CW70008,,67Y,Female,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C84391; Age-related macular degeneration,,
CVCL_DL66,CW70009,CW70009,,69Y,Female,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C84391; Age-related macular degeneration,,
CVCL_DL67,CW70010,CW70010,,80Y,Female,,Induced pluripotent stem cell,,,,,,NCIt; C84391; Age-related macular degeneration,,
CVCL_DL68,CW70011,CW70011,,83Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C84391; Age-related macular degeneration,,
CVCL_4S63,CW70012,CW70012,,90Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C84391; Age-related macular degeneration,,
CVCL_4S64,CW70013,CW70013,,55Y,Male,Asian,Induced pluripotent stem cell,,,,,,NCIt; C84391; Age-related macular degeneration,,
CVCL_4S65,CW70014,CW70014,,80Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C84391; Age-related macular degeneration,,
CVCL_4S66,CW70015,CW70015,,77Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,,,
CVCL_DL69,CW70016,CW70016,,49Y,Female,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_4S67,CW70017,CW70017,,46Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_4S68,CW70018,CW70018,,74Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_4S69,CW70019,CW70019,,67Y,Female,Caucasian,Induced pluripotent stem cell,,,,,,,,
CVCL_DL70,CW70021,CW70021,,91Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C84391; Age-related macular degeneration,,
CVCL_DL71,CW70022,CW70022,,20Y,Female,Latino or Hispanic,Induced pluripotent stem cell,,,,,,NCIt; C34538; Diabetic retinopathy,,
CVCL_DL72,CW70028,CW70028,,53Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C2986; Type 1 diabetes mellitus,,
CVCL_DL73,CW70029,CW70029,,70Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C2986; Type 1 diabetes mellitus,,
CVCL_DL74,CW70030,CW70030,,60Y,Male,Caucasian,Induced pluripotent stem cell,,,,,,,,
CVCL_DL75,CW70031,CW70031,,64Y,Male,,Induced pluripotent stem cell,,,,,,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_DL76,CW70032,CW70032,,59Y,Female,Caucasian,Induced pluripotent stem cell,,,,,,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_JJ32,CW70033,CW70033,,74Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_4S70,CW70034,CW70034,,73Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_4S71,CW70035,CW70035,,52Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34538; Diabetic retinopathy,,
CVCL_4S72,CW70036,CW70036,,52Y,Female,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_4S73,CW70037,CW70037,,25Y,Male,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2986; Type 1 diabetes mellitus,,
CVCL_4S74,CW70038,CW70038,,71Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_4S75,CW70039,CW70039,,72Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_4S76,CW70040,CW70040,,72Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_DL77,CW70041,CW70041,,66Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_4S77,CW70042,CW70042,,73Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_4S78,CW70043,CW70043,,86Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_4S79,CW70044,CW70044,,69Y,Female,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_4S80,CW70045,CW70045,,53Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_DL78,CW70047,CW70047,,72Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_4S81,CW70048,CW70048,,73Y,Female,,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_4S82,CW70049,CW70049,,58Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_4S83,CW70050,CW70050,,54Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_4S84,CW70051,CW70051,,60Y,Female,,Induced pluripotent stem cell,,,,,,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_4S85,CW70052,CW70052,,29Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2986; Type 1 diabetes mellitus,,
CVCL_4S86,CW70054,CW70054,,80Y,Male,,Induced pluripotent stem cell,,,,,,,,
CVCL_4S87,CW70055,CW70055,,75Y,Female,,Induced pluripotent stem cell,,,,,,NCIt; C84391; Age-related macular degeneration,,
CVCL_4S88,CW70056,CW70056,,65Y,Male,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,"NCIt; C2985; Diabetes mellitus,NCIt; C84391; Age-related macular degeneration",,
CVCL_DL79,CW70057,CW70057,,60Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_DL80,CW70059,CW70059,,88Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_JJ33,CW70060,CW70060,,51Y,Male,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2985; Diabetes mellitus,,
CVCL_4S89,CW70061,CW70061,,35Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35394; Primary open angle glaucoma,,
CVCL_4S90,CW70063,CW70063,,69Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C27604; Non-neoplastic eye disorder,,
CVCL_DL81,CW70064,CW70064,,53Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34538; Diabetic retinopathy,,
CVCL_DL82,CW70066,CW70066,,26Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_4S91,CW70067,CW70067,,21Y,Female,,Induced pluripotent stem cell,,,,,,,,
CVCL_4S92,CW70071,CW70071,,77Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_DL83,CW70072,CW70072,,81Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_4S93,CW70073,CW70073,,58Y,Male,,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_4S94,CW70075,CW70075,,67Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34538; Diabetic retinopathy,,
CVCL_4S95,CW70077,CW70077,,65Y,Female,African American,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34538; Diabetic retinopathy,,
CVCL_4S96,CW70078,CW70078,,,Male,,Induced pluripotent stem cell,,,,,,NCIt; C84391; Age-related macular degeneration,,
CVCL_4S97,CW70079,CW70079,,68Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_4S98,CW70080,CW70080,,61Y,Male,,Induced pluripotent stem cell,,,,,,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_4S99,CW70081,CW70081,,76Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_4T00,CW70082,CW70082,,58Y,Female,,Induced pluripotent stem cell,,,,,,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_DL84,CW70083,CW70083,,69Y,Female,,Induced pluripotent stem cell,,,,,,NCIt; C34538; Diabetic retinopathy,,
CVCL_DL85,CW70084,CW70084,,78Y,Female,,Induced pluripotent stem cell,,,,,,NCIt; C84391; Age-related macular degeneration,,
CVCL_DL86,CW70085,CW70085,,76Y,Male,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34538; Diabetic retinopathy,,
CVCL_HJ47,CW70086,CW70086,,85Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_4T01,CW70087,CW70087,,82Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_4T02,CW70088,CW70088,,69Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_4T03,CW70089,CW70089,,90Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_JJ34,CW70090,CW70090,,77Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_4T04,CW70091,CW70091,,58Y,Male,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34538; Diabetic retinopathy,,
CVCL_JJ35,CW70092,CW70092,,62Y,Male,Israeli,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35394; Primary open angle glaucoma,,
CVCL_4T05,CW70093,CW70093,,63Y,Male,African American,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35394; Primary open angle glaucoma,,
CVCL_4T06,CW70094,CW70094,,67Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35394; Primary open angle glaucoma,,
CVCL_4T07,CW70095,CW70095,,60Y,Male,,Induced pluripotent stem cell,,,,,,NCIt; C84391; Age-related macular degeneration,,
CVCL_4T08,CW70096,CW70096,,65Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_LK31,CW70097,CW70097,,56Y,Male,,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_DL87,CW70098,CW70098,,81Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34538; Diabetic retinopathy,,
CVCL_JJ36,CW70100,CW70100,,85Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_HJ21,CW70101,CW70101,,59Y,Female,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_DL88,CW70102,CW70102,,68Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_JJ37,CW70103,CW70103,,66Y,Female,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34538; Diabetic retinopathy,,
CVCL_JJ38,CW70104,CW70104,,70Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_DL89,CW70105,CW70105,,82Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_JJ39,CW70106,CW70106,,68Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_DL90,CW70107,CW70107,,82Y,Female,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_DL91,CW70108,CW70108,,82Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_DL92,CW70109,CW70109,,86Y,Female,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35394; Primary open angle glaucoma,,
CVCL_DL93,CW70110,CW70110,,93Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_DL94,CW70111,CW70111,,90Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34538; Diabetic retinopathy,,
CVCL_DL95,CW70112,CW70112,,84Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_DL96,CW70114,CW70114,,90Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_LK32,CW70115,CW70115,,71Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_4T09,CW70116,CW70116,,27Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34538; Diabetic retinopathy,,
CVCL_4T10,CW70117,CW70117,,90Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_DL97,CW70118,CW70118,,79Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_HJ22,CW70120,CW70120,,78Y,Female,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_4T11,CW70122,CW70122,,90Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_4T12,CW70123,CW70123,,72Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_DL98,CW70124,CW70124,,76Y,Female,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_4T13,CW70125,CW70125,,88Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_4T14,CW70127,CW70127,,68Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_4T15,CW70128,CW70128,,77Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_4T16,CW70129,CW70129,,31Y,Male,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34538; Diabetic retinopathy,,
CVCL_4T17,CW70130,CW70130,,82Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_JJ40,CW70131,CW70131,,74Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_HJ23,CW70132,CW70132,,80Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_DL99,CW70133,CW70133,,65Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_4T18,CW70134,CW70134,,69Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_4T19,CW70135,CW70135,,62Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_4T20,CW70136,CW70136,,74Y,Female,,Induced pluripotent stem cell,,,,,,NCIt; C84391; Age-related macular degeneration,,
CVCL_4T21,CW70137,CW70137,,75Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_JJ41,CW70138,CW70138,,81Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_DM00,CW70139,CW70139,,94Y,Male,,Induced pluripotent stem cell,,,,,,NCIt; C84391; Age-related macular degeneration,,
CVCL_HJ24,CW70140,CW70140,,58Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_4T22,CW70141,CW70141,,88Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_4T23,CW70142,CW70142,,82Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2985; Diabetes mellitus,,
CVCL_LK33,CW70143,CW70143,,51Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2986; Type 1 diabetes mellitus,,
CVCL_DM01,CW70144,CW70144,,75Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_DM02,CW70151,CW70151,,78Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_DM03,CW70152,CW70152,,76Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_LK34,CW70155,CW70155,,97Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_DM04,CW70156,CW70156,,64Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_DM05,CW70157,CW70157,,76Y,Female,,Induced pluripotent stem cell,,,,,,NCIt; C84391; Age-related macular degeneration,,
CVCL_DM06,CW70158,CW70158,,31Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_DM07,CW70159,CW70159,,50Y,Female,,Induced pluripotent stem cell,,,,,,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_DM08,CW70160,CW70160,,54Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34538; Diabetic retinopathy,,
CVCL_LJ29,CW70161,CW70161,,79Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_DM09,CW70163,CW70163,,77Y,Male,,Induced pluripotent stem cell,,,,,,NCIt; C84391; Age-related macular degeneration,,
CVCL_DM10,CW70164,CW70164,,83Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_DM11,CW70165,CW70165,,71Y,Male,Native North American,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_DM12,CW70166,CW70166,,77Y,Male,,Induced pluripotent stem cell,,,,,,NCIt; C84391; Age-related macular degeneration,,
CVCL_4T24,CW70167,CW70167,,90Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_DM13,CW70168,CW70168,,90Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_DM14,CW70170,CW70170,,48Y,Female,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_JJ42,CW70171,CW70171,,60Y,Female,Southeast Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_JJ43,CW70172,CW70172,,58Y,Male,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C27604; Non-neoplastic eye disorder,,
CVCL_DM15,CW70173,CW70173,,52Y,Male,Korean,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34538; Diabetic retinopathy,,
CVCL_DM16,CW70174,CW70174,,50Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_DM17,CW70175,CW70175,,62Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_DM18,CW70176,CW70176,,58Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C27604; Non-neoplastic eye disorder,,
CVCL_JJ44,CW70177,CW70177,,70Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_4T25,CW70178,CW70178,,55Y,Male,,Induced pluripotent stem cell,,,,,,NCIt; C34538; Diabetic retinopathy,,
CVCL_DM19,CW70179,CW70179,,86Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_DM20,CW70180,CW70180,,61Y,Male,,Induced pluripotent stem cell,,,,,,NCIt; C34538; Diabetic retinopathy,,
CVCL_4T26,CW70181,CW70181,,54Y,Male,African American,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C27604; Non-neoplastic eye disorder,,
CVCL_DM21,CW70182,CW70182,,77Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_DM22,CW70184,CW70184,,79Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,"NCIt; C84391; Age-related macular degeneration,NCIt; C26747; Type 2 diabetes mellitus",,
CVCL_DM23,CW70185,CW70185,,70Y,Female,Southeast Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34538; Diabetic retinopathy,,
CVCL_DM24,CW70186,CW70186,,83Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_DM25,CW70188,CW70188,,44Y,Female,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34538; Diabetic retinopathy,,
CVCL_DM26,CW70189,CW70189,,45Y,Male,Chinese,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35394; Primary open angle glaucoma,,
CVCL_DM27,CW70190,CW70190,,79Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35394; Primary open angle glaucoma,,
CVCL_DM28,CW70191,CW70191,,61Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C27604; Non-neoplastic eye disorder,,
CVCL_DM29,CW70193,CW70193,,89Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_DM30,CW70194,CW70194,,75Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_DM31,CW70195,CW70195,,72Y,Female,African American,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34538; Diabetic retinopathy,,
CVCL_DM32,CW70196,CW70196,,79Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_JJ45,CW70197,CW70197,,71Y,Male,Southeast Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34538; Diabetic retinopathy,,
CVCL_DM33,CW70198,CW70198,,73Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_LK35,CW70201,CW70201,,79Y,Female,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_JJ46,CW70203,CW70203,,45Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DM34,CW70205,CW70205,,39Y,Female,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_JJ47,CW70206,CW70206,,53Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_DM35,CW70207,CW70207,,51Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DM36,CW70208,CW70208,,37Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2986; Type 1 diabetes mellitus,,
CVCL_DM37,CW70210,CW70210,,70Y,Male,Japanese,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_DM38,CW70211,CW70211,,62Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,"NCIt; C34538; Diabetic retinopathy,NCIt; C26747; Type 2 diabetes mellitus",,
CVCL_DM39,CW70212,CW70212,,95Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_JJ48,CW70213,CW70213,,73Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_JJ49,CW70214,CW70214,,91Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_DM40,CW70215,CW70215,,78Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_DM41,CW70216,CW70216,,78Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_DM42,CW70217,CW70217,,82Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_JJ50,CW70219,CW70219,,77Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_DM43,CW70221,CW70221,,42Y,Female,Japanese,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_HJ25,CW70224,CW70224,,57Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DM44,CW70225,CW70225,,48Y,Female,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DM45,CW70226,CW70226,,84Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_DM46,CW70227,CW70227,,84Y,Female,,Induced pluripotent stem cell,,,,,,NCIt; C84391; Age-related macular degeneration,,
CVCL_DM47,CW70229,CW70229,,84Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_4T27,CW70230,CW70230,,73Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_HJ26,CW70232,CW70232,,78Y,Male,Chinese,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_HJ27,CW70233,CW70233,,92Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_DM48,CW70235,CW70235,,69Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_DM49,CW70239,CW70239,,68Y,Female,East Indian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_DM50,CW70240,CW70240,,98Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_DM51,CW70241,CW70241,,72Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DM52,CW70244,CW70244,,77Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_DM53,CW70245,CW70245,,75Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_DM54,CW70246,CW70246,,87Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_DM55,CW70247,CW70247,,84Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_HJ28,CW70248,CW70248,,80Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_DM56,CW70249,CW70249,,91Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_DM57,CW70250,CW70250,,77Y,Female,Chinese,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_DM58,CW70251,CW70251,,74Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DM59,CW70252,CW70252,,74Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DM60,CW70253,CW70253,,61Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C27604; Non-neoplastic eye disorder,,
CVCL_DM61,CW70254,CW70254,,60Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2986; Type 1 diabetes mellitus,,
CVCL_HJ29,CW70255,CW70255,,63Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_DM62,CW70256,CW70256,,61Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DM63,CW70257,CW70257,,47Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_JJ51,CW70258,CW70258,,27Y,Female,Chinese,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_JJ52,CW70259,CW70259,,48Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34538; Diabetic retinopathy,,
CVCL_DM64,CW70260,CW70260,,69Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_JJ53,CW70261,CW70261,,68Y,Female,Southeast Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_DM65,CW70262,CW70262,,66Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DM66,CW70263,CW70263,,40Y,Female,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34538; Diabetic retinopathy,,
CVCL_DM67,CW70264,CW70264,,56Y,Female,,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34538; Diabetic retinopathy,,
CVCL_JJ54,CW70265,CW70265,,86Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_DM68,CW70266,CW70266,,70Y,Female,African American,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34538; Diabetic retinopathy,,
CVCL_DM69,CW70267,CW70267,,20Y,Female,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DM70,CW70269,CW70269,,48Y,Male,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_JJ55,CW70270,CW70270,,72Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_DM71,CW70272,CW70272,,48Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_DM72,CW70273,CW70273,,61Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35394; Primary open angle glaucoma,,
CVCL_DM73,CW70274,CW70274,,80Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_DM74,CW70275,CW70275,,67Y,Male,African American,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_DM75,CW70276,CW70276,,64Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_DM76,CW70278,CW70278,,69Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_DM77,CW70279,CW70279,,62Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_DM78,CW70280,CW70280,,59Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34538; Diabetic retinopathy,,
CVCL_DM79,CW70281,CW70281,,64Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_DM80,CW70282,CW70282,,66Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_HJ30,CW70283,CW70283,,74Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_DM81,CW70284,CW70284,,69Y,Male,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_DM82,CW70286,CW70286,,68Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_DM83,CW70287,CW70287,,84Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_DM84,CW70289,CW70289,,79Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_JJ56,CW70290,CW70290,,71Y,Female,Southeast Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_DM85,CW70292,CW70292,,76Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_DM86,CW70296,CW70296,,49Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34538; Diabetic retinopathy,,
CVCL_DM87,CW70297,CW70297,,74Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_DM88,CW70298,CW70298,,84Y,Male,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C35394; Primary open angle glaucoma,,
CVCL_DM89,CW70299,CW70299,,47Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_JJ57,CW70300,CW70300,,28Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C27604; Non-neoplastic eye disorder,,
CVCL_DM90,CW70301,CW70301,,70Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DM91,CW70303,CW70303,,67Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_DM92,CW70304,CW70304,,52Y,Male,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_DM93,CW70305,CW70305,,56Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DM94,CW70306,CW70306,,59Y,Female,Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_DM95,CW70307,CW70307,,50Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_DM96,CW70308,CW70308,,50Y,Male,Caucasian and Japanese,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_DM97,CW70309,CW70309,,65Y,Female,Indian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34538; Diabetic retinopathy,,
CVCL_DM98,CW70310,CW70310,,67Y,Female,Southeast Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_DM99,CW70313,CW70313,,70Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34538; Diabetic retinopathy,,
CVCL_HJ31,CW70314,CW70314,,44Y,Male,Southeast Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2986; Type 1 diabetes mellitus,,
CVCL_DN00,CW70315,CW70315,,83Y,Male,Lebanese,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_DN01,CW70316,CW70316,,49Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_JJ58,CW70317,CW70317,,28Y,Male,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_DN02,CW70318,CW70318,,57Y,Male,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_DN03,CW70319,CW70319,,18Y,Female,Korean,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C27604; Non-neoplastic eye disorder,,
CVCL_DN04,CW70320,CW70320,,30Y,Male,,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2986; Type 1 diabetes mellitus,,
CVCL_DN05,CW70321,CW70321,,89Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_DN06,CW70322,CW70322,,60Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34538; Diabetic retinopathy,,
CVCL_DN07,CW70323,CW70323,,27Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C27604; Non-neoplastic eye disorder,,
CVCL_DN08,CW70324,CW70324,,65Y,Male,Southeast Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_DN09,CW70325,CW70325,,56Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_JJ59,CW70326,CW70326,,60Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C34538; Diabetic retinopathy,,
CVCL_HJ32,CW70327,CW70327,,69Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_DN10,CW70330,CW70330,,60Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DN11,CW70332,CW70332,,76Y,Female,Southeast Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_HJ33,CW70337,CW70337,,64Y,Female,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_DN12,CW70338,CW70338,,68Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_JJ60,CW70339,CW70339,,52Y,Male,Southeast Asian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C27604; Non-neoplastic eye disorder,,
CVCL_DN13,CW70341,CW70341,,74Y,Female,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_DN14,CW70342,CW70342,,50Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C27604; Non-neoplastic eye disorder,,
CVCL_LK36,CW70343,CW70343,,65Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_DN15,CW70344,CW70344,,62Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_DN16,CW70345,CW70345,,38Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_JJ61,CW70346,CW70346,,68Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C27604; Non-neoplastic eye disorder,,
CVCL_DN17,CW70347,CW70347,,74Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_HJ34,CW70348,CW70348,,44Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C27604; Non-neoplastic eye disorder,,
CVCL_HJ35,CW70350,CW70350,,17Y,Female,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2986; Type 1 diabetes mellitus,,
CVCL_HJ36,CW70351,CW70351,,61Y,Female,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_HJ37,CW70353,CW70353,,49Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2986; Type 1 diabetes mellitus,,
CVCL_HJ38,CW70354,CW70354,,49Y,Female,Cuban,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_JJ62,CW70355,CW70355,,68Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_JJ63,CW70356,CW70356,,31Y,Male,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C27604; Non-neoplastic eye disorder,,
CVCL_JJ64,CW70358,CW70358,,77Y,Male,Chinese,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_JJ65,CW70359,CW70359,,79Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_HJ39,CW70363,CW70363,,79Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,"NCIt; C84391; Age-related macular degeneration,NCIt; C26747; Type 2 diabetes mellitus",,
CVCL_HJ40,CW70364,CW70364,,76Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_LK37,CW70366,CW70366,,84Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_HJ41,CW70368,CW70368,,78Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_HJ42,CW70369,CW70369,,55Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C2986; Type 1 diabetes mellitus,,
CVCL_HJ43,CW70370,CW70370,,62Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_LK38,CW70371,CW70371,,52Y,Male,Latino or Hispanic,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_LK39,CW70372,CW70372,,54Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C84391; Age-related macular degeneration,,
CVCL_LK40,CW70373,CW70373,,55Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C27604; Non-neoplastic eye disorder,,
CVCL_RW12,CW70384,CW70384,,71Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_1155,D283 Med,,HTB-185,6Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0007795,"NCIt; C129445; Medulloblastoma, non-WNT/non-SHH, group 3",,
CVCL_0018,D341 Med,,HTB-187,3Y5M,Male,Caucasian,Cancer cell line,,,,,UBERON_0002037,"NCIt; C129445; Medulloblastoma, non-WNT/non-SHH, group 3",,
CVCL_4360,Dami,,CRL-9792,30Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000178,NCIt; C7152; Erythroleukemia, Mutation; HGNC; 6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Homozygous (from parent cell line).,
CVCL_1167,Daoy,,HTB-186,4Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0008788,"NCIt; C129442; Medulloblastoma, SHH-activated, TP53-mutant"," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (ATCC=HTB-186)., Mutation; HGNC; 11998; TP53; Simple; p.Cys242Phe (c.725G>T); ClinVar=VCV000376578; Zygosity=Homozygous (PubMed=22343310; ATCC=HTB-186; Cosmic-CLP=906833; DepMap=ACH-000211).",
CVCL_B5KW,Daudi-Luc2,,CCL-213-LUC2,16Y,Male,African,Cancer cell line,10376,Epstein-Barr virus (EBV).,,B-cell,UBERON_0000178,NCIt; C27694; EBV-related Burkitt lymphoma," Gene fusion; HGNC; 5477; IGH + HGNC; 7553; MYC; Name(s)=MYC-IGH (from parent cell line)., Mutation; HGNC; 2514; CTNNB1; Simple; p.Ala5_Ala80del (c.14_241del228); Zygosity=Homozygous (from parent cell line).",
CVCL_1168,DB,,CRL-2289,45Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0007795,NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type, Mutation; HGNC; 11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (Cosmic-CLP=906832).,
CVCL_1169,DBTRG-05MG,,CRL-2020,59Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000955,NCIt; C9477; Anaplastic astrocytoma, Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (ATCC=CRL-2020; Cosmic-CLP=906835; DepMap=ACH-000863).,
CVCL_1171,Detroit 562,,CCL-138,Age unspecified,Female,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C102872; Pharyngeal squamous cell carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=25275298).,
CVCL_2436,Detroit 6,,CCL-3,30Y6M,Female,African American,Cancer cell line,333761,Human papillomavirus type 18 (HPV18).,,,UBERON_0000002,NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma,,
CVCL_M618,Detroit 6 clone 12,,CCL-3.1,30Y6M,Female,African American,Cancer cell line,333761,Human papillomavirus type 18 (HPV18).,,,UBERON_0000002,NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma,,
CVCL_8188,Detroit 98,,CCL-18,30Y6M,Female,African American,Cancer cell line,333761,Human papillomavirus type 18 (HPV18).,,,UBERON_0000002,NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma,,
CVCL_8189,Detroit 98/AG,,CCL-18.2,30Y6M,Female,African American,Cancer cell line,333761,Human papillomavirus type 18 (HPV18).,,,UBERON_0000002,NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma,,
CVCL_8190,Detroit 98/AH-2,,CCL-18.3,30Y6M,Female,African American,Cancer cell line,333761,Human papillomavirus type 18 (HPV18).,,,UBERON_0000002,NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma,,
CVCL_8191,Detroit 98/AH-R,,CCL-18.4,30Y6M,Female,African American,Cancer cell line,333761,Human papillomavirus type 18 (HPV18).,,,UBERON_0000002,NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma,,
CVCL_8192,Detroit 98S,,CCL-18.1,30Y6M,Female,African American,Cancer cell line,333761,Human papillomavirus type 18 (HPV18).,,,UBERON_0000002,NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma,,
CVCL_0F29,DFCI-LU011,,CRL-2883,53Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C3512; Lung adenocarcinoma, Mutation; HGNC; 3236; EGFR; Simple; p.Leu747_Glu749del (c.2239_2247delTAAGAGAA); ClinVar=VCV000177765; Zygosity=Unspecified (PubMed=16983123).,
CVCL_0244,DG-75,,CRL-2625,10Y,Male,Jewish,Cancer cell line,,,,B-cell,UBERON_0000175,NCIt; C2912; Burkitt lymphoma, Mutation; HGNC; 959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Homozygous (PubMed=9583678).,
CVCL_0248,DLD-1,,CCL-221,67Y,Male,Caucasian,Cancer cell line,,,,Epithelial cell of colon,UBERON_0001155,NCIt; C4349; Colon adenocarcinoma," Mutation; HGNC; 173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (PubMed=12615714)., Mutation; HGNC; 583; APC; Simple; p.Lys993Asn (c.2979G>T); Zygosity=Unspecified (PubMed=24755471)., Mutation; HGNC; 583; APC; Simple; p.Arg2166Ter (c.6496C>T); ClinVar=VCV000438883; Zygosity=Unspecified (PubMed=24755471)., Mutation; HGNC; 914; B2M; Simple; p.Tyr30Ter (c.90C>A); Zygosity=Heterozygous (PubMed=8197130)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Unspecified (PubMed=12068308; PubMed=20570890; PubMed=24755471; PubMed=28683746)., Mutation; HGNC; 8975; PIK3CA; Simple; p.Asp549Asn (c.1645G>A); ClinVar=VCV000375900; Zygosity=Unspecified (PubMed=20570890; PubMed=24755471; PubMed=28683746)., Mutation; HGNC; 11998; TP53; Simple; p.Ser241Phe (c.722C>T); ClinVar=VCV000012359; Zygosity=Unspecified (PubMed=7651727; PubMed=16418264; PubMed=28683746).",
CVCL_1174,DMS 114,,CRL-2066,68Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C4917; Lung small cell carcinoma, Mutation; HGNC; 14446; PARD3B; Unexplicit; Ex2-14del; Zygosity=Homozygous (PubMed=20215515).,
CVCL_1175,DMS 153,,CRL-2064,44Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002107,NCIt; C4917; Lung small cell carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Thr155Pro (c.463A>C); Zygosity=Homozygous (PubMed=14660794; DepMap=ACH-000594).,
CVCL_1177,DMS 53,,CRL-2062,54Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C4917; Lung small cell carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Glu56Ter (c.166G>T); ClinVar=VCV001329425; Zygosity=Heterozygous (Cosmic-CLP=907295; DepMap=ACH-000698).,
CVCL_1178,DMS 79,,CRL-2049,65Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C4917; Lung small cell carcinoma," Mutation; HGNC; 9683; PTPRU; Simple; p.Glu442Ter (c.1324G>T); Zygosity=Heterozygous (Cosmic-CLP=753551; DepMap=ACH-000703)., Mutation; HGNC; 11998; TP53; Simple; p.Arg280Glufs*65 (c.837delG) (p.G279fs); Zygosity=Unspecified (DepMap=ACH-000703).",
CVCL_1181,DoTc2 4510,,CRL-7920,Age unspecified,Female,Caucasian,Cancer cell line,,,,Epithelial cell of uterus,UBERON_0000002,NCIt; C9039; Cervical carcinoma,,
CVCL_QX99,DS,,CRL-3381,70Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002371,NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type,,
CVCL_5278,DS-1 [Human],,CRL-3589,29Y,Female,,Cancer cell line,,,,,UBERON_0000175,"NCIt; C3457; B-cell non-Hodgkin lymphoma,ORDO; Orphanet_171915; B-cell non-Hodgkin lymphoma",,
CVCL_0105,DU145,,HTB-81,69Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000955,NCIt; C4863; Prostate carcinoma," Mutation; HGNC; 1787; CDKN2A; Simple; p.Asp84Tyr (c.250G>T) (p.Arg98Leu, c.293G>T); ClinVar=VCV000376306; Zygosity=Homozygous (PubMed=17088437; ATCC=HTB-81; Cosmic-CLP=905935; DepMap=ACH-000979)., Mutation; HGNC; 11389; STK11; Simple; p.Lys178fs*86 (c.532_536delAAGCC); Zygosity=Homozygous (PubMed=17088437)., Mutation; HGNC; 11998; TP53; Simple; p.Val274Phe (c.820G>T); ClinVar=VCV000376674; Zygosity=Heterozygous (PubMed=1873816; PubMed=8104329; PubMed=8510267; PubMed=11304728; PubMed=17088437; ATCC=HTB-81).",
CVCL_1183,DU4475,,CRL-7921,70Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002097,NCIt; C4872; Breast carcinoma," Gene deletion; HGNC; 6844; MAP2K4; Zygosity=Homozygous (PubMed=19593635)., Mutation; HGNC; 583; APC; Simple; p.Glu1577Ter (c.4729G>T); Zygosity=Homozygous (PubMed=19593635; ATCC=HTB-123).",
CVCL_X480,E006AA-hT,,CRL-3277,58Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002113,NCIt; C9385; Renal cell carcinoma," Mutation; HGNC; 9588; PTEN; Simple; p.Gln149Ter (c.445C>T); ClinVar=VCV000404164; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; c.560-2A>G; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line)., Mutation; HGNC; 12687; VHL; Simple; p.Gly104Alafs*55 (c.311delG); Zygosity=Homozygous (from parent cell line).",
CVCL_2027,EB1,,HTB-60,9Y,Female,African,Cancer cell line,10376,Epstein-Barr virus (EBV).,,B-cell,UBERON_0002397,NCIt; C27694; EBV-related Burkitt lymphoma, Mutation; HGNC; 11998; TP53; Simple; p.Gly244Asp (c.731G>A); ClinVar=VCV000372785; Zygosity=Unspecified (DepMap=ACH-000877).,
CVCL_1186,EB2,,HTB-61,7Y,Female,African,Cancer cell line,10376,Epstein-Barr virus (EBV).,,B-cell,UBERON_0000992,NCIt; C27694; EBV-related Burkitt lymphoma, Mutation; HGNC; 11110; ARID1A; Simple; p.Gln501Ter (c.1501C>T); Zygosity=Heterozygous (Cosmic-CLP=906846).,
CVCL_7260,ECC-1,,CRL-2923,39Y,Female,Japanese,Cancer cell line,,,,,UBERON_0001295,NCIt; C7359; Endometrial adenocarcinoma," Mutation; HGNC; 8979; PIK3R1; Simple; p.Leu570Pro (c.1709T>C); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 9177; POLE; Simple; p.Asn751fs (c.2252delA); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 9588; PTEN; Simple; p.Thr319fs*1 (c.950_953delTACT) (p.VL317fs) (V317fs*3); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.Met246Val (c.736A>G); ClinVar=VCV000100815; Zygosity=Heterozygous (from parent cell line).",
CVCL_2029,ECV-304,,CRL-1998,82Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0001255,NCIt; C4912; Bladder carcinoma," Mutation; HGNC; 5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).",
CVCL_T447,EH-118MG,,CRL-7719,47Y,Male,Caucasian,Cancer cell line,11886,RSV-EH].,,,UBERON_0000955,NCIt; C60781; Astrocytoma, Mutation; HGNC; 9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).,
CVCL_F666,EJ-30tgr,GM16260,,82Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0001255,NCIt; C4912; Bladder carcinoma," Mutation; HGNC; 5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).",
CVCL_3680,EL 1,,CRL-9854,37Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C8263; Adult acute monocytic leukemia," Gene fusion; HGNC; 16063; MLLT10 + HGNC; 15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line)., Mutation; HGNC; 9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line).",
CVCL_8193,EPLC-32M1,,CRL-2182,30Y6M,Female,African American,Cancer cell line,333761,Human papillomavirus type 18 (HPV18).,,,UBERON_0000002,NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma,,
CVCL_3509,ES-2,,CRL-1978,47Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000992,NCIt; C40078; Ovarian clear cell adenocarcinoma," Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22705003; PubMed=25230021; PubMed=28273451; Cosmic-CLP=1240128; DepMap=ACH-000906)., Mutation; HGNC; 11730; TERT; Simple; c.242_243CC>TT (-138/-139CC>TT); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).",
CVCL_J512,Esa-1,,HTB-83,14Y,Male,,Cancer cell line,,,,,,NCIt; C4817; Ewing sarcoma,,
CVCL_1218,FaDu,,HTB-43,56Y,Male,Indian,Cancer cell line,,,,,UBERON_0001051,NCIt; C4043; Hypopharyngeal squamous cell carcinoma," Mutation; HGNC; 1787; CDKN2A; Simple; c.151-1G>T; ClinVar=VCV000422058; Zygosity=Homozygous; Note=Splice acceptor mutation (ATCC=HTB-43; Cosmic-CLP=906863; DepMap=ACH-000846)., Mutation; HGNC; 11998; TP53; Simple; c.376-1G>A (p.Tyr126_Lys132del, c.376_396del21); ClinVar=VCV000481003; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=1394225; PubMed=11799138; PubMed=23613873; ATCC=HTB-43; Cosmic-CLP=906863; DepMap=ACH-000846).",
CVCL_A4CG,FaDu-Luc2,,HTB-43-LUC2,56Y,Male,Indian,Cancer cell line,,,,,UBERON_0001051,NCIt; C4043; Hypopharyngeal squamous cell carcinoma," Mutation; HGNC; 1787; CDKN2A; Simple; c.151-1G>T; ClinVar=VCV000422058; Zygosity=Homozygous; Note=Splice acceptor mutation (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; c.376-1G>A (p.Tyr126_Lys132del, c.376_396del21); ClinVar=VCV000481003; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).",
CVCL_3302,Farage,,CRL-2630,70Y,Female,Caucasian,Cancer cell line,10376,Epstein-Barr virus (EBV).,,,UBERON_0000027,NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type,,
CVCL_B6JL,Farage-Luc2,,CRL-2630-LUC2,70Y,Female,Caucasian,Cancer cell line,10376,Epstein-Barr virus (EBV).,,,UBERON_0000027,NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type,,
CVCL_1905,FL,,CCL-62,30Y6M,Female,African American,Cancer cell line,333761,Human papillomavirus type 18 (HPV18).,,,UBERON_0000002,NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma,,
CVCL_2909,G-292 clone A141B1,,CRL-1423,9Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002481,NCIt; C9145; Osteosarcoma, Gene fusion; HGNC; 2681; DAXX + HGNC; 6326; KIFC3; Name(s)=DAXX-KIFC3; Note=In frame (PubMed=30214690; PubMed=30872698).,
CVCL_1220,G-361,,CRL-1424,31Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002097,NCIt; C3224; Melanoma, Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=12068308; PubMed=15467732; ATCC=CRL-1424; Cosmic-CLP=906865; DepMap=ACH-000572).,
CVCL_0270,G-401,,CRL-1441,3M,Male,Caucasian,Cancer cell line,,,,,UBERON_0002113,NCIt; C8715; Rhabdoid tumor of the kidney, Gene deletion; HGNC; 11103; SMARCB1; Zygosity=Homozygous (PubMed=9671307; PubMed=10602515; PubMed=28945250).,
CVCL_1221,G-402,,CRL-1440,9M,Female,Caucasian,Cancer cell line,,,,,UBERON_0002113,NCIt; C3150; Kidney neoplasm,,
CVCL_1222,GA-10,,CRL-2392,41Y,Male,Caucasian,Cancer cell line,,,,B-cell,UBERON_0000178,NCIt; C7954; Adult Burkitt leukemia, Mutation; HGNC; 11998; TP53; Simple; p.Pro152Leu (c.455C>T); ClinVar=VCV000142766; Zygosity=Heterozygous (PubMed=11482875).,
CVCL_1223,GA-10 clone 20,,CRL-2394,41Y,Male,Caucasian,Cancer cell line,,,,B-cell,UBERON_0000178,NCIt; C7954; Adult Burkitt leukemia, Mutation; HGNC; 11998; TP53; Simple; p.Pro152Leu (c.455C>T); ClinVar=VCV000142766; Zygosity=Heterozygous (from parent cell line).,
CVCL_1224,GA-10 clone 4,,CRL-2393,41Y,Male,Caucasian,Cancer cell line,,,,B-cell,UBERON_0000178,NCIt; C7954; Adult Burkitt leukemia, Mutation; HGNC; 11998; TP53; Simple; p.Pro152Leu (c.455C>T); ClinVar=VCV000142766; Zygosity=Heterozygous (from parent cell line).,
CVCL_1229,GCT,,TIB-223,29Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C4247; Undifferentiated pleomorphic sarcoma," Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=12068308; ATCC=TIB-223; Cosmic-CLP=906999; DepMap=ACH-000835)., Mutation; HGNC; 11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Heterozygous (ATCC=TIB-223; Cosmic-CLP=906999; DepMap=ACH-000835).",
CVCL_1230,GDM-1,,CRL-2627,66Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000178,NCIt; C9154; Adult acute myeloid leukemia,,
CVCL_6395,GH329,,CRL-13002,30Y6M,Female,African American,Cancer cell line,333761,Human papillomavirus type 18 (HPV18).,,,UBERON_0000002,NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma,,
CVCL_6396,GH354,,CRL-13003,30Y6M,Female,African American,Cancer cell line,333761,Human papillomavirus type 18 (HPV18).,,,UBERON_0000002,NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma,,
CVCL_K171,GH364,,CRL-13004,30Y6M,Female,African American,Cancer cell line,333761,Human papillomavirus type 18 (HPV18).,,,UBERON_0000002,NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma,,
CVCL_H544,GHR3,GM15923,,82Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0001255,NCIt; C4912; Bladder carcinoma," Mutation; HGNC; 5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).",
CVCL_2254,Girardi Heart,,CCL-27,30Y6M,Female,African American,Cancer cell line,333761,Human papillomavirus type 18 (HPV18).,,,UBERON_0000002,NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma,,
CVCL_9Z58,GM01858,GM01858,,41Y,Male,Caucasian,Cancer cell line,,,,,,"NCIt; C3273; Neurofibromatosis type 1,ORDO; Orphanet_636; Neurofibromatosis type 1",,
CVCL_F188,GM03639,GM03639,,16Y,Female,,Cancer cell line,,,,T-cell,UBERON_0000178,NCIt; C7953; Childhood T acute lymphoblastic leukemia, Mutation; HGNC; 11998; TP53; None_reported; -; Zygosity=- (PubMed=2144611).,
CVCL_7935,253J,,HTB-108,53Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0035371,NCIt; C4912; Bladder carcinoma,,
CVCL_0D71,2A3 [Human squamous cell carcinoma],,CRL-3212,56Y,Male,Indian,Cancer cell line,,,,,UBERON_0001051,NCIt; C4043; Hypopharyngeal squamous cell carcinoma," Mutation; HGNC; 1787; CDKN2A; Simple; c.151-1G>T; ClinVar=VCV000422058; Zygosity=Homozygous; Note=Splice acceptor mutation (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; c.376-1G>A (p.Tyr126_Lys132del, c.376_396del21); ClinVar=VCV000481003; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).",
CVCL_6354,2B8 [Human Burkitt lymphoma],,CRL-12569,7Y,Male,African,Cancer cell line,10376,Epstein-Barr virus (EBV).,,B-cell,UBERON_0007795,NCIt; C27694; EBV-related Burkitt lymphoma," Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.Glu287Ter (c.859G>T); Zygosity=Unspecified (from parent cell line).",
CVCL_7940,486P,,HTB-7,61Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001255,NCIt; C4912; Bladder carcinoma,,
CVCL_F668,GM07489,GM07489,,13FW,Female,Southeast Asian,Cancer cell line,,,,,,NCIt; C3110; Hydatidiform mole,,
CVCL_UH45,GM11027,GM11027,,1Y4M,Male,Caucasian,Cancer cell line,,,,,,NCIt; C3270; Neuroblastoma,,
CVCL_UH46,GM11028,GM11028,,1Y4M,Male,Caucasian,Cancer cell line,,,,,,NCIt; C3270; Neuroblastoma,,
CVCL_F169,GM23225,GM23225,,20Y,Female,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C82342; Huntington's disease, Mutation; HGNC; 4851; HTT; Repeat_expansion; p.Gln18[71] (c.52CAG(71)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from parent cell line).,
CVCL_F170,GM23226,GM23226,,42Y,Female,Native North American,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C2986; Type 1 diabetes mellitus,,
CVCL_F176,GM23230,GM23230,,38Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002427,NCIt; C84587; Becker's muscular dystrophy,,
CVCL_F191,GM23232,GM23232,,3M,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3962; Adenosine deaminase deficiency, Mutation; HGNC; 186; ADA; Simple; p.Gly216Arg (c.646G>A); ClinVar=VCV000001968; Zygosity=Heterozygous (Coriell=GM23232).,
CVCL_F177,GM23262,GM23262,,6Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C84587; Becker's muscular dystrophy, Mutation; HGNC; 2928; DMD; Unexplicit; Ex45-53del; Zygosity=Hemizygous (from parent cell line).,
CVCL_F178,GM23279,GM23279,,36Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002067,,,
CVCL_F179,GM23280,GM23280,,36Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002067,,,
CVCL_F180,GM23298,GM23298,,8Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C75488; Rett syndrome," Mutation; HGNC; 6990; MECP2; Simple; p.Arg306Cys (c.916C>T) (p.Arg318Cys, c.952C>T); ClinVar=VCV000011824; Zygosity=Heterozygous (Coriell=GM23298).",
CVCL_CW86,GM23312,GM23312,,20Y,Male,,Cancer cell line,,,,,,NCIt; C3273; Neurofibromatosis type 1,,
CVCL_F182,GM23338,GM23338,,55Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002427,,,
CVCL_F184,GM23340,GM23340,,44Y,Male,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002427,,,
CVCL_F167,GM23392,GM23392,,20FW,Male,African American,Induced pluripotent stem cell,,,,Fibroblast of lung,UBERON_0005597,,,
CVCL_F166,GM23394,GM23394,,5M,Male,African American,Induced pluripotent stem cell,,,,Fibroblast of foreskin,UBERON_0001471,,,
CVCL_T815,GM23396,GM23396,,16FW,Female,African American,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_F192,GM23404,GM23404,,36Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C84718; Friedreich ataxia, Mutation; HGNC; 3951; FXN; Repeat_expansion; IVS1 GAA[330]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM23404).,
CVCL_T816,GM23411,GM23411,,3M,Female,Puerto Rican,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_F194,GM23413,GM23413,,16FW,Female,African American,Induced pluripotent stem cell,,,,Fibroblast of lung,UBERON_0005597,,,
CVCL_T817,GM23446,GM23446,,9Y,Female,African American,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_T802,GM23450,GM23450,,20FW,Male,African American,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_T841,GM23476,GM23476,,20Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_T803,GM23716,GM23716,,16FW,Female,African American,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_F195,GM23717,GM23717,,3Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C118783; Merosin-deficient congenital muscular dystrophy type 1A, Mutation; HGNC; 6482; LAMA2; Simple; p.Arg683Serfs*21 (c.2045_2046AG[2]) (c.2049_2050delAG); ClinVar=VCV000038340; Zygosity=Heterozygous (Coriell=GM23717).,
CVCL_T818,GM23720,GM23720,,22Y,Female,Caucasian,Induced pluripotent stem cell,10376,Epstein-Barr virus (EBV).,,,UBERON_0000178,,,
CVCL_T804,GM23760,GM23760,,26Y,Male,Jewish and Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3362; Schizophrenia,,
CVCL_T807,GM23761,GM23761,,27Y,Female,Jewish and Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002427,NCIt; C3362; Schizophrenia,,
CVCL_T808,GM23762,GM23762,,23Y,Male,Jewish,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3362; Schizophrenia,,
CVCL_U111,GM23764,GM23764,,27Y,Female,Jewish,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C34387; Anorexia nervosa,,
CVCL_T819,GM23913,GM23913,,30Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002427,NCIt; C84718; Friedreich ataxia, Mutation; HGNC; 3951; FXN; Repeat_expansion; IVS1 GAA[341]; ClinVar=VCV000561195; Zygosity=Heterozygous (from parent cell line).,
CVCL_T822,GM23937,GM23937,,1Y,Male,Jewish,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0004262,NCIt; C85184; Tay-Sachs disease, Mutation; HGNC; 4878; HEXA; Simple; p.Tyr427Ilefs*5 (c.1274_1277dupTATC) (c.1278insTATC); ClinVar=VCV000003889; Zygosity=Homozygous (Coriell=GM23937).,
CVCL_T825,GM24468,GM24468,,3Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002427,NCIt; C156310; Spinal muscular atrophy type 2, Gene amplification; HGNC; 11118; SMN2; Triplication; Zygosity=Unspecified (Coriell=GM24468).,
CVCL_T826,GM24474,GM24474,,30Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002427,, Gene amplification; HGNC; 11118; SMN2; Extensive; Zygosity=Unspecified; Note=5 copies (from parent cell line).,
CVCL_Y801,GM24559,GM24559,,2Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C84679; Dystrophia myotonica 1, Mutation; HGNC; 2933; DMPK; Repeat_expansion; c.*224CTG[~1700] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Heterozygous (from parent cell line).,
CVCL_1N90,GM24581,GM24581,,11Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_Y802,GM24683,GM24683,,13Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C2975; Cystic fibrosis, Mutation; HGNC; 1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (Coriell=GM24683).,
CVCL_Y803,GM25256,GM25256,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_1N93,GM25267,GM25267,,18Y,Female,Latino or Hispanic,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511+UBERON_0002067,NCIt; C137959; Long QT syndrome 3, Mutation; HGNC; 10593; SCN5A; Simple; p.Asn406Lys (c.1218C>A); ClinVar=VCV000067648; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM25267).,
CVCL_1N94,GM25305,GM25305,,48Y,Female,Chinese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511+UBERON_0002067,NCIt; C137957; Long QT syndrome 2, Mutation; HGNC; 6251; KCNH2; Simple; p.Ala422Thr (c.1264G>A); ClinVar=VCV000067174; Zygosity=Heterozygous (Coriell=GM25305).,
CVCL_5T43,GM25313,GM25313,,13Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C75482; Duchenne muscular dystrophy, Mutation; HGNC; 2928; DMD; Unexplicit; Ex45del; Zygosity=Hemizygous (Coriell=GM25313).,
CVCL_1N89,GM25318,GM25318,,26Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C75331; Tuberous sclerosis 2, Mutation; HGNC; 12363; TSC2; Simple; p.Arg1743Gln (c.5528G>A); ClinVar=VCV000049960; Zygosity=Heterozygous (Coriell=GM25318).,
CVCL_5T44,GM25541,GM25541,,9Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002427,NCIt; C61255; Lesch-Nyhan syndrome, Mutation; HGNC; 5157; HPRT1; Unexplicit; Ex2-3dup; Zygosity=Hemizygous (Coriell=GM25541).,
CVCL_VJ19,GM25864,GM25864,,9Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,"NCIt; C126864; Niemann-Pick disease, type C1", Mutation; HGNC; 7897; NPC1; Simple; p.Pro237Ser (c.709C>T); ClinVar=VCV000021142; Zygosity=Heterozygous (Coriell=GM25864).,
CVCL_IU31,GM26017,GM26017,,4Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C84691; Epidermolysis bullosa dystrophica,,
CVCL_IU33,GM26025,GM26025,,1Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002427,NCIt; C124852; Miller-Dieker syndrome,,
CVCL_IU30,GM26029,GM26029,,10Y,Male,Jewish,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C84798; Kearns-Sayre syndrome,,
CVCL_LP09,GM26077,GM26077,,74Y,Female,,Induced pluripotent stem cell,10376,Epstein-Barr virus (EBV).,,,UBERON_0000178,,,
CVCL_LP11,GM26105,GM26105,,45Y,Male,,Induced pluripotent stem cell,10376,Epstein-Barr virus (EBV).,,,UBERON_0000178,,,
CVCL_LP12,GM26107,GM26107,,33Y,Male,Chinese,Induced pluripotent stem cell,10376,Epstein-Barr virus (EBV).,,,UBERON_0000178,,,
CVCL_RU06,GM26644,GM26644,,2Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast,,NCIt; C61254; Krabbe disease," Mutation; HGNC; 4115; GALC; Unexplicit; Ex11-17del (30-KB DEL,IVS10); ClinVar=VCV000003819; Zygosity=Homozygous (Coriell=GM26644).",
CVCL_VI87,GM26650,GM26650,,57Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C34469; Choroideremia, Mutation; HGNC; 1940; CHM; Simple; c.189+1G>T (IVS3+1G>T); Zygosity=Hemizygous; Note=Splice donor mutation (Coriell=GM26650).,
CVCL_RU07,GM26656,GM26656,,1Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C61261; Hurler syndrome, Mutation; HGNC; 5391; IDUA; Simple; p.Trp402Ter (c.1205G>A); ClinVar=VCV000011908; Zygosity=Homozygous (Coriell=GM26656).,
CVCL_RT98,GM26663,GM26663,,20Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C34469; Choroideremia, Mutation; HGNC; 1940; CHM; Simple; p.Arg270Ter (c.808C>T); ClinVar=VCV000143078; Zygosity=Hemizygous (Coriell=GM26663).,
CVCL_ZG15,GM27102,GM27102,,13Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C2975; Cystic fibrosis, Mutation; HGNC; 1884; CFTR; Simple_corrected; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous; Note=By CRISPR/Cas9 (Coriell=GM27102).,
CVCL_VH44,GM27162,GM27162,,6Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C84897; Mucopolysaccharidosis type IIIA, Mutation; HGNC; 10818; SGSH; Simple; p.Arg245His (c.734G>A); ClinVar=VCV000005107; Zygosity=Heterozygous (Coriell=GM27162).,
CVCL_ZG16,GM27173,GM27173,,48Y,Female,Chinese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511+UBERON_0002067,NCIt; C137957; Long QT syndrome 2, Mutation; HGNC; 6251; KCNH2; Simple_corrected; p.Ala422Thr (c.1264G>A); ClinVar=VCV000067174; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (Coriell=GM27173).,
CVCL_VH45,GM27177,GM27177,,11Y,Female,,Induced pluripotent stem cell,10376,Epstein-Barr virus (EBV).,,,UBERON_0000178,NCIt; C85864; Neuronal ceroid lipofuscinosis type 2, Mutation; HGNC; 2073; TPP1; Simple; c.509-1G>A (IVS5-1G>A); ClinVar=VCV000207574; Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=GM27177).,
CVCL_XC52,GM27270,GM27270,,11Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_8480014,NCIt; C129872; Pitt-Hopkins syndrome, Mutation; HGNC; 11634; TCF4; Simple; p.Arg174Ter (c.520C>T); ClinVar=VCV000235853; Zygosity=Heterozygous (Coriell=GM27270).,
CVCL_VV62,GM27291,GM27291,,8Y,Male,Jewish,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002067,NCIt; C138174; Vici syndrome, Mutation; HGNC; 29331; EPG5; Simple; p.Gln336Arg (c.1007A>G); ClinVar=VCV000192333; Zygosity=Homozygous (PubMed=35700637).,
CVCL_VV71,GM27327,GM27327,,77Y,Female,,Induced pluripotent stem cell,10376,Epstein-Barr virus (EBV).,,,UBERON_0000178,NCIt; C172704; Facioscapulohumeral muscular dystrophy 1, Gene deletion; HGNC; 50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (from parent cell line).,
CVCL_XC50,GM27381,GM27381,,10Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C126746; Congenital disorder of deglycosylation," Mutation; HGNC; 1397; CACNA1S; Simple; p.Thr1354Ser (c.4060A>T); ClinVar=VCV000161208; Zygosity=Heterozygous (Coriell=GM27381)., Mutation; HGNC; 17646; NGLY1; Simple; p.Gly310Gly (c.930C>T); ClinVar=VCV000221583; Zygosity=Heterozygous (Coriell=GM27381).",
CVCL_WP03,GM27437,GM27437,,3Y,Female,Jewish,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C75488; Rett syndrome," Mutation; HGNC; 6990; MECP2; Simple; p.Leu386Argfs*8 (c.1157_1188del32) (p.Leu398Argfs*8, c.1193_1224del32) (1155del32); ClinVar=VCV000143366; Zygosity=Unspecified (Coriell=GM27437).",
CVCL_A8QQ,GM27463,GM27463,,Age unspecified,Male,Jewish,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,"NCIt; C126561; Niemann-Pick disease, type A", Mutation; HGNC; 11120; SMPD1; Simple; p.Leu304Pro (c.911T>C) (L302P); ClinVar=VCV000002989; Zygosity=Homozygous (Coriell=GM27463).,
CVCL_YE52,GM27464,GM27464,,2Y,Female,Jewish,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,"NCIt; C126561; Niemann-Pick disease, type A"," Mutation; HGNC; 11120; SMPD1; Simple; p.Phe333Serfs*52 (c.996delC) (P330fs, 990delC); ClinVar=VCV000002990; Zygosity=Heterozygous (Coriell=GM27464).",
CVCL_YE53,GM27578,GM27578,,2M,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C81315; Phenylketonuria, Mutation; HGNC; 8582; PAH; Simple; p.Phe299Cys (c.896T>G); ClinVar=VCV000000613; Zygosity=Heterozygous (Coriell=GM27578).,
CVCL_C7L3,GM27620,GM27620,,2Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,"NCIt; C176903; Rett syndrome, congenital variant", Mutation; HGNC; 3811; FOXG1; Simple; p.Glu154Glyfs*301 (c.460dupG); ClinVar=VCV000095268; Zygosity=Heterozygous (Coriell=GM27620).,
CVCL_YN46,GM27622,GM27622,,5Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,"NCIt; C176903; Rett syndrome, congenital variant", Mutation; HGNC; 3811; FOXG1; Simple; p.Gln86Profs*35 (c.256dupC); ClinVar=VCV000189613; Zygosity=Heterozygous (Coriell=GM27622).,
CVCL_C7KW,GM27624,GM27624,,5Y,Male,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,"NCIt; C176903; Rett syndrome, congenital variant", Gene deletion; HGNC; 3811; FOXG1; Zygosity=Heterozygous (from parent cell line).,
CVCL_YN47,GM27629,GM27629,,20Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,"NCIt; C176903; Rett syndrome, congenital variant", Mutation; HGNC; 3811; FOXG1; Simple; p.Asn232Ser (c.695A>G); ClinVar=VCV001698021; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM27629).,
CVCL_ZJ01,GM27717,GM27717,,67Y,Female,African American,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_ZH94,GM27730,GM27730,,45Y,Male,,Induced pluripotent stem cell,,,,,UBERON_0000178,,,
CVCL_A2SN,GM27857,GM27857,,4Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C125665; Cerebral creatine deficiency syndrome 1, Mutation; HGNC; 11055; SLC6A8; Unexplicit; Ex10-11del; Zygosity=Hemizygous (Coriell=GM27857).,
CVCL_ZH98,GM27860,GM27860,,1Y11M,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,"NCIt; C163754; Mental retardation, autosomal dominant 40", Mutation; HGNC; 20311; CHAMP1; Simple; p.Arg497Ter (c.1489C>T); ClinVar=VCV000210050; Zygosity=Heterozygous (Coriell=GM27860).,
CVCL_A2TB,GM27880,GM27880,,52Y,Male,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002427,"NCIt; C176903; Rett syndrome, congenital variant", Mutation; HGNC; 3811; FOXG1; Simple_edited; p.Ser19Glnfs*120 (c.53_54insT); Zygosity=Homozygous; Note=By CRISPR/Cas9 (Coriell=GM27880).,
CVCL_A2TC,GM27881,GM27881,,52Y,Male,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002427,"NCIt; C176903; Rett syndrome, congenital variant", Mutation; HGNC; 3811; FOXG1; Simple_edited; p.Phe18Thrfs*188 (c.49_58delTCGTTCAGCA); Zygosity=Homozygous; Note=By CRISPR/Cas9 (Coriell=GM27881).,
CVCL_A2TD,GM27882,GM27882,,52Y,Male,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002427,"NCIt; C176903; Rett syndrome, congenital variant", Mutation; HGNC; 3811; FOXG1; Simple_edited; p.Ser19Glnfs*120 (c.53_54insT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (Coriell=GM27882).,
CVCL_A2TE,GM27885,GM27885,,52Y,Male,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002427,,,
CVCL_A5MM,GM27918,GM27918,,21Y,Female,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C75469; Smith-Magenis syndrome,,
CVCL_A5MN,GM27925,GM27925,,7Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C98576; Osteogenesis imperfecta type IV, Mutation; HGNC; 2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM27925).,
CVCL_A9ZH,GM27930,GM27930,,6Y,Female,,Induced pluripotent stem cell,10376,Epstein-Barr virus (EBV).,,,UBERON_0000178,NCIt; C175210; Neurodegeneration with brain iron accumulation 5, Mutation; HGNC; 28912; WDR45; Simple; c.726-1G>A (c.729-1G>A) (IVS9-1G>A); ClinVar=VCV001803675; Zygosity=Heterozygous; Note=De novo mutation. Splice acceptor mutation (Coriell=GM27930).,
CVCL_A2TN,GM27933,GM27933,,5Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,"NCIt; C133742; Mental retardation, autosomal dominant 9", Mutation; HGNC; 888; KIF1A; Simple; p.Pro305Leu (c.914C>T); ClinVar=VCV000428604; Zygosity=Heterozygous (Coriell=GM27933).,
CVCL_A2TP,GM27934,GM27934,,2Y,Male,,Induced pluripotent stem cell,,,,,UBERON_0000178,"NCIt; C133742; Mental retardation, autosomal dominant 9", Mutation; HGNC; 888; KIF1A; Simple; p.Glu253Lys (c.757G>A); ClinVar=VCV000162059; Zygosity=Heterozygous (Coriell=GM27934).,
CVCL_A2TQ,GM27935,GM27935,,30Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,"NCIt; C133742; Mental retardation, autosomal dominant 9", Mutation; HGNC; 888; KIF1A; Simple; p.Cys151Tyr (c.452G>A); ClinVar=VCV000451648; Zygosity=Heterozygous (Coriell=GM27935).,
CVCL_A2TR,GM27936,GM27936,,4Y,Male,,Induced pluripotent stem cell,,,,,UBERON_0000178,"NCIt; C133742; Mental retardation, autosomal dominant 9", Mutation; HGNC; 888; KIF1A; Simple; p.Arg316Trp (c.946C>T); ClinVar=VCV000162060; Zygosity=Heterozygous (Coriell=GM27936).,
CVCL_A5MP,GM27937,GM27937,,18Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,"NCIt; C133742; Mental retardation, autosomal dominant 9", Mutation; HGNC; 888; KIF1A; Simple; p.Arg203Ser (c.609G>T); Zygosity=Mosaic (Coriell=GM27937).,
CVCL_A5MQ,GM27938,GM27938,,18Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,"NCIt; C133742; Mental retardation, autosomal dominant 9",,
CVCL_C7L6,GM27939,GM27939,,5Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C126690; Congenital muscular dystrophy-dystroglycanopathy with mental retardation type B2, Mutation; HGNC; 19743; POMT2; Simple; p.Gly353Ser (c.1057G>A); ClinVar=VCV000003231; Zygosity=Homozygous (Coriell=GM27939).,
CVCL_A5ML,GM27957,GM27957,,3Y,Female,Caucasian,Induced pluripotent stem cell,10376,Epstein-Barr virus (EBV).,,,UBERON_0000178,"NCIt; C178414; Mental retardation, autosomal dominant 5", Mutation; HGNC; 11497; SYNGAP1; Simple; p.Arg1240Ter (c.3718C>T); ClinVar=VCV000225077; Zygosity=Heterozygous (Coriell=GM27957).,
CVCL_A5MR,GM27978,GM27978,,4Y,Male,Caucasian and Native North American,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0004262,"NCIt; C163754; Mental retardation, autosomal dominant 40", Mutation; HGNC; 20311; CHAMP1; Simple; p.Ser181Cysfs*5 (c.542_543delCT); ClinVar=VCV000217909; Zygosity=Heterozygous (Coriell=GM27978).,
CVCL_B0IF,GM28249,GM28249,,1Y5M,Female,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C84611; Canavan disease," Mutation; HGNC; 756; ASPA; Simple; p.Gly176Asp (c.527C>A); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 4878; HEXA; Simple; p.Arg249Trp (c.745C>T); ClinVar=VCV000126510; Zygosity=Homozygous (from parent cell line).",
CVCL_B0IG,GM28252,GM28252,,17Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C75468; Charcot-Marie-Tooth disease type 1A, Gene amplification; HGNC; 9118; PMP22; Duplication; Zygosity=Unspecified (from parent cell line).,
CVCL_C0MD,GM28259,GM28259,,45Y,Female,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C85184; Tay-Sachs disease, Mutation; HGNC; 4878; HEXA; Simple; p.Gly269Ser (c.805G>A); ClinVar=VCV000003898; Zygosity=Heterozygous (Coriell=GM28259).,
CVCL_C0LV,GM28374,GM28374,,10Y,Female,Hispanic,Induced pluripotent stem cell,,,,Fibroblast of lung,UBERON_0002048,NCIt; C84927; Infantile neuroaxonal dystrophy,,
CVCL_C7MI,GM28399,GM28399,,10Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C84706; Familial dysautonomia, Mutation; HGNC; 5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Homozygous (Coriell=GM28399).,
CVCL_C0M4,GM28404,GM28404,,23Y,Male,Native Central American,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002427,,,
CVCL_D2ZG,GM28574,GM28574,,4Y,Female,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,"NCIt; C176903; Rett syndrome, congenital variant", Mutation; HGNC; 3811; FOXG1; Simple; p.Gln86Profs*35 (c.256dupC); ClinVar=VCV000189613; Zygosity=Heterozygous (Coriell=GM28574).,
CVCL_C7LV,GM28575,GM28575,,8M,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,"NCIt; C176903; Rett syndrome, congenital variant", Mutation; HGNC; 3811; FOXG1; Simple; p.Gly169Glyfs*23 (c.507del); Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM28575).,
CVCL_C7LW,GM28576,GM28576,,6Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,"NCIt; C176903; Rett syndrome, congenital variant", Mutation; HGNC; 3811; FOXG1; Simple; p.Trp308Ter (c.924G>A); ClinVar=VCV000013871; Zygosity=Unspecified; Note=De novo mutation (Coriell=GM28576).,
CVCL_C7LX,GM28577,GM28577,,2Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,"NCIt; C176903; Rett syndrome, congenital variant"," Mutation; HGNC; 13830; CNTNAP2; Simple; p.Ser269Asn (c.806G>A); ClinVar=VCV000373714; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 3811; FOXG1; Simple; p.Gly224Ser (c.670G>A); ClinVar=VCV000167092; Zygosity=Heterozygous (Coriell=GM28577).",
CVCL_C7LY,GM28578,GM28578,,7Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,"NCIt; C176903; Rett syndrome, congenital variant", Mutation; HGNC; 3811; FOXG1; Simple; p.Ser326Glufs*129 (c.974_975insA); Zygosity=Heterozygous (Coriell=GM28578).,
CVCL_C7LD,GM28589,GM28589,,18Y,Female,Chinese,Induced pluripotent stem cell,10376,Epstein-Barr virus (EBV).,,,UBERON_0000178,NCIt; C198575; Cerebral creatine deficiency syndrome 3, Mutation; HGNC; 4175; GATM; Simple; p.Ala97Valfs*11 (c.484+1G>T); ClinVar=VCV000021299; Zygosity=Homozygous (Coriell=GM28589).,
CVCL_C7MC,GM28603,GM28603,,5Y,Female,Caucasian,Induced pluripotent stem cell,10376,Epstein-Barr virus (EBV).,,,UBERON_0000178,NCIt; C198578; Female-restricted Wieacker-Wolff syndrome, Mutation; HGNC; 24931; ZC4H2; Unexplicit; 244kb microdeletion; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM28603).,
CVCL_C7P9,GM28862,GM28862,,8Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,"NCIt; C84814; Leigh disease,ORDO; Orphanet_506; Leigh syndrome", Mutation; HGNC; 11474; SURF1; Simple; p.Leu105Ter (c.312_321del10insAT) (p.Pro104_Leu105insTer); ClinVar=VCV000215237; Zygosity=Heterozygous (Coriell=GM28862).,
CVCL_D2ZH,GM28891,GM28891,,9Y,Female,Bangladeshi,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C150555; Schuurs-Hoeijmakers syndrome, Mutation; HGNC; 30032; PACS1; Simple; p.Arg203Trp (c.607C>T); ClinVar=VCV000039581; Zygosity=Heterozygous (Coriell=GM28891).,
CVCL_D2ZI,GM28907,GM28907,,16Y,Female,Caucasian and Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_C7LZ,GM28910,GM28910,,22Y,Female,Jewish,Induced pluripotent stem cell,10376,Epstein-Barr virus (EBV).,,,UBERON_0000178,NCIt; C129870; Nemaline myopathy 3, Mutation; HGNC; 129; ACTA1; Simple; p.Thr150Ala (c.448A>G); Zygosity=Heterozygous (Coriell=GM28910).,
CVCL_C7L9,GM28915,GM28915,,55Y,Female,Caucasian,Induced pluripotent stem cell,10376,Epstein-Barr virus (EBV).,,,UBERON_0000178,NCIt; C36107; Hereditary female breast carcinoma, Mutation; HGNC; 16627; CHEK2; Simple; p.Glu64Lys (c.190G>A); ClinVar=VCV000128068; Zygosity=Heterozygous (Coriell=GM28915).,
CVCL_D2ZJ,GM28930,GM28930,,8Y,Male,Jewish,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002067,NCIt; C138174; Vici syndrome, Mutation; HGNC; 29331; EPG5; Simple_corrected; p.Gln336Arg (c.1007A>G); ClinVar=VCV000192333; Zygosity=Homozygous; Note=By CRISPR/Cas9 (Coriell=GM28930).,
CVCL_C7M0,GM28937,GM28937,,4Y,Male,Caucasian,Induced pluripotent stem cell,10376,Epstein-Barr virus (EBV).,,,UBERON_0000178,NCIt; C125665; Cerebral creatine deficiency syndrome 1, Mutation; HGNC; 11055; SLC6A8; Simple; p.Phe408del (c.1216_1218TTC[2]) (c.1222_1224delTTC); ClinVar=VCV000011698; Zygosity=Hemizygous (Coriell=GM28937).,
CVCL_D2ZK,GM28955,GM28955,,16Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C75331; Tuberous sclerosis 2, Mutation; HGNC; 12363; TSC2; Simple; p.His522Thrfs*13 (c.1564delC); ClinVar=VCV000049640; Zygosity=Unspecified (Coriell=GM28955).,
CVCL_D2ZL,GM28959,GM28959,,17Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast,,NCIt; C75122; Tuberous sclerosis 1, Mutation; HGNC; 12362; TSC1; Simple; p.Trp750Ter (c.2249G>A); ClinVar=VCV000048922; Zygosity=Heterozygous (Coriell=GM28959).,
CVCL_D2ZM,GM28966,GM28966,,1Y,Male,Jewish,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0004262,NCIt; C85184; Tay-Sachs disease, Mutation; HGNC; 4878; HEXA; Simple_corrected; p.Tyr427Ilefs*5 (c.1274_1277dupTATC) (c.1278insTATC); ClinVar=VCV000003889; Zygosity=Homozygous; Note=By CRISPR/Cas9 (Coriell=GM28966).,
CVCL_D2ZN,GM28967,GM28967,,5Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0000178,"NCIt; C133742; Mental retardation, autosomal dominant 9", Mutation; HGNC; 888; KIF1A; Simple_corrected; p.Pro305Leu (c.914C>T); ClinVar=VCV000428604; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (Coriell=GM28967).,
CVCL_D2ZP,GM28978,GM28978,,26Y,Female,Korean,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002427,,,
CVCL_D3AI,GM29104,GM29104,,Age unspecified,Male,,Induced pluripotent stem cell,,,,,UBERON_0000178,"NCIt; C163754; Mental retardation, autosomal dominant 40",,
CVCL_D3AJ,GM29112,GM29112,,1Y9M,Male,,Induced pluripotent stem cell,10376,Epstein-Barr virus (EBV).,,,UBERON_0000178,NCIt; C118784; Nemaline myopathy 2," Mutation; HGNC; 4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Heterozygous (Coriell=GM29112)., Mutation; HGNC; 7720; NEB; Simple; p.Tyr8107Asnfs*74 (c.24318_24319insAA); ClinVar=VCV000422612; Zygosity=Heterozygous (Coriell=GM29112).",
CVCL_3334,H1HeLa,,CRL-1958,30Y6M,Female,African American,Cancer cell line,333761,Human papillomavirus type 18 (HPV18).,,,UBERON_0000002,NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma,,
CVCL_2461,H33HJ-JA1,,CRL-8163,14Y,Male,Caucasian,Cancer cell line,,,,T-cell,UBERON_0000178,NCIt; C7953; Childhood T acute lymphoblastic leukemia," Mutation; HGNC; 959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).",
CVCL_1239,H4,,HTB-148,37Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000955,NCIt; C60781; Astrocytoma," Gene deletion; HGNC; 9588; PTEN; Zygosity=Homozygous (PubMed=10560660)., Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).",
CVCL_3513,H69AR,,CRL-11351,55Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C4917; Lung small cell carcinoma," Mutation; HGNC; 8975; PIK3CA; Simple; p.Gly106_Arg108del (c.317_325delGGCAACCGT); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.Glu171Ter (c.511G>T); ClinVar=VCV000634771; Zygosity=Homozygous (from parent cell line).",
CVCL_4T78,H69PR,,CRL-11350,55Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C4917; Lung small cell carcinoma," Mutation; HGNC; 8975; PIK3CA; Simple; p.Gly106_Arg108del (c.317_325delGGCAACCGT); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.Glu171Ter (c.511G>T); ClinVar=VCV000634771; Zygosity=Homozygous (from parent cell line).",
CVCL_1240,H9,,HTB-176,53Y,Male,Caucasian,Cancer cell line,,,,T-cell,UBERON_0000178,NCIt; C3366; Sezary syndrome," Gene deletion; HGNC; 7208; MPDZ; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Homozygous (Cosmic-CLP=907043; DepMap=ACH-002240).",
CVCL_3514,H9/HTLV-IIIB,,CRL-8543,53Y,Male,Caucasian,Cancer cell line,,,,T-cell,UBERON_0000178,NCIt; C3366; Sezary syndrome," Gene deletion; HGNC; 7208; MPDZ; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Homozygous (from parent cell line).",
CVCL_S898,HAC15,,CRL-3301,48Y,Female,,Cancer cell line,,,,,UBERON_0002369,NCIt; C9325; Adrenal cortex carcinoma, Mutation; HGNC; 2514; CTNNB1; Simple; p.Ser45Pro (c.133T>C); ClinVar=VCV000017589; Zygosity=Heterozygous (from parent cell line).,
CVCL_8690,HAEND,AG13420,,61Y,Male,,Cancer cell line,,,,,,NCIt; C3088; Angiosarcoma,,
CVCL_AT91,HBMEC-2,,CRL-3023,82Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0001255,NCIt; C4912; Bladder carcinoma," Mutation; HGNC; 5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).",
CVCL_3374,HCC1007,,CRL-2318,67Y,Female,African American,Cancer cell line,,,,,UBERON_0000310,NCIt; C4017; Breast ductal carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Asp281His (c.841G>C); ClinVar=VCV000376588; Zygosity=Unspecified (PubMed=9865903).,
CVCL_1244,HCC1008,,CRL-2320,67Y,Female,African American,Cancer cell line,,,,,UBERON_0001097,NCIt; C4017; Breast ductal carcinoma,,
CVCL_1245,HCC1143,,CRL-2321,52Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000310,NCIt; C4017; Breast ductal carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (PubMed=28889351; ATCC=CRL-2321).,
CVCL_1247,HCC1187,,CRL-2322,41Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000310,NCIt; C4017; Breast ductal carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Gly108del (c.322_324delGGT); ClinVar=VCV000156516; Zygosity=Homozygous (Cosmic-CLP=749711; DepMap=ACH-000111).,
CVCL_1249,HCC1395,,CRL-2324,43Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000310,NCIt; C4017; Breast ductal carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (PubMed=9865903; Cosmic-CLP=749712; DepMap=ACH-000699).,
CVCL_1251,HCC1419,,CRL-2326,42Y,Female,,Cancer cell line,,,,,UBERON_0000310,NCIt; C4017; Breast ductal carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Ala74fs*47 (c.220_226delGCCCCTG); Zygosity=Heterozygous (Cosmic-CLP=907045).,
CVCL_1252,HCC1428,,CRL-2327,49Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C5214; Breast adenocarcinoma, Gene fusion; HGNC; 73; ABCG1 + HGNC; 11024; SLC37A1; Name(s)=SLC37A1-ABCG1 (PubMed=25485619).,
CVCL_1254,HCC1500,,CRL-2329,32Y,Female,African American,Cancer cell line,,,,,UBERON_0000310,NCIt; C4017; Breast ductal carcinoma,,
CVCL_1255,HCC1569,,CRL-2330,70Y,Female,African American,Cancer cell line,,,,,UBERON_0000310,NCIt; C4017; Breast ductal carcinoma," Mutation; HGNC; 1101; BRCA2; Simple; p.Asn1100Thr (c.3299A>C); Zygosity=Heterozygous (Cosmic-CLP=907046; DepMap=ACH-000930)., Mutation; HGNC; 3701; FHIT; Simple; p.Val97Phe (c.289G>T) (651G>T); dbSNP=rs139666727; Zygosity=Heterozygous; Note=Germline (PubMed=9288768)., Mutation; HGNC; 11998; TP53; Simple; p.Glu294Ter (c.880G>T); ClinVar=VCV000379471; Zygosity=Heterozygous (PubMed=9865903; Cosmic-CLP=907046; DepMap=ACH-000930).",
CVCL_1256,HCC1599,,CRL-2331,44Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000310,NCIt; C4017; Breast ductal carcinoma, Mutation; HGNC; 11998; TP53; Simple; c.673-2A>T (IVS6-2A>T); ClinVar=VCV000635388; Zygosity=Homozygous; Note=Splice acceptor mutation (Cosmic-CLP=749713; DepMap=ACH-000196).,
CVCL_9877,HCC1739,,CRL-2333,51Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000310,NCIt; C4017; Breast ductal carcinoma,,
CVCL_1258,HCC1806,,CRL-2335,60Y,Female,African American,Cancer cell line,,,,,UBERON_0000310,"NCIt; C40359; Breast squamous cell carcinoma, acantholytic variant", Mutation; HGNC; 3701; FHIT; Unexplicit; Ex4del; Zygosity=Homozygous (PubMed=9288768).,
CVCL_0290,HCC1937,,CRL-2336,24Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000310,NCIt; C4017; Breast ductal carcinoma," Gene deletion; HGNC; 9588; PTEN; Zygosity=Homozygous (PubMed=17334996; PubMed=19593635)., Mutation; HGNC; 9884; RB1; Simple; p.Thr738_Arg775del38 (c.2212_2325del114); Zygosity=Homozygous (PubMed=19593635)., Mutation; HGNC; 11876; TMPRSS2; Simple; p.Val197Met (c.589G>A) (p.Val160Met, c.478G>A); dbSNP=rs12329760; Zygosity=Homozygous (PubMed=34339474).",
CVCL_1259,HCC1954,,CRL-2338,61Y,Female,East Indian,Cancer cell line,,,,,UBERON_0000310,NCIt; C4017; Breast ductal carcinoma," Gene fusion; HGNC; 2092; CLTC + HGNC; 29559; VMP1; Name(s)=CLTC-VMP1 (PubMed=23637631)., Mutation; HGNC; 11998; TP53; Simple; p.Tyr163Cys (c.488A>G); ClinVar=VCV000127814; Zygosity=Homozygous (PubMed=28889351; ATCC=CRL-2338).",
CVCL_2062,HCC202,,CRL-2316,82Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000310,NCIt; C4017; Breast ductal carcinoma, Mutation; HGNC; 8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (Cosmic-CLP=1290906; DepMap=ACH-000725).,
CVCL_1261,HCC2157,,CRL-2340,48Y,Female,African American,Cancer cell line,,,,,UBERON_0000310,NCIt; C4017; Breast ductal carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (Cosmic-CLP=749715).,
CVCL_3375,HCC2185,,CRL-2342,49Y,Female,,Cancer cell line,,,,,UBERON_0000175,NCIt; C76328; Metastatic breast lobular carcinoma,,
CVCL_1263,HCC2218,,CRL-2343,38Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000310,NCIt; C4017; Breast ductal carcinoma, Mutation; HGNC; 7029; MET; Simple; c.3083-1G>T; Zygosity=Homozygous; Note=Splice acceptor mutation (Cosmic-CLP=749716).,
CVCL_5131,HCC2279,,CRL-2870,52Y,Female,Asian,Cancer cell line,,,,,UBERON_0002048,NCIt; C9133; Lung adenosquamous carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Tyr234Cys (c.701A>G); ClinVar=VCV000127820; Zygosity=Unspecified (PubMed=10353731).,
CVCL_1265,HCC2935,,CRL-2869,39Y,Male,Caucasian,Cancer cell line,,,,,,NCIt; C3512; Lung adenocarcinoma, Mutation; HGNC; 583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (DepMap=ACH-000150).,
CVCL_1267,HCC38,,CRL-2314,50Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000310,NCIt; C4017; Breast ductal carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Arg273Leu (c.818G>T); ClinVar=VCV000376655; Zygosity=Homozygous (PubMed=9865903; ATCC=CRL-2314).,
CVCL_1269,HCC4006,,CRL-2871,>50Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C3512; Lung adenocarcinoma, Mutation; HGNC; 3236; EGFR; Simple; p.Leu747_Glu749del (c.2239_2247delTAAGAGAA); ClinVar=VCV000177765; Zygosity=Heterozygous (ATCC=CRL-2871; DepMap=ACH-000066).,
CVCL_1270,HCC70,,CRL-2315,49Y,Female,African American,Cancer cell line,,,,Epithelial cell of mammary gland,UBERON_0000310,NCIt; C4017; Breast ductal carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (PubMed=9865903; PubMed=28889351; ATCC=CRL-2315).,
CVCL_3378,HCC712,,CRL-2317,41Y,Female,Asian,Cancer cell line,,,,,UBERON_0000310,NCIt; C4017; Breast ductal carcinoma,,
CVCL_2063,HCC827,,CRL-2868,39Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C3512; Lung adenocarcinoma, Mutation; HGNC; 3236; EGFR; Simple; p.Glu746_Ala750del (c.2236_2250del15); ClinVar=VCV000177620; Zygosity=Heterozygous (DepMap=ACH-000012).,
CVCL_C9CW,HCC827-GAS-Luc2,,CRL-2868-GAS-LUC2,39Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C3512; Lung adenocarcinoma, Mutation; HGNC; 3236; EGFR; Simple; p.Glu746_Ala750del (c.2236_2250del15); ClinVar=VCV000177620; Zygosity=Heterozygous (from parent cell line).,
CVCL_0291,HCT 116,,CCL-247,48Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4910; Colon carcinoma," Mutation; HGNC; 173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (PubMed=12615714; Cosmic-CLP=905936; DepMap=ACH-000971)., Mutation; HGNC; 1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (PubMed=17088437; DepMap=ACH-000971)., Mutation; HGNC; 1787; CDKN2A; Simple; p.Glu33Argfs*20 (c.97delG); Zygosity=Heterozygous (DepMap=ACH-000971)., Mutation; HGNC; 3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (Cosmic-CLP=905936; DepMap=ACH-000971)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (PubMed=12068308; PubMed=17088437; PubMed=20570890; PubMed=24755471; PubMed=28683746; Cosmic-CLP=905936; DepMap=ACH-000971)., Mutation; HGNC; 9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (PubMed=23649806; DepMap=ACH-000971)., Mutation; HGNC; 11998; TP53; None_reported; -; Zygosity=- (PubMed=9715273; PubMed=15900046; PubMed=16418264).",
CVCL_VU38,HCT 116-Luc2 [ATCC],,CCL-247-LUC2,48Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4910; Colon carcinoma," Mutation; HGNC; 173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).",
CVCL_0292,HCT 15,,CCL-225,67Y,Male,Caucasian,Cancer cell line,,,,Epithelial cell of colon,UBERON_0001155,NCIt; C4349; Colon adenocarcinoma," Mutation; HGNC; 583; APC; Simple; p.Arg727Met (c.2180G>T); Zygosity=Heterozygous (PubMed=17088437; PubMed=24755471; Cosmic-CLP=905937; DepMap=ACH-000997)., Mutation; HGNC; 583; APC; Simple; p.Ile1417Leufs*2 (c.4248delC); Zygosity=Heterozygous (PubMed=17088437; PubMed=24755471; Cosmic-CLP=905937; DepMap=ACH-000997)., Mutation; HGNC; 914; B2M; Simple; c.68-1G>T; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=8197130; Cosmic-CLP=905937; DepMap=ACH-000997)., Mutation; HGNC; 1101; BRCA2; Simple; p.Cys1200Terfs (c.3599_3600delGT) (3827delGT); Zygosity=Heterozygous (PubMed=17088437; Cosmic-CLP=905937; DepMap=ACH-000997)., Mutation; HGNC; 16627; CHEK2; Simple; p.Arg145Trp (c.433C>T); ClinVar=VCV000005592; Zygosity=Heterozygous (PubMed=18167186; Cosmic-CLP=905937; DepMap=ACH-000997)., Mutation; HGNC; 8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (PubMed=17088437; PubMed=20570890; PubMed=24755471; PubMed=28683746; Cosmic-CLP=905937; DepMap=ACH-000997)., Mutation; HGNC; 11998; TP53; Simple; p.Ser241Phe (c.722C>T); ClinVar=VCV000012359; Zygosity=Heterozygous (PubMed=9000147; PubMed=15900046; PubMed=17088437; PubMed=28683746; Cosmic-CLP=905937; DepMap=ACH-000997).",
CVCL_A4BZ,HCT-15-Luc2,,CCL-225-LUC2,67Y,Male,Caucasian,Cancer cell line,,,,Epithelial cell of colon,UBERON_0001155,NCIt; C4349; Colon adenocarcinoma," Mutation; HGNC; 583; APC; Simple; p.Arg727Met (c.2180G>T); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 583; APC; Simple; p.Ile1417Leufs*2 (c.4248delC); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 914; B2M; Simple; c.68-1G>T; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line)., Mutation; HGNC; 1101; BRCA2; Simple; p.Cys1200Terfs (c.3599_3600delGT) (3827delGT); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 16627; CHEK2; Simple; p.Arg145Trp (c.433C>T); ClinVar=VCV000005592; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.Ser241Phe (c.722C>T); ClinVar=VCV000012359; Zygosity=Heterozygous (from parent cell line).",
CVCL_UR40,HCT116 VIM RFP,,CCL-247EMT,48Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4910; Colon carcinoma," Mutation; HGNC; 173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).",
CVCL_D4CF,HCT116-MTCH1-KO-c4,,CRL-3498,48Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4910; Colon carcinoma," Mutation; HGNC; 173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).",CRISPR/Cas9; HGNC; 17586; MTCH1.
CVCL_D4CG,HCT116-MTCH1-KO-c7,,CRL-3499,48Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4910; Colon carcinoma," Mutation; HGNC; 173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).",CRISPR/Cas9; HGNC; 17586; MTCH1.
CVCL_D4CH,HCT116-SLC10A4-KO-c2,,CRL-3504,48Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4910; Colon carcinoma," Mutation; HGNC; 173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).",CRISPR/Cas9; HGNC; 22980; SLC10A4.
CVCL_D4CI,HCT116-SLC10A4-KO-c8,,CRL-3505,48Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4910; Colon carcinoma," Mutation; HGNC; 173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).",CRISPR/Cas9; HGNC; 22980; SLC10A4.
CVCL_D4CJ,HCT116-SLC15A4-KO-c10,,CRL-3510,48Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4910; Colon carcinoma," Mutation; HGNC; 173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).",CRISPR/Cas9; HGNC; 23090; SLC15A4.
CVCL_D4CK,HCT116-SLC15A4-KO-c12,,CRL-3511,48Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4910; Colon carcinoma," Mutation; HGNC; 173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).",CRISPR/Cas9; HGNC; 23090; SLC15A4.
CVCL_D4CL,HCT116-SLC25A14-KO-c10,,CRL-3482,48Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4910; Colon carcinoma," Mutation; HGNC; 173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).",CRISPR/Cas9; HGNC; 10984; SLC25A14.
CVCL_D4CM,HCT116-SLC25A14-KO-c11,,CRL-3483,48Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4910; Colon carcinoma," Mutation; HGNC; 173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).",CRISPR/Cas9; HGNC; 10984; SLC25A14.
CVCL_D4CN,HCT116-SLC25A15-KO-c6,,CRL-3484,48Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4910; Colon carcinoma," Mutation; HGNC; 173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).",CRISPR/Cas9; HGNC; 10985; SLC25A15.
CVCL_D4CP,HCT116-SLC25A15-KO-c7,,CRL-3485,48Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4910; Colon carcinoma," Mutation; HGNC; 173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).",CRISPR/Cas9; HGNC; 10985; SLC25A15.
CVCL_D4CQ,HCT116-SLC25A16-KO-c4,,CRL-3486,48Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4910; Colon carcinoma," Mutation; HGNC; 173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).",CRISPR/Cas9; HGNC; 10986; SLC25A16.
CVCL_D4CR,HCT116-SLC25A16-KO-c7,,CRL-3487,48Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4910; Colon carcinoma," Mutation; HGNC; 173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).",CRISPR/Cas9; HGNC; 10986; SLC25A16.
CVCL_D4CS,HCT116-SLC25A17-KO-c2,,CRL-3490,48Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4910; Colon carcinoma," Mutation; HGNC; 173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).",CRISPR/Cas9; HGNC; 10987; SLC25A17.
CVCL_D4CT,HCT116-SLC25A17-KO-c4,,CRL-3491,48Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4910; Colon carcinoma," Mutation; HGNC; 173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).",CRISPR/Cas9; HGNC; 10987; SLC25A17.
CVCL_D4CU,HCT116-SLC25A23-KO-c2,,CRL-3488,48Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4910; Colon carcinoma," Mutation; HGNC; 173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).",CRISPR/Cas9; HGNC; 19375; SLC25A23.
CVCL_D4CV,HCT116-SLC25A23-KO-c9,,CRL-3489,48Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4910; Colon carcinoma," Mutation; HGNC; 173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).",CRISPR/Cas9; HGNC; 19375; SLC25A23.
CVCL_D4CW,HCT116-SLC25A24-KO-c3,,CRL-3492,48Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4910; Colon carcinoma," Mutation; HGNC; 173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).",CRISPR/Cas9; HGNC; 20662; SLC25A24.
CVCL_D4D9,HCT116-SLC25A24-KO-c4,,CRL-3493,48Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4910; Colon carcinoma," Mutation; HGNC; 173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).",CRISPR/Cas9; HGNC; 20662; SLC25A24.
CVCL_D4CX,HCT116-SLC25A44-KO-c2,,CRL-3494,48Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4910; Colon carcinoma," Mutation; HGNC; 173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).",CRISPR/Cas9; HGNC; 29036; SLC25A44.
CVCL_D4CY,HCT116-SLC25A44-KO-c6,,CRL-3495,48Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4910; Colon carcinoma," Mutation; HGNC; 173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).",CRISPR/Cas9; HGNC; 29036; SLC25A44.
CVCL_D4CZ,HCT116-SLC25A46-KO-c11,,CRL-3506,48Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4910; Colon carcinoma," Mutation; HGNC; 173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).",CRISPR/Cas9; HGNC; 25198; SLC25A46.
CVCL_D4D0,HCT116-SLC25A46-KO-c12,,CRL-3507,48Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4910; Colon carcinoma," Mutation; HGNC; 173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).",CRISPR/Cas9; HGNC; 25198; SLC25A46.
CVCL_D4D1,HCT116-SLC25A6-KO-c4,,CRL-3496,48Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4910; Colon carcinoma," Mutation; HGNC; 173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).",CRISPR/Cas9; HGNC; 10992; SLC25A6.
CVCL_D4D2,HCT116-SLC25A6-KO-c8,,CRL-3497,48Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4910; Colon carcinoma," Mutation; HGNC; 173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).",CRISPR/Cas9; HGNC; 10992; SLC25A6.
CVCL_D4D3,HCT116-SLC27A2-KO-c10,,CRL-3508,48Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4910; Colon carcinoma," Mutation; HGNC; 173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).",CRISPR/Cas9; HGNC; 10996; SLC27A2.
CVCL_D4D4,HCT116-SLC27A2-KO-c7,,CRL-3509,48Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4910; Colon carcinoma," Mutation; HGNC; 173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).",CRISPR/Cas9; HGNC; 10996; SLC27A2.
CVCL_D4D5,HCT116-SLC35B3-KO-c11,,CRL-3500,48Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4910; Colon carcinoma," Mutation; HGNC; 173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).",CRISPR/Cas9; HGNC; 21601; SLC35B3.
CVCL_D4D6,HCT116-SLC35B3-KO-c9,,CRL-3501,48Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4910; Colon carcinoma," Mutation; HGNC; 173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).",CRISPR/Cas9; HGNC; 21601; SLC35B3.
CVCL_D4D7,HCT116-SLC35F2-KO-c2,,CRL-3502,48Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4910; Colon carcinoma," Mutation; HGNC; 173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).",CRISPR/Cas9; HGNC; 23615; SLC35F2.
CVCL_D4D8,HCT116-SLC35F2-KO-c3,,CRL-3503,48Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4910; Colon carcinoma," Mutation; HGNC; 173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).",CRISPR/Cas9; HGNC; 23615; SLC35F2.
CVCL_B367,HD-Mar,,CRL-2626,20Y,Male,,Cancer cell line,,,,T-cell,UBERON_0000175,NCIt; C7226; Adult T lymphoblastic lymphoma,,
CVCL_0293,HEC-1-A,,HTB-112,71Y,Female,Japanese,Cancer cell line,,,,,UBERON_0001295,NCIt; C7359; Endometrial adenocarcinoma," Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=12068308; DepMap=ACH-000954)., Mutation; HGNC; 7329; MSH6; Simple; c.4001+1G>T; ClinVar=VCV001736936; Zygosity=Heterozygous; Note=Splice donor mutation (DepMap=ACH-000954)., Mutation; HGNC; 11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (PubMed=15053063; PubMed=15901131; DepMap=ACH-000954).",
CVCL_0294,HEC-1-B,,HTB-113,71Y,Female,Japanese,Cancer cell line,,,,,UBERON_0001295,NCIt; C7359; Endometrial adenocarcinoma," Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (DepMap=ACH-000941)., Mutation; HGNC; 7329; MSH6; Simple; c.4001+1G>T; ClinVar=VCV001736936; Zygosity=Heterozygous; Note=Splice donor mutation (DepMap=ACH-000941)., Mutation; HGNC; 9588; PTEN; None_reported; -; Zygosity=- (PubMed=20944090).",
CVCL_0126,5637,,HTB-9,68Y,Male,,Cancer cell line,,,,,UBERON_0001255,NCIt; C4912; Bladder carcinoma," Mutation; HGNC; 6871; MAPK1; Simple; p.Arg79Lys (c.236G>A); Zygosity=Heterozygous (ATCC=HTB-9; Cosmic-CLP=687452; DepMap=ACH-000905)., Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680; PubMed=31068700).",
CVCL_6344,5637 subclone 1A6,,CRL-2742,68Y,Male,,Cancer cell line,,,,,UBERON_0001255,NCIt; C4912; Bladder carcinoma," Mutation; HGNC; 6871; MAPK1; Simple; p.Arg79Lys (c.236G>A); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).",
CVCL_7941,575A,,HTB-8,59Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001255,NCIt; C4912; Bladder carcinoma,,
CVCL_1048,639V,,HTB-109,69Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000056,NCIt; C4830; Ureter urothelial carcinoma," Mutation; HGNC; 1787; CDKN2A; Simple; p.Arg58Ter (c.172C>T) (p.Pro72Leu, c.215C>T); ClinVar=VCV000376310; Zygosity=Heterozygous (Cosmic-CLP=906798; DepMap=ACH-000973)., Mutation; HGNC; 9588; PTEN; Simple; p.Arg130Gln (c.389G>A); ClinVar=VCV000007829; Zygosity=Heterozygous (Cosmic-CLP=906798; DepMap=ACH-000973)., Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680).",
CVCL_1049,647V,,HTB-110,59Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001255,NCIt; C4912; Bladder carcinoma," Mutation; HGNC; 3373; EP300; Simple; p.Gln993Ter (c.2977C>T); Zygosity=Homozygous (Cosmic-CLP=906797; DepMap=ACH-000896)., Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680)., Mutation; HGNC; 11998; TP53; Simple; p.Glu336Ter (c.1006G>T); Zygosity=Heterozygous (Cosmic-CLP=906797; DepMap=ACH-000896).",
CVCL_6869,6T-CEM,,CRL-8296,3Y11M,Female,Caucasian,Cancer cell line,,,,T-cell,UBERON_0000178,NCIt; C7953; Childhood T acute lymphoblastic leukemia," Gene fusion; HGNC; 13222; BCL11B + HGNC; 2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line)., Mutation; HGNC; 3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).",
CVCL_1050,769-P,,CRL-1933,63Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002113,NCIt; C9385; Renal cell carcinoma,,
CVCL_1051,786-O,,CRL-1932,58Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002113,NCIt; C9385; Renal cell carcinoma," Mutation; HGNC; 9588; PTEN; Simple; p.Gln149Ter (c.445C>T); ClinVar=VCV000404164; Zygosity=Homozygous (PubMed=17088437; Cosmic-CLP=905947; DepMap=ACH-000649)., Mutation; HGNC; 11998; TP53; Simple; c.560-2A>G; Zygosity=Heterozygous; Note=Splice acceptor mutation (Cosmic-CLP=905947; DepMap=ACH-000649)., Mutation; HGNC; 12687; VHL; Simple; p.Gly104Alafs*55 (c.311delG); Zygosity=Homozygous (PubMed=7915601; PubMed=17088437; Cosmic-CLP=905947; DepMap=ACH-000649).",
CVCL_3484,8E5(CEM),,CRL-3617,3Y11M,Female,Caucasian,Cancer cell line,,,,T-cell,UBERON_0000178,NCIt; C7953; Childhood T acute lymphoblastic leukemia," Gene fusion; HGNC; 13222; BCL11B + HGNC; 2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line)., Mutation; HGNC; 3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).",
CVCL_U614,93T449,,CRL-3043,68Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0003693,NCIt; C6505; Atypical lipomatous tumor/well differentiated liposarcoma,,
CVCL_U613,94T778,,CRL-3044,69Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0003693,NCIt; C6505; Atypical lipomatous tumor/well differentiated liposarcoma,,
CVCL_0131,A-172,,CRL-1620,53Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000955,NCIt; C3058; Glioblastoma," Gene deletion; HGNC; 9588; PTEN; Zygosity=Homozygous (PubMed=9090379)., Mutation; HGNC; 5382; IDH1; None_reported; -; Zygosity=- (PubMed=19435942).",
CVCL_1058,A-204,,CRL-7900,1Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0001630,NCIt; C8971; Embryonal rhabdomyosarcoma, Mutation; HGNC; 11103; SMARCB1; Simple; p.Gln182Alafs*28 (c.543_544delTC); Zygosity=Heterozygous (PubMed=10602515; Cosmic-CLP=910784; DepMap=ACH-000201).,
CVCL_1060,A-253,,CRL-7902,54Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001736,NCIt; C5943; Submandibular gland squamous cell carcinoma," Mutation; HGNC; 1787; CDKN2A; Simple; p.Ala17fs*5 (c.49_61delGCCACGGCCGCGG); Zygosity=Heterozygous (ATCC=HTB-41; Cosmic-CLP=906794; DepMap=ACH-000740)., Mutation; HGNC; 9588; PTEN; Simple; p.Leu152Pro (c.455T>C); ClinVar=VCV000536551; Zygosity=Homozygous (Cosmic-CLP=906794; DepMap=ACH-000740).",
CVCL_0132,A-375,,CRL-1619,54Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002097,NCIt; C3802; Amelanotic melanoma," Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (PubMed=12068308; PubMed=15467732; PubMed=26405815; PubMed=29492214; ATCC=CRL-1619; Cosmic-CLP=906793; DepMap=ACH-000219)., Mutation; HGNC; 1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (PubMed=29492214; ATCC=CRL-1619; Cosmic-CLP=906793; DepMap=ACH-000219).",
CVCL_UD29,A-375 KRAS p.G13D,,CRL-1619IG-1,54Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002097,NCIt; C3802; Amelanotic melanoma," Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).",
CVCL_UR34,A-375 KRAS p.G13D-Luc2,,CRL-1619IG-1-LUC2,54Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002097,NCIt; C3802; Amelanotic melanoma," Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).",
CVCL_UD28,A-375 MEK1 p.Q56P,,CRL-1619IG-3,54Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002097,NCIt; C3802; Amelanotic melanoma," Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).",
CVCL_JF22,A-375 NRAS p.Q61K,,CRL-1619IG-2,54Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002097,NCIt; C3802; Amelanotic melanoma," Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).",
CVCL_VR65,A-375 NRAS p.Q61K-Luc2,,CRL-1619IG-2-LUC2,54Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002097,NCIt; C3802; Amelanotic melanoma," Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).",
CVCL_S186,A-382,,CRL-7903,10Y,Male,,Cancer cell line,,,,,UBERON_0000955,NCIt; C3058; Glioblastoma,,
CVCL_1063,A-388,,CRL-7905,86Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C4819; Skin squamous cell carcinoma," Mutation; HGNC; 3236; EGFR; Simple; p.Arg832Cys (c.2494C>T); ClinVar=VCV000936373; Zygosity=Heterozygous (ATCC=CRL-7905; DepMap=ACH-001442)., Mutation; HGNC; 11998; TP53; Simple; p.Cys135Phe (c.404G>T); ClinVar=VCV000376559; Zygosity=Heterozygous (ATCC=CRL-7905; Cosmic-CLP=910697; DepMap=ACH-001442).",
CVCL_1055,A-427,,CRL-7906,52Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C3512; Lung adenocarcinoma," Mutation; HGNC; 2514; CTNNB1; Simple; p.Thr41Ala (c.121A>G); ClinVar=VCV000017580; Zygosity=Homozygous (ATCC=HTB-53; DepMap=ACH-000757)., Mutation; HGNC; 11998; TP53; None_reported; -; Zygosity=- (PubMed=10536175; PubMed=20557307).",
CVCL_0037,A-431,,CRL-1555,85Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0001003,NCIt; C4819; Skin squamous cell carcinoma, Gene fusion; HGNC; 3236; EGFR + HGNC; 9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (PubMed=23637631).,
CVCL_A4BS,A-431-Luc2,,CRL-1555-LUC2,85Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0001003,NCIt; C4819; Skin squamous cell carcinoma, Gene fusion; HGNC; 3236; EGFR + HGNC; 9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).,
CVCL_1056,A-498,,CRL-7908,52Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002113,NCIt; C9385; Renal cell carcinoma," Mutation; HGNC; 8976; PIK3CB; Simple; p.Asp1067Val (c.3200A>T); Zygosity=Heterozygous (PubMed=26759240; Cosmic-CLP=905948; DepMap=ACH-000555)., Mutation; HGNC; 12687; VHL; Simple; p.Val142fs*30 (c.425_429delTTGAC); Zygosity=Unspecified (PubMed=8493574).",
CVCL_0023,A-549,,CCL-185,58Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C3512; Lung adenocarcinoma," Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (PubMed=1855224; PubMed=12794755; PubMed=17088437)., Mutation; HGNC; 11998; TP53; None_reported; -; Zygosity=- (PubMed=10536175; PubMed=15900046; PubMed=20557307).",
CVCL_0080,A-673,,CRL-1598,15Y,Female,Caucasian,Cancer cell line,,,,,,NCIt; C4817; Ewing sarcoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (PubMed=19787792; PubMed=25010205; PubMed=25223734; ATCC=CRL-1598)., Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=12068308; PubMed=22142829; PubMed=25010205; ATCC=CRL-1598; Cosmic-CLP=684052; DepMap=ACH-000052).",
CVCL_1065,A-704,,CRL-7911,78Y,Male,African American,Cancer cell line,,,,Epithelial cell of kidney,UBERON_0002113,NCIt; C9385; Renal cell carcinoma," Mutation; HGNC; 11998; TP53; Simple; p.Tyr126Asp (c.376T>G); ClinVar=VCV000265333; Zygosity=Heterozygous (Cosmic-CLP=910920)., Mutation; HGNC; 11998; TP53; Simple; p.Glu258Ter (c.772G>T); ClinVar=VCV000486557; Zygosity=Heterozygous (Cosmic-CLP=910920).",
CVCL_1057,A101D,,CRL-7898,56Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C3224; Melanoma, Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=12068308; ATCC=CRL-7898; Cosmic-CLP=910921; DepMap=ACH-000008).,
CVCL_1059,A2058,,CRL-3601,43Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C3802; Amelanotic melanoma," Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=12068308; PubMed=15048078; PubMed=15467732; PubMed=22383533; PubMed=24576830; ATCC=CRL-3601; Cosmic-CLP=906792; DepMap=ACH-000788)., Mutation; HGNC; 11998; TP53; Simple; p.Val274Phe (c.820G>T); ClinVar=VCV000376674; Zygosity=Homozygous (Cosmic-CLP=906792; DepMap=ACH-000788).",
CVCL_UR32,A375-Luc2,,CRL-1619-LUC2,54Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002097,NCIt; C3802; Amelanotic melanoma," Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).",
CVCL_X494,A375-MA1,,CRL-3222,54Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002097,NCIt; C3802; Amelanotic melanoma," Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).",
CVCL_X495,A375-MA2,,CRL-3223,54Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002097,NCIt; C3802; Amelanotic melanoma," Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).",
CVCL_6233,A375-P,,CRL-3224,54Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002097,NCIt; C3802; Amelanotic melanoma," Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).",
CVCL_0136,A375.S2,,CRL-1872,54Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002097,NCIt; C3802; Amelanotic melanoma," Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).",
CVCL_3485,A431NS,,CRL-2592,85Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0001003,NCIt; C4819; Skin squamous cell carcinoma, Gene fusion; HGNC; 3236; EGFR + HGNC; 9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).,
CVCL_VR73,A549 dCas9-KRAB,,CCL-185dCas9-KRAB,58Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C3512; Lung adenocarcinoma, Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).,
CVCL_JK07,A549 EML4-ALK,,CCL-185IG,58Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C3512; Lung adenocarcinoma, Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).,
CVCL_VR66,A549 EML4-ALK-Luc2,,CCL-185IG-LUC2,58Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C3512; Lung adenocarcinoma, Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).,
CVCL_LI35,A549 VIM RFP,,CCL-185EMT,58Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C3512; Lung adenocarcinoma, Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).,
CVCL_UR31,A549-Luc2,,CCL-185-LUC2,58Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C3512; Lung adenocarcinoma, Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).,
CVCL_UJ49,A549/SF,,CCL-185.1,58Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C3512; Lung adenocarcinoma, Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).,
CVCL_0001,HEL,GM06141,,30Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000178,NCIt; C7152; Erythroleukemia, Mutation; HGNC; 6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Homozygous (PubMed=16408098).,
CVCL_2481,HEL 92.1.7,,TIB-180,30Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000178,NCIt; C7152; Erythroleukemia, Mutation; HGNC; 6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Homozygous (from parent cell line).,
CVCL_0030,HeLa,,CCL-2,30Y6M,Female,African American,Cancer cell line,333761,Human papillomavirus type 18 (HPV18).,,,UBERON_0000002,NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma,,
CVCL_1276,HeLa 229,,CCL-2.1,30Y6M,Female,African American,Cancer cell line,333761,Human papillomavirus type 18 (HPV18).,,,UBERON_0000002,NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma,,
CVCL_B0A4,HeLa IFITM1/2/3-KO,,CRL-3452,30Y6M,Female,African American,Cancer cell line,333761,Human papillomavirus type 18 (HPV18).,,,UBERON_0000002,NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma,,"CRISPR/Cas9; HGNC; 5412; IFITM1.,CRISPR/Cas9; HGNC; 5414; IFITM3."
CVCL_1277,HeLa NR1,,CRL-13011,30Y6M,Female,African American,Cancer cell line,333761,Human papillomavirus type 18 (HPV18).,,,UBERON_0000002,NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma,,
CVCL_0058,HeLa S3,,CCL-2.2,30Y6M,Female,African American,Cancer cell line,333761,Human papillomavirus type 18 (HPV18).,,,UBERON_0000002,NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma,,
CVCL_B053,HeLaRC32,,CRL-2972,30Y6M,Female,African American,Cancer cell line,333761,Human papillomavirus type 18 (HPV18).,,,UBERON_0000002,NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma,,
CVCL_1278,HeLaSF,,CCL-2.3,30Y6M,Female,African American,Cancer cell line,333761,Human papillomavirus type 18 (HPV18).,,,UBERON_0000002,NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma,,
CVCL_0326,Hep 3B2.1-7,,HB-8064,8Y,Male,African American,Cancer cell line,10407,Hepatitis B virus (HBV).,,,UBERON_0002107,NCIt; C7955; Childhood hepatocellular carcinoma, Mutation; HGNC; 903; AXIN1; Simple; p.Arg146Ter (c.436C>T); Zygosity=Homozygous (PubMed=31395879; Cosmic-CLP=1240147; DepMap=ACH-000625).,
CVCL_1906,HEp-2,,CCL-23,30Y6M,Female,African American,Cancer cell line,333761,Human papillomavirus type 18 (HPV18).,,,UBERON_0000002,NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma,,
CVCL_0027,Hep-G2,,HB-8065,15Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002107,NCIt; C3728; Hepatoblastoma, Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (PubMed=8389256; PubMed=12068308; DepMap=ACH-000739).,
CVCL_3701,Hep-G2/2.2.1,,CRL-11997,15Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002107,NCIt; C3728; Hepatoblastoma, Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).,
CVCL_1098,Hep-G2/C3A,,CRL-3581,15Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002107,NCIt; C3728; Hepatoblastoma, Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (PubMed=12068308; Cosmic-CLP=910850; DepMap=ACH-001021).,
CVCL_AS98,Hep-G2/SF,,HB-8065.1,15Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002107,NCIt; C3728; Hepatoblastoma, Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).,
CVCL_M177,HepAD38,,CRL-3561,15Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002107,NCIt; C3728; Hepatoblastoma, Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).,
CVCL_TZ61,HepF,,CRL-7925,67Y,Male,,Cancer cell line,,,,,UBERON_0007795,NCIt; C7956; Adult hepatocellular carcinoma,,
CVCL_1N69,HepG2/C3A-2.5B1,,CRL-3533,15Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002107,NCIt; C3728; Hepatoblastoma, Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).,
CVCL_2Z96,HEY-T30,,CRL-3252,Age unspecified,Female,Caucasian,Cancer cell line,,,,,UBERON_0000992,NCIt; C105555; High grade ovarian serous adenocarcinoma, Mutation; HGNC; 1097; BRAF; Simple; p.Gly464Glu (c.1391G>A); ClinVar=VCV000013964; Zygosity=Homozygous (from parent cell line).,
CVCL_UI84,HF,,CRL-3383,77Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type,,
CVCL_1280,HH [Human lymphoma],,CRL-2105,61Y,Male,Caucasian,Cancer cell line,,,,T-cell,UBERON_0000178,NCIt; C3467; Primary cutaneous T-cell non-Hodgkin lymphoma, Gene fusion; HGNC; 6036; FOXK2 + HGNC; 15979; TP63; Name(s)=FOXK2-TP63 (PubMed=31160637).,
CVCL_0002,HL-60,,CCL-240,36Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000178,NCIt; C9154; Adult acute myeloid leukemia," Gene deletion; HGNC; 11998; TP53; Zygosity=Homozygous (PubMed=2858093)., Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (PubMed=12068308; PubMed=17088437; Cosmic-CLP=905938; DepMap=ACH-000002).",
CVCL_2493,HL-60 clone 15,,CRL-1964,36Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000178,NCIt; C9154; Adult acute myeloid leukemia," Gene deletion; HGNC; 11998; TP53; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).",
CVCL_A4BY,HL-60-Luc2,,CCL-240-LUC2,36Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000178,NCIt; C9154; Adult acute myeloid leukemia," Gene deletion; HGNC; 11998; TP53; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).",
CVCL_3332,HL-60/MX1,,CRL-2258,36Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000178,NCIt; C9154; Adult acute myeloid leukemia," Gene deletion; HGNC; 11998; TP53; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).",
CVCL_3333,HL-60/MX2,,CRL-2257,36Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000178,NCIt; C9154; Adult acute myeloid leukemia," Gene deletion; HGNC; 11998; TP53; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).",
CVCL_II77,HL-60/S4,,CRL-3306,36Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000178,NCIt; C9154; Adult acute myeloid leukemia," Gene deletion; HGNC; 11998; TP53; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).",
CVCL_3317,HMCB,,CRL-9607,,Female,Caucasian,Cancer cell line,,,,,,NCIt; C3224; Melanoma," Mutation; HGNC; 1787; CDKN2A; Simple; p.Trp110Ter (c.330G>A) (p.Gly125Arg, c.373G>A); ClinVar=VCV000376303; Zygosity=Homozygous (DepMap=ACH-000931)., Mutation; HGNC; 11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Homozygous (DepMap=ACH-000931).",
CVCL_0312,HOS,,CRL-1543,13Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000981,NCIt; C9145; Osteosarcoma, Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (PubMed=19787792).,
CVCL_3715,HP,,CRL-12012,35Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001269,NCIt; C3043; Fibrosarcoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).",
CVCL_3517,HPAC,,CRL-2119,64Y,Female,Caucasian,Cancer cell line,,,,Pancreatic ductal cell,UBERON_0001264,NCIt; C8294; Pancreatic adenocarcinoma," Mutation; HGNC; 1787; CDKN2A; Simple; p.Glu120Ter (c.358G>T); Zygosity=Unspecified (PubMed=15367885)., Mutation; HGNC; 11998; TP53; None_reported; -; Zygosity=- (PubMed=15367885).",
CVCL_0313,HPAF-II,,CRL-1997,44Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0007795,NCIt; C9120; Pancreatic ductal adenocarcinoma," Mutation; HGNC; 1787; CDKN2A; Simple; p.Arg29_Ala34del (c.85_102del18); Zygosity=Heterozygous (PubMed=11787853; PubMed=15367885; Cosmic-CLP=724869; DepMap=ACH-000094)., Mutation; HGNC; 11998; TP53; Simple; p.Pro151Ser (c.451C>T); ClinVar=VCV000012370; Zygosity=Homozygous (PubMed=11787853; PubMed=15367885; Cosmic-CLP=724869; DepMap=ACH-000094).",
CVCL_2514,HRT-18,,CCL-244,67Y,Male,Caucasian,Cancer cell line,,,,Epithelial cell of colon,UBERON_0001155,NCIt; C4349; Colon adenocarcinoma, Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (PubMed=12068308; DepMap=ACH-001091).,
CVCL_2515,HRT-18G,,CRL-3609,67Y,Male,Caucasian,Cancer cell line,,,,Epithelial cell of colon,UBERON_0001155,NCIt; C4349; Colon adenocarcinoma, Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).,
CVCL_N606,Hs 101.T,,CRL-7067,58Y,Male,,Cancer cell line,,,,,UBERON_0002113,NCIt; C9385; Renal cell carcinoma,,
CVCL_N499,Hs 126.T,,CRL-7080,62Y,Female,,Cancer cell line,,,,,UBERON_0002113,NCIt; C9385; Renal cell carcinoma,,
CVCL_0646,Hs 127.T,,CRL-7081,64Y,Male,,Cancer cell line,,,,,,NCIt; C4247; Undifferentiated pleomorphic sarcoma,,
CVCL_N305,Hs 13.T,,CRL-7010,10Y,Female,,Cancer cell line,,,,,UBERON_0002481,NCIt; C9145; Osteosarcoma,,
CVCL_0648,Hs 132.T,,CRL-7085,49Y,Male,Caucasian,Cancer cell line,,,,Fibroblast,,NCIt; C27005; Spindle cell sarcoma,,
CVCL_0650,Hs 14.T,,CRL-7823,45Y,Female,,Cancer cell line,,,,,UBERON_0002481,NCIt; C9145; Osteosarcoma,,
CVCL_S296,Hs 140.T,,CRL-7830,24Y,Male,,Cancer cell line,,,,,,NCIt; C2946; Chondrosarcoma,,
CVCL_N635,Hs 141.T,,CRL-7089,17Y,Male,,Cancer cell line,,,,,UBERON_0002481,NCIt; C9145; Osteosarcoma,,
CVCL_N637,Hs 148.T,,CRL-7095,55Y,Male,,Cancer cell line,,,,,,NCIt; C9385; Renal cell carcinoma,,
CVCL_0655,Hs 15.T,,CRL-7824,46Y,Male,,Cancer cell line,,,,,,NCIt; C3043; Fibrosarcoma,,
CVCL_N567,Hs 175.T,,CRL-7125,33Y,Female,,Cancer cell line,,,,,,NCIt; C9385; Renal cell carcinoma,,
CVCL_S299,Hs 183.T,,CRL-7835,42Y,Male,,Cancer cell line,,,,,UBERON_0000473,NCIt; C3756; Mixed embryonal carcinoma and teratoma,,
CVCL_0668,Hs 184.T,,CRL-7134,21Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002481,NCIt; C9145; Osteosarcoma,,
CVCL_N466,Hs 185.T,,CRL-7135,76Y,Female,,Cancer cell line,,,,,UBERON_0002481,NCIt; C9145; Osteosarcoma,,
CVCL_N467,Hs 187.T,,CRL-7139,56Y,Female,,Cancer cell line,,,,,UBERON_0001052,NCIt; C9383; Rectal adenocarcinoma,,
CVCL_0670,Hs 188.T,,CRL-7140,18Y,Male,,Cancer cell line,,,,,UBERON_0002481,NCIt; C9145; Osteosarcoma,,
CVCL_0671,Hs 190.T,,CRL-7145,11Y,Female,,Cancer cell line,,,,,,NCIt; C3262; Neoplasm,,
CVCL_N579,Hs 191.T,,CRL-7146,68Y,Male,,Cancer cell line,,,,,UBERON_0001255,NCIt; C4912; Bladder carcinoma,,
CVCL_N580,Hs 192.T,,CRL-7147,8Y,Male,,Cancer cell line,,,,,,NCIt; C3400; Synovial sarcoma,,
CVCL_0673,Hs 195.T,,CRL-7150,58Y,Male,,Cancer cell line,,,,,UBERON_0001255,NCIt; C4912; Bladder carcinoma,,
CVCL_N582,Hs 197.T,,CRL-7151,13Y,Male,,Cancer cell line,,,,,,NCIt; C3400; Synovial sarcoma,,
CVCL_0676,Hs 200.T,,CRL-7159,79Y,Male,,Cancer cell line,,,,,UBERON_0001052,NCIt; C9383; Rectal adenocarcinoma,,
CVCL_N460,Hs 205.T,,CRL-7167,38Y,Male,,Cancer cell line,,,,,,NCIt; C3194; Liposarcoma,,
CVCL_S445,Hs 206.T,,CRL-7837,19Y,Female,,Cancer cell line,,,,,,NCIt; C9118; Sarcoma,,
CVCL_3519,Hs 207.T,,CRL-7168,66Y,Female,,Cancer cell line,,,,,,NCIt; C43584; Rectosigmoid adenocarcinoma,,
CVCL_N468,Hs 210.T,,CRL-7172,20Y,Male,,Cancer cell line,,,,,,NCIt; C4349; Colon adenocarcinoma,,
CVCL_N647,Hs 214.T,,CRL-7174,57Y,Female,,Cancer cell line,,,,,UBERON_0001264,NCIt; C3850; Pancreatic carcinoma,,
CVCL_N469,Hs 217.T,,CRL-7179,60Y,Male,,Cancer cell line,,,,,UBERON_0001155,NCIt; C3850; Pancreatic carcinoma,,
CVCL_0692,Hs 219.T,,CRL-7184,61Y,Female,,Cancer cell line,,,,,UBERON_0001052,NCIt; C9383; Rectal adenocarcinoma,,
CVCL_N653,Hs 224.T,,CRL-7190,11M,Female,,Cancer cell line,,,,,,NCIt; C3359; Rhabdomyosarcoma,,
CVCL_N470,Hs 227.T,,CRL-7192,43Y,Male,,Cancer cell line,,,,,,NCIt; C9385; Renal cell carcinoma,,
CVCL_0697,Hs 228.T,,CRL-7193,67Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0001255,NCIt; C4912; Bladder carcinoma,,
CVCL_M903,Hs 237.T,,CRL-7202,65Y,Female,,Cancer cell line,,,,,,NCIt; C4349; Colon adenocarcinoma,,
CVCL_M899,Hs 238.T,,CRL-7204,54Y,Female,,Cancer cell line,,,,,UBERON_0000310,NCIt; C5214; Breast adenocarcinoma,,
CVCL_M901,Hs 239.Pe,,CRL-7205,79Y,Male,,Cancer cell line,,,,,UBERON_0000027,NCIt; C3209; Follicular lymphoma,,
CVCL_M902,Hs 240.Pe,,CRL-7206,46Y,Female,,Cancer cell line,,,,,UBERON_0000175,NCIt; C5214; Breast adenocarcinoma,,
CVCL_N471,Hs 241.T,,CRL-7207,54Y,Female,,Cancer cell line,,,,,,NCIt; C4349; Colon adenocarcinoma,,
CVCL_N618,Hs 242T,,HTB-145,63Y,Male,,Cancer cell line,,,,,,NCIt; C3512; Lung adenocarcinoma,,
CVCL_M900,Hs 243.T,,CRL-7208,51Y,Female,,Cancer cell line,,,,,UBERON_0000310,NCIt; C4872; Breast carcinoma,,
CVCL_N277,Hs 246.T,,CRL-7209,60Y,Male,,Cancer cell line,,,,,,NCIt; C4878; Lung carcinoma,,
CVCL_N655,Hs 248.T,,CRL-7210,57Y,Female,,Cancer cell line,,,,,,NCIt; C3158; Leiomyosarcoma,,
CVCL_N304,Hs 249.T,,CRL-7211,63Y,Male,,Cancer cell line,,,,,,NCIt; C9161; Anal squamous cell carcinoma,,
CVCL_N521,Hs 25.T,,CRL-7017,50Y,Male,,Cancer cell line,,,,,,NCIt; C3208; Lymphoma,,
CVCL_N472,Hs 252.T,,CRL-7212,61Y,Female,,Cancer cell line,,,,,UBERON_0000310,NCIt; C4872; Breast carcinoma,,
CVCL_S447,Hs 254.T,,CRL-7838,49Y,Female,,Cancer cell line,,,,,,NCIt; C3262; Neoplasm,,
CVCL_0708,Hs 257.T,,CRL-7214,71Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002106,NCIt; C2955; Colorectal carcinoma,,
CVCL_N657,Hs 265.T,,CRL-7216,63Y,Female,,Cancer cell line,,,,,,NCIt; C4349; Colon adenocarcinoma,,
CVCL_0709,Hs 268.T,,CRL-7218,51Y,Male,,Cancer cell line,,,,,,NCIt; C9357; Hodgkin lymphoma,,
CVCL_0714,Hs 280.T,,CRL-7226,46Y,Female,,Cancer cell line,,,,,UBERON_0000310,NCIt; C5214; Breast adenocarcinoma,,
CVCL_0716,Hs 284.Pe,,CRL-7228,59Y,Male,,Cancer cell line,,,,,,NCIt; C3493; Lung squamous cell carcinoma,,
CVCL_N661,Hs 285.T,,CRL-7229,66Y,Male,,Cancer cell line,,,,,,NCIt; C4024; Esophageal squamous cell carcinoma,,
CVCL_S454,Hs 291.T,,CRL-7839,48Y,Female,,Cancer cell line,,,,,,NCIt; C4878; Lung carcinoma,,
CVCL_N663,Hs 293.T,,CRL-7231,62Y,Female,,Cancer cell line,,,,,,NCIt; C5543; Cecum adenocarcinoma,,
CVCL_0331,Hs 294T,,HTB-140,56Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C3224; Melanoma, Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=15467732; DepMap=ACH-000014).,
CVCL_0718,Hs 295.T,,CRL-7233,83Y,Female,,Cancer cell line,,,,,UBERON_0002097,NCIt; C3224; Melanoma,,
CVCL_0720,Hs 3.T,,CRL-7005,51Y,Female,African American,Cancer cell line,,,,,UBERON_0002481,NCIt; C9145; Osteosarcoma,,
CVCL_0721,Hs 313.T,,CRL-7235,54Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C3208; Lymphoma,,
CVCL_0722,Hs 319.T,,CRL-7236,42Y,Female,,Cancer cell line,,,,,,NCIt; C4194; Invasive breast carcinoma of no special type,,
CVCL_0723,Hs 324.T,,CRL-7239,72Y,Male,,Cancer cell line,,,,,UBERON_0000027,NCIt; C27349; Histiocytic sarcoma,,
CVCL_0725,Hs 329.T,,CRL-7242,54Y,Female,,Cancer cell line,,,,,UBERON_0000310,NCIt; C4872; Breast carcinoma,,
CVCL_S293,Hs 34.T,,CRL-7825,55Y,Female,,Cancer cell line,,,,,,NCIt; C3158; Leiomyosarcoma,,
CVCL_N807,Hs 341.T,,CRL-7244,67Y,Female,,Cancer cell line,,,,,,NCIt; C3043; Fibrosarcoma,,
CVCL_0727,Hs 344.T,,CRL-7246,59Y,Female,,Cancer cell line,,,,,UBERON_0000310,NCIt; C4872; Breast carcinoma,,
CVCL_N611,Hs 347.T,,CRL-7247,44Y,Male,,Cancer cell line,,,,,UBERON_0000955,NCIt; C3058; Glioblastoma,,
CVCL_N525,Hs 35.T,,CRL-7021,58Y,Male,,Cancer cell line,,,,,,NCIt; C3739; Benign fibrous histiocytoma,,
CVCL_0728,Hs 350.T,,CRL-7248,55Y,Female,,Cancer cell line,,,,,UBERON_0000310,NCIt; C4872; Breast carcinoma,,
CVCL_N614,Hs 355.T,,CRL-7251,64Y,Male,,Cancer cell line,,,,,UBERON_0002110,NCIt; C3844; Gallbladder carcinoma,,
CVCL_0729,Hs 357.T,,CRL-7252,56Y,Female,,Cancer cell line,,,,,UBERON_0002097,NCIt; C4683; Dermatofibrosarcoma protuberans,,
CVCL_N526,Hs 36.T,,CRL-7022,16Y,Male,,Cancer cell line,,,,,UBERON_0002481,NCIt; C9145; Osteosarcoma,,
CVCL_0730,Hs 362.T,,CRL-7253,78Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000310,NCIt; C4872; Breast carcinoma,,
CVCL_0733,Hs 371.T,,CRL-7256,28Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000310,NCIt; C4872; Breast carcinoma,,
CVCL_N810,Hs 377.T,,CRL-7258,40Y,Female,,Cancer cell line,,,,Fibroblast,UBERON_0000310,NCIt; C4872; Breast carcinoma,,
CVCL_0735,Hs 38.T,,CRL-7826,Age unspecified,Female,,Cancer cell line,,,,,UBERON_0000992,NCIt; C8110; Ovarian teratoma,,
CVCL_N683,Hs 382.T,,CRL-7259,63Y,Female,,Cancer cell line,,,,Fibroblast,UBERON_0000310,NCIt; C4872; Breast carcinoma,,
CVCL_N684,Hs 383.T,,CRL-7260,60Y,Female,,Cancer cell line,,,,,UBERON_0000310,NCIt; C4872; Breast carcinoma,,
CVCL_N685,Hs 385.T,,CRL-7261,68Y,Female,,Cancer cell line,,,,,UBERON_0000310,NCIt; C4872; Breast carcinoma,,
CVCL_0737,Hs 387.T,,CRL-7263,13Y,Female,,Cancer cell line,,,,,UBERON_0002481,NCIt; C9145; Osteosarcoma,,
CVCL_N615,Hs 388.T,,CRL-7264,45Y,Male,,Cancer cell line,,,,,UBERON_0000027,NCIt; C9357; Hodgkin lymphoma,,
CVCL_0740,Hs 39.T,,CRL-7023,17Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002481,NCIt; C9145; Osteosarcoma,,
CVCL_3520,Hs 398.T,,CRL-7273,25Y,Male,,Cancer cell line,,,,,,NCIt; C3262; Neoplasm,,
CVCL_N475,Hs 402.T,,CRL-7277,61Y,Female,,Cancer cell line,,,,,UBERON_0000310,NCIt; C4872; Breast carcinoma,,
CVCL_0755,Hs 414.T,,CRL-7287,13Y,Male,Caucasian,Cancer cell line,,,,,,NCIt; C3043; Fibrosarcoma,,
CVCL_0757,Hs 416.T,,CRL-7289,62Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002097,NCIt; C4819; Skin squamous cell carcinoma,,
CVCL_S294,Hs 42.T,,CRL-7827,13Y,Female,,Cancer cell line,,,,,,NCIt; C2946; Chondrosarcoma,,
CVCL_N617,Hs 422.T,,CRL-7293,64Y,Male,,Cancer cell line,,,,,,NCIt; C3272; Neurofibroma,,
CVCL_N691,Hs 425.T,,CRL-7294,Age unspecified,Female,,Cancer cell line,,,,,,NCIt; C3194; Liposarcoma,,
CVCL_N692,Hs 426.T,,CRL-7295,70Y,Female,,Cancer cell line,,,,,,NCIt; C2946; Chondrosarcoma,,
CVCL_S453,Hs 430.T,,CRL-7843,24Y,Male,,Cancer cell line,,,,,,NCIt; C3798; Malignant peripheral nerve sheath tumor,,
CVCL_0759,Hs 431.T,,CRL-7298,20Y,Male,,Cancer cell line,,,,,,NCIt; C3400; Synovial sarcoma,,
CVCL_2256,Hs 432.T,,CRL-7299,67Y,Male,,Cancer cell line,,,,,,NCIt; C3224; Melanoma,,
CVCL_S451,Hs 439.T,,CRL-7844,31Y,Male,,Cancer cell line,,,,,,NCIt; C3404; Testicular neoplasm,,
CVCL_S246,Hs 444(A).T,,CRL-7799,15Y,Male,,Cancer cell line,,,,,,NCIt; C7328; Testicular seminoma,,
CVCL_S251,Hs 444(B).T,,CRL-7800,15Y,Male,,Cancer cell line,,,,,,NCIt; C7328; Testicular seminoma,,
CVCL_0764,Hs 454.T,,CRL-7802,2Y,Male,,Cancer cell line,,,,,,NCIt; C3016; Eosinophilic granuloma,,
CVCL_S252,Hs 455.T,,CRL-7803,31Y,Male,,Cancer cell line,,,,,,NCIt; C9357; Hodgkin lymphoma,,
CVCL_D782,Hs 456.T,,CRL-7806,80Y,Female,,Cancer cell line,,,,,,NCIt; C2921; Skin basal cell carcinoma,,
CVCL_D783,Hs 467.T,,CRL-7809,44Y,Female,,Cancer cell line,,,,,UBERON_0000310,NCIt; C4872; Breast carcinoma,,
CVCL_S288,Hs 474.T,,CRL-7812,7Y,Male,,Cancer cell line,,,,,,NCIt; C8712; Pineal region germinoma,,
CVCL_0772,Hs 479.T,,CRL-7813,53Y,Female,,Cancer cell line,,,,,UBERON_0000310,NCIt; C4872; Breast carcinoma,,
CVCL_S289,Hs 484.T,,CRL-7816,83Y,Female,,Cancer cell line,,,,,UBERON_0001255,NCIt; C4912; Bladder carcinoma,,
CVCL_S290,Hs 485.T,,CRL-7817,63Y,Male,,Cancer cell line,,,,,UBERON_0002372,NCIt; C3417; Tonsillar neoplasm,,
CVCL_0777,Hs 491.T,,CRL-7818,42Y,Female,,Cancer cell line,,,,,UBERON_0000027,NCIt; C7540; Small lymphocytic lymphoma,,
CVCL_G021,Hs 496.T,,CRL-7303,59Y,Female,,Cancer cell line,,,,,UBERON_0000310,NCIt; C4872; Breast carcinoma,,
CVCL_0778,Hs 5.T,,CRL-7822,81Y,Female,,Cancer cell line,,,,,UBERON_0002384,NCIt; C3158; Leiomyosarcoma,,
CVCL_N697,Hs 504.T,,CRL-7305,68Y,Male,,Cancer cell line,,,,,,NCIt; C3224; Melanoma,,
CVCL_0779,Hs 505.T,,CRL-7306,Age unspecified,Female,African American,Cancer cell line,,,,,UBERON_0000027,NCIt; C7540; Small lymphocytic lymphoma,,
CVCL_N698,Hs 507.T,,CRL-7308,22Y,Female,,Cancer cell line,,,,,UBERON_0000310,NCIt; C4872; Breast carcinoma,,
CVCL_3521,Hs 51.T,,CRL-7030,14Y,Male,,Cancer cell line,,,,,,NCIt; C27005; Spindle cell sarcoma,,
CVCL_N757,Hs 517.T,,CRL-7312,78Y,Female,,Cancer cell line,,,,,UBERON_0000310,NCIt; C4872; Breast carcinoma,,
CVCL_0782,Hs 518.T,,CRL-7313,Age unspecified,Male,,Cancer cell line,,,,,,NCIt; C7540; Small lymphocytic lymphoma,,
CVCL_0786,Hs 53.T,,CRL-7033,13Y,Female,African American,Cancer cell line,,,,,UBERON_0002097,NCIt; C3272; Neurofibroma,,
CVCL_N476,Hs 54.T,,CRL-7034,57Y,Female,,Cancer cell line,,,,,UBERON_0000310,NCIt; C4872; Breast carcinoma,,
CVCL_0788,Hs 540.T,,CRL-7316,79Y,Female,,Cancer cell line,,,,,UBERON_0000310,NCIt; C4872; Breast carcinoma,,
CVCL_N299,Hs 564(A).T,,CRL-7326,53Y,Female,,Cancer cell line,,,,,UBERON_0000310,NCIt; C4194; Invasive breast carcinoma of no special type,,
CVCL_N294,Hs 566(A).T,,CRL-7335,35Y,Female,,Cancer cell line,,,,,UBERON_0000310,NCIt; C4872; Breast carcinoma,,
CVCL_0799,Hs 566(B).T,,CRL-7336,35Y,Female,,Cancer cell line,,,,,UBERON_0000310,NCIt; C4872; Breast carcinoma,,
CVCL_N763,Hs 567(A).T,,CRL-7338,47Y,Female,,Cancer cell line,,,,,UBERON_0000310,NCIt; C4872; Breast carcinoma,,
CVCL_0801,Hs 57.T,,CRL-7037,22Y,Male,,Cancer cell line,,,,,,NCIt; C3262; Neoplasm,,
CVCL_N765,Hs 570.T,,CRL-7341,50Y,Female,,Cancer cell line,,,,,UBERON_0000310,NCIt; C4872; Breast carcinoma,,
CVCL_0802,Hs 571.T,,CRL-7846,Age unspecified,Female,Caucasian,Cancer cell line,,,,,UBERON_0000992,NCIt; C4908; Ovarian carcinoma, Mutation; HGNC; 2514; CTNNB1; Simple; p.Ser37Ala (c.109T>G); ClinVar=VCV000376235; Zygosity=Homozygous (DepMap=ACH-001092).,
CVCL_0804,Hs 573.T,,CRL-7343,71Y,Male,,Cancer cell line,,,,,UBERON_0002048,NCIt; C4878; Lung carcinoma,,
CVCL_0806,Hs 574.T,,CRL-7345,Age unspecified,Female,,Cancer cell line,,,,,UBERON_0000310,NCIt; C4872; Breast carcinoma,,
CVCL_0332,Hs 578T,,CRL-7849,74Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000310,NCIt; C4194; Invasive breast carcinoma of no special type," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (PubMed=19593635)., Mutation; HGNC; 7427; MT-CYB; Simple; p.Ala125Thr (m.15119G>A); ClinVar=VCV000693829; Zygosity=Homoplasmic (PubMed=29671673).",
CVCL_F647,Hs 579.T,,CRL-7348,Age unspecified,Female,,Cancer cell line,,,,,UBERON_0000310,NCIt; C4872; Breast carcinoma,,
CVCL_N478,Hs 586.T,,CRL-7351,76Y,Male,,Cancer cell line,,,,,UBERON_0001155,NCIt; C4910; Colon carcinoma,,
CVCL_0810,Hs 587.Int,,CRL-7352,59Y,Female,,Cancer cell line,,,,,UBERON_0001155,NCIt; C5105; Colorectal adenocarcinoma,,
CVCL_0811,Hs 588.T,,CRL-7850,29Y,Female,,Cancer cell line,,,,,UBERON_0000002,NCIt; C4029; Cervical adenocarcinoma,,
CVCL_R689,Hs 593.T,,CRL-7355,63Y,Female,,Cancer cell line,,,,,UBERON_0000310,NCIt; C4872; Breast carcinoma,,
CVCL_G017,Hs 597.T,,CRL-7357,Age unspecified,Female,,Cancer cell line,,,,,UBERON_0002097,NCIt; C3224; Melanoma,,
CVCL_R692,Hs 601.T,,CRL-7361,27Y,Male,,Cancer cell line,,,,,,NCIt; C6451; Thymic lymphoma,,
CVCL_0815,Hs 602,,HTB-142,Age unspecified,Female,,Cancer cell line,,,,,UBERON_0002429,NCIt; C3208; Lymphoma,,
CVCL_0818,Hs 605.T,,CRL-7365,61Y,Female,Caucasian,Cancer cell line,,,,Fibroblast,UBERON_0000310,NCIt; C4872; Breast carcinoma,,
CVCL_N479,Hs 607.T,,CRL-7369,Age unspecified,Female,,Cancer cell line,,,,,UBERON_0000310,NCIt; C4194; Invasive breast carcinoma of no special type,,
CVCL_N772,Hs 608.T,,CRL-7371,54Y,Female,,Cancer cell line,,,,,UBERON_0000310,NCIt; C4872; Breast carcinoma,,
CVCL_0823,Hs 611.T,,CRL-7373,48Y,Female,Caucasian,Cancer cell line,10376,Epstein-Barr virus (EBV).,,,UBERON_0000027,NCIt; C9357; Hodgkin lymphoma,,
CVCL_S303,Hs 612.T,,CRL-7851,87Y,Male,,Cancer cell line,,,,,UBERON_0001255,NCIt; C4912; Bladder carcinoma,,
CVCL_N480,Hs 614.T,,CRL-7376,59Y,Male,,Cancer cell line,,,,,UBERON_0001255,NCIt; C9383; Rectal adenocarcinoma,,
CVCL_N767,Hs 615.T,,CRL-7377,85Y,Male,,Cancer cell line,,,,,UBERON_0000027,NCIt; C27349; Histiocytic sarcoma,,
CVCL_N769,Hs 619.T,,CRL-7382,69Y,Male,,Cancer cell line,,,,,UBERON_0001155,NCIt; C4910; Colon carcinoma,,
CVCL_D784,Hs 621.T,,CRL-7384,Age unspecified,Male,,Cancer cell line,,,,,,NCIt; C3262; Neoplasm,,
CVCL_F648,Hs 622.T,,CRL-7386,23Y,Male,,Cancer cell line,,,,,UBERON_0000007,NCIt; C3329; Pituitary gland adenoma,,
CVCL_R695,Hs 623.T,,CRL-7387,16Y,Male,,Cancer cell line,,,,,,NCIt; C3224; Melanoma,,
CVCL_R697,Hs 625.T,,CRL-7389,11Y,Female,,Cancer cell line,,,,,UBERON_0037522,NCIt; C3208; Lymphoma,,
CVCL_R698,Hs 626.T,,CRL-7390,24Y,Female,,Cancer cell line,,,,,UBERON_0002046,NCIt; C8054; Thyroid gland follicular carcinoma,,
CVCL_0831,Hs 63.T,,CRL-7043,34Y,Female,African American,Cancer cell line,,,,,UBERON_0002097,NCIt; C4683; Dermatofibrosarcoma protuberans,,
CVCL_R702,Hs 630.T,,CRL-7394,Fetus,Male,Caucasian,Cancer cell line,,,,,UBERON_0006237,NCIt; C4646; Gestational choriocarcinoma,,
CVCL_N481,Hs 631.T,,CRL-7853,,Female,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C4194; Invasive breast carcinoma of no special type,,
CVCL_0832,Hs 633.T,,CRL-7395,25Y,Female,,Cancer cell line,,,,,,NCIt; C3043; Fibrosarcoma, Mutation; HGNC; 6407; KRAS; Simple; p.Ala146Pro (c.436G>C); ClinVar=VCV000375963; Zygosity=Heterozygous (Cosmic-CLP=1240149; DepMap=ACH-002246).,
CVCL_N622,Hs 64.T,,CRL-7044,26Y,Female,,Cancer cell line,,,,,UBERON_0000310,NCIt; C4872; Breast carcinoma,,
CVCL_S305,Hs 653.T,,CRL-7854,49Y,Female,,Cancer cell line,,,,,UBERON_0000945,NCIt; C4004; Gastric adenocarcinoma,,
CVCL_N491,Hs 674.T,,CRL-7398,63Y,Male,,Cancer cell line,,,,,UBERON_0002107,NCIt; C2955; Colorectal carcinoma,,
CVCL_N482,Hs 674.T/cc,,CRL-7399,63Y,Male,,Cancer cell line,,,,,,NCIt; C2955; Colorectal carcinoma,,
CVCL_R711,Hs 679.T,,CRL-7410,15Y,Female,,Cancer cell line,,,,,,NCIt; C4817; Ewing sarcoma,,
CVCL_N483,Hs 682.T,,CRL-7423,60Y,Male,,Cancer cell line,,,,,UBERON_0001155,NCIt; C2955; Colorectal carcinoma,,
CVCL_0844,Hs 683,,HTB-138,76Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002808,NCIt; C3288; Oligodendroglioma, Mutation; HGNC; 11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=10416987).,
CVCL_0847,Hs 688(B).T,,CRL-7426,69Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001542,NCIt; C3224; Melanoma,,
CVCL_0849,Hs 692(A).T,,CRL-7428,64Y,Female,,Cancer cell line,,,,,,NCIt; C2955; Colorectal carcinoma,,
CVCL_C119,Hs 692(B).T,,CRL-7429,64Y,Female,,Cancer cell line,,,,,,NCIt; C2955; Colorectal carcinoma,,
CVCL_0851,Hs 695T,,HTB-137,26Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C3802; Amelanotic melanoma, Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (ATCC=HTB-137; DepMap=ACH-000799).,
CVCL_0852,Hs 696,,CRL-7432,48Y,Male,,Cancer cell line,,,,,UBERON_0003690,NCIt; C3262; Neoplasm,,
CVCL_R721,Hs 699.T,,CRL-7438,60Y,Male,,Cancer cell line,,,,,UBERON_0002113,NCIt; C9385; Renal cell carcinoma,,
CVCL_0858,Hs 700T,,HTB-147,61Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002355,NCIt; C3262; Neoplasm, Mutation; HGNC; 11998; TP53; Simple; p.Arg249Met (c.746G>T); ClinVar=VCV000376653; Zygosity=Unspecified (PubMed=1630814; PubMed=7961102).,
CVCL_0859,Hs 701.T,,CRL-7440,60Y,Female,,Cancer cell line,,,,,,NCIt; C3400; Synovial sarcoma,,
CVCL_S306,Hs 702.T,,CRL-7856,42Y,Female,,Cancer cell line,,,,,UBERON_0002370,NCIt; C3412; Thymus neoplasm,,
CVCL_N488,Hs 703.T,,CRL-7442,55Y,Male,,Cancer cell line,,,,,UBERON_0001155,NCIt; C7956; Adult hepatocellular carcinoma,,
CVCL_0861,Hs 704.T,,CRL-7444,13Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002481,NCIt; C9145; Osteosarcoma,,
CVCL_R723,Hs 705.T,,CRL-7445,28Y,Male,,Cancer cell line,,,,,,NCIt; C2946; Chondrosarcoma,,
CVCL_0863,Hs 706.T,,CRL-7447,16Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002481,NCIt; C4304; Malignancy in giant cell tumor of bone, Mutation; HGNC; 11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).,
CVCL_0864,Hs 707(A).T,,CRL-7448,13Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002481,NCIt; C9145; Osteosarcoma,,
CVCL_R758,Hs 708.T,,CRL-7451,57Y,Female,,Cancer cell line,,,,,UBERON_0002370,NCIt; C3411; Thymoma,,
CVCL_0866,Hs 709.T,,CRL-7453,10Y,Female,,Cancer cell line,,,,,,NCIt; C3064; Granuloma,,
CVCL_N342,Hs 717.T,,CRL-7455,55Y,Male,,Cancer cell line,,,,,,NCIt; C4878; Lung carcinoma,,
CVCL_S307,Hs 718.T,,CRL-7858,64Y,Female,,Cancer cell line,,,,,UBERON_0002369,NCIt; C3326; Adrenal gland pheochromocytoma,,
CVCL_0868,Hs 722.T,,CRL-7456,74Y,Male,,Cancer cell line,,,,,UBERON_0001052,NCIt; C9383; Rectal adenocarcinoma,,
CVCL_0871,Hs 729.T,,CRL-7862,74Y,Male,Caucasian,Cancer cell line,,,,Fibroblast of muscle,UBERON_0001630,NCIt; C8971; Embryonal rhabdomyosarcoma, Mutation; HGNC; 11998; TP53; Simple; p.His179Arg (c.536A>G); ClinVar=VCV000376606; Zygosity=Homozygous (DepMap=ACH-000133).,
CVCL_0877,Hs 735.T,,CRL-7471,16Y,Female,,Cancer cell line,,,,,UBERON_0002481,NCIt; C9145; Osteosarcoma,,
CVCL_0884,Hs 740.T,,CRL-7870,69Y,Male,,Cancer cell line,,,,,UBERON_0000945,NCIt; C4911; Gastric carcinoma,,
CVCL_0886,Hs 741.T,,CRL-7480,47Y,Female,,Cancer cell line,,,,,UBERON_0000310,NCIt; C4872; Breast carcinoma,,
CVCL_N485,Hs 743.T,,CRL-7484,61Y,Female,,Cancer cell line,,,,,UBERON_0000310,NCIt; C4872; Breast carcinoma,,
CVCL_0333,Hs 746.T,,HTB-135,74Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001383,NCIt; C4004; Gastric adenocarcinoma,,
CVCL_0889,Hs 748.T,,CRL-7486,48Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000310,NCIt; C4872; Breast carcinoma,,
CVCL_S402,Hs 749.T,,CRL-7872,56Y,Female,,Cancer cell line,,,,,UBERON_0000310,NCIt; C4872; Breast carcinoma,,
CVCL_N486,Hs 750.T,,CRL-7873,74Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000945,NCIt; C4004; Gastric adenocarcinoma,,
CVCL_S069,Hs 754.T,,CRL-7874,18Y,Male,,Cancer cell line,,,,,,NCIt; C3359; Rhabdomyosarcoma,,
CVCL_N346,Hs 755(A).T,,CRL-7877,18Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0005893,NCIt; C9145; Osteosarcoma,,
CVCL_0892,Hs 755(B).T,,CRL-7489,18Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0008772,NCIt; C9145; Osteosarcoma,,
CVCL_S070,Hs 756.T,,CRL-7875,62Y,Male,,Cancer cell line,,,,,,NCIt; C9385; Renal cell carcinoma,,
CVCL_S066,Hs 758.T,,CRL-7878,77Y,Male,,Cancer cell line,,,,,,NCIt; C9385; Renal cell carcinoma,,
CVCL_R831,Hs 760.T,,CRL-7491,52Y,Female,,Cancer cell line,,,,,,NCIt; C3043; Fibrosarcoma,,
CVCL_R832,Hs 762.T,,CRL-7493,83Y,Male,,Cancer cell line,,,,,,"NCIt; C3043; Fibrosarcoma,ORDO; Orphanet_2030; Fibrosarcoma",,
CVCL_0334,Hs 766T,,HTB-134,64Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C8294; Pancreatic adenocarcinoma," Gene deletion; HGNC; 6770; SMAD4; Zygosity=Homozygous (PubMed=10408907; PubMed=15367885; PubMed=18380791)., Mutation; HGNC; 11998; TP53; None_reported; -; Zygosity=- (PubMed=8026879; PubMed=15367885).",
CVCL_S068,Hs 767.T,,CRL-7880,45Y,Male,,Cancer cell line,,,,,UBERON_0002367,NCIt; C4863; Prostate carcinoma,,
CVCL_S038,Hs 768(A).T,,CRL-7496,16Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C9145; Osteosarcoma,,
CVCL_0896,Hs 769.T,,CRL-7882,59Y,Female,African American,Cancer cell line,,,,,UBERON_0000057,NCIt; C6166; Urethral urothelial carcinoma,,
CVCL_S043,Hs 773.T,,CRL-7501,82Y,Female,,Cancer cell line,,,,,UBERON_0001255,NCIt; C4912; Bladder carcinoma,,
CVCL_S045,Hs 775.T,,CRL-7504,13Y,Male,,Cancer cell line,,,,,,NCIt; C40407; Kidney Wilms tumor,,
CVCL_S047,Hs 776.T,,CRL-7506,26Y,Male,,Cancer cell line,,,,,,NCIt; C3224; Melanoma,,
CVCL_0899,Hs 777.T,,CRL-7507,67Y,Female,,Cancer cell line,,,,,UBERON_0000027,NCIt; C3208; Lymphoma,,
CVCL_0900,Hs 778(A).T,,CRL-7508,58Y,Female,,Cancer cell line,,,,,,NCIt; C3043; Fibrosarcoma,,
CVCL_0901,Hs 778(B).T,,CRL-7509,58Y,Female,,Cancer cell line,,,,,,NCIt; C3043; Fibrosarcoma,,
CVCL_N600,Hs 78.T,,CRL-7056,13Y,Male,,Cancer cell line,,,,,,NCIt; C4817; Ewing sarcoma,,
CVCL_0903,Hs 781.T,,CRL-7511,12Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000979,NCIt; C9145; Osteosarcoma,,
CVCL_S049,Hs 783.T,,CRL-7883,4Y,Male,,Cancer cell line,,,,,,NCIt; C3270; Neuroblastoma,,
CVCL_N487,Hs 785.T,,CRL-7884,58Y,Male,,Cancer cell line,,,,,UBERON_0001155,NCIt; C2955; Colorectal carcinoma,,
CVCL_S051,Hs 788.T,,CRL-7517,17Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000981,NCIt; C9145; Osteosarcoma,,
CVCL_0908,Hs 789.T,,CRL-7886,67Y,Female,Caucasian,Cancer cell line,,,,Epithelial cell,UBERON_0000056,NCIt; C39851; Bladder urothelial carcinoma,,
CVCL_N601,Hs 79.T,,CRL-7057,11Y,Male,,Cancer cell line,,,,,UBERON_0002481,NCIt; C9145; Osteosarcoma,,
CVCL_S301,Hs 791.T,,CRL-7798,20Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0004406,NCIt; C9145; Osteosarcoma,,
CVCL_0910,Hs 792(A).T,,CRL-7520,29Y,Female,Caucasian,Cancer cell line,,,,,,NCIt; C9145; Osteosarcoma,,
CVCL_0911,Hs 792(B).T,,CRL-7521,29Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002481,NCIt; C9145; Osteosarcoma,,
CVCL_S053,Hs 794.T,,CRL-7887,9M,Male,,Cancer cell line,,,,,UBERON_0002113,NCIt; C40407; Kidney Wilms tumor,,
CVCL_S057,Hs 800.T,,CRL-7531,49Y,Male,,Cancer cell line,,,,,,NCIt; C3262; Neoplasm,,
CVCL_S058,Hs 802.T,,CRL-7532,64Y,Male,,Cancer cell line,,,,,UBERON_0002429,NCIt; C4041; Floor of mouth squamous cell carcinoma,,
CVCL_0921,Hs 803.T,,CRL-7534,16Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000979,NCIt; C9145; Osteosarcoma,,
CVCL_G026,Hs 804.T,,CRL-7889,60Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002367,NCIt; C4863; Prostate carcinoma,,
CVCL_0922,Hs 805.T,,CRL-7537,10Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0004411,NCIt; C9145; Osteosarcoma,,
CVCL_S059,Hs 806.T,,CRL-7538,82Y,Female,,Cancer cell line,,,,,UBERON_0001255,NCIt; C4912; Bladder carcinoma,,
CVCL_S061,Hs 807.T,,CRL-7540,72Y,Female,,Cancer cell line,,,,,,NCIt; C9385; Renal cell carcinoma,,
CVCL_0923,Hs 811.T,,CRL-7543,10Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002481,NCIt; C9145; Osteosarcoma,,
CVCL_0926,Hs 814.T,,CRL-7547,50Y,Female,,Cancer cell line,,,,,UBERON_0001130,NCIt; C4304; Malignancy in giant cell tumor of bone,,
CVCL_N536,Hs 818.T,,CRL-7890,22Y,Female,,Cancer cell line,,,,,UBERON_0002481,NCIt; C9145; Osteosarcoma,,
CVCL_0930,Hs 820.T,,CRL-7552,23Y,Male,Caucasian,Cancer cell line,,,,Fibroblast,UBERON_0002481,NCIt; C3262; Neoplasm,,
CVCL_S074,Hs 823.T,,CRL-7557,54Y,Female,,Cancer cell line,,,,,UBERON_0000981,NCIt; C4872; Breast carcinoma,,
CVCL_S075,Hs 824.T,,CRL-7559,69Y,Female,,Cancer cell line,,,,,,NCIt; C27349; Histiocytic sarcoma,,
CVCL_S077,Hs 826.T,,CRL-7562,30Y,Male,,Cancer cell line,,,,,,NCIt; C3224; Melanoma,,
CVCL_S079,Hs 828.T,,CRL-7565,60Y,Male,,Cancer cell line,,,,,UBERON_0002048,NCIt; C3043; Fibrosarcoma,,
CVCL_0939,Hs 835.T,,CRL-7569,,Male,,Cancer cell line,,,,,UBERON_0002113,NCIt; C9385; Renal cell carcinoma,,
CVCL_G025,Hs 836.T,,CRL-7571,Age unspecified,Male,,Cancer cell line,,,,,UBERON_0002481,NCIt; C9145; Osteosarcoma,,
CVCL_0943,Hs 841.T,,CRL-7574,48Y,Female,,Cancer cell line,,,,,UBERON_0000310,NCIt; C4872; Breast carcinoma,,
CVCL_S080,Hs 843.T,,CRL-7575,49Y,Male,,Cancer cell line,,,,,,NCIt; C9385; Renal cell carcinoma,,
CVCL_N489,Hs 844.T,,CRL-7892,57Y,Male,,Cancer cell line,,,,,,NCIt; C4349; Colon adenocarcinoma,,
CVCL_0945,Hs 845.T,,CRL-7577,31Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002481,NCIt; C9145; Osteosarcoma,,
CVCL_0947,Hs 846.T,,CRL-7579,20Y,Female,,Cancer cell line,,,,,,NCIt; C4304; Malignancy in giant cell tumor of bone,,
CVCL_S082,Hs 848.T,,CRL-7582,37Y,Male,,Cancer cell line,,,,,UBERON_0002048,NCIt; C4912; Bladder carcinoma,,
CVCL_0948,Hs 849.T,,CRL-7583,41Y,Female,,Cancer cell line,,,,,,NCIt; C4872; Breast carcinoma,,
CVCL_0949,Hs 851.T,,CRL-7584,61Y,Female,,Cancer cell line,,,,,,NCIt; C4872; Breast carcinoma,,
CVCL_0950,Hs 852.T,,CRL-7585,53Y,Male,Asian,Cancer cell line,,,,Epithelial cell,UBERON_0002097,NCIt; C3224; Melanoma, Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000040470; Zygosity=Heterozygous (ATCC=CRL-7585).,
CVCL_N021,Hs 853.T,,CRL-7588,44Y,Male,,Cancer cell line,,,,,UBERON_0002048,NCIt; C4912; Bladder carcinoma,,
CVCL_N306,Hs 854.T,,CRL-7590,61Y,Female,,Cancer cell line,,,,,UBERON_0002097,NCIt; C4872; Breast carcinoma,,
CVCL_0954,Hs 856.T,,CRL-7593,16Y,Female,African American,Cancer cell line,,,,,UBERON_0002384,NCIt; C35765; Histiocytoma,,
CVCL_0957,Hs 860.T,,CRL-7595,22Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002481,NCIt; C9145; Osteosarcoma,,
CVCL_0958,Hs 861.T,,CRL-7596,42Y,Female,,Cancer cell line,,,,Fibroblast,UBERON_0000310,NCIt; C4872; Breast carcinoma,,
CVCL_N020,Hs 862.T,,CRL-7597,59Y,Female,,Cancer cell line,,,,,UBERON_0002097,NCIt; C3224; Melanoma,,
CVCL_0961,Hs 864.T,,CRL-7600,75Y,Female,,Cancer cell line,,,,,,NCIt; C9145; Osteosarcoma,,
CVCL_0963,Hs 866.T,,CRL-7602,8Y,Female,,Cancer cell line,,,,Fibroblast,UBERON_0002481,NCIt; C9145; Osteosarcoma,,
CVCL_0965,Hs 868.T,,CRL-7604,13Y,Female,Caucasian,Cancer cell line,,,,Fibroblast,,NCIt; C3043; Fibrosarcoma,,
CVCL_N599,Hs 869.T,,CRL-7605,60Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000955,NCIt; C4004; Gastric adenocarcinoma,,
CVCL_3522,Hs 871.T,,CRL-7609,22Y,Male,,Cancer cell line,,,,,,NCIt; C3294; Osteoblastoma,,
CVCL_0968,Hs 873.T,,CRL-7610,37Y,Female,,Cancer cell line,,,,,,NCIt; C4872; Breast carcinoma,,
CVCL_0969,Hs 874.T,,CRL-7611,40Y,Female,,Cancer cell line,,,,,,NCIt; C4872; Breast carcinoma,,
CVCL_0970,Hs 875.T,,CRL-7612,21Y,Female,,Cancer cell line,,,,,UBERON_0000310,NCIt; C4872; Breast carcinoma,,
CVCL_0971,Hs 877.T,,CRL-7613,42Y,Female,,Cancer cell line,,,,,,NCIt; C4872; Breast carcinoma,,
CVCL_0973,Hs 88.T,,CRL-7060,25Y,Female,Caucasian,Cancer cell line,,,,Fibroblast,UBERON_0002481,NCIt; C9145; Osteosarcoma,,
CVCL_0974,Hs 880.T,,CRL-7616,47Y,Female,,Cancer cell line,,,,,UBERON_0000310,NCIt; C4872; Breast carcinoma,,
CVCL_0975,Hs 883.T,,CRL-7617,19Y,Female,,Cancer cell line,,,,,,NCIt; C4304; Malignancy in giant cell tumor of bone,,
CVCL_0976,Hs 885.T,,CRL-7618,31Y,Female,,Cancer cell line,,,,,UBERON_0000310,NCIt; C4872; Breast carcinoma,,
CVCL_N343,Hs 887.T,,CRL-7621,21Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C9385; Renal cell carcinoma,,
CVCL_0982,Hs 889.T,,CRL-7626,14Y,Male,Caucasian,Cancer cell line,,,,,,NCIt; C9145; Osteosarcoma,,
CVCL_0984,Hs 890.T,,CRL-7628,40Y,Male,,Cancer cell line,,,,Fibroblast,UBERON_0002481,NCIt; C9145; Osteosarcoma,,
CVCL_0985,Hs 891.T,,CRL-7629,21Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002113,NCIt; C9385; Renal cell carcinoma,,
CVCL_0986,Hs 892.T,,CRL-7630,57Y,Female,,Cancer cell line,,,,,,NCIt; C3146; Keratoacanthoma,,
CVCL_0987,Hs 894(A).T,,CRL-7631,20Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002481,NCIt; C9145; Osteosarcoma,,
CVCL_0988,Hs 894(B).T,,CRL-7632,20Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002481,NCIt; C9145; Osteosarcoma,,
CVCL_0989,Hs 894(C).T,,CRL-7633,20Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002481,NCIt; C9145; Osteosarcoma,,
CVCL_0990,Hs 894(D).T,,CRL-7634,20Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002481,NCIt; C9145; Osteosarcoma,,
CVCL_S012,Hs 897.T,,CRL-7639,61Y,Female,,Cancer cell line,,,,,UBERON_0000310,NCIt; C4872; Breast carcinoma,,
CVCL_0995,Hs 898.T,,CRL-7641,57Y,Female,,Cancer cell line,,,,,,NCIt; C3146; Keratoacanthoma,,
CVCL_0996,Hs 899(A).T,,CRL-7642,20Y,Male,Caucasian,Cancer cell line,,,,,,NCIt; C9145; Osteosarcoma,,
CVCL_0997,Hs 899(B).T,,CRL-7643,20Y,Male,Caucasian,Cancer cell line,,,,,,NCIt; C9145; Osteosarcoma,,
CVCL_0998,Hs 899(C).T,,CRL-7644,20Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C9145; Osteosarcoma,,
CVCL_0999,Hs 899(D).T,,CRL-7645,20Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C9145; Osteosarcoma,,
CVCL_1000,Hs 900.T,,CRL-7646,20Y,Female,,Cancer cell line,,,,,,NCIt; C3297; Osteoid osteoma,,
CVCL_S013,Hs 902.T,,CRL-7647,84Y,Female,,Cancer cell line,,,,,,NCIt; C4872; Breast carcinoma,,
CVCL_1002,Hs 903.T,,CRL-7649,29Y,Female,,Cancer cell line,,,,,,NCIt; C3297; Osteoid osteoma,,
CVCL_1004,Hs 904.T,,CRL-7651,68Y,Female,,Cancer cell line,,,,,,NCIt; C3262; Neoplasm,,
CVCL_1005,Hs 905.T,,CRL-7652,67Y,Female,,Cancer cell line,,,,,,NCIt; C4872; Breast carcinoma,,
CVCL_1006,Hs 906(A).M,,CRL-7653,58Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002097,NCIt; C3224; Melanoma,,
CVCL_1007,Hs 906(B).T,,CRL-7654,58Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002097,NCIt; C3224; Melanoma,,
CVCL_1009,Hs 908.T,,CRL-7658,61Y,Male,,Cancer cell line,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3224; Melanoma,,
CVCL_N671,Hs 910.T,,CRL-7659,13Y,Female,,Cancer cell line,,,,,,NCIt; C3043; Fibrosarcoma,,
CVCL_1012,Hs 912.T,,CRL-7661,36Y,Female,,Cancer cell line,,,,,,NCIt; C3262; Neoplasm,,
CVCL_N665,Hs 913(A).T,,CRL-7663,51Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002384,NCIt; C3043; Fibrosarcoma,,
CVCL_1013,Hs 913(B).T,,CRL-7664,51Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C3043; Fibrosarcoma,,
CVCL_1014,Hs 913(C).T,,CRL-7665,51Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002384,NCIt; C3043; Fibrosarcoma,,
CVCL_1015,Hs 913(D).T,,CRL-7666,51Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C3043; Fibrosarcoma,,
CVCL_N664,Hs 913(E).T,,CRL-7667,51Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C3043; Fibrosarcoma,,
CVCL_1016,Hs 913(F).T,,CRL-7668,51Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C3043; Fibrosarcoma,,
CVCL_1017,Hs 913T,,HTB-152,51Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C3043; Fibrosarcoma,,
CVCL_1023,Hs 919.T,,CRL-7672,34Y,Female,,Cancer cell line,,,,,UBERON_0002481,NCIt; C3297; Osteoid osteoma,,
CVCL_S019,Hs 924.LiT,,CRL-7675,7M,Female,Pacific,Cancer cell line,,,,,UBERON_0002107,NCIt; C3270; Neuroblastoma,,
CVCL_S446,Hs 924.T,,CRL-7918,7M,Female,Pacific,Cancer cell line,,,,,,NCIt; C3270; Neuroblastoma,,
CVCL_1026,Hs 925.T,,CRL-7677,58Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002097,NCIt; C7073; Paget disease,,
CVCL_1027,Hs 926.T,,CRL-7678,2Y,Female,,Cancer cell line,,,,Epithelial cell,UBERON_0002113,NCIt; C8971; Embryonal rhabdomyosarcoma,,
CVCL_S020,Hs 927.T,,CRL-7679,58Y,Female,,Cancer cell line,,,,,,NCIt; C4872; Breast carcinoma,,
CVCL_S086,Hs 929.T,,CRL-7682,5Y,Male,,Cancer cell line,,,,,,NCIt; C3016; Eosinophilic granuloma,,
CVCL_1029,Hs 93.T,,CRL-7062,12Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002384,NCIt; C3043; Fibrosarcoma,,
CVCL_1032,Hs 935.T,,CRL-7685,58Y,Female,Caucasian,Cancer cell line,,,,Fibroblast,UBERON_0002384,NCIt; C3224; Melanoma,,
CVCL_1033,Hs 936.T,,CRL-7686,Age unspecified,Male,Caucasian,Cancer cell line,,,,,UBERON_0002097,NCIt; C3224; Melanoma, Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (DepMap=ACH-000801).,
CVCL_1034,Hs 936.T(C1),,CRL-7687,Age unspecified,Male,Caucasian,Cancer cell line,,,,,UBERON_0002097,NCIt; C3224; Melanoma, Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).,
CVCL_1036,Hs 939.T,,CRL-7690,24Y,Female,Caucasian,Cancer cell line,,,,,,NCIt; C3224; Melanoma, Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=15009714; Cosmic-CLP=1298144; DepMap=ACH-000814).,
CVCL_1037,Hs 94.T,,CRL-7064,70Y,Female,,Cancer cell line,,,,,,NCIt; C3359; Rhabdomyosarcoma,,
CVCL_1039,Hs 941.T,,CRL-7692,26Y,Male,,Cancer cell line,,,,,UBERON_0002097,NCIt; C4683; Dermatofibrosarcoma protuberans,,
CVCL_1040,Hs 944.T,,CRL-7693,51Y,Male,Caucasian,Cancer cell line,,,,,,NCIt; C3510; Cutaneous melanoma," Mutation; HGNC; 1787; CDKN2A; Simple; p.His83Tyr (c.247C>T) (p.Ala97Val, c.290C>T); ClinVar=VCV000376307; Zygosity=Homozygous (DepMap=ACH-000632)., Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (PubMed=10766161; PubMed=15009714; DepMap=ACH-000632)., Mutation; HGNC; 11730; TERT; Simple; c.242_243CC>TT (-138/-139CC>TT); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).",
CVCL_S295,Hs 99.T,,CRL-7829,54Y,Female,,Cancer cell line,,,,,,NCIt; C3359; Rhabdomyosarcoma,,
CVCL_2516,HS-Sultan,,CRL-1484,7Y,Male,African,Cancer cell line,10376,Epstein-Barr virus (EBV).,,B-cell,UBERON_0007795,NCIt; C27694; EBV-related Burkitt lymphoma, Mutation; HGNC; 11998; TP53; Simple; p.Lys132Gln (c.394A>C); ClinVar=VCV000376628; Zygosity=Unspecified (from parent cell line).,
CVCL_1290,HT,,CRL-2260,70Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0007795,NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type, Mutation; HGNC; 11998; TP53; Simple; p.Val216Met (c.646G>A); ClinVar=VCV000182965; Zygosity=Heterozygous (Cosmic-CLP=907063).,
CVCL_0317,HT-1080,,CCL-121,35Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001269,NCIt; C3043; Fibrosarcoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (ATCC=CCL-121)., Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (PubMed=12068308; ATCC=CCL-121; Cosmic-CLP=907064; DepMap=ACH-000054).",
CVCL_UZ99,HT-1080-Luc2,,CCL-121-LUC2,35Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001269,NCIt; C3043; Fibrosarcoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).",
CVCL_1291,HT-1197,,CRL-1473,44Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001255,NCIt; C7899; Recurrent bladder carcinoma," Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=12068308)., Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680).",
CVCL_1292,HT-1376,,CRL-1472,58Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0001255,NCIt; C4912; Bladder carcinoma," Mutation; HGNC; 9884; RB1; Simple; p.Gln702Ter (c.2104C>T); ClinVar=VCV000428683; Zygosity=Homozygous (PubMed=27270441)., Mutation; HGNC; 11998; TP53; Simple; p.Pro250Leu (c.749C>T); ClinVar=VCV000420136; Zygosity=Unspecified (PubMed=7787250; PubMed=9850064).",
CVCL_3523,HT-1417,,CRL-7797,67Y,Female,,Cancer cell line,,,,,,NCIt; C3208; Lymphoma,,
CVCL_0318,HT-144,,HTB-63,29Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002072,NCIt; C3224; Melanoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (PubMed=9354451; PubMed=17363583)., Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (PubMed=12068308; PubMed=15048078; PubMed=15467732; PubMed=17363583; PubMed=22383533; PubMed=26405815; Cosmic-CLP=907067; DepMap=ACH-000322).",
CVCL_0320,HT-29,,HTB-38,44Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4349; Colon adenocarcinoma," Mutation; HGNC; 583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (PubMed=17088437; PubMed=24755471; PubMed=28179481; Cosmic-CLP=905939; DepMap=ACH-000552)., Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=12068308; PubMed=17088437; PubMed=20570890; PubMed=24755471; PubMed=28683746; Cosmic-CLP=905939; DepMap=ACH-000552)., Mutation; HGNC; 6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (PubMed=17088437; PubMed=24755471; Cosmic-CLP=905939; DepMap=ACH-000552).",
CVCL_N341,HT-295.T,,CRL-7781,76Y,Female,,Cancer cell line,,,,,UBERON_0002097,NCIt; C2921; Skin basal cell carcinoma,,
CVCL_1293,HT-3,,HTB-32,58Y,Female,Caucasian,Cancer cell line,10611,Human papillomavirus type 30 (HPV30).,,,UBERON_0000027,NCIt; C9039; Cervical carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Gly245Val (c.734G>T); ClinVar=VCV000376603; Zygosity=Unspecified (PubMed=1648218).,
CVCL_3524,HT-728.T,,CRL-7783,Age unspecified,Sex unspecified,,Cancer cell line,,,,,UBERON_0002481,NCIt; C9145; Osteosarcoma,,
CVCL_N465,HT-738.T,,CRL-7784,Age unspecified,Sex unspecified,,Cancer cell line,,,,,UBERON_0000945,NCIt; C4911; Gastric carcinoma,,
CVCL_N462,HT-756.T,,CRL-7787,57Y,Female,,Cancer cell line,,,,,UBERON_0002048,NCIt; C4878; Lung carcinoma,,
CVCL_3525,HT-762.T,,CRL-7789,Age unspecified,Female,,Cancer cell line,,,,,,NCIt; C4872; Breast carcinoma,,
CVCL_C7KX,HT140A,GM27465,,Age unspecified,Female,Latino or Hispanic,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C85864; Neuronal ceroid lipofuscinosis type 2, Mutation; HGNC; 2073; TPP1; Simple; p.Arg127Ter (c.379C>T); ClinVar=VCV000207569; Zygosity=Heterozygous (PubMed=29631617).,
CVCL_B5TJ,HT142C,GM28383,,12Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C61265; Scheie syndrome, Mutation; HGNC; 5391; IDUA; Simple; c.590-7G>A (IVS5AS-7G>A); ClinVar=VCV000222996; Zygosity=Heterozygous (from parent cell line).,
CVCL_UD78,HT144A,GM27446,,2M,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C61271; Wolman disease, Mutation; HGNC; 6617; LIPA; Simple; p.Ala199Cysfs*13 (c.594dupT); ClinVar=VCV000000080; Zygosity=Heterozygous (Coriell=GM27446).,
CVCL_C7L2,HT264B,GM28380,,Age unspecified,Male,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C85864; Neuronal ceroid lipofuscinosis type 2, Mutation; HGNC; 2073; TPP1; Simple; p.Arg127Gln (c.380G>A); ClinVar=VCV000068746; Zygosity=Heterozygous (PubMed=29631617).,
CVCL_3526,HuT 102,,TIB-162,28Y,Male,African American,Cancer cell line,11908,Human T-lymphotropic virus 1 (HTLV-1).,,T-cell,UBERON_0000027,NCIt; C3246; Mycosis fungoides,,
CVCL_0337,HuT 78,,TIB-161,53Y,Male,Caucasian,Cancer cell line,,,,T-cell,UBERON_0000178,NCIt; C3366; Sezary syndrome," Gene deletion; HGNC; 7208; MPDZ; Zygosity=Homozygous (PubMed=20215515)., Mutation; HGNC; 11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Homozygous (PubMed=2144611; DepMap=ACH-000509).",
CVCL_1301,HuTu 80,,CRL-7928,53Y,Male,,Cancer cell line,,,,,UBERON_0002114,NCIt; C7889; Duodenal adenocarcinoma, Mutation; HGNC; 2514; CTNNB1; Simple; p.Ser37Phe (c.110C>T); ClinVar=VCV000017586; Zygosity=Heterozygous (ATCC=HTB-40).,
CVCL_3318,HX,,CRL-12011,35Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001269,NCIt; C3043; Fibrosarcoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).",
CVCL_3724,I 2.1,,CRL-2572,14Y,Male,Caucasian,Cancer cell line,,,,T-cell,UBERON_0000178,NCIt; C7953; Childhood T acute lymphoblastic leukemia," Mutation; HGNC; 959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).",
CVCL_3725,I 9.2,,CRL-2571,14Y,Male,Caucasian,Cancer cell line,,,,T-cell,UBERON_0000178,NCIt; C7953; Childhood T acute lymphoblastic leukemia," Mutation; HGNC; 959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).",
CVCL_1907,Intestine 407,,CCL-6,30Y6M,Female,African American,Cancer cell line,333761,Human papillomavirus type 18 (HPV18).,,,UBERON_0000002,NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma,,
CVCL_5779,IOMM-Lee,,CRL-3370,61Y,Male,Chinese,Cancer cell line,,,,,UBERON_0000955,NCIt; C4656; Intracranial meningioma, Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (DepMap=ACH-000629).,
CVCL_6G16,IOWA-1T,,CRL-3292,55Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000310,NCIt; C4194; Invasive breast carcinoma of no special type,,
CVCL_C878,iPS-SMA-3.6,GM23240,,3Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002427,NCIt; C156310; Spinal muscular atrophy type 2, Gene amplification; HGNC; 11118; SMN2; Triplication; Zygosity=Unspecified (from parent cell line).,
CVCL_C879,iPS-WT 4.2,GM23241,,30Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002427,, Gene amplification; HGNC; 11118; SMN2; Extensive; Zygosity=Unspecified; Note=5 copies (from parent cell line).,
CVCL_F642,IST-1 [Human contaminated placenta],,CRL-2734,64Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0007795,NCIt; C7978; Ovarian serous cystadenocarcinoma," Mutation; HGNC; 583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).",
CVCL_2965,J-111,,CCL-24,30Y6M,Female,African American,Cancer cell line,333761,Human papillomavirus type 18 (HPV18).,,,UBERON_0000002,NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma,,
CVCL_0354,J.CaM1.6,,CRL-2063,14Y,Male,Caucasian,Cancer cell line,,,,T-cell,UBERON_0000178,NCIt; C7953; Childhood T acute lymphoblastic leukemia," Mutation; HGNC; 959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).",
CVCL_6410,J.gamma1,,CRL-2678,14Y,Male,Caucasian,Cancer cell line,,,,T-cell,UBERON_0000178,NCIt; C7953; Childhood T acute lymphoblastic leukemia," Mutation; HGNC; 959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).",
CVCL_6411,J.gamma1.WT,,CRL-2679,14Y,Male,Caucasian,Cancer cell line,,,,T-cell,UBERON_0000178,NCIt; C7953; Childhood T acute lymphoblastic leukemia," Mutation; HGNC; 959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).",
CVCL_1316,J.RT3-T3.5,,TIB-153,14Y,Male,Caucasian,Cancer cell line,,,,T-cell,UBERON_0000178,NCIt; C7953; Childhood T acute lymphoblastic leukemia," Gene fusion; HGNC; 1777; CDK6 + HGNC; 28629; FAM133B; Name(s)=FAM133B-CDK6 (PubMed=23637631)., Mutation; HGNC; 959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).",
CVCL_2530,J45.01,,CRL-1990,14Y,Male,Caucasian,Cancer cell line,,,,T-cell,UBERON_0000178,NCIt; C7953; Childhood T acute lymphoblastic leukemia," Mutation; HGNC; 959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).",
CVCL_0359,J82,,HTB-1,58Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001255,NCIt; C4912; Bladder carcinoma," Mutation; HGNC; 583; APC; Simple; p.Ser770Pro (c.2308T>C); ClinVar=VCV000140988; Zygosity=Heterozygous (Cosmic-CLP=753566; DepMap=ACH-000396)., Mutation; HGNC; 9588; PTEN; Simple; p.Asn212fs*1 (c.635_1212del578); Zygosity=Homozygous (ATCC=HTB-1)., Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680)., Mutation; HGNC; 11998; TP53; Simple; p.Lys320Asn (c.960G>C); Zygosity=Heterozygous (PubMed=7787250; PubMed=9850064; ATCC=HTB-1).",
CVCL_0360,JAR,,HTB-144,Fetus,Male,,Cancer cell line,,,,,,NCIt; C4646; Gestational choriocarcinoma,,
CVCL_0363,JEG-3,,HTB-36,Fetus,Male,Caucasian,Cancer cell line,,,,,UBERON_0006237,NCIt; C4646; Gestational choriocarcinoma,,
CVCL_1865,JeKo-1,,CRL-3006,78Y,Female,Korean,Cancer cell line,,,,,UBERON_0000178,NCIt; C4337; Mantle cell lymphoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Heterozygous (PubMed=16448697)., Mutation; HGNC; 11998; TP53; Simple; p.Pro58Glnfs*65 (c.173delC); ClinVar=VCV001394451; Zygosity=Heterozygous (PubMed=16448697).",
CVCL_L154,JHC7,,CRL-3267,61Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0003690,NCIt; C129927; Sacral chordoma, Mutation; HGNC; 11998; TP53; Simple; p.Arg213Leu (c.638G>T); ClinVar=VCV000376650; Zygosity=Unspecified (DepMap=ACH-001955).,
CVCL_5986,JHU-011,,CRL-2719,45Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001737,NCIt; C4044; Laryngeal squamous cell carcinoma,,
CVCL_5987,JHU-012,,CRL-2720,53Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001737,NCIt; C4044; Laryngeal squamous cell carcinoma,,
CVCL_5989,JHU-019,,CRL-2721,62Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002481,NCIt; C4863; Prostate carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).,
CVCL_5991,JHU-022,,CRL-2722,53Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001737,NCIt; C4044; Laryngeal squamous cell carcinoma,,
CVCL_5993,JHU-029,,CRL-2723,70Y,Male,African American,Cancer cell line,,,,,UBERON_0001737,NCIt; C4044; Laryngeal squamous cell carcinoma,,
CVCL_5985,JHU-06,,CRL-2718,42Y,Male,,Cancer cell line,,,,,UBERON_0001723,NCIt; C4648; Tongue squamous cell carcinoma,,
CVCL_JL97,JK28,,CRL-3358,14Y,Male,Caucasian,Cancer cell line,,,,T-cell,UBERON_0000178,NCIt; C7953; Childhood T acute lymphoblastic leukemia," Mutation; HGNC; 959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).",
CVCL_3532,JM-1,,CRL-10423,Age unspecified,Male,Caucasian,Cancer cell line,,,,,UBERON_0000178,NCIt; C8644; B acute lymphoblastic leukemia,,
CVCL_UJ14,JMP-1,,CRL-3378,Age unspecified,Male,,Cancer cell line,10376,Epstein-Barr virus (EBV).,,,UBERON_0000175,NCIt; C4337; Mantle cell lymphoma,,
CVCL_3728,JSC-1,,CRL-2769,52Y,Male,Caucasian,Cancer cell line,10376,Epstein-Barr virus (EBV).,,,UBERON_0007795,NCIt; C6915; Primary effusion lymphoma, Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (Cosmic-CLP=1327769; DepMap=ACH-002253).,
CVCL_1061,Jurkat clone A3,,CRL-2570,14Y,Male,Caucasian,Cancer cell line,,,,T-cell,UBERON_0000178,NCIt; C7953; Childhood T acute lymphoblastic leukemia," Mutation; HGNC; 959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).",
CVCL_3502,Jurkat D1.1,,CRL-3600,14Y,Male,Caucasian,Cancer cell line,,,,T-cell,UBERON_0000178,NCIt; C7953; Childhood T acute lymphoblastic leukemia," Mutation; HGNC; 959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).",
CVCL_0367,Jurkat E6.1,,TIB-152,14Y,Male,Caucasian,Cancer cell line,,,,T-cell,UBERON_0000178,NCIt; C7953; Childhood T acute lymphoblastic leukemia," Mutation; HGNC; 959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (PubMed=29739316)., Mutation; HGNC; 16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (PubMed=29739316)., Mutation; HGNC; 7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (PubMed=29739316).",
CVCL_U326,Jurkat-111,,CRL-8129,14Y,Male,Caucasian,Cancer cell line,,,,T-cell,UBERON_0000178,NCIt; C7953; Childhood T acute lymphoblastic leukemia," Mutation; HGNC; 959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).",
CVCL_JL99,JX17,,CRL-3360,14Y,Male,Caucasian,Cancer cell line,,,,T-cell,UBERON_0000178,NCIt; C7953; Childhood T acute lymphoblastic leukemia," Mutation; HGNC; 959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).",
CVCL_JM00,K-562-GFP,,CCL-243-GFP,53Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000175,"NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive"," Gene fusion; HGNC; 76; ABL1 + HGNC; 1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).",
CVCL_UR39,K-562-luc2,,CCL-243-LUC2,53Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000175,"NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive"," Gene fusion; HGNC; 76; ABL1 + HGNC; 1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).",
CVCL_UC14,K562-r,,CRL-3344,53Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000175,"NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive"," Gene fusion; HGNC; 76; ABL1 + HGNC; 1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).",
CVCL_UC15,K562-s,,CRL-3343,53Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000175,"NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive"," Gene fusion; HGNC; 76; ABL1 + HGNC; 1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).",
CVCL_0589,Kasumi-1,,CRL-2724,7Y,Male,Japanese,Cancer cell line,,,,,UBERON_0000178,NCIt; C9381; Childhood acute myeloid leukemia with maturation," Gene fusion; HGNC; 10471; RUNX1 + HGNC; 1535; RUNX1T1; Name(s)=RUNX1-RUNX1T1, AML1-ETO (PubMed=11753612; PubMed=15843827; PubMed=24976338; PubMed=25485619)., Mutation; HGNC; 9811; RAD21; Simple; p.Lys330Profs*6 (c.987insCCGG); Zygosity=Unspecified (PubMed=23955599).",
CVCL_0612,Kasumi-3,,CRL-2725,57Y,Male,Japanese,Cancer cell line,,,,Myeloblast,UBERON_0002371,NCIt; C8303; Adult acute myeloid leukemia with minimal differentiation,,
CVCL_0613,Kasumi-4,,CRL-2726,6Y,Female,Japanese,Cancer cell line,,,,,UBERON_0000178,"NCIt; C7320; Childhood chronic myelogenous leukemia, BCR-ABL1 positive"," Gene fusion; HGNC; 76; ABL1 + HGNC; 1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=10071072; PubMed=32180206).",
CVCL_0614,Kasumi-6,,CRL-2775,64Y,Male,Japanese and Korean,Cancer cell line,,,,,UBERON_0000178,NCIt; C9154; Adult acute myeloid leukemia," Mutation; HGNC; 1833; CEBPA; Simple; p.Arg306Pro (c.917G>C); Zygosity=Heterozygous (PubMed=12508245; DepMap=ACH-000166)., Mutation; HGNC; 11998; TP53; Simple; p.Tyr234Asp (c.700T>G); ClinVar=VCV000219759; Zygosity=Homozygous (DepMap=ACH-000166).",
CVCL_0371,KATO III,,HTB-103,57Y,Male,Japanese,Cancer cell line,,,,,UBERON_0000175,"NCIt; C2993; Down syndrome,ORDO; Orphanet_870; Down syndrome", Gene deletion; HGNC; 11998; TP53; Zygosity=Homozygous (PubMed=1370612; PubMed=1933850; PubMed=11107048).,
CVCL_0372,KB,,CCL-17,30Y6M,Female,African American,Cancer cell line,333761,Human papillomavirus type 18 (HPV18).,,,UBERON_0000002,NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma,,
CVCL_2091,KCL-22,,CRL-3349,32Y,Female,Japanese,Cancer cell line,,,,,UBERON_0000175,"NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive"," Gene fusion; HGNC; 76; ABL1 + HGNC; 1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (PubMed=10071072; PubMed=10576511; DepMap=ACH-000983)., Mutation; HGNC; 7329; MSH6; Simple; p.Phe1088Leufs*5 (c.3261dupC) (3261_3262insC); ClinVar=VCV000089364; Zygosity=Heterozygous (PubMed=9510473; Cosmic-CLP=1330931; DepMap=ACH-000983).",
CVCL_DP58,KCL22-r,,CRL-3350,32Y,Female,Japanese,Cancer cell line,,,,,UBERON_0000175,"NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive"," Gene fusion; HGNC; 76; ABL1 + HGNC; 1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.Pro301Glnfs*44 (c.902delC); ClinVar=VCV000233908; Zygosity=Homozygous (from parent cell line).",
CVCL_0374,KG-1,,CCL-246,59Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002371,NCIt; C9154; Adult acute myeloid leukemia," Gene fusion; HGNC; 3688; FGFR1 + HGNC; 23098; FGFR1OP2; Name(s)=FGFR1OP2-FGFR1 (PubMed=31160637)., Mutation; HGNC; 11998; TP53; Simple; c.672+1G>A; ClinVar=VCV000216078; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=1571549; Cosmic-CLP=907278; DepMap=ACH-000386).",
CVCL_1824,KG-1a,,CCL-246.1,59Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002371,NCIt; C9154; Adult acute myeloid leukemia," Gene fusion; HGNC; 3688; FGFR1 + HGNC; 23098; FGFR1OP2; Name(s)=FGFR1OP2-FGFR1 (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; c.672+1G>A; ClinVar=VCV000216078; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).",
CVCL_2544,KHOS-240S,,CRL-1545,13Y,Female,Caucasian,Cancer cell line,11808,Kirsten murine sarcoma virus (Ki-MSV).,,,UBERON_0000981,NCIt; C9145; Osteosarcoma, Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (from parent cell line).,
CVCL_2545,KHOS-312H,,CRL-1546,13Y,Female,Caucasian,Cancer cell line,11808,Kirsten murine sarcoma virus (Ki-MSV).,,,UBERON_0000981,NCIt; C9145; Osteosarcoma, Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (from parent cell line).,
CVCL_2546,KHOS/NP,,CRL-1544,13Y,Female,Caucasian,Cancer cell line,11808,Kirsten murine sarcoma virus (Ki-MSV).,,,UBERON_0000981,NCIt; C9145; Osteosarcoma, Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (from parent cell line).,
CVCL_AS99,KLC,GM16726,,27Y,Male,African American,Cancer cell line,,,,,UBERON_0000178,NCIt; C8644; B acute lymphoblastic leukemia,,
CVCL_AT00,KLC-HSV2,GM16727,,27Y,Male,African American,Cancer cell line,,,,,UBERON_0000178,NCIt; C8644; B acute lymphoblastic leukemia,,
CVCL_1329,KLE,,CRL-1622,68Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0001295,NCIt; C7359; Endometrial adenocarcinoma, Mutation; HGNC; 16712; FBXW7; Simple; p.Arg479Gln (c.1436G>A); ClinVar=VCV000376419; Zygosity=Heterozygous (Cosmic-CLP=924187; DepMap=ACH-000293).,
CVCL_0379,Ku812,,CRL-2099,38Y,Male,Japanese,Cancer cell line,,,,Basophil progenitor cell,UBERON_0000178,"NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive"," Gene fusion; HGNC; 76; ABL1 + HGNC; 1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (PubMed=10071072; PubMed=10576511; PubMed=15843827; PubMed=20809971; DepMap=ACH-000074).",
CVCL_0615,Ku812E,,CRL-2100,38Y,Male,Japanese,Cancer cell line,,,,Basophil progenitor cell,UBERON_0000178,"NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive"," Gene fusion; HGNC; 76; ABL1 + HGNC; 1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).",
CVCL_0616,Ku812F,,CRL-2101,38Y,Male,Japanese,Cancer cell line,,,,Basophil progenitor cell,UBERON_0000178,"NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive"," Gene fusion; HGNC; 76; ABL1 + HGNC; 1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).",
CVCL_1908,L-132,,CCL-5,30Y6M,Female,African American,Cancer cell line,333761,Human papillomavirus type 18 (HPV18).,,,UBERON_0000002,NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma,,
CVCL_DP57,LAMA84-r,,CRL-3348,29Y,Female,,Cancer cell line,,,,,UBERON_0000178,"NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive"," Gene fusion; HGNC; 76; ABL1 + HGNC; 1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).",
CVCL_UE08,LAMA84-s,,CRL-3347,29Y,Female,,Cancer cell line,,,,,UBERON_0000178,"NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive"," Gene fusion; HGNC; 76; ABL1 + HGNC; 1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).",
CVCL_4744,LAPC-4,,CRL-13009,Age unspecified,Male,,Cancer cell line,,,,,UBERON_0000027,NCIt; C4863; Prostate carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=11304728; PubMed=14518029).,
CVCL_UE17,LASCPC-01,,CRL-3356,75-80Y,Male,Caucasian,Cancer cell line,,,,,,NCIt; C39903; Prostate adenocarcinoma with neuroendocrine differentiation,,
CVCL_UC30,LM-MEL-19,,CRL-3328,28Y,Male,,Cancer cell line,,,,,UBERON_0000027,NCIt; C3224; Melanoma, Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=23527996).,
CVCL_UC16,LM-MEL-1a,,CRL-3329,62Y,Female,,Cancer cell line,,,,,UBERON_0000376+UBERON_0002072,NCIt; C3224; Melanoma, Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=23527996).,
CVCL_UC33,LM-MEL-25,,CRL-3330,71Y,Male,,Cancer cell line,,,,,UBERON_0008953,NCIt; C3224; Melanoma,,
CVCL_UC36,LM-MEL-28,,CRL-3331,63Y,Female,,Cancer cell line,,,,,UBERON_0001542,NCIt; C3224; Melanoma, Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23527996).,
CVCL_UC38,LM-MEL-30,,CRL-3332,54Y,Male,,Cancer cell line,,,,,UBERON_0001097,NCIt; C3224; Melanoma, Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23527996).,
CVCL_UC40,LM-MEL-33,,CRL-3333,42Y,Male,,Cancer cell line,,,,,UBERON_0001542,NCIt; C3224; Melanoma, Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23527996).,
CVCL_UC47,LM-MEL-41,,CRL-3334,45Y,Male,,Cancer cell line,,,,,UBERON_0002429,NCIt; C3224; Melanoma, Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23527996).,
CVCL_UC48,LM-MEL-42,,CRL-3335,67Y,Male,,Cancer cell line,,,,,UBERON_0002106,NCIt; C3224; Melanoma, Mutation; HGNC; 1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Unspecified (PubMed=23527996).,
CVCL_UC50,LM-MEL-45,,CRL-3336,33Y,Female,,Cancer cell line,,,,,UBERON_0002807,NCIt; C3224; Melanoma, Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23527996).,
CVCL_UC56,LM-MEL-53,,CRL-3337,69Y,Female,,Cancer cell line,,,,,UBERON_0034929,NCIt; C3224; Melanoma,,
CVCL_UC57,LM-MEL-57,,CRL-3338,48Y,Male,,Cancer cell line,,,,,UBERON_0002170,NCIt; C3224; Melanoma,,
CVCL_UC60,LM-MEL-62,,CRL-3339,72Y,Male,,Cancer cell line,,,,,UBERON_0001097,NCIt; C3224; Melanoma," Mutation; HGNC; 1097; BRAF; Simple; p.Gly469Glu (c.1406G>A) (p.Gly509Glu, c.1526G>A); ClinVar=VCV000013974; Zygosity=Unspecified (PubMed=23527996).",
CVCL_UC64,LM-MEL-71,,CRL-3340,48Y,Male,,Cancer cell line,,,,,UBERON_0002807,NCIt; C3224; Melanoma, Mutation; HGNC; 1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Unspecified (PubMed=23527996).,
CVCL_UC66,LM-MEL-75,,CRL-3341,75Y,Male,,Cancer cell line,,,,,UBERON_0001097,NCIt; C3224; Melanoma,,
CVCL_0392,LN-18,,CRL-2610,61Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002809,NCIt; C3058; Glioblastoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (PubMed=9842975)., Mutation; HGNC; 11998; TP53; Simple; p.Cys238Ser (c.713G>C); ClinVar=VCV000376575; Zygosity=Homozygous (PubMed=7732013; PubMed=10416987; PubMed=14614447; Cosmic-CLP=1240168; DepMap=ACH-000819).",
CVCL_0393,LN-229,,CRL-2611,60Y,Female,Caucasian,Cancer cell line,,,,,,NCIt; C3058; Glioblastoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (PubMed=9842975)., Mutation; HGNC; 9811; RAD21; Simple; p.Gln132Ter (c.394C>T); Zygosity=Heterozygous (Cosmic-CLP=1240169)., Mutation; HGNC; 11998; TP53; Simple; p.Pro98Leu (c.293C>T); ClinVar=VCV000528236; Zygosity=Homozygous (PubMed=10416987; Cosmic-CLP=1240169).",
CVCL_4783,LNCaP C4,,CRL-3313,50Y,Male,Caucasian,Cancer cell line,,,,,UBERON_8480056,NCIt; C4863; Prostate carcinoma," Mutation; HGNC; 644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line)., Mutation; HGNC; 8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).",
CVCL_4782,LNCaP C4-2,,CRL-3314,50Y,Male,Caucasian,Cancer cell line,,,,,UBERON_8480056,NCIt; C4863; Prostate carcinoma," Mutation; HGNC; 644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (PubMed=26499105)., Mutation; HGNC; 8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).",
CVCL_4784,LNCaP C4-2B,,CRL-3315,50Y,Male,Caucasian,Cancer cell line,,,,,UBERON_8480056,NCIt; C4863; Prostate carcinoma," Mutation; HGNC; 644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line)., Mutation; HGNC; 8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).",
CVCL_1379,LNCaP clone FGC,,CRL-1740,50Y,Male,Caucasian,Cancer cell line,,,,,UBERON_8480056,NCIt; C4863; Prostate carcinoma," Mutation; HGNC; 644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (Cosmic-CLP=907788; DepMap=ACH-000977)., Mutation; HGNC; 8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (Cosmic-CLP=907788; DepMap=ACH-000977).",
CVCL_A4BQ,LNCaP clone FGC-Luc2,,CRL-1740-LUC2,50Y,Male,Caucasian,Cancer cell line,,,,,UBERON_8480056,NCIt; C4863; Prostate carcinoma," Mutation; HGNC; 644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line)., Mutation; HGNC; 8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).",
CVCL_3539,LNZTA3WT11,,CRL-11544,60Y,Male,Caucasian,Cancer cell line,,,,,,NCIt; C60781; Astrocytoma,,
CVCL_3540,LNZTA3WT4,,CRL-11543,60Y,Male,Caucasian,Cancer cell line,,,,,,NCIt; C60781; Astrocytoma,,
CVCL_1380,Loucy,,CRL-2629,38Y,Female,Caucasian,Cancer cell line,,,,T-cell,UBERON_0000178,NCIt; C9142; Adult T acute lymphoblastic leukemia, Gene fusion; HGNC; 8064; NUP214 + HGNC; 10760; SET; Name(s)=SET-NUP214 (PubMed=19166587).,
CVCL_0399,LoVo,,CCL-229,56Y,Male,Caucasian,Cancer cell line,,,,,UBERON_8480056,NCIt; C4349; Colon adenocarcinoma," Mutation; HGNC; 173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (PubMed=12615714; Cosmic-CLP=907790; DepMap=ACH-000950)., Mutation; HGNC; 583; APC; Simple; p.Met1431fs*42 (c.4289delC) (p.T1430fs); Zygosity=Heterozygous (PubMed=24755471; Cosmic-CLP=907790; DepMap=ACH-000950)., Mutation; HGNC; 914; B2M; Simple; p.Leu15Phefs*41 (c.43_44delCT); Zygosity=Heterozygous (PubMed=8197130; Cosmic-CLP=907790; DepMap=ACH-000950)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (PubMed=12068308; PubMed=20570890; PubMed=24755471; PubMed=28683746; Cosmic-CLP=907790; DepMap=ACH-000950)., Mutation; HGNC; 11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (PubMed=12615714).",
CVCL_1382,LS1034,,CRL-2158,54Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001153,NCIt; C5543; Cecum adenocarcinoma," Mutation; HGNC; 583; APC; Simple; p.Glu1309Aspfs*4 (c.3927_3931delAAAGA); ClinVar=VCV000000816; Zygosity=Homozygous (ATCC=CRL-2158)., Mutation; HGNC; 11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Homozygous (PubMed=9000147; PubMed=16418264; PubMed=28683746; Cosmic-CLP=917486; DepMap=ACH-000252).",
CVCL_1383,LS123,,CCL-255,65Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4349; Colon adenocarcinoma," Mutation; HGNC; 583; APC; Simple; p.Gln625Ter (c.1873C>T); ClinVar=VCV000232045; Zygosity=Heterozygous (ATCC=CCL-255; Cosmic-CLP=907792; DepMap=ACH-000501)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Heterozygous (Cosmic-CLP=907792; DepMap=ACH-000501).",
CVCL_1384,LS174T,,CL-188,58Y,Female,Caucasian,Cancer cell line,,,,Epithelial cell of colon,UBERON_0001155,NCIt; C4349; Colon adenocarcinoma," Mutation; HGNC; 2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (PubMed=24755471; ATCC=CL-188)., Mutation; HGNC; 8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (PubMed=20570890; PubMed=24042735; PubMed=24755471; PubMed=28683746).",
CVCL_0397,LS180,,CL-187,58Y,Female,Caucasian,Cancer cell line,,,,Epithelial cell of colon,UBERON_0001155,NCIt; C4349; Colon adenocarcinoma," Mutation; HGNC; 173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (PubMed=12615714)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=20570890; PubMed=24755471; ATCC=CL-187)., Mutation; HGNC; 11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (PubMed=12615714).",
CVCL_1385,LS411N,,CRL-2159,32Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001153,NCIt; C5543; Cecum adenocarcinoma," Mutation; HGNC; 583; APC; Simple; p.Gln789Ter (c.2365C>T); ClinVar=VCV000092341; Zygosity=Heterozygous (PubMed=24755471; ATCC=CRL-2159; Cosmic-CLP=907794; DepMap=ACH-000985)., Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (PubMed=12068308; PubMed=20570890; PubMed=24755471; ATCC=CRL-2159; Cosmic-CLP=907794; DepMap=ACH-000985)., Mutation; HGNC; 9588; PTEN; Simple; p.Lys164Argfs*3 (c.491delA); ClinVar=VCV000189448; Zygosity=Heterozygous (PubMed=24755471; Cosmic-CLP=907794; DepMap=ACH-000985).",
CVCL_1386,LS513,,CRL-2134,63Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000569,NCIt; C5543; Cecum adenocarcinoma," Mutation; HGNC; 2514; CTNNB1; Simple; p.Ala5_Ala80del (c.14_241del228); Zygosity=Homozygous (ATCC=CRL-2134)., Mutation; HGNC; 11998; TP53; None_reported; -; Zygosity=- (PubMed=16418264).",
CVCL_N273,Ly47,GM08688,,Age unspecified,Male,African,Cancer cell line,10376,Epstein-Barr virus (EBV).,,B-cell,,NCIt; C27694; EBV-related Burkitt lymphoma, Gene fusion; HGNC; 5853; IGL + HGNC; 7553; MYC; Name(s)=MYC-IGL (PubMed=6806672).,
CVCL_N276,Ly91,GM08689,,7Y,Female,African,Cancer cell line,10376,Epstein-Barr virus (EBV).,,B-cell,,NCIt; C27694; EBV-related Burkitt lymphoma, Gene fusion; HGNC; 5715; IGK + HGNC; 7553; MYC; Name(s)=MYC-IGK (PubMed=6441706; PubMed=6806672).,
CVCL_0400,M059J,,CRL-2366,33Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000955,NCIt; C3058; Glioblastoma," Mutation; HGNC; 9413; PRKDC; Simple; p.Thr1351Profs*8 (c.4051delA); Zygosity=Heterozygous (PubMed=11418067; DepMap=ACH-001118)., Mutation; HGNC; 11998; TP53; Simple; p.Glu286lys (c.856G>A); Zygosity=Homozygous (PubMed=11023613; Cosmic-CLP=949094; DepMap=ACH-001118).",
CVCL_0401,M059K,,CRL-2365,33Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000955,NCIt; C3058; Glioblastoma, Mutation; HGNC; 9588; PTEN; Simple; p.Pro204fs*17 (c.610delC); Zygosity=Homozygous (DepMap=ACH-000152).,
CVCL_3486,M2A7,,CRL-2500,Age unspecified,Sex unspecified,,Cancer cell line,,,,,UBERON_0002097,NCIt; C3510; Cutaneous melanoma,,
CVCL_B057,M4A4,,CRL-2914,33Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0013691+UBERON_0002072,NCIt; C3802; Amelanotic melanoma," Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 1787; CDKN2A; Simple; c.455insCdel26; Zygosity=Heterozygous (from parent cell line).",
CVCL_B058,M4A4 GFP,,CRL-2915,33Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0013691+UBERON_0002072,NCIt; C3802; Amelanotic melanoma," Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 1787; CDKN2A; Simple; c.455insCdel26; Zygosity=Heterozygous (from parent cell line).",
CVCL_B059,M4A4 LM3-2 GFP,,CRL-2916,33Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0013691+UBERON_0002072,NCIt; C3802; Amelanotic melanoma," Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 1787; CDKN2A; Simple; c.455insCdel26; Zygosity=Heterozygous (from parent cell line).",
CVCL_B060,M4A4 LM3-4 CL16 GFP,,CRL-2917,33Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0013691+UBERON_0002072,NCIt; C3802; Amelanotic melanoma," Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 1787; CDKN2A; Simple; c.455insCdel26; Zygosity=Heterozygous (from parent cell line).",
CVCL_1438,Malme-3M,,HTB-64,43Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C3224; Melanoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Unspecified (PubMed=29492214)., Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).",
CVCL_1831,MAVER-1,,CRL-3008,82Y,Male,,Cancer cell line,,,,,UBERON_0000178,NCIt; C4337; Mantle cell lymphoma, Mutation; HGNC; 11998; TP53; Simple; p.Asp281Glu (c.843C>G); ClinVar=VCV000376587; Zygosity=Hemizygous (PubMed=16434369; DepMap=ACH-002485).,
CVCL_1399,MC116,,CRL-1649,Age unspecified,Male,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C3457; B-cell non-Hodgkin lymphoma, Mutation; HGNC; 11998; TP53; Simple; p.Cys238Tyr (c.713G>A); ClinVar=VCV000182935; Zygosity=Unspecified (PubMed=2052620; PubMed=8344493).,
CVCL_0031,MCF-7,,HTB-22,69Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C4194; Invasive breast carcinoma of no special type," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (PubMed=19593635)., Mutation; HGNC; 8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (PubMed=17088437; PubMed=19593635; PubMed=28889351).",
CVCL_A4AQ,MCF-7 Tam1,,CRL-3435,69Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C4194; Invasive breast carcinoma of no special type," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).",
CVCL_A4CH,MCF7 dCas9-KRAB,,HTB-22dCas9-KRAB,69Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C4194; Invasive breast carcinoma of no special type," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).",
CVCL_A4CI,MCF7-Luc2,,HTB-22-LUC2,69Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C4194; Invasive breast carcinoma of no special type," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).",
CVCL_UI82,MDA-EJ-1,,CRL-3380,43Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0007795,NCIt; C8851; Diffuse large B-cell lymphoma,,
CVCL_6421,MDA-kb2,,CRL-2713,48Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002409,NCIt; C5214; Breast adenocarcinoma," Mutation; HGNC; 644; AR; Simple; p.Gln868His (c.2604G>T); Zygosity=Unspecified (from parent cell line)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Unspecified (from parent cell line)., Mutation; HGNC; 9588; PTEN; Simple; p.Glu307Lys (c.919G>A); Zygosity=Heterozygous (from parent cell line).",
CVCL_0617,MDA-MB-134-VI,,HTB-23,47Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C7950; Invasive breast lobular carcinoma," Mutation; HGNC; 1748; CDH1; Simple; p.Leu230fs*4 (c.688_832del145); Zygosity=Homozygous (PubMed=19593635)., Mutation; HGNC; 6844; MAP2K4; Simple; p.Ser184Leu (c.551C>T); Zygosity=Homozygous (PubMed=9331070; PubMed=19593635; DepMap=ACH-000044).",
CVCL_0618,MDA-MB-157,,CRL-7721,44Y,Female,African American,Cancer cell line,,,,,UBERON_0000175,NCIt; C4872; Breast carcinoma," Mutation; HGNC; 7329; MSH6; Simple; p.Pro42Ser (c.124C>T); ClinVar=VCV000089180; Zygosity=Heterozygous (PubMed=19593635; DepMap=ACH-000621)., Mutation; HGNC; 11998; TP53; Simple; p.Pro87fs*53 (c.261_286del26) (p.Ala88Cysfs*52); Zygosity=Homozygous (PubMed=16541312; ATCC=HTB-24; DepMap=ACH-000621).",
CVCL_1400,MDA-MB-175-VII,,HTB-25,56Y,Female,African American,Cancer cell line,,,,,UBERON_0000175,NCIt; C4194; Invasive breast carcinoma of no special type," Gene fusion; HGNC; 7997; NRG1 + HGNC; 29945; TENM4; Name(s)=TENM4-NRG1, DOC4-NRG1; Note=In frame (PubMed=12800145; PubMed=29610121).",
CVCL_0062,MDA-MB-231,,HTB-26,51Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C5214; Breast adenocarcinoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (PubMed=17334996; PubMed=19593635; ATCC=HTB-26)., Mutation; HGNC; 1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (PubMed=17088437; PubMed=19593635; ATCC=HTB-26)., Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).",
CVCL_VR67,MDA-MB-231 VIM RFP,,HTB-26MET,51Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C5214; Breast adenocarcinoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).",
CVCL_0619,MDA-MB-330,,HTB-127,43Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C7950; Invasive breast lobular carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Unspecified (PubMed=16541312; PubMed=28889351).,
CVCL_0620,MDA-MB-361,,HTB-27,40Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000955,NCIt; C5214; Breast adenocarcinoma," Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (Cosmic-CLP=908121; DepMap=ACH-000934)., Mutation; HGNC; 1787; CDKN2A; Simple; p.Met52Ile (c.156G>C) (p.Asp67His, c.199G>C); ClinVar=VCV002132254; Zygosity=Homozygous (PubMed=19593635; ATCC=HTB-27; Cosmic-CLP=908121; DepMap=ACH-000934)., Mutation; HGNC; 8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (PubMed=19593635; Cosmic-CLP=908121; DepMap=ACH-000934)., Mutation; HGNC; 11998; TP53; Simple; p.Glu56Ter (c.166G>T); ClinVar=VCV001329425; Zygosity=Homozygous (PubMed=16541312; Cosmic-CLP=908121; DepMap=ACH-000934).",
CVCL_0621,MDA-MB-415,,HTB-128,38Y,Female,,Cancer cell line,,,,,UBERON_0000175,NCIt; C5214; Breast adenocarcinoma," Mutation; HGNC; 6844; MAP2K4; Simple; p.Ser280Ter (c.839C>A); Zygosity=Homozygous (PubMed=9331070; PubMed=19593635)., Mutation; HGNC; 11998; TP53; Simple; p.Tyr236Cys (c.707A>G); ClinVar=VCV000376693; Zygosity=Homozygous (PubMed=16541312; ATCC=HTB-128).",
CVCL_0622,MDA-MB-435S,,HTB-129,33Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0013691+UBERON_0002072,NCIt; C3802; Amelanotic melanoma," Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=19593635; DepMap=ACH-000884)., Mutation; HGNC; 1787; CDKN2A; Simple; c.455insCdel26; Zygosity=Heterozygous (PubMed=19593635)., Mutation; HGNC; 3373; EP300; Simple; p.Glu1013Gly (c.3038A>G); ClinVar=VCV000562024; Zygosity=Hemizygous (PubMed=10700188).",
CVCL_0623,MDA-MB-436,,HTB-130,43Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C4194; Invasive breast carcinoma of no special type," Gene deletion; HGNC; 3701; FHIT; Zygosity=Homozygous (PubMed=9288768)., Mutation; HGNC; 9884; RB1; Simple; p.Gly203fs*9 (c.607_608ins227); Zygosity=Homozygous (PubMed=19593635).",
CVCL_0418,MDA-MB-453,,HTB-131,48Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002409,NCIt; C5214; Breast adenocarcinoma," Mutation; HGNC; 644; AR; Simple; p.Gln868His (c.2604G>T); Zygosity=Unspecified (PubMed=22719059)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Unspecified (PubMed=22121396)., Mutation; HGNC; 9588; PTEN; Simple; p.Glu307Lys (c.919G>A); Zygosity=Heterozygous (PubMed=19593635; Cosmic-CLP=908122; DepMap=ACH-000910).",
CVCL_0419,MDA-MB-468,,HTB-132,51Y,Female,African American,Cancer cell line,,,,,UBERON_0000175,NCIt; C5214; Breast adenocarcinoma," Mutation; HGNC; 9588; PTEN; Simple; c.253+1G>T; ClinVar=VCV000189475; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=19593635)., Mutation; HGNC; 11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (PubMed=1961733; PubMed=16541312; PubMed=28889351; ATCC=HTB-132).",
CVCL_VR71,MDA-PATC50,,CRL-3430,60Y,Female,,Cancer cell line,,,,,UBERON_0001264,NCIt; C9120; Pancreatic ductal adenocarcinoma, Gene deletion; HGNC; 6770; SMAD4; Zygosity=Homozygous (PubMed=25485535).,
CVCL_VR69,MDA-PATC53,,CRL-3431,65Y,Male,,Cancer cell line,,,,,UBERON_0002107,NCIt; C9120; Pancreatic ductal adenocarcinoma, Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=25485535).,
CVCL_VR72,MDA-PATC66,,CRL-3432,63Y,Female,,Cancer cell line,,,,,UBERON_0001264,NCIt; C9120; Pancreatic ductal adenocarcinoma, Gene deletion; HGNC; 6770; SMAD4; Zygosity=Homozygous (PubMed=25485535).,
CVCL_4747,MDA-PCa-2a,,CRL-2421,63Y,Male,African American,Cancer cell line,,,,,UBERON_0002481,NCIt; C4863; Prostate carcinoma,,
CVCL_4748,MDA-PCa-2b,,CRL-2422,63Y,Male,African American,Cancer cell line,,,,,UBERON_0002481,NCIt; C4863; Prostate carcinoma,,
CVCL_QW85,MDA-T120,,CRL-3355,72Y,Female,,Cancer cell line,,,,,UBERON_0002429,NCIt; C4035; Thyroid gland papillary carcinoma," Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=25427145; PubMed=30737244)., Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (PubMed=25427145; PubMed=30737244).",
CVCL_W913,MDA-T32,,CRL-3351,74Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002046,NCIt; C4035; Thyroid gland papillary carcinoma," Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=23833040; PubMed=25427145; PubMed=30737244)., Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (PubMed=23833040; PubMed=25427145; PubMed=30737244).",
CVCL_W914,MDA-T41,,CRL-3352,74Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C4035; Thyroid gland papillary carcinoma," Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=23833040; PubMed=25427145; PubMed=30737244)., Mutation; HGNC; 11998; TP53; Simple; p.Phe19fs (c.56_65delTTTCAGACCT); Zygosity=Heterozygous (PubMed=30737244).",
CVCL_QW83,MDA-T68,,CRL-3353,75Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002046,NCIt; C8054; Thyroid gland follicular carcinoma, Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=25427145).,
CVCL_QW84,MDA-T85,,CRL-3354,61Y,Male,Hispanic,Cancer cell line,,,,,UBERON_0000027,NCIt; C4035; Thyroid gland papillary carcinoma," Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=25427145; PubMed=30737244)., Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (PubMed=25427145; PubMed=30737244).",
CVCL_0420,MDAH 2774,,CRL-10303,Age unspecified,Female,,Cancer cell line,,,,,UBERON_0007795,NCIt; C7979; Ovarian endometrioid adenocarcinoma," Mutation; HGNC; 16712; FBXW7; Simple; c.862-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=11565033)., Mutation; HGNC; 11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (PubMed=8557231; PubMed=25230021).",
CVCL_1401,ME-180,,CRL-7932,66Y,Female,Caucasian,Cancer cell line,45240,Human papillomavirus type 68 (HPV68).,,,UBERON_0003688,NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma, Mutation; HGNC; 8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (Cosmic-CLP=687514; DepMap=ACH-001359).,
CVCL_0425,MEG-01,,CRL-2021,55Y,Male,Japanese,Cancer cell line,,,,,UBERON_0002371,"NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive"," Gene fusion; HGNC; 76; ABL1 + HGNC; 1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (PubMed=10071072; PubMed=10576511; PubMed=15843827; PubMed=20809971; DepMap=ACH-000072)., Mutation; HGNC; 11998; TP53; Simple; p.His233del (c.697_699delCAC); Zygosity=Heterozygous (Cosmic-CLP=908126; DepMap=ACH-000072).",
CVCL_CZ92,MES-OV,,CRL-3272,53Y,Female,,Cancer cell line,,,,,UBERON_0007795,NCIt; C7978; Ovarian serous cystadenocarcinoma,,
CVCL_1404,MES-SA,,CRL-1976,56Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000995,NCIt; C6339; Uterine corpus sarcoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (ATCC=CRL-1976)., Mutation; HGNC; 11110; ARID1A; Simple; p.Thr1690Asnfs*8 (c.5068dupA) (c.5067_5068insA); Zygosity=Heterozygous (Cosmic-CLP=908127; DepMap=ACH-000449).",
CVCL_2598,MES-SA/Dx5,,CRL-1977,56Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000995,NCIt; C6339; Uterine corpus sarcoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 11110; ARID1A; Simple; p.Thr1690Asnfs*8 (c.5068dupA) (c.5067_5068insA); Zygosity=Heterozygous (from parent cell line).",
CVCL_2599,MES-SA/MX2,,CRL-2274,56Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000995,NCIt; C6339; Uterine corpus sarcoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 11110; ARID1A; Simple; p.Thr1690Asnfs*8 (c.5068dupA) (c.5067_5068insA); Zygosity=Heterozygous (from parent cell line).",
CVCL_0445,MeWo,,HTB-65,78Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C3510; Cutaneous melanoma," Gene deletion; HGNC; 1788; CDKN2B; Zygosity=Heterozygous (PubMed=9598804)., Mutation; HGNC; 3688; FGFR1; Simple; p.Pro252Ser (c.754C>T); Zygosity=Unspecified (PubMed=23851445)., Mutation; HGNC; 11998; TP53; Simple; p.Gln317Ter (c.949C>T); ClinVar=VCV000450344; Zygosity=Unspecified (PubMed=17260012; PubMed=23851445).",
CVCL_0426,MG-63,,CRL-1427,14Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000981,NCIt; C9145; Osteosarcoma, Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (PubMed=19787792; ATCC=CRL-1427).,
CVCL_C9CX,MG-63-GAS-Luc2,,CRL-1427-GAS-LUC2,14Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000981,NCIt; C9145; Osteosarcoma, Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (from parent cell line).,
CVCL_0428,MIA PaCa-2,,CRL-1420,65Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001264,NCIt; C9120; Pancreatic ductal adenocarcinoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (PubMed=11787853)., Mutation; HGNC; 11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (PubMed=1630814; PubMed=1764370; PubMed=7961102; PubMed=8026879; PubMed=8194712; PubMed=11115575; PubMed=11169959; PubMed=11787853; PubMed=21607521; Cosmic-CLP=724870; DepMap=ACH-000601).",
CVCL_8264,Minnesota EE,,CCL-4,30Y6M,Female,African American,Cancer cell line,333761,Human papillomavirus type 18 (HPV18).,,,UBERON_0000002,NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma,,
CVCL_1872,Mino,,CRL-3000,68Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000178,NCIt; C4337; Mantle cell lymphoma," Mutation; HGNC; 1787; CDKN2A; Simple; p.Glu88Lys (c.262G>A); ClinVar=VCV000821566; Zygosity=Homozygous (DepMap=ACH-000220)., Mutation; HGNC; 11998; TP53; Simple; p.Val147Gly (c.440T>G); Zygosity=Homozygous (DepMap=ACH-000220).",
CVCL_1414,MJ,,CRL-8294,50Y,Male,Caucasian,Cancer cell line,11908,Human T-lymphotropic virus 1 (HTLV-1).,,T-cell,UBERON_0000178,NCIt; C3467; Primary cutaneous T-cell non-Hodgkin lymphoma,,
CVCL_8794,MM1.R,,CRL-2975,45Y,Female,African American,Cancer cell line,,,,B-cell,UBERON_0000178,NCIt; C3242; Plasma cell myeloma, Mutation; HGNC; 12033; TRAF3; Simple; p.Val536_Asn545delValPheValAlaGlnThrValLeuGluAsninsAsp (c.1604-1630delTCTTTGTGGCCCAAACTGTTCTAGAAA); Zygosity=Homozygous (PubMed=17692805).,
CVCL_8792,MM1.S,,CRL-2974,45Y,Female,African American,Cancer cell line,,,,B-cell,UBERON_0000178,NCIt; C3242; Plasma cell myeloma, Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Heterozygous (PubMed=21173094; Cosmic-CLP=1659818; DepMap=ACH-000763).,
CVCL_4D15,MM28,,CRL-3295,72Y,Male,,Cancer cell line,,,,,UBERON_0002107,NCIt; C7712; Uveal melanoma, Mutation; HGNC; 950; BAP1; Simple; p.Tyr627Ter (c.1881C>A); Zygosity=Unspecified (PubMed=24994677).,
CVCL_0439,MNNG/HOS Cl #5,,CRL-1547,13Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000981,NCIt; C9145; Osteosarcoma, Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (PubMed=19787792).,
CVCL_5624,MNT-1,,CRL-3450,Age unspecified,Sex unspecified,,Cancer cell line,,,,,UBERON_0000027,NCIt; C3224; Melanoma,,
CVCL_1439,Mo,,CRL-8066,33Y,Male,Caucasian,Cancer cell line,11909,Human T-lymphotropic virus 2 (HTLV-2).,,T-cell,UBERON_0002106,NCIt; C7402; Hairy cell leukemia,,
CVCL_0624,MOLT-3,,CRL-1552,19Y,Male,Caucasian,Cancer cell line,,,,T-cell,UBERON_0000178,NCIt; C9142; Adult T acute lymphoblastic leukemia," Mutation; HGNC; 7881; NOTCH1; Simple; p.Leu1600Pro (c.4799T>C); Zygosity=Heterozygous (PubMed=15472075; DepMap=ACH-000964)., Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (DepMap=ACH-000964).",
CVCL_4D11,MP38,,CRL-3296,Age unspecified,Male,,Cancer cell line,,,,,UBERON_0001768,NCIt; C7712; Uveal melanoma, Mutation; HGNC; 950; BAP1; Simple; c.68-9_72del; Zygosity=Unspecified (PubMed=24994677).,
CVCL_4D12,MP41,,CRL-3297,49Y,Female,,Cancer cell line,,,,,UBERON_0001768,NCIt; C7712; Uveal melanoma, Mutation; HGNC; 4379; GNA11; Simple; p.Gln209Leu (c.626A>T); ClinVar=VCV000376002; Zygosity=Unspecified (PubMed=24994677).,
CVCL_4D13,MP46,,CRL-3298,69Y,Male,,Cancer cell line,,,,,UBERON_0001768,NCIt; C7712; Uveal melanoma, Mutation; HGNC; 4390; GNAQ; Simple; p.Gln209Leu (c.626A>T); ClinVar=VCV000375955; Zygosity=Unspecified (PubMed=24994677).,
CVCL_4D14,MP65,,CRL-3299,42Y,Female,,Cancer cell line,,,,,UBERON_0001768,NCIt; C7712; Uveal melanoma, Mutation; HGNC; 950; BAP1; Simple; p.Leu573Trpfs*3 (c.1717delC); ClinVar=VCV000221278; Zygosity=Unspecified (PubMed=24994677).,
CVCL_7165,MPanc-96,,CRL-2380,62Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0007795,NCIt; C9120; Pancreatic ductal adenocarcinoma," Gene deletion; HGNC; 6844; MAP2K4; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Homozygous (PubMed=15367885)., Mutation; HGNC; 11998; TP53; Simple; p.Cys135Alafs*35 (c.403delT); ClinVar=VCV001069265; Zygosity=Heterozygous (PubMed=15367885).",
CVCL_4996,MS751,,HTB-34,47Y,Female,Caucasian,Cancer cell line,333761,Human papillomavirus type 18 (HPV18).,,,UBERON_0000027,NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma,,
CVCL_1430,MSTO-211H,,CRL-2081,62Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C45665; Pleural biphasic mesothelioma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (PubMed=16630136)., Mutation; HGNC; 6515; LATS2; Simple; p.Met785_Leu798del14 (c.2355_2396del42); Zygosity=Heterozygous (PubMed=21245096; Cosmic-CLP=908152; DepMap=ACH-000335).",
CVCL_AV05,MUG-CC1,,CRL-3327,72Y,Male,,Cancer cell line,,,,,UBERON_0004108,NCIt; C5412; Clivus chordoma, Mutation; HGNC; 11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Unspecified (PubMed=28515451).,
CVCL_9277,MUG-Chor1,,CRL-3219,57Y,Female,,Cancer cell line,,,,,UBERON_0003690,NCIt; C129927; Sacral chordoma, Mutation; HGNC; 11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Unspecified (PubMed=28515451).,
CVCL_3549,Murphy,,CRL-7722,Age unspecified,Sex unspecified,,Cancer cell line,,,,,,NCIt; C9145; Osteosarcoma,,
CVCL_7204,MV-522,,CRL-2519,44Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4349; Colon adenocarcinoma," Mutation; HGNC; 583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).",
CVCL_0064,MV4-11,,CRL-9591,10Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000178,NCIt; C9163; Childhood acute monocytic leukemia," Gene fusion; HGNC; 7135; AFF1 + HGNC; 7132; KMT2A; Name(s)=KMT2A-AFF1, MLL-AFF1, ALL-1/AF4 (PubMed=1423625; PubMed=8358709).",
CVCL_0E37,MV522/MDR1,,CRL-2520,44Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4349; Colon adenocarcinoma," Mutation; HGNC; 583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).",
CVCL_0E38,MV522/MRP,,CRL-2521,44Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4349; Colon adenocarcinoma," Mutation; HGNC; 583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).",
CVCL_F671,N1000,GM11534,,14Y,Male,,Cancer cell line,,,,,,NCIt; C7542; Askin tumor,,
CVCL_UJ06,N6/ADR,,CRL-3274,19Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000178,NCIt; C9143; Adult B acute lymphoblastic leukemia," Gene fusion; HGNC; 50800; DUX4 + HGNC; 5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line)., Mutation; HGNC; 7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).",
CVCL_0091,NALM-1,,CRL-1567,3Y,Female,African American,Cancer cell line,,,,,UBERON_0000178,"NCIt; C7320; Childhood chronic myelogenous leukemia, BCR-ABL1 positive"," Gene fusion; HGNC; 76; ABL1 + HGNC; 1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (PubMed=10071072; PubMed=10576511; PubMed=15843827; DepMap=ACH-000462).",
CVCL_UJ05,"NALM6, clone G5",,CRL-3273,19Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000178,NCIt; C9143; Adult B acute lymphoblastic leukemia," Gene fusion; HGNC; 50800; DUX4 + HGNC; 5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line)., Mutation; HGNC; 7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).",
CVCL_0067,Namalwa,,CRL-1432,Children,Female,African,Cancer cell line,10376,Epstein-Barr virus (EBV).,,B-cell,,NCIt; C27694; EBV-related Burkitt lymphoma, Mutation; HGNC; 11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=2052620; PubMed=8344493; PubMed=8402660; Cosmic-CLP=908159; DepMap=ACH-000944).,
CVCL_F013,NBFL,,CRL-3525,11M,,,Cancer cell line,,,,,UBERON_0002429,NCIt; C4827; Adrenal gland neuroblastoma,,
CVCL_3042,NC-37,,CCL-214,11Y,Male,African,Cancer cell line,10376,Epstein-Barr virus (EBV).,,B-cell,UBERON_0002397,NCIt; C27694; EBV-related Burkitt lymphoma," Gene fusion; HGNC; 5477; IGH + HGNC; 7553; MYC; Name(s)=MYC-IGH (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).",
CVCL_B5TT,NCATS-CL9318,GM28622,,1M,Male,African American,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C84734; Glycogen storage disease type II, Mutation; HGNC; 4065; GAA; Simple; p.Arg854Ter (c.2560C>T); ClinVar=VCV000004034; Zygosity=Homozygous (from parent cell line).,
CVCL_1451,NCC-IT,,CRL-2073,24Y,Male,Japanese,Cancer cell line,,,,,,NCIt; C6341; Testicular embryonal carcinoma," Mutation; HGNC; 6844; MAP2K4; Simple; p.Lys309Asn (c.927G>C); Zygosity=Unspecified (PubMed=9331070)., Mutation; HGNC; 11998; TP53; Simple; p.Val272Cysfs*73 (c.814delG); Zygosity=Homozygous (Cosmic-CLP=908441; DepMap=ACH-001578).",
CVCL_1453,NCI-H1048,,CRL-5853,53Y,Female,African American,Cancer cell line,,,,,UBERON_0000175,NCIt; C4917; Lung small cell carcinoma," Mutation; HGNC; 8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (Cosmic-CLP=687995; DepMap=ACH-000866)., Mutation; HGNC; 11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Heterozygous (PubMed=1312696; PubMed=1565469; ATCC=CRL-5853; Cosmic-CLP=687995; DepMap=ACH-000866).",
CVCL_A483,NCI-H1059,,CRL-5854,59Y,Female,,Cancer cell line,,,,,,NCIt; C4917; Lung small cell carcinoma,,
CVCL_1454,NCI-H1092,,CRL-5855,67Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002371,NCIt; C4917; Lung small cell carcinoma," Mutation; HGNC; 2514; CTNNB1; Simple; p.Asp6Gly (c.17A>G); Zygosity=Homozygous (PubMed=11464291; ATCC=CRL-5855; Cosmic-CLP=687997; DepMap=ACH-000514)., Mutation; HGNC; 11998; TP53; Simple; c.673-2A>C (IVS6-2A>C); ClinVar=VCV000635387; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=1312696; PubMed=1565469; DepMap=ACH-000514).",
CVCL_1455,NCI-H1105,,CRL-5856,73Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C4917; Lung small cell carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Arg249Ser (c.747G>T); ClinVar=VCV000012352; Zygosity=Homozygous (ATCC=CRL-5856; Cosmic-CLP=908468; DepMap=ACH-000780).,
CVCL_1456,NCI-H1155,,CRL-5818,36Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C4450; Lung large cell carcinoma," Mutation; HGNC; 583; APC; Simple; p.Arg232Ter (c.694C>T); ClinVar=VCV000042248; Zygosity=Heterozygous (Cosmic-CLP=908467; DepMap=ACH-000980)., Mutation; HGNC; 9588; PTEN; Simple; p.Arg233Ter (c.697C>T); ClinVar=VCV000007813; Zygosity=Homozygous (Cosmic-CLP=908467; DepMap=ACH-000980).",
CVCL_1457,NCI-H1173,,CRL-5857,63Y,Female,,Cancer cell line,,,,,UBERON_0034929,NCIt; C4917; Lung small cell carcinoma,,
CVCL_1458,NCI-H1184,,CRL-5858,42Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C4917; Lung small cell carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Gly334Val (c.1001G>T); Zygosity=Unspecified (PubMed=1312696; PubMed=1565469; PubMed=20557307).,
CVCL_1459,NCI-H1238,,CRL-5859,64Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002371,NCIt; C4917; Lung small cell carcinoma,,
CVCL_3968,NCI-H125,,CRL-5801,61Y,Male,African American,Cancer cell line,,,,,UBERON_0002072,NCIt; C9133; Lung adenosquamous carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Cys238fs (c.714_715ins1); Zygosity=Unspecified (PubMed=1311061; PubMed=12820372).,
CVCL_3970,NCI-H1264,,CRL-5860,59Y,Male,,Cancer cell line,,,,,,NCIt; C3493; Lung squamous cell carcinoma," Mutation; HGNC; 1787; CDKN2A; Simple; p.His83Tyr (c.247C>T) (p.Ala97Val, c.290C>T); ClinVar=VCV000376307; Zygosity=Unspecified (from autologous cell line NCI-H157)., Mutation; HGNC; 11998; TP53; Simple; p.Glu298Ter (c.892G>T); ClinVar=VCV000093323; Zygosity=Unspecified (PubMed=1311061).",
CVCL_1460,NCI-H128,,CCL-258,60Y,Male,African American,Cancer cell line,,,,,UBERON_0000175,NCIt; C4917; Lung small cell carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Glu62Ter (c.184G>T); ClinVar=VCV000617472; Zygosity=Unspecified (PubMed=20557307).,
CVCL_1461,NCI-H1284,,CRL-5861,75Y,Male,,Cancer cell line,,,,,UBERON_0002371,NCIt; C4917; Lung small cell carcinoma,,
CVCL_0060,NCI-H1299,,CRL-5803,43Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C4450; Lung large cell carcinoma, Gene deletion; HGNC; 11998; TP53; Zygosity=Homozygous (PubMed=1311061; PubMed=1565469; PubMed=20557307; ATCC=CRL-5803).,
CVCL_1462,NCI-H1304,,CRL-5862,,Female,Caucasian,Cancer cell line,,,,,,NCIt; C4917; Lung small cell carcinoma," Mutation; HGNC; 8975; PIK3CA; Simple; p.His1047Leu (c.3140A>T); ClinVar=VCV000013653; Zygosity=Heterozygous (Cosmic-CLP=753599; DepMap=ACH-002169)., Mutation; HGNC; 11998; TP53; Simple; p.Tyr234Cys (c.701A>G); ClinVar=VCV000127820; Zygosity=Homozygous (Cosmic-CLP=753599; DepMap=ACH-002169).",
CVCL_3971,NCI-H1334,,CRL-5863,52Y,Male,Caucasian,Cancer cell line,,,,Club cell,UBERON_0002048,NCIt; C2923; Minimally invasive lung adenocarcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Arg248Leu (c.743G>T); ClinVar=VCV000230253; Zygosity=Homozygous (from parent cell line).,
CVCL_A472,NCI-H1339,,CRL-5979,49Y,Female,,Cancer cell line,,,,,UBERON_0000175,NCIt; C4917; Lung small cell carcinoma, Mutation; HGNC; 11998; TP53; Simple; c.993+1G>T (IVS9+1G>T); ClinVar=VCV000634766; Zygosity=Unspecified; Note=Splice donor mutation (PubMed=1312696; PubMed=1565469; PubMed=20557307).,
CVCL_1463,NCI-H1341,,CRL-5864,26Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000002,NCIt; C4917; Lung small cell carcinoma,,
CVCL_1464,NCI-H1355,,CRL-5865,53Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C3512; Lung adenocarcinoma," Mutation; HGNC; 1101; BRCA2; Simple; p.Gly2044Asp (c.6131G>A); ClinVar=VCV000495479; Zygosity=Homozygous (Cosmic-CLP=724866; DepMap=ACH-000666)., Mutation; HGNC; 11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Homozygous (PubMed=1311061; PubMed=1565469; Cosmic-CLP=724866; DepMap=ACH-000666).",
CVCL_1465,NCI-H1373,,CRL-5866,56Y,Male,African American,Cancer cell line,,,,,UBERON_0002048,NCIt; C3512; Lung adenocarcinoma, Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (PubMed=1311061; DepMap=ACH-000845).,
CVCL_1466,NCI-H1385,,CRL-5867,49Y,Female,African American,Cancer cell line,,,,,UBERON_0000027,NCIt; C3493; Lung squamous cell carcinoma, Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Heterozygous (DepMap=ACH-000737).,
CVCL_1467,NCI-H1395,,CRL-5868,55Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C3512; Lung adenocarcinoma," Mutation; HGNC; 795; ATM; Simple; p.Thr2666Ala (c.7996A>G); ClinVar=VCV000219594; Zygosity=Homozygous (PubMed=27602502)., Mutation; HGNC; 11998; TP53; None_reported; -; Zygosity=- (PubMed=20557307).",
CVCL_1468,NCI-H1404,,CRL-5819,48Y,Male,,Cancer cell line,,,,,UBERON_0000027,NCIt; C5650; Lung papillary adenocarcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Gln144Ter (c.430C>T); ClinVar=VCV000634688; Zygosity=Unspecified (PubMed=1311061).,
CVCL_1469,NCI-H1417,,CRL-5869,61Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C4917; Lung small cell carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Arg175Leu (c.524G>T); ClinVar=VCV000182963; Zygosity=Homozygous (ATCC=CRL-5869).,
CVCL_1470,NCI-H1435,,CRL-5870,35Y,Female,,Cancer cell line,,,,,UBERON_0002048,NCIt; C3512; Lung adenocarcinoma," Mutation; HGNC; 583; APC; Simple; p.Arg1158fs*7 (c.3471_3476GAGACC>AAAAA); Zygosity=Heterozygous (Cosmic-CLP=1298347)., Mutation; HGNC; 11998; TP53; Simple; p.Cys141Trp (c.423C>G); ClinVar=VCV000376564; Zygosity=Homozygous (PubMed=1311061; DepMap=ACH-000852).",
CVCL_1471,NCI-H1436,,CRL-5871,39Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C4917; Lung small cell carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.His179Gln (c.537T>G); ClinVar=VCV000376607; Zygosity=Unspecified (PubMed=1312696; PubMed=1565469).,
CVCL_1472,NCI-H1437,,CRL-5872,60Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C3512; Lung adenocarcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Arg267Pro (c.800G>C); ClinVar=VCV000428867; Zygosity=Homozygous (PubMed=1311061; PubMed=1565469; PubMed=20557307; ATCC=CRL-5872; Cosmic-CLP=687794; DepMap=ACH-000589).,
CVCL_1473,NCI-H146,,HTB-173,59Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002371,NCIt; C4917; Lung small cell carcinoma," Mutation; HGNC; 7133; KMT2D; Simple; p.Glu2911Ter (c.8731G>T); Zygosity=Heterozygous (Cosmic-CLP=910899; DepMap=ACH-000506)., Mutation; HGNC; 9884; RB1; Simple; p.Gln850Ter (c.2548C>T); ClinVar=VCV000284733; Zygosity=Homozygous (Cosmic-CLP=910899; DepMap=ACH-000506).",
CVCL_4363,NCI-H1514,,CRL-5873,Age unspecified,Male,,Cancer cell line,,,,,UBERON_0002371,NCIt; C4917; Lung small cell carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Glu68Ter (c.202G>T); ClinVar=VCV000224551; Zygosity=Unspecified (PubMed=1312696; PubMed=1565469).,
CVCL_1474,NCI-H1522,,CRL-5874,53Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C4917; Lung small cell carcinoma,,
CVCL_1475,NCI-H1563,,CRL-5875,Age unspecified,Male,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C3512; Lung adenocarcinoma,,
CVCL_1476,NCI-H1568,,CRL-5876,48Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C3512; Lung adenocarcinoma, Mutation; HGNC; 795; ATM; Simple; p.Gly506Phe (c.1516_1517GG>TT); Zygosity=Heterozygous (PubMed=27602502; Cosmic-CLP=1298348; DepMap=ACH-000869).,
CVCL_0463,NCI-H157,,CRL-5802,59Y,Male,,Cancer cell line,,,,,,NCIt; C3493; Lung squamous cell carcinoma," Mutation; HGNC; 1787; CDKN2A; Simple; p.His83Tyr (c.247C>T) (p.Ala97Val, c.290C>T); ClinVar=VCV000376307; Zygosity=Homozygous (PubMed=30038707; DepMap=ACH-000921)., Mutation; HGNC; 11998; TP53; Simple; p.Leu35fs*8 (c.102_103insT) (c.103_104insT); Zygosity=Heterozygous (PubMed=10536175; PubMed=20557307; DepMap=ACH-000921).",
CVCL_1478,NCI-H1573,,CRL-5877,35Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C3512; Lung adenocarcinoma," Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Heterozygous (Cosmic-CLP=908472; DepMap=ACH-000916)., Mutation; HGNC; 9644; PTPN11; Simple; p.Arg351Ter (c.1051C>T); ClinVar=VCV000372552; Zygosity=Heterozygous (Cosmic-CLP=908472; DepMap=ACH-000916).",
CVCL_1479,NCI-H1581,,CRL-5878,44Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C4450; Lung large cell carcinoma, Mutation; HGNC; 583; APC; Simple; p.Ala1107fs*12 (c.3317_3318insG); Zygosity=Homozygous (ATCC=CRL-5878; Cosmic-CLP=908471; DepMap=ACH-000015).,
CVCL_1480,NCI-H1618,,CRL-5879,55Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002371,NCIt; C4917; Lung small cell carcinoma, Mutation; HGNC; 9884; RB1; Simple; p.Pro39Argfs*26 (c.116delC); Zygosity=Homozygous (ATCC=CRL-5879; DepMap=ACH-000179).,
CVCL_4364,NCI-H1622,,CRL-5880,Age unspecified,Male,,Cancer cell line,,,,,UBERON_0000027,NCIt; C4917; Lung small cell carcinoma,,
CVCL_1481,NCI-H1623,,CRL-5881,58Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C3512; Lung adenocarcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Arg273Leu (c.818G>T); ClinVar=VCV000376655; Zygosity=Homozygous (PubMed=1311061; Cosmic-CLP=687798; DepMap=ACH-000744).,
CVCL_A503,NCI-H1628,,CRL-5980,50Y,Male,,Cancer cell line,,,,,UBERON_0000027,NCIt; C4917; Lung small cell carcinoma,,
CVCL_1482,NCI-H1648,,CRL-5882,39Y,Male,African American,Cancer cell line,,,,,UBERON_0000027,NCIt; C3512; Lung adenocarcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Leu35fs*8 (c.102_103insT) (c.103_104insT); Zygosity=Heterozygous (PubMed=1311061; PubMed=20557307; Cosmic-CLP=687799; DepMap=ACH-000766).,
CVCL_1483,NCI-H1650,,CRL-5883,27Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C2923; Minimally invasive lung adenocarcinoma, Mutation; HGNC; 3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Heterozygous (PubMed=17332333; Cosmic-CLP=687800; DepMap=ACH-000035).,
CVCL_C9CY,NCI-H1650-GAS-Luc2,,CRL-5883-GAS-LUC2,27Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C2923; Minimally invasive lung adenocarcinoma, Mutation; HGNC; 3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Heterozygous (from parent cell line).,
CVCL_1484,NCI-H1651,,CRL-5884,71Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C3512; Lung adenocarcinoma, Mutation; HGNC; 7765; NF1; Simple; p.Arg997fs*15 (c.2990delG); Zygosity=Heterozygous (Cosmic-CLP=910900; DepMap=ACH-000893).,
CVCL_1485,NCI-H1666,,CRL-5885,50Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C2923; Minimally invasive lung adenocarcinoma, Mutation; HGNC; 1097; BRAF; Simple; p.Gly466Val (c.1397G>T); ClinVar=VCV000013967; Zygosity=Unspecified (PubMed=12068308).,
CVCL_1486,NCI-H1672,,CRL-5886,58Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C4917; Lung small cell carcinoma," Mutation; HGNC; 9588; PTEN; Simple; p.His61Arg (c.182A>G); ClinVar=VCV000189402; Zygosity=Unspecified (PubMed=22961666)., Mutation; HGNC; 12687; VHL; Simple; p.Gly106Asp (c.317G>A); Zygosity=Unspecified (PubMed=8183553).",
CVCL_1487,NCI-H1688,,CCL-257,50Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002107,NCIt; C4917; Lung small cell carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Gln192Ter (c.574C>T); ClinVar=VCV000406579; Zygosity=Homozygous (Cosmic-CLP=1298349; DepMap=ACH-002170).,
CVCL_1488,NCI-H1693,,CRL-5887,55Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C3512; Lung adenocarcinoma, Mutation; HGNC; 11100; SMARCA4; Simple; p.Leu1085Glnfs*32 (c.3254_3270del); Zygosity=Heterozygous (Cosmic-CLP=687802; DepMap=ACH-000021).,
CVCL_1489,NCI-H1694,,CRL-5888,61Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0007795,NCIt; C4917; Lung small cell carcinoma, Mutation; HGNC; 11998; TP53; Simple; c.783-1G>T; ClinVar=VCV000634661; Zygosity=Homozygous; Note=Splice acceptor mutation (Cosmic-CLP=688006; DepMap=ACH-000431).,
CVCL_1490,NCI-H1703,,CRL-5889,54Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C3493; Lung squamous cell carcinoma, Mutation; HGNC; 1787; CDKN2A; Simple; p.Asp84Val (c.251A>T); ClinVar=VCV002136746; Zygosity=Homozygous (Cosmic-CLP=908474; DepMap=ACH-000747).,
CVCL_A507,NCI-H1717,,CRL-5890,66Y,Male,,Cancer cell line,,,,,UBERON_0002048,NCIt; C3493; Lung squamous cell carcinoma,,
CVCL_1491,NCI-H1734,,CRL-5891,56Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C3512; Lung adenocarcinoma," Mutation; HGNC; 795; ATM; Simple; p.Gln65Pro (c.194A>C); ClinVar=VCV000820386; Zygosity=Heterozygous (PubMed=27602502; Cosmic-CLP=722058; DepMap=ACH-000675)., Mutation; HGNC; 9884; RB1; Simple; p.Ser127Ile (c.380G>T); ClinVar=VCV000958692; Zygosity=Homozygous (Cosmic-CLP=722058; DepMap=ACH-000675).",
CVCL_1492,NCI-H1755,,CRL-5892,65Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002107,NCIt; C3512; Lung adenocarcinoma, Mutation; HGNC; 1097; BRAF; Simple; p.Gly469Ala (c.1406G>C); ClinVar=VCV000013971; Zygosity=Heterozygous (PubMed=12068308; Cosmic-CLP=908475; DepMap=ACH-000282).,
CVCL_1493,NCI-H1770,,CRL-5893,57Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C2926; Lung non-small cell carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Arg248Trp (c.741_742delinsTT) (c.741_742CC>TT); ClinVar=VCV000437017; Zygosity=Homozygous (PubMed=20557307; Cosmic-CLP=687804; DepMap=ACH-001362).,
CVCL_1494,NCI-H1781,,CRL-5894,66Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C2923; Minimally invasive lung adenocarcinoma, Mutation; HGNC; 9588; PTEN; Simple; p.Gln245fs*6 (c.735_739delGCCGT); Zygosity=Heterozygous (Cosmic-CLP=1298350; DepMap=ACH-000379).,
CVCL_A510,NCI-H1788,,CRL-5981,57Y,Male,,Cancer cell line,,,,,UBERON_0002371,NCIt; C4917; Lung small cell carcinoma,,
CVCL_1495,NCI-H1792,,CRL-5895,50Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C3512; Lung adenocarcinoma," Mutation; HGNC; 1787; CDKN2A; Simple; p.Trp110Ter (c.330G>A) (p.Gly125Arg, c.373G>A); ClinVar=VCV000376303; Zygosity=Heterozygous (Cosmic-CLP=724868)., Mutation; HGNC; 11998; TP53; Simple; c.672+1G>A; ClinVar=VCV000216078; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=1311061; Cosmic-CLP=724868; DepMap=ACH-000496).",
CVCL_1496,NCI-H1793,,CRL-5896,52Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C3512; Lung adenocarcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Arg209Ter (c.625A>T); Zygosity=Heterozygous (PubMed=1311061; Cosmic-CLP=908463; DepMap=ACH-000888).,
CVCL_1497,NCI-H1819,,CRL-5897,55Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C3512; Lung adenocarcinoma, Mutation; HGNC; 11998; TP53; Simple; c.993+1G>T (IVS9+1G>T); ClinVar=VCV000634766; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=20557307; DepMap=ACH-000033).,
CVCL_1498,NCI-H1836,,CRL-5898,52Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C4917; Lung small cell carcinoma, Mutation; HGNC; 427; ALK; Simple; p.Arg1496Glufs*27 (c.4485delC) (p.S1495fs); Zygosity=Heterozygous (Cosmic-CLP=1240182; DepMap=ACH-000559).,
CVCL_1499,NCI-H1838,,CRL-5899,Age unspecified,Female,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C3512; Lung adenocarcinoma," Mutation; HGNC; 795; ATM; Simple; p.Trp1279Ter (c.3836G>A); ClinVar=VCV000127376; Zygosity=Heterozygous (Cosmic-CLP=687807; DepMap=ACH-000733)., Mutation; HGNC; 11998; TP53; Simple; p.Arg273Leu (c.818G>T); ClinVar=VCV000376655; Zygosity=Homozygous (Cosmic-CLP=687807; DepMap=ACH-000733).",
CVCL_1500,NCI-H1869,,CRL-5900,58Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C3493; Lung squamous cell carcinoma,,
CVCL_1501,NCI-H187,,CRL-5804,47Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C4917; Lung small cell carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Ser241Cys (c.722C>G); ClinVar=VCV000177791; Zygosity=Homozygous (PubMed=20557307; ATCC=CRL-5804).,
CVCL_1502,NCI-H1870,,CRL-5901,Age unspecified,Female,Caucasian,Cancer cell line,,,,,,NCIt; C4917; Lung small cell carcinoma,,
CVCL_1503,NCI-H1876,,CRL-5902,59Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C4917; Lung small cell carcinoma, Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (Cosmic-CLP=1330972; DepMap=ACH-000586).,
CVCL_1504,NCI-H1882,,CRL-5903,59Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002371,NCIt; C4917; Lung small cell carcinoma,,
CVCL_1505,NCI-H1915,,CRL-5904,61Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C2926; Lung non-small cell carcinoma," Mutation; HGNC; 1787; CDKN2A; Simple; p.Phe90Leu (c.270C>G); Zygosity=Homozygous (Cosmic-CLP=1240184; DepMap=ACH-000434)., Mutation; HGNC; 11998; TP53; Simple; p.Lys291Ter (c.871A>T); Zygosity=Homozygous (PubMed=1311061; Cosmic-CLP=1240184; DepMap=ACH-000434).",
CVCL_1506,NCI-H1926,,CRL-5905,27Y,Male,,Cancer cell line,,,,,UBERON_0002048,NCIt; C4917; Lung small cell carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Unspecified (PubMed=1312696; PubMed=1565469).,
CVCL_1507,NCI-H1930,,CRL-5906,41Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C4917; Lung small cell carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Gly245Arg (c.733G>C); ClinVar=VCV000376604; Zygosity=Homozygous (ATCC=CRL-5906).,
CVCL_1508,NCI-H1944,,CRL-5907,62Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C3512; Lung adenocarcinoma, Mutation; HGNC; 882; ATR; Simple; p.Arg2363Ter (c.7087C>T); Zygosity=Heterozygous (Cosmic-CLP=1240185; DepMap=ACH-000414).,
CVCL_1509,NCI-H196,,CRL-5823,68Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C4917; Lung small cell carcinoma,,
CVCL_1510,NCI-H1963,,CRL-5982,56Y,Male,African American,Cancer cell line,,,,,UBERON_0002048,NCIt; C4917; Lung small cell carcinoma," Mutation; HGNC; 9884; RB1; Simple; p.Cys61Ter (c.183T>A); Zygosity=Homozygous (Cosmic-CLP=688010; DepMap=ACH-000729)., Mutation; HGNC; 11998; TP53; Simple; p.His214Arg (c.641A>G); ClinVar=VCV000376615; Zygosity=Heterozygous (PubMed=1312696; PubMed=20557307; Cosmic-CLP=688010; DepMap=ACH-000729).",
CVCL_1511,NCI-H1975,,CRL-5908,Age unspecified,Female,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C3512; Lung adenocarcinoma," Mutation; HGNC; 3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Heterozygous (PubMed=17332333; PubMed=21498706; Cosmic-CLP=924244; DepMap=ACH-000587)., Mutation; HGNC; 8975; PIK3CA; Simple; p.Gly118Asp (c.353G>A); ClinVar=VCV000156446; Zygosity=Heterozygous (Cosmic-CLP=924244; DepMap=ACH-000587).",
CVCL_1512,NCI-H1993,,CRL-5909,47Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C3512; Lung adenocarcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Cys242Trp (c.726C>G); ClinVar=VCV000376580; Zygosity=Homozygous (Cosmic-CLP=908476; DepMap=ACH-001137).,
CVCL_1513,NCI-H1994,,CRL-5910,69Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C4917; Lung small cell carcinoma,,
CVCL_1514,NCI-H2009,,CRL-5911,68Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C3512; Lung adenocarcinoma," Mutation; HGNC; 914; B2M; Simple; p.Met1Val (c.1A>G); ClinVar=VCV000376369; Zygosity=Heterozygous (Cosmic-CLP=724873; DepMap=ACH-000886)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Heterozygous (PubMed=1311061; PubMed=12068308; Cosmic-CLP=724873; DepMap=ACH-000886)., Mutation; HGNC; 11998; TP53; Simple; p.Arg273Leu (c.818G>T); ClinVar=VCV000376655; Zygosity=Homozygous (PubMed=1311061; PubMed=20557307; Cosmic-CLP=724873; DepMap=ACH-000886).",
CVCL_1515,NCI-H2023,,CRL-5912,26Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C3512; Lung adenocarcinoma, Mutation; HGNC; 11100; SMARCA4; Simple; p.Ser828Profs*3 (c.2481delC) (p.Ala826fs) (c.2477delC); Zygosity=Heterozygous (Cosmic-CLP=1240187; DepMap=ACH-000781).,
CVCL_1516,NCI-H2029,,CRL-5913,69Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C4917; Lung small cell carcinoma, Mutation; HGNC; 9884; RB1; Simple; c.265-1G>T; Zygosity=Homozygous; Note=Splice acceptor mutation (Cosmic-CLP=688011; DepMap=ACH-000298).,
CVCL_1517,NCI-H2030,,CRL-5914,Age unspecified,Male,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C3512; Lung adenocarcinoma, Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (Cosmic-CLP=722045; DepMap=ACH-000521).,
CVCL_1518,NCI-H2052,,CRL-5915,65Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C45663; Pleural sarcomatoid mesothelioma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (PubMed=16630136; PubMed=21642991)., Mutation; HGNC; 7773; NF2; Simple; p.Arg341Ter (c.1021C>T); ClinVar=VCV000003292; Zygosity=Homozygous (PubMed=16630136; PubMed=25902174; Cosmic-CLP=688058; DepMap=ACH-000153)., Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).",
CVCL_1519,NCI-H2059,,CRL-5916,58Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C4917; Lung small cell carcinoma,,
CVCL_1520,NCI-H2066,,CRL-5917,70Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C3493; Lung squamous cell carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Val157Phe (c.469G>T); ClinVar=VCV000012353; Zygosity=Homozygous (PubMed=1311061; Cosmic-CLP=1330973; DepMap=ACH-000727).,
CVCL_1521,NCI-H2073,,CRL-5918,47Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C3512; Lung adenocarcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Cys242Trp (c.726C>G); ClinVar=VCV000376580; Zygosity=Homozygous (PubMed=1311061; DepMap=ACH-000590).,
CVCL_5157,NCI-H2077,,CRL-5919,58Y,Male,,Cancer cell line,,,,,,NCIt; C3512; Lung adenocarcinoma,,
CVCL_1522,NCI-H2081,,CRL-5920,59Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C4917; Lung small cell carcinoma,,
CVCL_1523,NCI-H2085,,CRL-5921,45Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C3512; Lung adenocarcinoma, Mutation; HGNC; 11100; SMARCA4; Simple; p.Glu463Ter (c.1387G>T); Zygosity=Heterozygous (Cosmic-CLP=687812; DepMap=ACH-000451).,
CVCL_1524,NCI-H2087,,CRL-5922,69Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C3512; Lung adenocarcinoma," Mutation; HGNC; 795; ATM; Simple; p.Glu848Gln (c.2542G>C); ClinVar=VCV001686474; Zygosity=Heterozygous (PubMed=27602502; Cosmic-CLP=724834; DepMap=ACH-000841)., Mutation; HGNC; 7553; MYC; Simple; p.Glu54Lys (c.160G>A); Zygosity=Heterozygous (Cosmic-CLP=724834; DepMap=ACH-000841)., Mutation; HGNC; 11998; TP53; Simple; p.Val157Phe (c.469G>T); ClinVar=VCV000012353; Zygosity=Homozygous (PubMed=1311061; PubMed=1565469; PubMed=20557307; Cosmic-CLP=724834; DepMap=ACH-000841).",
CVCL_1525,NCI-H209,,HTB-172,55Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002371,NCIt; C4917; Lung small cell carcinoma, Mutation; HGNC; 9884; RB1; Simple; p.Cys706Phe (c.2117G>T); ClinVar=VCV000376330; Zygosity=Homozygous (ATCC=HTB-172; Cosmic-CLP=688013; DepMap=ACH-000290).,
CVCL_1526,NCI-H2106,,CRL-5923,58Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C4450; Lung large cell carcinoma, Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).,
CVCL_1527,NCI-H2107,,CRL-5983,36Y,Male,African American,Cancer cell line,,,,,UBERON_0002371,NCIt; C4917; Lung small cell carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Lys101Ter (c.301A>T); Zygosity=Unspecified (PubMed=20557307).,
CVCL_1528,NCI-H2108,,CRL-5984,36Y,Male,African American,Cancer cell line,,,,,UBERON_0002371,NCIt; C4917; Lung small cell carcinoma,,
CVCL_1529,NCI-H211,,CRL-5824,50Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002371,NCIt; C4917; Lung small cell carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=1312696; PubMed=1565469).,
CVCL_1530,NCI-H2110,,CRL-5924,Age unspecified,Sex unspecified,African American,Cancer cell line,,,,,UBERON_0000175,NCIt; C2926; Lung non-small cell carcinoma,,
CVCL_1531,NCI-H2122,,CRL-5985,46Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C3512; Lung adenocarcinoma," Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (PubMed=1311061; Cosmic-CLP=722046; DepMap=ACH-000311)., Mutation; HGNC; 11998; TP53; Simple; p.Cys176Phe (c.527G>T); ClinVar=VCV000376569; Zygosity=Heterozygous (PubMed=20557307; Cosmic-CLP=722046; DepMap=ACH-000311).",
CVCL_1532,NCI-H2126,,CCL-256,65Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C4450; Lung large cell carcinoma, Mutation; HGNC; 11100; SMARCA4; Simple; p.Trp764Arg (c.2290T>A); Zygosity=Homozygous (Cosmic-CLP=687814; DepMap=ACH-000785).,
CVCL_1533,NCI-H2135,,CRL-5926,Age unspecified,Sex unspecified,Caucasian,Cancer cell line,,,,,,NCIt; C2926; Lung non-small cell carcinoma," Mutation; HGNC; 914; B2M; Simple; p.Ser16Alafs*27 (c.45_48delTTCT); Zygosity=Heterozygous (Cosmic-CLP=1298352; DepMap=ACH-001363)., Mutation; HGNC; 6770; SMAD4; Simple; p.Arg496Leu (c.1487G>T); Zygosity=Heterozygous (Cosmic-CLP=1298352; DepMap=ACH-001363).",
CVCL_1534,NCI-H2141,,CRL-5927,58Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C4917; Lung small cell carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Arg209Ter (c.625A>T); Zygosity=Homozygous (PubMed=1312696; PubMed=20557307; ATCC=CRL-5927).,
CVCL_1535,NCI-H2170,,CRL-5928,Age unspecified,Male,Caucasian,Cancer cell line,,,,,,NCIt; C3493; Lung squamous cell carcinoma, Mutation; HGNC; 667; RHOA; Simple; p.Gly17Val (c.50G>T); Zygosity=Heterozygous (Cosmic-CLP=687815; DepMap=ACH-000481).,
CVCL_1536,NCI-H2171,,CRL-5929,50Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C4917; Lung small cell carcinoma," Gene fusion; HGNC; 20202; CACNA2D4 + HGNC; 28945; WDR43; Name(s)=CACNA2D4-WDR43; Note=Out of frame (PubMed=18438408)., Gene fusion; HGNC; 20626; CHD7 + HGNC; 9709; PVT1; Name(s)=PVT1-CHD7 (PubMed=18438408; PubMed=23716474)., Mutation; HGNC; 9884; RB1; Simple; p.Ser567Ter (c.1700C>A); Zygosity=Homozygous (ATCC=CRL-5929; Cosmic-CLP=688015; DepMap=ACH-000525).",
CVCL_1537,NCI-H2172,,CRL-5930,Age unspecified,Female,African American,Cancer cell line,,,,,UBERON_0002048,NCIt; C2926; Lung non-small cell carcinoma,,
CVCL_1538,NCI-H2195,,CRL-5931,67Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002371,NCIt; C4917; Lung small cell carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Val157Phe (c.469G>T); ClinVar=VCV000012353; Zygosity=Unspecified (PubMed=20557307).,
CVCL_1539,NCI-H2196,,CRL-5932,67Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002371,NCIt; C4917; Lung small cell carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Val157Phe (c.469G>T); ClinVar=VCV000012353; Zygosity=Homozygous (Cosmic-CLP=908481; DepMap=ACH-000399).,
CVCL_1540,NCI-H2198,,CRL-5933,67Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C4917; Lung small cell carcinoma,,
CVCL_1541,NCI-H220,,CRL-5825,51Y,Male,African American,Cancer cell line,,,,,UBERON_0000175,NCIt; C4917; Lung small cell carcinoma,,
CVCL_1542,NCI-H2227,,CRL-5934,54Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C4917; Lung small cell carcinoma, Mutation; HGNC; 11998; TP53; Simple; c.783-2A>C; ClinVar=VCV000635386; Zygosity=Unspecified; Note=Splice acceptor mutation (PubMed=1312696; PubMed=1565469).,
CVCL_1543,NCI-H2228,,CRL-5935,Age unspecified,Female,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C3512; Lung adenocarcinoma," Gene fusion; HGNC; 427; ALK + HGNC; 1316; EML4; Name(s)=EML4-ALK; Note=E6A20 v3 fusion (PubMed=18594010; DOI=10.1101/2022.06.08.495301; DepMap=ACH-000447)., Mutation; HGNC; 11998; TP53; Simple; p.Gln331Ter (c.991C>T); ClinVar=VCV000922893; Zygosity=Homozygous (Cosmic-CLP=687816; DepMap=ACH-000447).",
CVCL_A527,NCI-H2250,,CRL-5936,46Y,Male,,Cancer cell line,,,,,,NCIt; C3512; Lung adenocarcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Ala161Thr (c.481G>A); ClinVar=VCV000161518; Zygosity=Unspecified (PubMed=1311061).,
CVCL_1544,NCI-H226,,CRL-5826,Age unspecified,Male,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C45662; Pleural epithelioid mesothelioma, Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (ATCC=CRL-5826).,
CVCL_S142,NCI-H2280,,CRL-5937,Age unspecified,Female,,Cancer cell line,,,,,,NCIt; C3262; Neoplasm,,
CVCL_1545,NCI-H2286,,CRL-5938,57Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C3493; Lung squamous cell carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Lys291Ter (c.871A>T); Zygosity=Homozygous (DepMap=ACH-000912).,
CVCL_1546,NCI-H2291,,CRL-5939,Age unspecified,Male,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C3512; Lung adenocarcinoma, Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Phe (c.34_35GG>TT) (c.34_35delinsTT); Zygosity=Homozygous (PubMed=12068308; Cosmic-CLP=724874; DepMap=ACH-000718).,
CVCL_1547,NCI-H23,,CRL-5800,51Y,Male,African American,Cancer cell line,,,,,UBERON_0002048,NCIt; C3512; Lung adenocarcinoma," Mutation; HGNC; 795; ATM; Simple; p.Gln1919Pro (c.5756A>C); ClinVar=VCV000580726; Zygosity=Homozygous (PubMed=27602502)., Mutation; HGNC; 11389; STK11; Simple; p.Trp332Ter (c.996G>A); ClinVar=VCV000376339; Zygosity=Homozygous (PubMed=17088437).",
CVCL_1548,NCI-H2330,,CRL-5940,57Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C4917; Lung small cell carcinoma,,
CVCL_1549,NCI-H2342,,CRL-5941,55Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C3512; Lung adenocarcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (Cosmic-CLP=687819; DepMap=ACH-000951).,
CVCL_1550,NCI-H2347,,CRL-5942,54Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C3512; Lung adenocarcinoma," Mutation; HGNC; 914; B2M; Simple; p.Gln28Ter (c.82C>T); Zygosity=Homozygous (Cosmic-CLP=687820; DepMap=ACH-000875)., Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Homozygous (PubMed=12068308; Cosmic-CLP=687820; DepMap=ACH-000875).",
CVCL_A533,NCI-H2373,,CRL-5943,Adult,Male,Caucasian,Cancer cell line,,,,,UBERON_0000977,NCIt; C45663; Pleural sarcomatoid mesothelioma, Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (PubMed=16630136; PubMed=21642991).,
CVCL_A534,NCI-H2380,,CRL-5986,Age unspecified,Female,,Cancer cell line,,,,,,NCIt; C5214; Breast adenocarcinoma,,
CVCL_1551,NCI-H2405,,CRL-5944,47Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C3512; Lung adenocarcinoma, Mutation; HGNC; 1097; BRAF; Simple; p.Leu485_Pro490delinsTyr (c.1454_1469delinsA); Zygosity=Unspecified (PubMed=12068308).,
CVCL_1552,NCI-H2444,,CRL-5945,Age unspecified,Male,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C2926; Lung non-small cell carcinoma, Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (Cosmic-CLP=1298356; DepMap=ACH-000186).,
CVCL_1553,NCI-H2452,,CRL-5946,Adult,Male,Caucasian,Cancer cell line,,,,,UBERON_0000977,NCIt; C45665; Pleural biphasic mesothelioma," Gene deletion; HGNC; 950; BAP1; Zygosity=Heterozygous (PubMed=21642991)., Mutation; HGNC; 950; BAP1; Simple; p.Ala95Asp (c.284C>A); Zygosity=Heterozygous (PubMed=21642991; PubMed=26011428).",
CVCL_A537,NCI-H249,,CRL-5827,55Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C4917; Lung small cell carcinoma," Mutation; HGNC; 8975; PIK3CA; Simple; p.Gly106_Arg108del (c.317_325delGGCAACCGT); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.Glu171Ter (c.511G>T); ClinVar=VCV000634771; Zygosity=Homozygous (from parent cell line).",
CVCL_1554,NCI-H250,,CRL-5828,34Y,Male,African American,Cancer cell line,,,,,UBERON_0000955,NCIt; C4917; Lung small cell carcinoma, Mutation; HGNC; 9884; RB1; Simple; p.Gly840fs (c.2518delG); Zygosity=Heterozygous (Cosmic-CLP=924241; DepMap=ACH-002171).,
CVCL_1555,NCI-H28,,CRL-5820,48Y,Male,,Cancer cell line,,,,,UBERON_0000175,NCIt; C7376; Pleural malignant mesothelioma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (PubMed=16630136)., Mutation; HGNC; 950; BAP1; Simple; p.Arg146Alafs*48 (c.438-24_438-2del23); Zygosity=Homozygous (PubMed=21642991; PubMed=26011428)., Mutation; HGNC; 12687; VHL; Simple; p.Leu89His (c.266T>A); ClinVar=VCV000376047; Zygosity=Homozygous (PubMed=8183553; DepMap=ACH-000648).",
CVCL_A553,NCI-H285,,CRL-5829,35Y,Male,,Cancer cell line,,,,,UBERON_0000027,NCIt; C4917; Lung small cell carcinoma,,
CVCL_0455,NCI-H292,,CRL-1848,32Y,Female,African American,Cancer cell line,,,,,UBERON_0000027,NCIt; C45544; Lung mucoepidermoid carcinoma," Gene fusion; HGNC; 16062; CRTC1 + HGNC; 16259; MAML2; Name(s)=CRTC1-MAML2, MECT1-MAML2 (PubMed=12539049; PubMed=25485619).",
CVCL_0456,NCI-H295,,CRL-10296,48Y,Female,,Cancer cell line,,,,,UBERON_0002369,NCIt; C9325; Adrenal cortex carcinoma, Mutation; HGNC; 2514; CTNNB1; Simple; p.Ser45Pro (c.133T>C); ClinVar=VCV000017589; Zygosity=Heterozygous (ATCC=CRL-10296).,
CVCL_0458,NCI-H295R,,CRL-2128,48Y,Female,,Cancer cell line,,,,,UBERON_0002369,NCIt; C9325; Adrenal cortex carcinoma, Mutation; HGNC; 2514; CTNNB1; Simple; p.Ser45Pro (c.133T>C); ClinVar=VCV000017589; Zygosity=Heterozygous (from parent cell line).,
CVCL_1556,NCI-H322,,CRL-5806,52Y,Male,Caucasian,Cancer cell line,,,,Club cell,UBERON_0002048,NCIt; C2923; Minimally invasive lung adenocarcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Arg248Leu (c.743G>T); ClinVar=VCV000230253; Zygosity=Homozygous (PubMed=1311061; PubMed=1565469; PubMed=10536175; PubMed=20557307).,
CVCL_6831,NCI-H3255,,CRL-2882,47Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C3512; Lung adenocarcinoma, Mutation; HGNC; 11998; TP53; Simple; c.560-1G>A; ClinVar=VCV000634769; Zygosity=Unspecified; Note=Splice acceptor mutation (DepMap=ACH-000109).,
CVCL_1558,NCI-H345,,HTB-180,64Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002371,NCIt; C4917; Lung small cell carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Tyr236Cys (c.707A>G); ClinVar=VCV000376693; Zygosity=Homozygous (PubMed=20557307; ATCC=HTB-180).,
CVCL_1559,NCI-H358,,CRL-5807,Age unspecified,Male,Caucasian,Cancer cell line,,,,Club cell,UBERON_0002048,NCIt; C2923; Minimally invasive lung adenocarcinoma," Gene deletion; HGNC; 11998; TP53; Zygosity=Homozygous (PubMed=1311061; PubMed=1565469; PubMed=20557307)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Heterozygous (PubMed=1311061; PubMed=9649128; PubMed=12068308).",
CVCL_1560,NCI-H378,,CRL-5808,66Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C4917; Lung small cell carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Tyr163Cys (c.488A>G); ClinVar=VCV000127814; Zygosity=Homozygous (ATCC=CRL-5808; Cosmic-CLP=688022).,
CVCL_1561,NCI-H441,,HTB-174,33Y,Male,Caucasian,Cancer cell line,,,,Club cell,UBERON_0002409,NCIt; C5650; Lung papillary adenocarcinoma, Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous (PubMed=1311061; ATCC=HTB-174; Cosmic-CLP=908460; DepMap=ACH-000638).,
CVCL_1562,NCI-H446,,HTB-171,61Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C4917; Lung small cell carcinoma, Gene fusion; HGNC; 6728; LY6H + HGNC; 9709; PVT1; Name(s)=PVT1-LY6H (PubMed=23716474).,
CVCL_0459,NCI-H460,,HTB-177,Age unspecified,Male,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C4450; Lung large cell carcinoma," Mutation; HGNC; 6407; KRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000045117; Zygosity=Homozygous (PubMed=12068308; PubMed=12794755; PubMed=17088437; DepMap=ACH-000463)., Mutation; HGNC; 11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (PubMed=17088437).",
CVCL_1563,NCI-H498,,CCL-254,56Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002358,NCIt; C5543; Cecum adenocarcinoma,,
CVCL_1564,NCI-H508,,CCL-253,55Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0003697,NCIt; C5543; Cecum adenocarcinoma," Mutation; HGNC; 1097; BRAF; Simple; p.Gly596Arg (c.1786G>C); ClinVar=VCV000375943; Zygosity=Heterozygous (PubMed=12068308; PubMed=20570890; PubMed=24042735; PubMed=28683746; ATCC=CCL-253)., Mutation; HGNC; 11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (PubMed=28683746).",
CVCL_1565,NCI-H510A,,HTB-184,53Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002369,NCIt; C4917; Lung small cell carcinoma," Mutation; HGNC; 9884; RB1; Simple; p.Lys265Ter (c.793A>T); Zygosity=Homozygous (ATCC=HTB-184; Cosmic-CLP=753605; DepMap=ACH-000871)., Mutation; HGNC; 11998; TP53; Simple; p.Arg282Gly (c.844C>G); ClinVar=VCV000140821; Zygosity=Homozygous (PubMed=1312696; PubMed=1565469; PubMed=20557307; ATCC=HTB-184; Cosmic-CLP=753605; DepMap=ACH-000871).",
CVCL_A570,NCI-H513,,CRL-5830,61Y,Male,African American,Cancer cell line,,,,,UBERON_0002072,NCIt; C9133; Lung adenosquamous carcinoma,,
CVCL_1566,NCI-H520,,HTB-182,Age unspecified,Male,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C3493; Lung squamous cell carcinoma," Mutation; HGNC; 795; ATM; Simple; p.Pro383Ala (c.1147C>G); ClinVar=VCV001001330; Zygosity=Heterozygous (PubMed=27602502; Cosmic-CLP=908443; DepMap=ACH-000395)., Mutation; HGNC; 11998; TP53; Simple; p.Trp146Ter (c.438G>A); ClinVar=VCV000428890; Zygosity=Homozygous (PubMed=1311061; PubMed=10536175; PubMed=20557307; Cosmic-CLP=908443; DepMap=ACH-000395).",
CVCL_1567,NCI-H522,,CRL-5810,58Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C3512; Lung adenocarcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Pro191fs*56 (c.571delC); Zygosity=Homozygous (PubMed=1311061; PubMed=1565469; PubMed=15900046; PubMed=17088437; PubMed=18277095; PubMed=20557307).,
CVCL_1568,NCI-H524,,CRL-5831,63Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C4917; Lung small cell carcinoma," Mutation; HGNC; 795; ATM; Simple; p.Arg337Cys (c.1009C>T); ClinVar=VCV000127327; Zygosity=Heterozygous (Cosmic-CLP=908483; DepMap=ACH-000816)., Mutation; HGNC; 11998; TP53; Simple; p.Thr155Asn (c.464C>A); ClinVar=VCV000406564; Zygosity=Homozygous (ATCC=CRL-5831; Cosmic-CLP=908483; DepMap=ACH-000816).",
CVCL_1569,NCI-H526,,CRL-5811,55Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002371,NCIt; C4917; Lung small cell carcinoma, Mutation; HGNC; 11998; TP53; Simple; c.97-1G>C (IVS3-1G>C); Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=1312696; PubMed=1565469; PubMed=20557307).,
CVCL_1570,NCI-H548,,CCL-249,52Y,Male,,Cancer cell line,,,,,UBERON_0001159,NCIt; C4349; Colon adenocarcinoma,,
CVCL_1571,NCI-H596,,HTB-178,73Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C9133; Lung adenosquamous carcinoma," Mutation; HGNC; 8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (Cosmic-CLP=908459; DepMap=ACH-000628)., Mutation; HGNC; 11998; TP53; Simple; p.Gly245Cys (c.733G>T); ClinVar=VCV000012349; Zygosity=Homozygous (PubMed=1311061; PubMed=10536175; PubMed=20557307; Cosmic-CLP=908459; DepMap=ACH-000628).",
CVCL_A592,NCI-H60,,CRL-5821,Age unspecified,Female,,Cancer cell line,,,,,UBERON_0002048,NCIt; C4917; Lung small cell carcinoma," Gene fusion; HGNC; 23139; CLVS1 + HGNC; 9709; PVT1; Name(s)=PVT1-CLVS1 (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.Glu298Ter (c.892G>T); ClinVar=VCV000093323; Zygosity=Unspecified (from parent cell line).",
CVCL_1573,NCI-H64,,CRL-5976,48Y,Female,,Cancer cell line,,,,,UBERON_0000027,NCIt; C4917; Lung small cell carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Arg283Pro (c.848G>C); ClinVar=VCV000486555; Zygosity=Homozygous (Cosmic-CLP=688026; DepMap=ACH-001599).,
CVCL_1574,NCI-H647,,CRL-5834,56Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C9133; Lung adenosquamous carcinoma, Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Homozygous (PubMed=1311061; Cosmic-CLP=1240191; DepMap=ACH-000378).,
CVCL_1575,NCI-H650,,CRL-5835,Age unspecified,Male,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C3512; Lung adenocarcinoma," Mutation; HGNC; 1101; BRCA2; Simple; p.Ser871Ter (c.2612C>A); ClinVar=VCV000051315; Zygosity=Heterozygous (Cosmic-CLP=722066; DepMap=ACH-000945)., Mutation; HGNC; 6342; KIT; Simple; p.Glu306Ter (c.916G>T); Zygosity=Heterozygous (Cosmic-CLP=722066; DepMap=ACH-000945)., Mutation; HGNC; 11998; TP53; Simple; p.Lys164Asn (c.492G>T); Zygosity=Homozygous (PubMed=1311061; Cosmic-CLP=722066; DepMap=ACH-000945).",
CVCL_1576,NCI-H660,,CRL-5813,63Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002429,NCIt; C6766; Prostate small cell carcinoma, Gene fusion; HGNC; 3446; ERG + HGNC; 11876; TMPRSS2; Name(s)=TMPRSS2-ERG (PubMed=17401460).,
CVCL_1577,NCI-H661,,HTB-183,43Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C4450; Lung large cell carcinoma," Mutation; HGNC; 1787; CDKN2A; Simple; c.457+1G>T; ClinVar=VCV000635367; Zygosity=Homozygous; Note=Splice donor mutation (Cosmic-CLP=687829; DepMap=ACH-000853)., Mutation; HGNC; 11998; TP53; Simple; p.Arg158Leu (c.473G>T); ClinVar=VCV000528248; Zygosity=Heterozygous (PubMed=1311061; PubMed=20557307; Cosmic-CLP=687829; DepMap=ACH-000853).",
CVCL_1578,NCI-H676B,,HTB-179,63Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C3512; Lung adenocarcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Val217Leu (c.649G>T); ClinVar=VCV001386154; Zygosity=Unspecified (PubMed=1311061).,
CVCL_A581,NCI-H679,,CRL-5977,65Y,Male,,Cancer cell line,,,,,,NCIt; C4038; Lung carcinoid tumor, Mutation; HGNC; 11998; TP53; Simple; p.Tyr103Thrfs*20 (c.306delC) (p.Thr102fs); Zygosity=Unspecified (PubMed=1311061).,
CVCL_1579,NCI-H69,,HTB-119,55Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C4917; Lung small cell carcinoma," Mutation; HGNC; 8975; PIK3CA; Simple; p.Gly106_Arg108del (c.317_325delGGCAACCGT); Zygosity=Heterozygous (PubMed=19394761; ATCC=HTB-119)., Mutation; HGNC; 11998; TP53; Simple; p.Glu171Ter (c.511G>T); ClinVar=VCV000634771; Zygosity=Homozygous (PubMed=10536175; PubMed=20557307; ATCC=HTB-119).",
CVCL_1580,NCI-H711,,CRL-5836,49Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002371,NCIt; C4917; Lung small cell carcinoma,,
CVCL_1581,NCI-H716,,CCL-251,33Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0007795,NCIt; C5543; Cecum adenocarcinoma," Gene fusion; HGNC; 18261; NPLOC4 + HGNC; 8789; PDE6G; Name(s)=NPLOC4-PDE6G (PubMed=25485619)., Mutation; HGNC; 11998; TP53; Simple; p.Glu224Asp (c.672G>T); ClinVar=VCV000635390; Zygosity=Homozygous (PubMed=16418264; Cosmic-CLP=908458; DepMap=ACH-000491).",
CVCL_1582,NCI-H719,,CRL-5837,55Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002371,NCIt; C4917; Lung small cell carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (ATCC=CRL-5837).,
CVCL_1583,NCI-H720,,CRL-5838,Age unspecified,Male,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C4038; Lung carcinoid tumor, Mutation; HGNC; 9884; RB1; Simple; p.Gln344Ter (c.1030C>T); ClinVar=VCV001771021; Zygosity=Homozygous (PubMed=26087898; ATCC=CRL-5838; Cosmic-CLP=687600; DepMap=ACH-002174).,
CVCL_1584,NCI-H727,,CRL-5815,65Y,Female,Caucasian,Cancer cell line,,,,,,NCIt; C4038; Lung carcinoid tumor," Gene fusion; HGNC; 18053; PKD1L1 + HGNC; 21616; TNS3; Name(s)=TNS3-PKD1L1 (PubMed=25485619)., Mutation; HGNC; 11998; TP53; Simple; p.Gln165_Ser166insTyrLysGln (c.496_497insACAAGCAGT) (c.492_493ins9); Zygosity=Heterozygous (PubMed=1311061; PubMed=20557307; Cosmic-CLP=724855; DepMap=ACH-000775).",
CVCL_1585,NCI-H735,,CRL-5978,58Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002107,NCIt; C4917; Lung small cell carcinoma,,
CVCL_4365,NCI-H738,,CRL-5839,67Y,Male,,Cancer cell line,,,,,,NCIt; C4917; Lung small cell carcinoma,,
CVCL_1586,NCI-H740,,CRL-5840,63Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C4917; Lung small cell carcinoma,,
CVCL_1587,NCI-H747,,CCL-252,69Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C5543; Cecum adenocarcinoma," Mutation; HGNC; 583; APC; Simple; p.Gln161Ter (c.481C>T); ClinVar=VCV000229997; Zygosity=Heterozygous (ATCC=CCL-252; Cosmic-CLP=908457; DepMap=ACH-000403)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (PubMed=12068308; PubMed=20570890; Cosmic-CLP=908457; DepMap=ACH-000403).",
CVCL_1588,NCI-H748,,CRL-5841,62Y,Male,African American,Cancer cell line,,,,,UBERON_0000027,NCIt; C4917; Lung small cell carcinoma," Mutation; HGNC; 1101; BRCA2; Simple; p.Asp2237Metfs*4 (c.6709del); Zygosity=Heterozygous (Cosmic-CLP=909194; DepMap=ACH-003071)., Mutation; HGNC; 11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (Cosmic-CLP=909194; DepMap=ACH-003071).",
CVCL_1589,NCI-H774,,CRL-5842,43Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0034929,NCIt; C4917; Lung small cell carcinoma, Gene deletion; HGNC; 6844; MAP2K4; Zygosity=Homozygous (PubMed=9331070).,
CVCL_1590,NCI-H810,,CRL-5816,51Y,Male,African American,Cancer cell line,,,,,UBERON_0002048,NCIt; C4450; Lung large cell carcinoma, Mutation; HGNC; 2731; DDR2; Simple; p.Asn373del (c.1117_1119del); Zygosity=Heterozygous (Cosmic-CLP=925341; DepMap=ACH-000789).,
CVCL_1591,NCI-H82,,HTB-175,41Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C4917; Lung small cell carcinoma, Gene fusion; HGNC; 7577; MYH7 + HGNC; 9709; PVT1; Name(s)=PVT1-MYH7 (PubMed=23716474).,
CVCL_1592,NCI-H820,,HTB-181,53Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C5650; Lung papillary adenocarcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Thr284Pro (c.850A>C); ClinVar=VCV001763670; Zygosity=Homozygous (PubMed=1311061; PubMed=1565469; PubMed=20557307; DepMap=ACH-001140).,
CVCL_1593,NCI-H835,,CRL-5843,48Y,Female,African American,Cancer cell line,,,,,UBERON_0002048,NCIt; C4038; Lung carcinoid tumor,,
CVCL_1594,NCI-H838,,CRL-5844,59Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C3512; Lung adenocarcinoma, Mutation; HGNC; 11110; ARID1A; Simple; p.Pro1876Serfs*22 (c.5625_5632del) (p.CPP1657fs) (c.5621_5628delGCCCACCA); Zygosity=Heterozygous (Cosmic-CLP=910399; DepMap=ACH-000416).,
CVCL_1595,NCI-H841,,CRL-5845,51Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C4917; Lung small cell carcinoma, Mutation; HGNC; 11100; SMARCA4; Simple; p.Lys934Ter (c.2800A>T); Zygosity=Homozygous (Cosmic-CLP=1240192; DepMap=ACH-000292).,
CVCL_1596,NCI-H847,,CRL-5846,63Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C4917; Lung small cell carcinoma,,
CVCL_A584,NCI-H854,,CRL-5847,75Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4349; Colon adenocarcinoma, Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (DepMap=ACH-000710).,
CVCL_A585,NCI-H862,,CRL-5848,,Female,,Cancer cell line,,,,,,NCIt; C4917; Lung small cell carcinoma,,
CVCL_1597,NCI-H865,,CRL-5849,54Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C4917; Lung small cell carcinoma,,
CVCL_1598,NCI-H889,,CRL-5817,69Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C4917; Lung small cell carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Cys242Ser (c.725G>C); ClinVar=VCV000647334; Zygosity=Unspecified (PubMed=1312696; PubMed=1565469).,
CVCL_1599,NCI-H920,,CRL-5850,43Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C3512; Lung adenocarcinoma, Mutation; HGNC; 11998; TP53; Simple; c.560-1G>T; Zygosity=Unspecified; Note=Splice acceptor mutation (PubMed=1311061; PubMed=1565469).,
CVCL_1600,NCI-H929,,CRL-3580,62Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C3242; Plasma cell myeloma, Mutation; HGNC; 7989; NRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000013901; Zygosity=Heterozygous (PubMed=11157491; PubMed=12068308; PubMed=21173094; ATCC=CRL-3580).,
CVCL_1601,NCI-H969,,CRL-5852,66Y,Male,,Cancer cell line,,,,,UBERON_0000175,NCIt; C3512; Lung adenocarcinoma,,
CVCL_1602,NCI-N417,,CRL-5809,Age unspecified,Female,,Cancer cell line,,,,,UBERON_0002048,NCIt; C4917; Lung small cell carcinoma," Gene fusion; HGNC; 23139; CLVS1 + HGNC; 9709; PVT1; Name(s)=PVT1-CLVS1 (PubMed=23716474)., Mutation; HGNC; 11998; TP53; Simple; p.Glu298Ter (c.892G>T); ClinVar=VCV000093323; Zygosity=Unspecified (PubMed=1565469; PubMed=10536175; PubMed=20557307).",
CVCL_A590,NCI-N592,,CRL-5832,55Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C4917; Lung small cell carcinoma," Mutation; HGNC; 8975; PIK3CA; Simple; p.Gly106_Arg108del (c.317_325delGGCAACCGT); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.Glu171Ter (c.511G>T); ClinVar=VCV000634771; Zygosity=Homozygous (from parent cell line).",
CVCL_1603,NCI-N87,,CRL-5822,Age unspecified,Male,,Cancer cell line,,,,,UBERON_0002107,NCIt; C5473; Gastric tubular adenocarcinoma," Gene deletion; HGNC; 6770; SMAD4; Zygosity=Homozygous (ATCC=CRL-5822)., Mutation; HGNC; 11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (PubMed=1676761; ATCC=CRL-5822).",
CVCL_0461,NCTC 2544,,CCL-19,30Y6M,Female,African American,Cancer cell line,333761,Human papillomavirus type 18 (HPV18).,,,UBERON_0000002,NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma,,
CVCL_8156,NCTC 3075,,CCL-19.1,30Y6M,Female,African American,Cancer cell line,333761,Human papillomavirus type 18 (HPV18).,,,UBERON_0000002,NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma,,
CVCL_F202,ND34391,ND34391,,55Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002067,"NCIt; C198604; Parkinson disease 4, autosomal dominant", Gene amplification; HGNC; 11138; SNCA; Triplication; Zygosity=Heterozygous (NHCDR=ND34391).,
CVCL_A9R1,ND34392,ND34392,,79Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,"NCIt; C198605; Parkinson disease 8, autosomal dominant", Mutation; HGNC; 18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Homozygous (Coriell=ND34392).,
CVCL_T843,ND34393,ND34393,,58Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,"NCIt; C198605; Parkinson disease 8, autosomal dominant", Mutation; HGNC; 18618; LRRK2; Simple; p.Arg1441Cys (c.4321C>T); ClinVar=VCV000001938; Zygosity=Unspecified (from parent cell line).,
CVCL_T844,ND34394,ND34394,,58Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,"NCIt; C198605; Parkinson disease 8, autosomal dominant", Mutation; HGNC; 18618; LRRK2; Simple; p.Arg1441Cys (c.4321C>T); ClinVar=VCV000001938; Zygosity=Unspecified (from parent cell line).,
CVCL_T845,ND35367,ND35367,,79Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,"NCIt; C198605; Parkinson disease 8, autosomal dominant", Mutation; HGNC; 18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Homozygous (NHCDR=ND35367).,
CVCL_T846,ND35371,ND35371,,58Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,"NCIt; C198605; Parkinson disease 8, autosomal dominant", Mutation; HGNC; 18618; LRRK2; Simple; p.Arg1441Cys (c.4321C>T); ClinVar=VCV000001938; Zygosity=Unspecified (from parent cell line).,
CVCL_T847,ND35658,ND35658,,48Y,Male,African American,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C168749; Amyotrophic lateral sclerosis 1, Mutation; HGNC; 11179; SOD1; Simple; p.Asn140Lys (c.420C>A) (N139K); ClinVar=VCV000586635; Zygosity=Unspecified (NHCDR=ND35658).,
CVCL_T848,ND35659,ND35659,,58Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C168749; Amyotrophic lateral sclerosis 1, Mutation; HGNC; 11179; SOD1; Simple; p.Ala5Val (c.14C>T) (A4V); ClinVar=VCV000014763; Zygosity=Unspecified (NHCDR=ND35659).,
CVCL_T850,ND35660,ND35660,,50Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C168749; Amyotrophic lateral sclerosis 1, Mutation; HGNC; 11179; SOD1; Simple; p.Asp91Ala (c.272A>C) (D90A); ClinVar=VCV000014766; Zygosity=Unspecified (Coriell=ND35660).,
CVCL_T852,ND35661,ND35661,,55Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C168749; Amyotrophic lateral sclerosis 1, Mutation; HGNC; 11179; SOD1; Simple; p.Ile114Thr (c.341T>C) (I113T); ClinVar=VCV000197145; Zygosity=Unspecified (Coriell=ND35661).,
CVCL_T853,ND35662,ND35662,,43Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C168749; Amyotrophic lateral sclerosis 1, Mutation; HGNC; 11179; SOD1; Simple; p.Glu101Gly (c.302A>G) (E100G); ClinVar=VCV000014761; Zygosity=Unspecified (NHCDR=ND35662).,
CVCL_T854,ND35663,ND35663,,50Y,Female,Cape Verdian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,"NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia", Mutation; HGNC; 4010; FUS; Simple; p.His517Gln (c.1551C>G); ClinVar=VCV000016221; Zygosity=Homozygous (NHCDR=ND35663).,
CVCL_T858,ND35664,ND35664,,64Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C168749; Amyotrophic lateral sclerosis 1, Mutation; HGNC; 11179; SOD1; Simple; p.Asp91Ala (c.272A>C) (D90A); ClinVar=VCV000014766; Zygosity=Unspecified (Coriell=ND35664).,
CVCL_A9PM,ND35665,ND35665,,55Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C168749; Amyotrophic lateral sclerosis 1,,
CVCL_T859,ND35666,ND35666,,56Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C168749; Amyotrophic lateral sclerosis 1, Mutation; HGNC; 11179; SOD1; Simple; p.Asp91Ala (c.272A>C) (D90A); ClinVar=VCV000014766; Zygosity=Unspecified (Coriell=ND35666).,
CVCL_T861,ND35668,ND35668,,49Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C168749; Amyotrophic lateral sclerosis 1, Mutation; HGNC; 11179; SOD1; Simple; p.Glu50Lys (c.148G>A) (E49K); ClinVar=VCV000658902; Zygosity=Unspecified (NHCDR=ND35668).,
CVCL_T863,ND35669,ND35669,,67Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C168753; Amyotrophic lateral sclerosis 11, Mutation; HGNC; 16873; FIG4; Simple; p.Ile9Ile (c.27C>T); ClinVar=VCV000137376; Zygosity=Unspecified (from parent cell line).,
CVCL_Y804,ND35670,ND35670,,56Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C168749; Amyotrophic lateral sclerosis 1, Mutation; HGNC; 11179; SOD1; Simple; p.Val149Gly (c.446T>G) (V148G); ClinVar=VCV000873204; Zygosity=Unspecified (NHCDR=ND35670).,
CVCL_T865,ND35671,ND35671,,65Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C168749; Amyotrophic lateral sclerosis 1, Mutation; HGNC; 11179; SOD1; Simple; p.Ala5Val (c.14C>T) (A4V); ClinVar=VCV000014763; Zygosity=Unspecified (NHCDR=ND35671).,
CVCL_Y805,ND35673,ND35673,,45Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C168749; Amyotrophic lateral sclerosis 1, Mutation; HGNC; 11179; SOD1; Simple; p.Ala5Val (c.14C>T) (A4V); ClinVar=VCV000014763; Zygosity=Unspecified (NHCDR=ND35673).,
CVCL_Y808,ND36997,ND36997,,21Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C82342; Huntington's disease, Mutation; HGNC; 4851; HTT; Repeat_expansion; p.Gln18[33] (c.52CAG(33)) (c.52CAG[(27_35)]); ClinVar=VCV000031915; Zygosity=Heterozygous (NHCDR=ND36997).,
CVCL_Y807,ND36998,ND36998,,29Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C82342; Huntington's disease, Mutation; HGNC; 4851; HTT; Repeat_expansion; p.Gln18[60] (c.52CAG(60)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (NHCDR=ND36998).,
CVCL_W577,ND36999,ND36999,,6Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C82342; Huntington's disease, Mutation; HGNC; 4851; HTT; Repeat_expansion; p.Gln18[179] (c.52CAG(179)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (NHCDR=ND36999).,
CVCL_Y812,ND38477,ND38477,,50Y,Male,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,"NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile", Mutation; HGNC; 8607; PRKN; Simple; p.Asn52Metfs*29 (c.155delA) (255delA); ClinVar=VCV000536457; Zygosity=Heterozygous (Coriell=ND38477).,
CVCL_Y814,ND38545,ND38545,,30Y,Female,"South American (Brazil, Guyana, Venezuela)",Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C82342; Huntington's disease, Mutation; HGNC; 4851; HTT; Repeat_expansion; p.Gln18[45] (c.52CAG(45)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (NHCDR=ND38545).,
CVCL_Y815,ND38546,ND38546,,48Y,Female,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C82342; Huntington's disease, Mutation; HGNC; 4851; HTT; Repeat_expansion; p.Gln18[45] (c.52CAG(45)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (NHCDR=ND38546).,
CVCL_Y816,ND38547,ND38547,,53Y,Male,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C82342; Huntington's disease, Mutation; HGNC; 4851; HTT; Repeat_expansion; p.Gln18[44] (c.52CAG(45)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (NHCDR=ND38547).,
CVCL_Y817,ND38548,ND38548,,44Y,Female,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C82342; Huntington's disease, Mutation; HGNC; 4851; HTT; Repeat_expansion; p.Gln18[42] (c.52CAG(42)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (NHCDR=ND38548).,
CVCL_Y818,ND38549,ND38549,,34Y,Female,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_Y819,ND38551,ND38551,,43Y,Male,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C82342; Huntington's disease, Mutation; HGNC; 4851; HTT; Repeat_expansion; p.Gln18[50] (c.52CAG(50)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (NHCDR=ND38551).,
CVCL_Y820,ND38552,ND38552,,37Y,Female,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C82342; Huntington's disease, Mutation; HGNC; 4851; HTT; Repeat_expansion; p.Gln18[49-50] (c.52CAG(49-50)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (NHCDR=ND38552).,
CVCL_Y821,ND38554,ND38554,,39Y,Female,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_Y822,ND38555,ND38555,,48Y,Female,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_Y823,ND39030,ND39030,,50Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C168749; Amyotrophic lateral sclerosis 1, Mutation; HGNC; 11179; SOD1; Simple; p.Asp91Ala (c.272A>C) (D90A); ClinVar=VCV000014766; Zygosity=Unspecified (Coriell=ND39030).,
CVCL_Y824,ND39032,ND39032,,51Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C168749; Amyotrophic lateral sclerosis 1, Mutation; HGNC; 11179; SOD1; Simple; p.Leu145Phe (c.435G>C) (L144F); ClinVar=VCV000586637; Zygosity=Unspecified (NHCDR=ND39032).,
CVCL_Y825,ND39034,ND39034,,37Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,"NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia", Mutation; HGNC; 4010; FUS; Simple; p.Arg522Arg (c.1566G>A); ClinVar=VCV000540280; Zygosity=Unspecified; Note=Mislocalized protein (from parent cell line).,
CVCL_Y826,ND39036,ND39036,,78Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C168749; Amyotrophic lateral sclerosis 1, Mutation; HGNC; 11179; SOD1; Simple; p.Gly86Arg (c.256G>C) (G85R); ClinVar=VCV000014758; Zygosity=Unspecified (NHCDR=ND39036).,
CVCL_Y827,ND39037,ND39037,,65Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C34373; Amyotrophic lateral sclerosis,,
CVCL_Y828,ND39896,ND39896,,77Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C26845; Parkinson's disease,,
CVCL_Y829,ND40018,ND40018,,60Y,Female,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,"NCIt; C198605; Parkinson disease 8, autosomal dominant", Mutation; HGNC; 18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Homozygous (Coriell=ND40018).,
CVCL_Y830,ND40019,ND40019,,Age unspecified,Male,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,"NCIt; C198605; Parkinson disease 8, autosomal dominant", Mutation; HGNC; 18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (NHCDR=ND40019).,
CVCL_Y831,ND40020,ND40020,,Age unspecified,Male,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,"NCIt; C198605; Parkinson disease 8, autosomal dominant", Mutation; HGNC; 18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (NHCDR=ND40020).,
CVCL_UF61,ND40597,ND40597,,66Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,"NCIt; C198605; Parkinson disease 8, autosomal dominant", Mutation; HGNC; 18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (Coriell=ND40597).,
CVCL_UF62,ND40599,ND40599,,81Y,Male,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,"NCIt; C198605; Parkinson disease 8, autosomal dominant", Mutation; HGNC; 18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (Coriell=ND40599).,
CVCL_UF63,ND40600,ND40600,,,,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C26845; Parkinson's disease,,
CVCL_Y809,ND41113,ND41113,,21Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C82342; Huntington's disease, Mutation; HGNC; 4851; HTT; Repeat_expansion; p.Gln18[33] (c.52CAG(33)) (c.52CAG[(27_35)]); ClinVar=VCV000031915; Zygosity=Heterozygous (NHCDR=ND41113).,
CVCL_Y832,ND41114,ND41114,,30Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002427,, Gene amplification; HGNC; 11118; SMN2; Extensive; Zygosity=Unspecified; Note=5 copies (from parent cell line).,
CVCL_UF69,ND41180,ND41180,,36Y,Male,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,"NCIt; C198605; Parkinson disease 8, autosomal dominant", Mutation; HGNC; 18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (Coriell=ND41180).,
CVCL_UF70,ND41181,ND41181,,66Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,"NCIt; C198605; Parkinson disease 8, autosomal dominant", Mutation; HGNC; 18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (Coriell=ND41181).,
CVCL_Y833,ND41654,ND41654,,76Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_Y834,ND41656,ND41656,,29Y,Female,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C82342; Huntington's disease, Mutation; HGNC; 4851; HTT; Repeat_expansion; p.Gln18[57] (c.52CAG(57)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (NHCDR=ND41656).,
CVCL_Y835,ND41657,ND41657,,29Y,Female,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C82342; Huntington's disease, Mutation; HGNC; 4851; HTT; Repeat_expansion; p.Gln18[57] (c.52CAG(57)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (NHCDR=ND41657).,
CVCL_Y836,ND41658,ND41658,,76Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_1N97,ND41864,ND41864,,64Y,Male,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_Y837,ND41865,ND41865,,64Y,Male,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_Y838,ND41866,ND41866,,64Y,Male,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_Y839,ND41867,ND41867,,Age unspecified,Male,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C84719; Frontotemporal dementia,,
CVCL_Y840,ND41869,ND41869,,67Y,Male,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C84719; Frontotemporal dementia,,
CVCL_RY02,ND41870,ND41870,,64Y,Male,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C84719; Frontotemporal dementia, Mutation; HGNC; 4601; GRN; Simple; p.Ser116Ter (c.347C>A); Zygosity=Unspecified (PubMed=23063362).,
CVCL_RY03,ND41871,ND41871,,64Y,Male,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C84719; Frontotemporal dementia, Mutation; HGNC; 4601; GRN; Simple; p.Ser116Ter (c.347C>A); Zygosity=Unspecified (PubMed=23063362).,
CVCL_RY04,ND41872,ND41872,,64Y,Male,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C84719; Frontotemporal dementia, Mutation; HGNC; 4601; GRN; Simple; p.Ser116Ter (c.347C>A); Zygosity=Unspecified (PubMed=23063362).,
CVCL_Y844,ND42222,ND42222,,9Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C82342; Huntington's disease, Mutation; HGNC; 4851; HTT; Repeat_expansion; p.Gln18[109] (c.52CAG(109)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (Coriell=ND42222).,
CVCL_1N95,ND42223,ND42223,,9Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C82342; Huntington's disease, Mutation; HGNC; 4851; HTT; Repeat_expansion; p.Gln18[109] (c.52CAG(109)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (Coriell=ND42223).,
CVCL_Y845,ND42224,ND42224,,9Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C82342; Huntington's disease, Mutation; HGNC; 4851; HTT; Repeat_expansion; p.Gln18[109] (c.52CAG(109)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (Coriell=ND42224).,
CVCL_1N96,ND42228,ND42228,,20Y,Female,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C82342; Huntington's disease, Mutation; HGNC; 4851; HTT; Repeat_expansion; p.Gln18[71] (c.52CAG(71)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from parent cell line).,
CVCL_Y846,ND42229,ND42229,,20Y,Female,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C82342; Huntington's disease, Mutation; HGNC; 4851; HTT; Repeat_expansion; p.Gln18[71] (c.52CAG(71)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from parent cell line).,
CVCL_Y847,ND42230,ND42230,,20Y,Female,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C82342; Huntington's disease, Mutation; HGNC; 4851; HTT; Repeat_expansion; p.Gln18[71] (c.52CAG(71)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from parent cell line).,
CVCL_Y848,ND42235,ND42235,,37Y,Female,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C82342; Huntington's disease, Mutation; HGNC; 4851; HTT; Repeat_expansion; p.Gln18[49-50] (c.52CAG(49-50)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from parent cell line).,
CVCL_Y849,ND42240,ND42240,,30Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002427,, Gene amplification; HGNC; 11118; SMN2; Extensive; Zygosity=Unspecified; Note=5 copies (from parent cell line).,
CVCL_Y850,ND42241,ND42241,,30Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002427,, Gene amplification; HGNC; 11118; SMN2; Extensive; Zygosity=Unspecified; Note=5 copies (from parent cell line).,
CVCL_Y851,ND42242,ND42242,,52Y,Female,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,,,
CVCL_Y852,ND42245,ND42245,,6Y,Male,African American,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_8410021,,,
CVCL_1N98,ND42765,ND42765,,65Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1, Mutation; HGNC; 28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (NHCDR=ND42765).,
CVCL_EZ87,ND42767,ND42767,,48Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1, Mutation; HGNC; 28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (NHCDR=ND42767).,
CVCL_1N99,ND43208,ND43208,,65Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1, Mutation; HGNC; 28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (NHCDR=ND43208).,
CVCL_EZ88,ND43209,ND43209,,60Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C84719; Frontotemporal dementia, Mutation; HGNC; 4601; GRN; Simple; p.Arg493Ter (c.1477C>T); ClinVar=VCV000016014; Zygosity=Unspecified (NHCDR=ND43209).,
CVCL_U621,Neo Jurkat,,CRL-2898,14Y,Male,Caucasian,Cancer cell line,,,,T-cell,UBERON_0000178,NCIt; C7953; Childhood T acute lymphoblastic leukemia," Mutation; HGNC; 959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).",
CVCL_2142,NK-92,,CRL-2407,50Y,Male,Caucasian,Cancer cell line,10376,Epstein-Barr virus (EBV).,,Natural killer cell,UBERON_0000178,NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma, Mutation; HGNC; 882; ATR; Unexplicit; Ex29-34del; Zygosity=Heterozygous (PubMed=16827800).,
CVCL_U271,NK-92CI,,CRL-2409,50Y,Male,Caucasian,Cancer cell line,,,,Natural killer cell,UBERON_0000178,NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma,,
CVCL_3755,NK-92MI,,CRL-2408,50Y,Male,Caucasian,Cancer cell line,,,,Natural killer cell,UBERON_0000178,NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma,,
CVCL_B064,NM2C5,,CRL-2918,33Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0013691+UBERON_0002072,NCIt; C3802; Amelanotic melanoma," Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 1787; CDKN2A; Simple; c.455insCdel26; Zygosity=Heterozygous (from parent cell line).",
CVCL_B065,NM2C5 GFP,,CRL-2919,33Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0013691+UBERON_0002072,NCIt; C3802; Amelanotic melanoma," Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 1787; CDKN2A; Simple; c.455insCdel26; Zygosity=Heterozygous (from parent cell line).",
CVCL_V429,NoGFP-CD16.NK92,,PTA-6967,50Y,Male,Caucasian,Cancer cell line,,,,Natural killer cell,UBERON_0000178,NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma,,
CVCL_S912,NOU-1,AG13904,,52Y,Female,,Cancer cell line,,,,,UBERON_0001295,NCIt; C7359; Endometrial adenocarcinoma, Gene deletion; HGNC; 9588; PTEN; Zygosity=Homozygous (PubMed=20944090).,
CVCL_3407,NT2-D1,,CRL-1973,22Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C3752; Embryonal carcinoma,,
CVCL_1877,NU-DUL-1,,CRL-2969,43Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001359,NCIt; C36081; Diffuse large B-cell lymphoma activated B-cell type," Mutation; HGNC; 6407; KRAS; Simple; p.Asp119Asn (c.355G>A); ClinVar=VCV000040460; Zygosity=Heterozygous (Cosmic-CLP=1330982; DepMap=ACH-000287)., Mutation; HGNC; 11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (Cosmic-CLP=1330982; DepMap=ACH-000287).",
CVCL_DH02,OCI-C1p,,CRL-3548,Age unspecified,Female,,Cancer cell line,,,,,UBERON_0000992,NCIt; C40078; Ovarian clear cell adenocarcinoma, Mutation; HGNC; 8975; PIK3CA; Simple; p.Pro539Arg (c.1616C>G); ClinVar=VCV000376243; Zygosity=Unspecified (PubMed=26080861).,
CVCL_DH06,OCI-C5x,,CRL-3553,Age unspecified,Female,,Cancer cell line,,,,,UBERON_0000992,NCIt; C40078; Ovarian clear cell adenocarcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (DepMap=ACH-001369).,
CVCL_DH18,OCI-P5x,,CRL-3552,Age unspecified,Female,,Cancer cell line,,,,,UBERON_0000992,NCIt; C7550; Ovarian serous adenocarcinoma, Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (DepMap=ACH-001370).,
CVCL_A4BI,OHRI-MEL-13,,CRL-3427,59Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0015876,NCIt; C3224; Melanoma, Mutation; HGNC; 1097; BRAF; Simple; p.Lys601Asn (c.1803A>T); ClinVar=VCV000376285; Zygosity=Homozygous (PubMed=33555379).,
CVCL_4366,OV-1063,,CRL-2183,57Y,Female,,Cancer cell line,,,,,UBERON_0007795,NCIt; C5228; Ovarian cystadenocarcinoma," Mutation; HGNC; 16712; FBXW7; Simple; p.Glu40Ter (c.118G>T); Zygosity=Unspecified (PubMed=11565033)., Mutation; HGNC; 11998; TP53; Simple; p.Val274Phe (c.820G>T); ClinVar=VCV000376674; Zygosity=Unspecified (PubMed=25846456).",
CVCL_3768,OV-90,,CRL-3585,64Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0007795,NCIt; C7700; Ovarian adenocarcinoma," Gene fusion; HGNC; 1790; CDKN2D + HGNC; 20482; WDFY2; Name(s)=CDKN2D-WDFY2 (PubMed=24675677)., Mutation; HGNC; 11998; TP53; Simple; p.Ser215Arg (c.643A>C); ClinVar=VCV000428895; Zygosity=Homozygous (PubMed=10949993; PubMed=20204287; PubMed=24023729; PubMed=25230021; PubMed=28273451; DepMap=ACH-000291).",
CVCL_0465,OVCAR-3,,HTB-161,60Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0007795,NCIt; C105555; High grade ovarian serous adenocarcinoma, Mutation; HGNC; 8979; PIK3R1; Simple; c.1746-2A>T; Zygosity=Heterozygous; Note=Splice acceptor mutation (DepMap=ACH-000001).,
CVCL_6429,P116,,CRL-2676,14Y,Male,Caucasian,Cancer cell line,,,,T-cell,UBERON_0000178,NCIt; C7953; Childhood T acute lymphoblastic leukemia," Mutation; HGNC; 959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).",
CVCL_6430,P116.cl39,,CRL-2677,14Y,Male,Caucasian,Cancer cell line,,,,T-cell,UBERON_0000178,NCIt; C7953; Childhood T acute lymphoblastic leukemia," Mutation; HGNC; 959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).",
CVCL_2676,P3HR-1,,HTB-62,7Y,Male,African,Cancer cell line,10376,Epstein-Barr virus (EBV).,,B-cell,UBERON_0007795,NCIt; C27694; EBV-related Burkitt lymphoma," Mutation; HGNC; 7553; MYC; Simple; p.Pro72Ser (c.214C>T); ClinVar=VCV000012574; Zygosity=Unspecified (PubMed=8108117)., Mutation; HGNC; 11998; TP53; Simple; p.Tyr163His (c.487T>C); ClinVar=VCV000376680; Zygosity=Unspecified (PubMed=2052620; PubMed=8344493; PubMed=8402660).",
CVCL_J916,p53R,,CRL-2781,Age unspecified,Sex unspecified,,Cancer cell line,,,,,UBERON_0001155,NCIt; C4910; Colon carcinoma," Mutation; HGNC; 173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 11773; TGFBR2; Simple; p.Leu452Pro (c.1355T>C); ClinVar=VCV000930524; Zygosity=Heterozygous (from parent cell line).",
CVCL_0479,PA-1,,CRL-1572,12Y,Female,,Cancer cell line,,,,,UBERON_0007795,NCIt; C8114; Ovarian mixed germ cell tumor, Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous; Note=Not found in early passages (PubMed=6740333).,
CVCL_7666,Panc 01.28,,CRL-2548,,,,Cancer cell line,,,,,UBERON_0001264,NCIt; C8294; Pancreatic adenocarcinoma,,
CVCL_1633,Panc 02.03,,CRL-2553,70Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0001264,NCIt; C8294; Pancreatic adenocarcinoma, Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=9612602; Cosmic-CLP=1298475; DepMap=ACH-000042).,
CVCL_1634,Panc 02.13,,CRL-2554,64Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0001264,NCIt; C8294; Pancreatic adenocarcinoma, Mutation; HGNC; 6407; KRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000045115; Zygosity=Heterozygous (DepMap=ACH-000031).,
CVCL_1635,Panc 03.27,,CRL-2549,65Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0001264,NCIt; C8294; Pancreatic adenocarcinoma, Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous (ATCC=CRL-2549; Cosmic-CLP=925346; DepMap=ACH-000139).,
CVCL_1636,Panc 04.03,,CRL-2555,70Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001264,NCIt; C9120; Pancreatic ductal adenocarcinoma," Gene fusion; HGNC; 16935; ATG7 + HGNC; 9829; RAF1; Name(s)=ATG7-RAF1 (PubMed=23637631)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=9612602; ATCC=CRL-2555; Cosmic-CLP=1298476; DepMap=ACH-000235).",
CVCL_7664,Panc 04.21,,CRL-2556,,,,Cancer cell line,,,,,UBERON_0001264,NCIt; C8294; Pancreatic adenocarcinoma,,
CVCL_1637,Panc 05.04,,CRL-2557,77Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0001264,NCIt; C9120; Pancreatic ductal adenocarcinoma, Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=9612602; DepMap=ACH-000093).,
CVCL_7665,Panc 06.03,,CRL-2550,,,,Cancer cell line,,,,,UBERON_0001264,NCIt; C9120; Pancreatic ductal adenocarcinoma, Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (ATCC=CRL-2550).,
CVCL_1638,Panc 08.13,,CRL-2551,85Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001264,NCIt; C9120; Pancreatic ductal adenocarcinoma, Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Homozygous (PubMed=9612602; ATCC=CRL-2551).,
CVCL_U873,Panc 09.06,,CRL-2552,53Y,Female,,Cancer cell line,,,,,UBERON_0001264,NCIt; C9120; Pancreatic ductal adenocarcinoma, Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=9612602).,
CVCL_1639,Panc 10.05,,CRL-2547,81Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001264,NCIt; C9120; Pancreatic ductal adenocarcinoma, Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=9612602; ATCC=CRL-2547; Cosmic-CLP=925348; DepMap=ACH-000060).,
CVCL_0480,PANC-1,,CRL-1469,56Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001264,NCIt; C9120; Pancreatic ductal adenocarcinoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (PubMed=11787853; PubMed=15367885)., Mutation; HGNC; 11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (PubMed=1630814; PubMed=1764370; PubMed=7961102; PubMed=8026879; PubMed=11115575; PubMed=11787853; PubMed=15367885; PubMed=21607521; DepMap=ACH-000164).",
CVCL_A4BT,PANC-1 Ecadherin EmGFP,,CRL-1469MET,56Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001264,NCIt; C9120; Pancreatic ductal adenocarcinoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).",
CVCL_A4BU,PANC-1-Luc2,,CRL-1469-LUC2,56Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001264,NCIt; C9120; Pancreatic ductal adenocarcinoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).",
CVCL_0035,PC-3,,CRL-1435,62Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002481,NCIt; C4863; Prostate carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (PubMed=1873816; PubMed=8104329; PubMed=17088437; Cosmic-CLP=905934; DepMap=ACH-000090).,
CVCL_A4BV,PC-3-Luc2,,CRL-1435-LUC2,62Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002481,NCIt; C4863; Prostate carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).,
CVCL_B0E3,PC3-EMT14,,CRL-3471,62Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002481,NCIt; C4863; Prostate carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).,
CVCL_B0CB,PC3-epi,,CRL-3470,62Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002481,NCIt; C4863; Prostate carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).,
CVCL_UJ04,PF-1,,CRL-3379,43Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000178,NCIt; C4337; Mantle cell lymphoma, Gene fusion; HGNC; 1582; CCND1 + HGNC; 5477; IGH; Name(s)=IGH-CCND1 (PubMed=24611650).,
CVCL_3326,Pfeiffer,,CRL-2632,Adult,Male,Caucasian,Cancer cell line,,,,B-cell,UBERON_0000175,NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type, Mutation; HGNC; 583; APC; Simple; p.Arg1171Cys (c.3511C>T); ClinVar=VCV000133518; Zygosity=Heterozygous (DepMap=ACH-000140).,
CVCL_1642,PFSK-1,,CRL-2060,1Y10M,Male,Caucasian,Cancer cell line,,,,,UBERON_0002810,NCIt; C3716; Primitive neuroectodermal tumor, Mutation; HGNC; 11998; TP53; Simple; p.Cys275Gly (c.823T>G); ClinVar=VCV001414106; Zygosity=Homozygous (Cosmic-CLP=683667).,
CVCL_L107,PH [Human],,CRL-9851,37Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C8263; Adult acute monocytic leukemia," Gene fusion; HGNC; 16063; MLLT10 + HGNC; 15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line)., Mutation; HGNC; 9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line).",
CVCL_3567,PL45,,CRL-2558,81Y,Male,Caucasian,Cancer cell line,,,,,,NCIt; C9120; Pancreatic ductal adenocarcinoma, Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (ATCC=CRL-2558).,
CVCL_0485,PLC/PRF/5,,CRL-8024,24Y,Male,African,Cancer cell line,10407,Hepatitis B virus (HBV).,,,UBERON_0002107,NCIt; C7956; Adult hepatocellular carcinoma," Mutation; HGNC; 1787; CDKN2A; Simple; p.Arg112Gly (c.334C>G) (p.Pro126Arg, c.377C>G); ClinVar=VCV000233484; Zygosity=Homozygous (PubMed=31378681; DepMap=ACH-001318)., Mutation; HGNC; 12363; TSC2; Simple; p.Asn1651Ser (c.4952A>G); ClinVar=VCV000049335; Zygosity=Homozygous (DepMap=ACH-001318).",
CVCL_A665,PM-WK,,CRL-2624,Age unspecified,Sex unspecified,,Cancer cell line,,,,,UBERON_0002097,NCIt; C3510; Cutaneous melanoma, Gene deletion; HGNC; 9588; PTEN; Zygosity=Homozygous (PubMed=9692547; PubMed=10766161).,
CVCL_4778,PPC-1,,HTB-190,62Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002481,NCIt; C4863; Prostate carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (PubMed=11304728).,
CVCL_1644,PSN1,,CRL-3211,Age unspecified,Male,Japanese,Cancer cell line,,,,,UBERON_0001264,NCIt; C8294; Pancreatic adenocarcinoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (PubMed=11787853)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Arg (c.34G>C); ClinVar=VCV000012579; Zygosity=Heterozygous (PubMed=3778442; PubMed=11787853; Cosmic-CLP=910546; DepMap=ACH-000320).",
CVCL_AT71,R1192,,CRL-7935,49Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002097,NCIt; C4033; Clear cell renal cell carcinoma, Mutation; HGNC; 9884; RB1; Simple; p.Leu98Pro (c.293T>C); ClinVar=VCV001502192; Zygosity=Heterozygous (from parent cell line).,
CVCL_C9CV,Raji-Luc2,,CCL-86-LUC2,11Y,Male,African,Cancer cell line,10376,Epstein-Barr virus (EBV).,,B-cell,UBERON_0002397,NCIt; C27694; EBV-related Burkitt lymphoma," Gene fusion; HGNC; 5477; IGH + HGNC; 7553; MYC; Name(s)=MYC-IGH (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).",
CVCL_0597,Ramos,,CRL-1596,3Y,Male,Caucasian,Cancer cell line,,,,B-cell,UBERON_0007795,NCIt; C2912; Burkitt lymphoma, Gene fusion; HGNC; 5477; IGH + HGNC; 7553; MYC; Name(s)=MYC-IGH (PubMed=10918597).,
CVCL_1646,Ramos.2G6.4C10,,CRL-1923,3Y,Male,Caucasian,Cancer cell line,,,,B-cell,UBERON_0007795,NCIt; C2912; Burkitt lymphoma, Gene fusion; HGNC; 5477; IGH + HGNC; 7553; MYC; Name(s)=MYC-IGH (from parent cell line).,
CVCL_9U45,RC,,CRL-3382,71Y,Female,,Cancer cell line,,,,,UBERON_0000175,NCIt; C125904; High grade B-cell lymphoma with MYC and BCL2 or BCL6 rearrangements, Gene fusion; HGNC; 990; BCL2 + HGNC; 5477; IGH; Name(s)=IGH-BCL2 (PubMed=26515759).,
CVCL_1649,RD,,CCL-136,7Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0001325,NCIt; C8971; Embryonal rhabdomyosarcoma, Mutation; HGNC; 7989; NRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000373003; Zygosity=Heterozygous (PubMed=3158613; PubMed=12068308; PubMed=16518851; PubMed=22142829; ATCC=CCL-136; Cosmic-CLP=909264; DepMap=ACH-000169).,
CVCL_2169,RD-ES,,HTB-166,19Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000976,NCIt; C4817; Ewing sarcoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (PubMed=18160777; PubMed=19787792)., Mutation; HGNC; 11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (PubMed=8221663; PubMed=8378080; PubMed=19787792; PubMed=25010205; PubMed=25223734; DepMap=ACH-000041).",
CVCL_1884,REC-1,,CRL-3004,61Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000178,NCIt; C4337; Mantle cell lymphoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (PubMed=16448697)., Mutation; HGNC; 11998; TP53; Simple; p.Gln317Ter (c.949C>T); ClinVar=VCV000450344; Zygosity=Heterozygous (DepMap=ACH-000068).",
CVCL_1650,Reh,,CRL-8286,15Y,Female,,Cancer cell line,,,,,UBERON_0000178,"NCIt; C9140; Childhood B acute lymphoblastic leukemia,ORDO; Orphanet_585929; B-lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1)"," Gene fusion; HGNC; 3495; ETV6 + HGNC; 10471; RUNX1; Name(s)=ETV6-RUNX1; TEL-AML1 (PubMed=8704231; PubMed=9067587; PubMed=15843827; PubMed=35354797)., Mutation; HGNC; 9588; PTEN; Simple; p.Arg173Cys (c.517C>T); ClinVar=VCV000189500; Zygosity=Homozygous (Cosmic-CLP=909696; DepMap=ACH-000960).",
CVCL_3580,RF-1,,CRL-1864,62Y,Male,,Cancer cell line,,,,,,NCIt; C3208; Lymphoma,,
CVCL_1657,RF-48,,CRL-1863,62Y,Male,,Cancer cell line,,,,,,NCIt; C3208; Lymphoma,,
CVCL_0041,Rh30,,CRL-2061,17Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002371,NCIt; C3749; Alveolar rhabdomyosarcoma," Gene fusion; HGNC; 3819; FOXO1 + HGNC; 8617; PAX3; Name(s)=PAX3-FOXO1, PAX3-FKHR (PubMed=8275086; PubMed=17471488; PubMed=23578105; PubMed=25485619; PubMed=25806826)., Mutation; HGNC; 11998; TP53; Simple; p.Tyr205Cys (c.614A>G); ClinVar=VCV000376681; Zygosity=Heterozygous (Cosmic-CLP=909716; DepMap=ACH-000833)., Mutation; HGNC; 11998; TP53; Simple; p.Arg280Ser (c.840A>T); ClinVar=VCV000988616; Zygosity=Heterozygous (Cosmic-CLP=909716; DepMap=ACH-000833).",
CVCL_0504,RKO,,CRL-2577,Age unspecified,Sex unspecified,,Cancer cell line,,,,,UBERON_0001155,NCIt; C4910; Colon carcinoma," Mutation; HGNC; 173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (PubMed=12615714; Cosmic-CLP=909698; DepMap=ACH-000943)., Mutation; HGNC; 8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (PubMed=20570890; PubMed=24042735; PubMed=24755471; PubMed=28683746; Cosmic-CLP=909698; DepMap=ACH-000943)., Mutation; HGNC; 11773; TGFBR2; Simple; p.Leu452Pro (c.1355T>C); ClinVar=VCV000930524; Zygosity=Heterozygous (PubMed=12615714).",
CVCL_3786,RKO-AS45-1,,CRL-2579,Age unspecified,Sex unspecified,,Cancer cell line,,,,,UBERON_0001155,NCIt; C4910; Colon carcinoma," Mutation; HGNC; 173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 11773; TGFBR2; Simple; p.Leu452Pro (c.1355T>C); ClinVar=VCV000930524; Zygosity=Heterozygous (from parent cell line).",
CVCL_3787,RKO-E6,,CRL-2578,Age unspecified,Sex unspecified,,Cancer cell line,,,,,UBERON_0001155,NCIt; C4910; Colon carcinoma," Mutation; HGNC; 173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 11773; TGFBR2; Simple; p.Leu452Pro (c.1355T>C); ClinVar=VCV000930524; Zygosity=Heterozygous (from parent cell line).",
CVCL_1660,RL,,CRL-2261,52Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0007795,NCIt; C8851; Diffuse large B-cell lymphoma, Mutation; HGNC; 11998; TP53; Simple; p.Ala138Pro (c.412G>C); ClinVar=VCV000012376; Zygosity=Homozygous (PubMed=17363600; Cosmic-CLP=910861; DepMap=ACH-000371).,
CVCL_0505,RL95-2,,CRL-1671,65Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0001295,NCIt; C114656; Endometrial adenosquamous carcinoma," Mutation; HGNC; 11110; ARID1A; Simple; p.Arg693Ter (c.2077C>T); Zygosity=Heterozygous (Cosmic-CLP=930082; DepMap=ACH-000965)., Mutation; HGNC; 7133; KMT2D; Simple; p.Arg1252Ter (c.3754C>T); ClinVar=VCV000167228; Zygosity=Heterozygous (Cosmic-CLP=930082; DepMap=ACH-000965)., Mutation; HGNC; 9588; PTEN; Simple; p.Asn323Metfs*21 (c.968delA); ClinVar=VCV000653412; Zygosity=Heterozygous (PubMed=20944090)., Mutation; HGNC; 11998; TP53; Simple; p.Val218del (c.646_648GTG[2]) (c.652_654delGTG); ClinVar=VCV000634761; Zygosity=Heterozygous (PubMed=9887230; Cosmic-CLP=930082; DepMap=ACH-000965).",
CVCL_M543,RPM-MC,,CRL-2499,Age unspecified,Sex unspecified,,Cancer cell line,,,,,UBERON_0002097,NCIt; C3510; Cutaneous melanoma,,
CVCL_RP63,RPMI-1922,,HTB-84,59Y,Female,,Cancer cell line,,,,,,NCIt; C3194; Liposarcoma,,
CVCL_1664,RPMI-2650,,CCL-30,52Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000175,"NCIt; C34447; Head and neck squamous cell carcinoma,ORDO; Orphanet_443167; NUT midline carcinoma"," Gene fusion; HGNC; 13575; BRD4 + HGNC; 29919; NUTM1; Name(s)=BRD4-NUTM1, BRD4-NUT; Note=BRD4 exon 15 fused to NUTM1 exon 2 (PubMed=25485619; PubMed=29348827).",
CVCL_1666,RPMI-7951,,HTB-66,18Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C3224; Melanoma," Gene deletion; HGNC; 9588; PTEN; Zygosity=Homozygous (ATCC=HTB-66)., Mutation; HGNC; 11730; TERT; Simple; c.242_243CC>TT (-138/-139CC>TT); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).",
CVCL_1667,RPMI-8402,,CRL-1994,16Y,Female,Caucasian,Cancer cell line,,,,T-cell,UBERON_0000178,NCIt; C7953; Childhood T acute lymphoblastic leukemia," Gene fusion; HGNC; 6641; LMO1 + HGNC; 12252; TRD; Name(s)=LMO1-TRD (PubMed=2501659; PubMed=29496689)., Mutation; HGNC; 16712; FBXW7; Simple; p.Arg465His (c.1394G>A); ClinVar=VCV000376415; Zygosity=Homozygous (PubMed=22675565; PubMed=26870252; Cosmic-CLP=909702)., Mutation; HGNC; 9588; PTEN; Simple; p.Arg159Ser (c.477G>T); ClinVar=VCV000375959; Zygosity=Heterozygous (PubMed=22675565; PubMed=26870252; Cosmic-CLP=909702)., Mutation; HGNC; 12796; WT1; Simple; p.Ser121Ter (c.362C>A); Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=909702).",
CVCL_0093,RS4;11,,CRL-1873,32Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002371,"NCIt; C9143; Adult B acute lymphoblastic leukemia,ORDO; Orphanet_585918; B-lymphoblastic leukemia/lymphoma with t(v;11q23.3)"," Gene fusion; HGNC; 7135; AFF1 + HGNC; 7132; KMT2A; Name(s)=KMT2A-AFF1, MLL-AFF1, ALL-1/AF4; Note=In frame (PubMed=1423625; PubMed=8358709; PubMed=32721124).",
CVCL_0036,RT-4,,CRL-7937,63Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001255,NCIt; C4912; Bladder carcinoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (PubMed=9850064)., Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680)., Mutation; HGNC; 11998; TP53; None_reported; -; Zygosity=- (PubMed=7787250).",
CVCL_A2TY,S1123-01 iPS #3,GM27879,,52Y,Male,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002427,,,
CVCL_8910,SA-4,,CRL-7938,30Y6M,Female,African American,Cancer cell line,333761,Human papillomavirus type 18 (HPV18).,,,UBERON_0000002,NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma,,
CVCL_9997,SAML-1,,CRL-2776,37Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C8263; Adult acute monocytic leukemia," Gene fusion; HGNC; 16063; MLLT10 + HGNC; 15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line)., Mutation; HGNC; 9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line).",
CVCL_9998,SAML-2,,CRL-2840,42Y,Male,,Cancer cell line,,,,,UBERON_0002371,NCIt; C8252; Therapy-related acute myeloid leukemia, Gene deletion; HGNC; 11998; TP53; Zygosity=Heterozygous (PubMed=12759925).,
CVCL_0548,SaOS-2,,CRL-7939,11Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002481,NCIt; C9145; Osteosarcoma, Gene deletion; HGNC; 11998; TP53; Zygosity=Homozygous (PubMed=2823272; PubMed=16888811; PubMed=19787792).,
CVCL_6444,SC [Human contaminated U-937],,CRL-3622,37Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C8263; Adult acute monocytic leukemia," Gene fusion; HGNC; 16063; MLLT10 + HGNC; 15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line)., Mutation; HGNC; 9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line).",
CVCL_3599,SCaBER,,HTB-3,58Y,Male,African American,Cancer cell line,,,,,UBERON_0001255,NCIt; C4031; Bladder squamous cell carcinoma, Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680; PubMed=31068700).,
CVCL_1681,SCC-15,,CRL-1623,55Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001723,NCIt; C4648; Tongue squamous cell carcinoma,,
CVCL_1682,SCC-25,,CRL-1628,70Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001723,NCIt; C4648; Tongue squamous cell carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Arg209Lysfs*6 (c.626_627delGA); ClinVar=VCV000372539; Zygosity=Heterozygous (Cosmic-CLP=910701; DepMap=ACH-000188).,
CVCL_1684,SCC-4,,CRL-1624,55Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001723,NCIt; C4648; Tongue squamous cell carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Pro151Ser (c.451C>T); ClinVar=VCV000012370; Zygosity=Unspecified (PubMed=8390283).,
CVCL_1685,SCC-9,,CRL-1629,25Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0010032,NCIt; C4648; Tongue squamous cell carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Val274_Glu285del (c.820_851del32); Zygosity=Unspecified (PubMed=1423286; PubMed=25275298).,
CVCL_D4Z5,ACE2plusC3,,CRL-3560,58Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C3512; Lung adenocarcinoma, Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).,
CVCL_1067,ACHN,,CRL-1611,22Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C6975; Papillary renal cell carcinoma, Mutation; HGNC; 7773; NF2; Simple; p.Arg57Ter (c.169C>T); ClinVar=VCV000003285; Zygosity=Homozygous (Cosmic-CLP=905950; DepMap=ACH-000046).,
CVCL_B0CD,SFT,,CRL-3469,34Y,Female,Caucasian,Cancer cell line,,,,,,NCIt; C3796; Gliosarcoma, Mutation; HGNC; 9884; RB1; Simple; p.Thr116Leufs*8 (c.346_349delACTT); Zygosity=Heterozygous (from parent cell line).,
CVCL_0519,SG231,,CRL-2126,42Y,Male,,Cancer cell line,,,,,,NCIt; C35417; Intrahepatic cholangiocarcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Thr125Pro (c.373A>C); ClinVar=VCV000376666; Zygosity=Unspecified (DepMap=ACH-001857).,
CVCL_1692,SH-4,,CRL-7724,60Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C3224; Melanoma, Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (PubMed=12068308; Cosmic-CLP=909713; DepMap=ACH-000441).,
CVCL_0F47,SH-EP1,,CRL-2269,4Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002371,NCIt; C3270; Neuroblastoma, Mutation; HGNC; 427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Heterozygous (from parent cell line).,
CVCL_0019,SH-SY5Y,,CRL-2266,4Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002371,NCIt; C3270; Neuroblastoma, Mutation; HGNC; 427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (PubMed=28350380).,
CVCL_1693,SHP-77,,CRL-2195,54Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0008952,NCIt; C4917; Lung small cell carcinoma," Mutation; HGNC; 76; ABL1; Simple; p.Val1128Glu (c.3383T>A); Zygosity=Heterozygous (Cosmic-CLP=724872; DepMap=ACH-000790)., Mutation; HGNC; 9801; RAC1; Simple; p.Tyr32Cys (c.95A>G); Zygosity=Heterozygous (Cosmic-CLP=724872; DepMap=ACH-000790).",
CVCL_0032,SiHa,,HTB-35,55Y,Female,Japanese,Cancer cell line,333760,Human papillomavirus type 16 (HPV16).,,,UBERON_0000002,NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma,,
CVCL_1697,SJSA-1,,CRL-2098,19Y,Male,African American,Cancer cell line,,,,,UBERON_0000981,NCIt; C9145; Osteosarcoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Hemizygous (PubMed=19787792)., Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (Cosmic-CLP=909717; DepMap=ACH-000748).",
CVCL_T283,SK-BR-1 III,,HTB-28,55Y,Female,,Cancer cell line,,,,,UBERON_0000175,NCIt; C4872; Breast carcinoma,,
CVCL_T284,SK-BR-2 III,,HTB-29,79Y,Female,,Cancer cell line,,,,,UBERON_0007795,NCIt; C4872; Breast carcinoma,,
CVCL_0033,SK-BR-3,,HTB-30,43Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C5214; Breast adenocarcinoma, Gene deletion; HGNC; 1748; CDH1; Zygosity=Homozygous (PubMed=17334996; PubMed=19593635).,
CVCL_0626,SK-CO-1,,HTB-39,65Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0007795,NCIt; C4349; Colon adenocarcinoma," Mutation; HGNC; 583; APC; Simple; p.Phe1089fs*37 (c.3266delT); Zygosity=Heterozygous (ATCC=HTB-39; Cosmic-CLP=909718; DepMap=ACH-000400)., Mutation; HGNC; 4392; GNAS; Simple; p.Arg201Cys (c.601C>T); ClinVar=VCV000015933; Zygosity=Heterozygous (Cosmic-CLP=909718; DepMap=ACH-000400)., Mutation; HGNC; 11998; TP53; None_reported; -; Zygosity=- (PubMed=16418264).",
CVCL_0627,SK-ES-1,,HTB-86,18Y,Male,Caucasian,Cancer cell line,,,,,,NCIt; C4817; Ewing sarcoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (PubMed=18160777; PubMed=19787792)., Mutation; HGNC; 11355; STAG2; Simple; p.Gln735Ter (c.2203C>T); Zygosity=Unspecified (PubMed=25010205; PubMed=25223734).",
CVCL_T285,SK-ES-2,,HTB-87,,Female,,Cancer cell line,,,,,,NCIt; C4817; Ewing sarcoma,,
CVCL_0525,SK-HEP-1,,HTB-52,52Y,Male,Caucasian,Cancer cell line,,,,Endothelial cell,UBERON_0007795,NCIt; C7106; Liver and intrahepatic bile duct epithelial neoplasm, Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (ATCC=HTB-52).,
CVCL_0628,SK-LMS-1,,HTB-88,43Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000997,NCIt; C40318; Vulvar leiomyosarcoma, Mutation; HGNC; 11998; TP53; Simple; p.Met237Lys (c.710T>A); ClinVar=VCV000376636; Zygosity=Unspecified (PubMed=2216456; PubMed=16142349).,
CVCL_0629,SK-LU-1,,HTB-57,60Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C3512; Lung adenocarcinoma," Mutation; HGNC; 11110; ARID1A; Simple; p.Asn1253fs*16 (c.3753delC); Zygosity=Heterozygous (Cosmic-CLP=909721; DepMap=ACH-000309)., Mutation; HGNC; 11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Homozygous (PubMed=1855224; PubMed=12794755; Cosmic-CLP=909721; DepMap=ACH-000309).",
CVCL_0068,SK-MEL-1,,HTB-67,29Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0007644,NCIt; C3224; Melanoma, Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=21725359; PubMed=24576830; Cosmic-CLP=909723; DepMap=ACH-000465).,
CVCL_0069,SK-MEL-2,,HTB-68,60Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0004262,NCIt; C3224; Melanoma," Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Homozygous (PubMed=12068308; PubMed=15467732; PubMed=17088437; PubMed=21725359; PubMed=24576830; PubMed=25728708; PubMed=27533468)., Mutation; HGNC; 11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Heterozygous (PubMed=17088437; PubMed=18277095; PubMed=21912889; PubMed=27533468).",
CVCL_0599,SK-MEL-24,,HTB-71,67Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C3224; Melanoma," Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=12068308; PubMed=26405815; DepMap=ACH-000822)., Mutation; HGNC; 11998; TP53; None_reported; -; Zygosity=- (Cosmic-CLP=909725; DepMap=ACH-000822).",
CVCL_0526,SK-MEL-28,,HTB-72,51Y,Male,Caucasian,Cancer cell line,,,,Melanocyte of skin,UBERON_0002097,NCIt; C3510; Cutaneous melanoma," Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (PubMed=12068308; PubMed=15467732; PubMed=17088437; PubMed=17260012; PubMed=17363583; PubMed=19799798; PubMed=24576830; PubMed=26405815; PubMed=29492214; Cosmic-CLP=905954; DepMap=ACH-000615)., Mutation; HGNC; 3236; EGFR; Simple; p.Pro753Ser (c.2257C>T); ClinVar=VCV000376081; Zygosity=Homozygous (PubMed=17088437; Cosmic-CLP=905954; DepMap=ACH-000615)., Mutation; HGNC; 11730; TERT; Simple; c.-57A>C (c.161A>C) (A161C); ClinVar=VCV000242210; Zygosity=Unspecified; Note=In promoter (PubMed=31068700).",
CVCL_0550,SK-MEL-3,,HTB-69,42Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C3510; Cutaneous melanoma, Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=12068308; PubMed=17260012; ATCC=HTB-69; Cosmic-CLP=909724; DepMap=ACH-000423).,
CVCL_0600,SK-MEL-31,,HTB-73,33Y,Female,Caucasian,Cancer cell line,,,,,,NCIt; C3510; Cutaneous melanoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (PubMed=9598804; PubMed=17260012)., Gene deletion; HGNC; 9588; PTEN; Zygosity=Homozygous (PubMed=17260012).",
CVCL_0527,SK-MEL-5,,HTB-70,24Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0001097,NCIt; C3510; Cutaneous melanoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (PubMed=17363583)., Mutation; HGNC; 11730; TERT; Simple; c.242_243CC>TT (-138/-139CC>TT); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).",
CVCL_0630,SK-MES-1,,HTB-58,65Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C3493; Lung squamous cell carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Glu298Ter (c.892G>T); ClinVar=VCV000093323; Zygosity=Homozygous (PubMed=12794755; PubMed=20557307; Cosmic-CLP=909728; DepMap=ACH-000665).,
CVCL_1700,SK-N-AS,,CRL-2137,6Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002371,NCIt; C3270; Neuroblastoma, Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (PubMed=12068308; Cosmic-CLP=724828; DepMap=ACH-000260).,
CVCL_0528,SK-N-BE(2),,CRL-2271,2Y2M,Male,Caucasian,Cancer cell line,,,,,UBERON_0002371,NCIt; C3270; Neuroblastoma, Gene deletion; HGNC; 11998; TP53; Zygosity=Heterozygous (from child cell line SK-N-BE(2)-C).,
CVCL_0529,SK-N-BE(2)-C,,CRL-2268,2Y2M,Male,Caucasian,Cancer cell line,,,,,UBERON_0002371,NCIt; C3270; Neuroblastoma, Gene deletion; HGNC; 11998; TP53; Zygosity=Heterozygous (PubMed=11196202).,
CVCL_0167,SK-N-BE(2)-M17,,CRL-2267,2Y2M,Male,Caucasian,Cancer cell line,,,,,UBERON_0002371,NCIt; C3270; Neuroblastoma, Gene deletion; HGNC; 11998; TP53; Zygosity=Heterozygous (from parent cell line).,
CVCL_1701,SK-N-DZ,,CRL-2149,2Y,Female,Caucasian and Native North American,Cancer cell line,,,,,UBERON_0002371,NCIt; C3270; Neuroblastoma, Mutation; HGNC; 11998; TP53; Simple; p.Arg110Leu (c.329G>T); ClinVar=VCV000406597; Zygosity=Homozygous (Cosmic-CLP=688086; DepMap=ACH-000366).,
CVCL_1702,SK-N-FI,,CRL-2142,11Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002371,NCIt; C3270; Neuroblastoma, Mutation; HGNC; 7765; NF1; Unexplicit; Partial deletion; Zygosity=Homozygous (PubMed=20655465).,
CVCL_0530,SK-N-MC,,HTB-10,12Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0004088,NCIt; C7542; Askin tumor," Gene fusion; HGNC; 3508; EWSR1 + HGNC; 3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 1 fusion (Ex7/Ex6) (PubMed=7591257; PubMed=8040301; PubMed=25010205).",
CVCL_1398,SK-N-MC-IXC,,CRL-2270,12Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0004088,NCIt; C7542; Askin tumor," Gene fusion; HGNC; 3508; EWSR1 + HGNC; 3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 1 fusion (Ex7/Ex6) (from parent cell line).",
CVCL_0531,SK-N-SH,,HTB-11,4Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002371,NCIt; C3270; Neuroblastoma, Mutation; HGNC; 427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Heterozygous (PubMed=18724359; PubMed=18923523; PubMed=28350380; Cosmic-CLP=717431; DepMap=ACH-000149).,
CVCL_0631,SK-NEP-1,,HTB-48,25Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C4817; Ewing sarcoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (PubMed=25010205)., Mutation; HGNC; 11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Homozygous (PubMed=25010205; DepMap=ACH-001192).",
CVCL_1E47,SK-OS-10,,HTB-90,13Y,Male,,Cancer cell line,,,,,UBERON_0002048,NCIt; C9145; Osteosarcoma,,
CVCL_LK69,SK-OS-5,,HTB-89,,Male,,Cancer cell line,,,,,,NCIt; C9145; Osteosarcoma,,
CVCL_0532,SK-OV-3,,HTB-77,64Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0007795,NCIt; C7978; Ovarian serous cystadenocarcinoma," Mutation; HGNC; 583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (PubMed=17088437)., Mutation; HGNC; 8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (PubMed=17088437; PubMed=22705003; PubMed=25846456; PubMed=28273451).",
CVCL_1703,SK-PN-DW,,CRL-2139,17Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0003693,NCIt; C3716; Primitive neuroectodermal tumor," Gene fusion; HGNC; 3508; EWSR1 + HGNC; 3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 1 fusion (Ex7/Ex6) (PubMed=8040301)., Mutation; HGNC; 11998; TP53; Simple; p.Cys176Phe (c.527G>T); ClinVar=VCV000376569; Zygosity=Homozygous (Cosmic-CLP=909731; DepMap=ACH-001193).",
CVCL_0533,SK-UT-1,,HTB-114,75Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000995,NCIt; C6340; Uterine corpus leiomyosarcoma," Mutation; HGNC; 583; APC; Simple; p.Gln1096Ter (c.3286C>T); ClinVar=VCV000156475; Zygosity=Heterozygous (ATCC=HTB-114)., Mutation; HGNC; 8975; PIK3CA; Simple; p.Arg88Gln (c.263G>A); ClinVar=VCV000376049; Zygosity=Heterozygous (ATCC=HTB-114)., Mutation; HGNC; 9588; PTEN; Simple; p.Asn323fs*2 (c.968_969insA); Zygosity=Heterozygous (ATCC=HTB-114)., Mutation; HGNC; 11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (PubMed=2216456; ATCC=HTB-114).",
CVCL_2250,SK-UT-1B,,HTB-115,75Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000995,NCIt; C6340; Uterine corpus leiomyosarcoma," Mutation; HGNC; 583; APC; Simple; p.Gln1096Ter (c.3286C>T); ClinVar=VCV000156475; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 8975; PIK3CA; Simple; p.Arg88Gln (c.263G>A); ClinVar=VCV000376049; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 9588; PTEN; Simple; p.Asn323fs*2 (c.968_969insA); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).",
CVCL_E053,SKI-DLCL-1,GM20259,,65Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0007795,NCIt; C8851; Diffuse large B-cell lymphoma,,
CVCL_4974,SKO-007,,CRL-8033-1,53Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000178,NCIt; C3242; Plasma cell myeloma," Mutation; HGNC; 1097; BRAF; Simple; p.Lys601Asn (c.1803A>T); ClinVar=VCV000376285; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.Ala161Thr (c.481G>A); ClinVar=VCV000161518; Zygosity=Homozygous (from parent cell line).",
CVCL_4975,SKO-007 clone J3,,CRL-8033-2,53Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000178,NCIt; C3242; Plasma cell myeloma," Mutation; HGNC; 1097; BRAF; Simple; p.Lys601Asn (c.1803A>T); ClinVar=VCV000376285; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.Ala161Thr (c.481G>A); ClinVar=VCV000161518; Zygosity=Homozygous (from parent cell line).",
CVCL_0535,SNB-19,,CRL-2219,75Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001872,NCIt; C60781; Astrocytoma," Mutation; HGNC; 9588; PTEN; Simple; p.Glu242Valfs*15 (c.723_724dupTG); ClinVar=VCV000536553; Zygosity=Homozygous (PubMed=17088437)., Mutation; HGNC; 11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (PubMed=17088437).",
CVCL_K280,sNF02.2,,CRL-2885,35Y,Male,,Cancer cell line,,,,,UBERON_0002048,"NCIt; C3798; Malignant peripheral nerve sheath tumor,ORDO; Orphanet_3148; Malignant peripheral nerve sheath tumor",,
CVCL_K164,sNF94.3,,CRL-2886,43Y,Female,,Cancer cell line,,,,Schwann cell,UBERON_0002048,"NCIt; C3798; Malignant peripheral nerve sheath tumor,ORDO; Orphanet_3148; Malignant peripheral nerve sheath tumor",,
CVCL_K281,sNF96.2,,CRL-2884,27Y,Male,,Cancer cell line,,,,Schwann cell,UBERON_0004218,"NCIt; C3798; Malignant peripheral nerve sheath tumor,ORDO; Orphanet_3148; Malignant peripheral nerve sheath tumor", Mutation; HGNC; 7765; NF1; Simple; p.Asn1229Metfs*11 (c.3683delC); Zygosity=Hemizygous (PubMed=17876295).,
CVCL_0099,SNU-1,,CRL-5971,44Y,Male,Korean,Cancer cell line,,,,,UBERON_0000945,NCIt; C4004; Gastric adenocarcinoma," Mutation; HGNC; 795; ATM; Simple; p.Leu1154fs*12 (c.3457_3458insT); Zygosity=Heterozygous (Cosmic-CLP=908444; DepMap=ACH-000932)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=12068308; DepMap=ACH-000932).",
CVCL_0076,SNU-16,,CRL-5974,33Y,Female,Korean,Cancer cell line,,,,,UBERON_0007795,NCIt; C4004; Gastric adenocarcinoma," Gene fusion; HGNC; 1681; CD44 + HGNC; 10940; SLC1A2; Name(s)=CD44-SLC1A2 (PubMed=23637631)., Mutation; HGNC; 11998; TP53; Simple; p.Tyr205Phe (c.614A>T); ClinVar=VCV000376682; Zygosity=Homozygous (PubMed=1676761; Cosmic-CLP=908446; DepMap=ACH-000581).",
CVCL_0090,SNU-182,,CRL-2235,24Y,Male,Korean,Cancer cell line,10407,Hepatitis B virus (HBV).,,,UBERON_0002107,NCIt; C7956; Adult hepatocellular carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Ser215Ile (c.644G>T); ClinVar=VCV000376660; Zygosity=Unspecified (PubMed=8824565; PubMed=31378681).,
CVCL_0250,SNU-387,,CRL-2237,41Y,Female,Korean,Cancer cell line,10407,Hepatitis B virus (HBV).,,,UBERON_0002107,NCIt; C7956; Adult hepatocellular carcinoma," Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (Cosmic-CLP=909736; DepMap=ACH-000478)., Mutation; HGNC; 11998; TP53; Simple; p.Lys164Ter (c.490A>T); ClinVar=VCV000935480; Zygosity=Homozygous (PubMed=8824565; PubMed=31378681; Cosmic-CLP=909736; DepMap=ACH-000478).",
CVCL_0077,SNU-398,,CRL-2233,42Y,Male,Korean,Cancer cell line,10407,Hepatitis B virus (HBV).,,,UBERON_0002107,NCIt; C7956; Adult hepatocellular carcinoma, Mutation; HGNC; 2514; CTNNB1; Simple; p.Ser37Cys (c.110C>G); ClinVar=VCV000017579; Zygosity=Heterozygous (PubMed=31378681; Cosmic-CLP=1240217; DepMap=ACH-000221).,
CVCL_0366,SNU-423,,CRL-2238,40Y,Male,Korean,Cancer cell line,10407,Hepatitis B virus (HBV).,,,UBERON_0002107,NCIt; C7956; Adult hepatocellular carcinoma, Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700; PubMed=31378681).,
CVCL_0454,SNU-449,,CRL-2234,52Y,Male,Korean,Cancer cell line,10407,Hepatitis B virus (HBV).,,,UBERON_0002107,NCIt; C7956; Adult hepatocellular carcinoma," Mutation; HGNC; 11110; ARID1A; Simple; p.Glu2250Argfs*28 (c.6747dupA); Zygosity=Unspecified (PubMed=31378681)., Mutation; HGNC; 11998; TP53; Simple; p.Lys139Arg (c.416A>G); ClinVar=VCV001500748; Zygosity=Unspecified (PubMed=8824565).",
CVCL_0497,SNU-475,,CRL-2236,43Y,Male,Korean,Cancer cell line,10407,Hepatitis B virus (HBV).,,,UBERON_0002107,NCIt; C7956; Adult hepatocellular carcinoma," Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700)., Mutation; HGNC; 11998; TP53; Simple; p.Gly262Asp (c.785G>A); Zygosity=Heterozygous (Cosmic-CLP=909739; DepMap=ACH-000422)., Mutation; HGNC; 11998; TP53; Simple; p.Asn288Ser (c.863A>G); Zygosity=Unspecified (PubMed=8824565).",
CVCL_0078,SNU-5,,CRL-5973,33Y,Female,Korean,Cancer cell line,,,,,UBERON_0007795,NCIt; C4004; Gastric adenocarcinoma," Mutation; HGNC; 1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (DepMap=ACH-000303).",
CVCL_1708,SNU-C1,,CRL-5972,71Y,Male,Korean,Cancer cell line,,,,,UBERON_0002358,NCIt; C4349; Colon adenocarcinoma, Gene fusion; HGNC; 17581; APIP + HGNC; 10940; SLC1A2; Name(s)=APIP-SLC1A2; Note=In frame (PubMed=23637631).,
CVCL_1709,SNU-C2A,,CCL-250.1,43Y,Female,Korean,Cancer cell line,,,,,UBERON_0001153,NCIt; C5543; Cecum adenocarcinoma," Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (DepMap=ACH-000967)., Mutation; HGNC; 11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (DepMap=ACH-000967).",
CVCL_1710,SNU-C2B,,CCL-250,43Y,Female,Korean,Cancer cell line,,,,,UBERON_0001153,NCIt; C5543; Cecum adenocarcinoma," Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=20570890)., Mutation; HGNC; 11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (PubMed=16418264).",
CVCL_0551,SqCC/Y1,,CRL-2980,,,,Cancer cell line,,,,,,NCIt; C4833; Oral cavity squamous cell carcinoma,,
CVCL_1711,SR,,CRL-2262,11Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000175,"NCIt; C37193; Anaplastic large cell lymphoma, ALK-positive", Gene fusion; HGNC; 427; ALK + HGNC; 7910; NPM1; Name(s)=NPM1-ALK (PubMed=25485619; PubMed=29899875).,
CVCL_1712,ST486,,CRL-1647,Age unspecified,Female,Caucasian,Cancer cell line,,,,B-cell,UBERON_0007795,NCIt; C2912; Burkitt lymphoma, Gene fusion; HGNC; 5477; IGH + HGNC; 7553; MYC; Name(s)=MYC-IGH (PubMed=6328505; PubMed=9643977; PubMed=11587216).,
CVCL_B470,SU-CCS-1,,CRL-2971,16Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C3745; Clear cell sarcoma of soft tissue," Gene fusion; HGNC; 783; ATF1 + HGNC; 3508; EWSR1; Name(s)=EWSR1-ATF1, EWS-ATF (PubMed=7753552; PubMed=15150091).",
CVCL_0538,SU-DHL-1,,CRL-2955,10Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000175,"NCIt; C37193; Anaplastic large cell lymphoma, ALK-positive", Gene fusion; HGNC; 427; ALK + HGNC; 7910; NPM1; Name(s)=NPM1-ALK (PubMed=7824924; PubMed=9121481; PubMed=25485619; PubMed=26657151; PubMed=29899875).,
CVCL_1889,SU-DHL-10,,CRL-2963,25Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type," Mutation; HGNC; 9588; PTEN; Simple; p.Tyr68His (c.202T>C); ClinVar=VCV000189474; Zygosity=Homozygous (PubMed=9787181; Cosmic-CLP=1331033; DepMap=ACH-000271)., Mutation; HGNC; 11998; TP53; Simple; c.994-1G>A; ClinVar=VCV000142161; Zygosity=Homozygous; Note=Splice acceptor mutation (Cosmic-CLP=1331033; DepMap=ACH-000271).",
CVCL_1890,SU-DHL-16,,CRL-2964,Age unspecified,Male,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C3457; B-cell non-Hodgkin lymphoma,,
CVCL_9550,SU-DHL-2,,CRL-2956,73Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C36081; Diffuse large B-cell lymphoma activated B-cell type," Mutation; HGNC; 7562; MYD88; Simple; p.Ser209Arg (c.627T>G) (p.Ser222Arg, c.666T>G) (S222R); Zygosity=Heterozygous (PubMed=21179087).",
CVCL_0539,SU-DHL-4,,CRL-2957,38Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001268,NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type," Gene fusion; HGNC; 990; BCL2 + HGNC; 5477; IGH; Name(s)=IGH-BCL2 (PubMed=2875799)., Mutation; HGNC; 3527; EZH2; Simple; p.Tyr666Asn (c.1996T>A) (Y661N); Zygosity=Heterozygous (Cosmic-CLP=1331035; DepMap=ACH-000365).",
CVCL_1735,SU-DHL-5,,CRL-2958,17Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type,,
CVCL_2206,SU-DHL-6,,CRL-2959,43Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001268,NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type," Gene fusion; HGNC; 990; BCL2 + HGNC; 5477; IGH; Name(s)=IGH-BCL2 (DSMZ=ACC-572)., Mutation; HGNC; 7133; KMT2D; Simple; p.Gln211Ter (c.631C>T); Zygosity=Heterozygous (Cosmic-CLP=1331037; DepMap=ACH-000611)., Mutation; HGNC; 11998; TP53; Simple; c.673-2A>C (IVS6-2A>C); ClinVar=VCV000635387; Zygosity=Heterozygous; Note=Splice acceptor mutation (Cosmic-CLP=1331037; DepMap=ACH-000611).",
CVCL_2207,SU-DHL-8,,CRL-2961,59Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type," Mutation; HGNC; 7133; KMT2D; Simple; p.Pro648Thrfs*2 (c.1940dupC) (c.1940_1941insC); ClinVar=VCV000432829; Zygosity=Heterozygous (Cosmic-CLP=1331038; DepMap=ACH-000656)., Mutation; HGNC; 11998; TP53; Simple; p.Arg249Gly (c.745A>G); ClinVar=VCV000376654; Zygosity=Heterozygous (Cosmic-CLP=1331038; DepMap=ACH-000656).",
CVCL_3881,SU.86.86,,CRL-1837,57Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002107,NCIt; C8294; Pancreatic adenocarcinoma, Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Hemizygous (PubMed=11115575).,
CVCL_0103,SUP-B15,,CRL-1929,9Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002371,NCIt; C68659; Childhood B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1," Gene fusion; HGNC; 76; ABL1 + HGNC; 1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 1 fused to ABL1 exon 2 (e1a2 transcript) (PubMed=3162827; PubMed=10071072; PubMed=10576511; PubMed=15843827; PubMed=25485619; PubMed=35354797; DepMap=ACH-000059).",
CVCL_1714,SUP-T1,,CRL-1942,8Y,Male,Caucasian,Cancer cell line,,,,T-cell,UBERON_0000175,NCIt; C7210; Childhood T lymphoblastic lymphoma," Mutation; HGNC; 3236; EGFR; Simple; p.Cys251Tyr (c.752G>A); Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=909743)., Mutation; HGNC; 7029; MET; Simple; p.Arg191Trp (c.571C>T); ClinVar=VCV000568557; Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=909743)., Mutation; HGNC; 8975; PIK3CA; Simple; p.Glu970Lys (c.2908G>A); ClinVar=VCV001057635; Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=909743)., Mutation; HGNC; 15533; SPRY4; Simple; p.Arg25Trp (c.73C>T); Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=909743; DepMap=ACH-000953).",
CVCL_1715,SW1088,,HTB-12,72Y,Male,Caucasian,Cancer cell line,,,,,,NCIt; C60781; Astrocytoma, Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (Cosmic-CLP=909745; DepMap=ACH-000437).,
CVCL_0544,SW1116,,CCL-233,73Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4349; Colon adenocarcinoma," Mutation; HGNC; 583; APC; Simple; p.Gln264Ter (c.790C>T); ClinVar=VCV001761174; Zygosity=Heterozygous (PubMed=24755471; ATCC=CCL-233)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Heterozygous (PubMed=12068308; PubMed=20570890; PubMed=24755471; PubMed=28683746).",
CVCL_1716,SW1271,,CRL-2177,69Y,Male,Caucasian,Cancer cell line,,,,Epithelial cell,UBERON_0002048,NCIt; C4917; Lung small cell carcinoma, Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Homozygous (PubMed=1855224; ATCC=CRL-2177; Cosmic-CLP=1299062; DepMap=ACH-000890).,
CVCL_0542,SW13,,CCL-105,55Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002369,NCIt; C9325; Adrenal cortex carcinoma, Mutation; HGNC; 11100; SMARCA4; Simple; p.Gln164Ter (c.490C>T); ClinVar=VCV001436624; Zygosity=Heterozygous (Cosmic-CLP=909744; DepMap=ACH-001401).,
CVCL_0543,SW1353,,HTB-94,72Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000976,NCIt; C7155; Primary central chondrosarcoma, Mutation; HGNC; 5383; IDH2; Simple; p.Arg172Ser (c.516G>C); ClinVar=VCV000375985; Zygosity=Heterozygous (PubMed=22057234; DepMap=ACH-000418).,
CVCL_1717,SW1417,,CCL-238,53Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4349; Colon adenocarcinoma," Mutation; HGNC; 583; APC; Simple; p.Arg1450Ter (c.4348C>T); ClinVar=VCV000194585; Zygosity=Homozygous (ATCC=CCL-238; Cosmic-CLP=909747; DepMap=ACH-000236)., Mutation; HGNC; 6844; MAP2K4; Simple; p.Arg274Gly (c.820A>G); Zygosity=Homozygous (PubMed=9331070; Cosmic-CLP=909747; DepMap=ACH-000236).",
CVCL_1718,SW1463,,CCL-234,66Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0001052,NCIt; C9383; Rectal adenocarcinoma," Mutation; HGNC; 583; APC; Simple; p.Val452Serfs*7 (c.1348_1349GT[3]) (c.1354_1355delGT); ClinVar=VCV000537527; Zygosity=Homozygous (ATCC=CCL-234; Cosmic-CLP=909748; DepMap=ACH-000470)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (PubMed=12068308; PubMed=28683746; ATCC=CCL-234; Cosmic-CLP=909748; DepMap=ACH-000470).",
CVCL_LK66,SW1494,,HTB-116,Age unspecified,Female,,Cancer cell line,,,,,,"NCIt; C7736; Vaginal squamous cell carcinoma, not otherwise specified",,
CVCL_1719,SW156,,CRL-2175,75Y,Male,,Cancer cell line,,,,,UBERON_0002113,NCIt; C9385; Renal cell carcinoma,,
CVCL_1720,SW1573,,CRL-2170,44Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C2923; Minimally invasive lung adenocarcinoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (ATCC=CRL-2170)., Mutation; HGNC; 2514; CTNNB1; Simple; p.Ser33Phe (c.98C>T); ClinVar=VCV000017583; Zygosity=Heterozygous (ATCC=CRL-2170; Cosmic-CLP=724878)., Mutation; HGNC; 8975; PIK3CA; Simple; p.Lys111Glu (c.331A>G); ClinVar=VCV000376482; Zygosity=Heterozygous (ATCC=CRL-2170; Cosmic-CLP=724878).",
CVCL_1722,SW1783,,HTB-13,68Y,Male,Caucasian,Cancer cell line,,,,,,NCIt; C9477; Anaplastic astrocytoma," Mutation; HGNC; 9588; PTEN; Simple; p.Arg233Ter (c.697C>T); ClinVar=VCV000007813; Zygosity=Homozygous (ATCC=HTB-13; Cosmic-CLP=909750; DepMap=ACH-000883)., Mutation; HGNC; 11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Heterozygous (ATCC=HTB-13; Cosmic-CLP=909750; DepMap=ACH-000883).",
CVCL_1723,SW1990,,CRL-2172,56Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001264,NCIt; C8294; Pancreatic adenocarcinoma," Mutation; HGNC; 27310; FLCN; Simple; p.Gln533Ter (c.1597C>T); ClinVar=VCV000096480; Zygosity=Heterozygous (Cosmic-CLP=910907; DepMap=ACH-000155)., Mutation; HGNC; 11998; TP53; Simple; p.Pro191del (c.569_571CTC[1]) (c.572_574delCTC); ClinVar=VCV000458551; Zygosity=Heterozygous (Cosmic-CLP=910907; DepMap=ACH-000155).",
CVCL_0545,SW403,,CCL-230,51Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4349; Colon adenocarcinoma," Mutation; HGNC; 583; APC; Simple; p.Asn125Lys (c.375T>G); Zygosity=Heterozygous (PubMed=24755471; PubMed=28179481; Cosmic-CLP=910908; DepMap=ACH-000820)., Mutation; HGNC; 583; APC; Simple; p.Ser1278Ter (c.3833C>A); Zygosity=Heterozygous (PubMed=24755471; PubMed=28179481; Cosmic-CLP=910908; DepMap=ACH-000820)., Mutation; HGNC; 8975; PIK3CA; Simple; p.Gln546Lys (c.1636C>A); ClinVar=VCV000013657; Zygosity=Heterozygous (PubMed=24755471; Cosmic-CLP=910908; DepMap=ACH-000820).",
CVCL_1724,SW48,,CCL-231,83Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4349; Colon adenocarcinoma," Mutation; HGNC; 173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (PubMed=12615714)., Mutation; HGNC; 914; B2M; Simple; p.Ser14fs*29 (c.41_44delCTCT); Zygosity=Heterozygous (PubMed=8197130)., Mutation; HGNC; 2514; CTNNB1; Simple; p.Ser33Tyr (c.98C>A); ClinVar=VCV000017577; Zygosity=Heterozygous (PubMed=9294210; PubMed=24755471; ATCC=CCL-231)., Mutation; HGNC; 11998; TP53; None_reported; -; Zygosity=- (PubMed=16418264).",
CVCL_0546,SW480,,CCL-228,51Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4349; Colon adenocarcinoma," Mutation; HGNC; 583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (PubMed=24755471; DepMap=ACH-000842)., Mutation; HGNC; 11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (PubMed=7651727; PubMed=9000147; PubMed=9715273; PubMed=16418264; PubMed=24755471; PubMed=28683746; DepMap=ACH-000842).",
CVCL_A4BX,SW480-Luc2,,CCL-228-LUC2,51Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4349; Colon adenocarcinoma," Mutation; HGNC; 583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).",
CVCL_3799,SW527,,CRL-7940,51Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4349; Colon adenocarcinoma," Mutation; HGNC; 583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).",
CVCL_3603,SW579,,HTB-107,59Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002046,NCIt; C46008; Thyroid gland squamous cell carcinoma, Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).,
CVCL_F649,SW598,,CRL-2176,51Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4349; Colon adenocarcinoma," Mutation; HGNC; 583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).",
CVCL_F650,SW613,,CRL-2146,51Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4349; Colon adenocarcinoma," Mutation; HGNC; 583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).",
CVCL_0547,SW620,,CCL-227,51Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C4349; Colon adenocarcinoma," Mutation; HGNC; 583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (PubMed=17088437; PubMed=24755471)., Mutation; HGNC; 11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (PubMed=17088437; PubMed=21912889; PubMed=24755471; PubMed=28683746).",
CVCL_1725,SW626,,HTB-78,46Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000992,NCIt; C4349; Colon adenocarcinoma," Mutation; HGNC; 583; APC; Simple; p.Arg976fs*9 (c.2926_2927insA); Zygosity=Homozygous (ATCC=HTB-78; Cosmic-CLP=909753; DepMap=ACH-001399)., Mutation; HGNC; 6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (PubMed=25846456; Cosmic-CLP=909753; DepMap=ACH-001399).",
CVCL_1726,SW684,,HTB-91,68Y,Male,Caucasian,Cancer cell line,,,,,,NCIt; C3043; Fibrosarcoma, Mutation; HGNC; 3432; ERBB4; Simple; p.Glu452Lys (c.1354G>A); ClinVar=VCV000091898; Zygosity=Heterozygous (Cosmic-CLP=909754; DepMap=ACH-002309).,
CVCL_1727,SW756,,CRL-3584,46Y,Female,Caucasian,Cancer cell line,333761,Human papillomavirus type 18 (HPV18).,,,UBERON_0000002,NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma, Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Heterozygous (PubMed=12068308; Cosmic-CLP=724839; DepMap=ACH-001402).,
CVCL_1728,SW780,,CRL-2169,80Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0001255,NCIt; C4912; Bladder carcinoma, Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680).,
CVCL_1729,SW837,,CCL-235,53Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001052,NCIt; C9383; Rectal adenocarcinoma," Mutation; HGNC; 583; APC; Simple; p.Arg1450Ter (c.4348C>T); ClinVar=VCV000194585; Zygosity=Unspecified (PubMed=24755471)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Heterozygous (PubMed=12068308; PubMed=20570890; PubMed=24755471; PubMed=28683746).",
CVCL_3604,SW839,,HTB-49,54Y,Female,,Cancer cell line,,,,,UBERON_0002113,NCIt; C4033; Clear cell renal cell carcinoma,,
CVCL_1730,SW872,,HTB-92,36Y,Male,Caucasian,Cancer cell line,,,,,,NCIt; C3194; Liposarcoma," Gene deletion; HGNC; 9588; PTEN; Zygosity=Homozygous (ATCC=HTB-92)., Mutation; HGNC; 1787; CDKN2A; Simple; p.Arg80Ter (c.237_238CC>TT) (c.237_238delinsTT) (p.Pro94Leu, c.280_281CC>TT); Zygosity=Homozygous (PubMed=26643872; ATCC=HTB-92; Cosmic-CLP=909756; DepMap=ACH-002310).",
CVCL_1731,SW900,,HTB-59,53Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C3493; Lung squamous cell carcinoma, Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous (PubMed=12068308; Cosmic-CLP=724879).,
CVCL_0632,SW948,,CCL-237,81Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4349; Colon adenocarcinoma," Mutation; HGNC; 583; APC; Simple; p.Arg1114Ter (c.3340C>T); ClinVar=VCV000236589; Zygosity=Unspecified (PubMed=24755471)., Mutation; HGNC; 8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Unspecified (PubMed=20570890; PubMed=24755471; PubMed=28683746)., Mutation; HGNC; 11998; TP53; Simple; p.Thr118Glnfs*5 (c.351delG) (p.G117fs); Zygosity=Unspecified (PubMed=28683746).",
CVCL_1732,SW954,,HTB-117,86Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000997,NCIt; C4052; Vulvar squamous cell carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Arg158His (c.473G>A); ClinVar=VCV000141963; Zygosity=Homozygous (Cosmic-CLP=924247; DepMap=ACH-001400).,
CVCL_1733,SW962,,HTB-118,64Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C4866; Vulvar carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Gly266Val (c.797G>T); ClinVar=VCV000233303; Zygosity=Heterozygous (Cosmic-CLP=909758; DepMap=ACH-002200).,
CVCL_1734,SW982,,HTB-93,25Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0007616,NCIt; C4279; Biphasic synovial sarcoma, Gene deletion; HGNC; 7208; MPDZ; Zygosity=Homozygous (PubMed=20215515).,
CVCL_U955,T 174,,CRL-7726,44Y,Male,,Cancer cell line,,,,,,NCIt; C3359; Rhabdomyosarcoma,,
CVCL_0553,T-47D,,HTB-133,54Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C4194; Invasive breast carcinoma of no special type, Mutation; HGNC; 8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (PubMed=17088437; PubMed=19593635; PubMed=28889351).,
CVCL_A4AN,T-47D Tam1,,CRL-3436,54Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C4194; Invasive breast carcinoma of no special type, Mutation; HGNC; 8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).,
CVCL_A4AP,T-47D Tam2,,CRL-3437,54Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C4194; Invasive breast carcinoma of no special type, Mutation; HGNC; 8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).,
CVCL_0554,T24,,HTB-4,82Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0001255,NCIt; C4912; Bladder carcinoma," Mutation; HGNC; 5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (PubMed=12068308; ATCC=HTB-4)., Mutation; HGNC; 11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (PubMed=7787250; ATCC=HTB-4).",
CVCL_K229,T47D-KBluc,,CRL-2865,54Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C4194; Invasive breast carcinoma of no special type, Mutation; HGNC; 8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).,
CVCL_0555,T84,,CCL-248,72Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C4349; Colon adenocarcinoma," Mutation; HGNC; 583; APC; Simple; p.Leu1488Phefs*19 (c.4464delA); Zygosity=Homozygous (PubMed=24755471; ATCC=CCL-248; Cosmic-CLP=909761; DepMap=ACH-000381)., Mutation; HGNC; 8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Heterozygous (PubMed=20570890; PubMed=24755471; Cosmic-CLP=909761; DepMap=ACH-000381)., Mutation; HGNC; 11998; TP53; Simple; c.560-1G>T; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=16418264; Cosmic-CLP=909761; DepMap=ACH-000381).",
CVCL_0556,T98G,,CRL-1690,61Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000955,NCIt; C3058; Glioblastoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (PubMed=9842975)., Mutation; HGNC; 16051; PARD3; Unexplicit; Ex3-20del; Zygosity=Homozygous (PubMed=20215515)., Mutation; HGNC; 11998; TP53; Simple; p.Met237Ile (c.711G>T); ClinVar=VCV000634770; Zygosity=Unspecified (PubMed=10416987; PubMed=14614447).",
CVCL_2771,TALL-104,,CRL-11386,2Y,Male,,Cancer cell line,,,,T-cell,UBERON_0000178,NCIt; C7953; Childhood T acute lymphoblastic leukemia, Gene fusion; HGNC; 76; ABL1 + HGNC; 8064; NUP214; Name(s)=NUP214-ABL1; Note=NUP214 exon 32 fused to ABL1 exon 2 (PubMed=15361874; PubMed=35354797).,
CVCL_2213,TC-71,GM11654,,22Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000976,NCIt; C4817; Ewing sarcoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (PubMed=18160777; PubMed=19787792; PubMed=25010205; PubMed=25223734)., Mutation; HGNC; 11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Unspecified (PubMed=19787792; PubMed=25010205; PubMed=25223734; DepMap=ACH-000424).",
CVCL_1738,TCCSUP,,HTB-5,67Y,Female,Caucasian,Cancer cell line,,,,,,NCIt; C4912; Bladder carcinoma, Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680).,
CVCL_S336,TE 114.T,,CRL-7743,16Y,Female,,Cancer cell line,,,,,UBERON_0000027,NCIt; C9357; Hodgkin lymphoma,,
CVCL_S338,TE 131.T,,CRL-7747,9Y,Male,,Cancer cell line,,,,,UBERON_0000027,NCIt; C3211; Non-Hodgkin lymphoma,,
CVCL_S262,TE 138.T,,CRL-7946,2Y,Male,,Cancer cell line,,,,,UBERON_0002113,NCIt; C40407; Kidney Wilms tumor,,
CVCL_S339,TE 139.T,,CRL-7748,11Y,Female,,Cancer cell line,,,,,,NCIt; C3403; Teratoma,,
CVCL_S340,TE 141.T,,CRL-7749,4Y,Male,,Cancer cell line,,,,,,NCIt; C3017; Ependymoma,,
CVCL_S341,TE 143.T,,CRL-7750,9Y,Male,,Cancer cell line,,,,,UBERON_0000027,NCIt; C9357; Hodgkin lymphoma,,
CVCL_1742,TE 149.T,,CRL-7751,18Y,Male,,Cancer cell line,,,,,,NCIt; C3262; Neoplasm,,
CVCL_1744,TE 161.T,,CRL-7753,11Y,Male,,Cancer cell line,,,,B-cell,UBERON_0000027,NCIt; C2912; Burkitt lymphoma,,
CVCL_1746,TE 175.T,,CRL-7755,4Y,Male,,Cancer cell line,,,,,UBERON_0000027,NCIt; C3211; Non-Hodgkin lymphoma,,
CVCL_S261,TE 189.T,,CRL-7947,10Y,Male,,Cancer cell line,,,,,,NCIt; C3262; Neoplasm,,
CVCL_S403,TE 193.T,,CRL-7756,2Y,Male,,Cancer cell line,,,,,,NCIt; C3270; Neuroblastoma,,
CVCL_1748,TE 206.T,,CRL-7758,1Y,Male,,Cancer cell line,,,,,,NCIt; C3262; Neoplasm,,
CVCL_N531,TE 210.T,,CRL-7759,1Y,Male,,Cancer cell line,,,,,,NCIt; C3222; Medulloblastoma,,
CVCL_N532,TE 211.T,,CRL-7760,8Y,Female,,Cancer cell line,,,,,,NCIt; C3043; Fibrosarcoma,,
CVCL_1750,TE 354.T,,CRL-7762,Age unspecified,Female,,Cancer cell line,,,,Fibroblast of skin,UBERON_0002097,NCIt; C2921; Skin basal cell carcinoma,,
CVCL_1751,TE 381.T,,CRL-7763,7Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0001325,NCIt; C8971; Embryonal rhabdomyosarcoma, Mutation; HGNC; 7989; NRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000373003; Zygosity=Heterozygous (from parent cell line).,
CVCL_N279,TE 415.T,,CRL-7764,16Y,Male,,Cancer cell line,,,,,UBERON_0002481,NCIt; C9145; Osteosarcoma,,
CVCL_1752,TE 417.T,,CRL-7765,Age unspecified,Male,,Cancer cell line,,,,,UBERON_0002481,NCIt; C9145; Osteosarcoma,,
CVCL_1753,TE 418.T,,CRL-7766,16Y,Male,,Cancer cell line,,,,,UBERON_0002481,NCIt; C9145; Osteosarcoma,,
CVCL_1754,TE 441.T,,CRL-7767,14Y,Female,African American,Cancer cell line,,,,,UBERON_0002384,NCIt; C3359; Rhabdomyosarcoma,,
CVCL_N603,TE 449.T,,CRL-7948,Age unspecified,Male,,Cancer cell line,,,,,,NCIt; C3222; Medulloblastoma,,
CVCL_S397,TE 453.T,,CRL-7768,Age unspecified,Female,,Cancer cell line,,,,,,NCIt; C3017; Ependymoma,,
CVCL_S395,TE 491.T,,CRL-7769,9Y,Female,,Cancer cell line,,,,,,NCIt; C60781; Astrocytoma,,
CVCL_S394,TE 501.T,,CRL-7770,5Y,Male,,Cancer cell line,,,,,UBERON_0001542,NCIt; C3167; Acute lymphoblastic leukemia,,
CVCL_S396,TE 543.T,,CRL-7771,9Y,Male,,Cancer cell line,,,,,UBERON_0002429,NCIt; C3211; Non-Hodgkin lymphoma,,
CVCL_S260,TE 585.T,,CRL-7949,10Y,Male,,Cancer cell line,,,,,UBERON_0000027,NCIt; C9357; Hodgkin lymphoma,,
CVCL_S259,TE 596.T,,CRL-7950,6Y,Male,,Cancer cell line,,,,B-cell,UBERON_0000027,NCIt; C2912; Burkitt lymphoma,,
CVCL_S098,TE 615.T,,CRL-7773,1Y1M,Female,,Cancer cell line,,,,,,NCIt; C3790; Ganglioneuroblastoma,,
CVCL_1755,TE 617.T,,CRL-7774,1Y8M,Female,Caucasian,Cancer cell line,,,,,UBERON_0002384,NCIt; C3359; Rhabdomyosarcoma,,
CVCL_1756,TE 671,,HTB-139,7Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0001325,NCIt; C8971; Embryonal rhabdomyosarcoma, Mutation; HGNC; 7989; NRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000373003; Zygosity=Heterozygous (from parent cell line).,
CVCL_2731,TE 671 Subline No.2,,CRL-8805,7Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0001325,NCIt; C8971; Embryonal rhabdomyosarcoma, Mutation; HGNC; 7989; NRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000373003; Zygosity=Heterozygous (from parent cell line).,
CVCL_S333,TE 79.T,,CRL-7733,7Y,Female,,Cancer cell line,,,,,UBERON_0002113,NCIt; C40407; Kidney Wilms tumor,,
CVCL_1758,TE 84.T,,CRL-7944,8Y,Female,,Cancer cell line,,,,,,NCIt; C8110; Ovarian teratoma,,
CVCL_N533,TE 87.T,,CRL-7737,3Y,Female,,Cancer cell line,,,,,,NCIt; C3222; Medulloblastoma,,
CVCL_N535,TE 89.T,,CRL-7738,9Y,Female,,Cancer cell line,,,,,UBERON_0002481,NCIt; C9145; Osteosarcoma,,
CVCL_2776,Tera-1,,HTB-105,47Y,Male,,Cancer cell line,,,,,UBERON_0002048,NCIt; C3752; Embryonal carcinoma,,
CVCL_2777,Tera-2,,HTB-106,22Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002048,NCIt; C3752; Embryonal carcinoma,,
CVCL_0559,TF-1,,CRL-2003,35Y,Male,Japanese,Cancer cell line,,,,,UBERON_0002371,NCIt; C7152; Erythroleukemia," Gene fusion; HGNC; 15868; ABHD12 + HGNC; 1537; CBFA2T3; Name(s)=CBFA2T3-ABHD12 (PubMed=31160637)., Mutation; HGNC; 11998; TP53; Simple; p.Ile251Thrfs*94 (c.752delT); ClinVar=VCV001759367; Zygosity=Unspecified (PubMed=1571549).",
CVCL_UE10,TF-1 IDH2 p.R140Q,,CRL-2003IG,35Y,Male,Japanese,Cancer cell line,,,,,UBERON_0002371,NCIt; C7152; Erythroleukemia," Gene fusion; HGNC; 15868; ABHD12 + HGNC; 1537; CBFA2T3; Name(s)=CBFA2T3-ABHD12 (from parent cell line)., Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Pro (c.182A>C); ClinVar=VCV000280409; Zygosity=Heterozygous (from parent cell line).",
CVCL_A4BL,TF-1 IDH2 p.R140Q-Luc2,,CRL-2003IG-LUC2,35Y,Male,Japanese,Cancer cell line,,,,,UBERON_0002371,NCIt; C7152; Erythroleukemia," Gene fusion; HGNC; 15868; ABHD12 + HGNC; 1537; CBFA2T3; Name(s)=CBFA2T3-ABHD12 (from parent cell line)., Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Pro (c.182A>C); ClinVar=VCV000280409; Zygosity=Heterozygous (from parent cell line).",
CVCL_A4BP,TF-1-Luc2,,CRL-2003-LUC2,35Y,Male,Japanese,Cancer cell line,,,,,UBERON_0002371,NCIt; C7152; Erythroleukemia," Gene fusion; HGNC; 15868; ABHD12 + HGNC; 1537; CBFA2T3; Name(s)=CBFA2T3-ABHD12 (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.Ile251Thrfs*94 (c.752delT); ClinVar=VCV001759367; Zygosity=Unspecified (from parent cell line).",
CVCL_3607,TF-1.CN5a.1,,CRL-2512,35Y,Male,Japanese,Cancer cell line,,,,,UBERON_0002371,NCIt; C7152; Erythroleukemia," Gene fusion; HGNC; 15868; ABHD12 + HGNC; 1537; CBFA2T3; Name(s)=CBFA2T3-ABHD12 (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.Ile251Thrfs*94 (c.752delT); ClinVar=VCV001759367; Zygosity=Unspecified (from parent cell line).",
CVCL_3608,TF-1a,,CRL-2451,35Y,Male,Japanese,Cancer cell line,,,,,UBERON_0002371,NCIt; C7152; Erythroleukemia," Gene fusion; HGNC; 15868; ABHD12 + HGNC; 1537; CBFA2T3; Name(s)=CBFA2T3-ABHD12 (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.Ile251Thrfs*94 (c.752delT); ClinVar=VCV001759367; Zygosity=Unspecified (from parent cell line).",
CVCL_0006,THP-1,,TIB-202,1Y,Male,Japanese,Cancer cell line,,,,,UBERON_0000178,NCIt; C9163; Childhood acute monocytic leukemia," Gene fusion; HGNC; 2457; CSNK2A1 + HGNC; 13917; DDX39B; Name(s)=CSNK2A1-DDX39B (PubMed=31160637)., Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (PubMed=12068308; ATCC=TIB-202; Cosmic-CLP=909771; DepMap=ACH-000146).",
CVCL_A4CA,THP-1 AP1-Luc2,,TIB-202-AP1-LUC2,1Y,Male,Japanese,Cancer cell line,,,,,UBERON_0000178,NCIt; C9163; Childhood acute monocytic leukemia," Gene fusion; HGNC; 2457; CSNK2A1 + HGNC; 13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line)., Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).",
CVCL_A4CB,THP-1 CRE-Luc2,,TIB-202-CRE-LUC2,1Y,Male,Japanese,Cancer cell line,,,,,UBERON_0000178,NCIt; C9163; Childhood acute monocytic leukemia," Gene fusion; HGNC; 2457; CSNK2A1 + HGNC; 13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line)., Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).",
CVCL_A4CD,THP-1 GAS-Luc2,,TIB-202-GAS-LUC2,1Y,Male,Japanese,Cancer cell line,,,,,UBERON_0000178,NCIt; C9163; Childhood acute monocytic leukemia," Gene fusion; HGNC; 2457; CSNK2A1 + HGNC; 13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line)., Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).",
CVCL_A4CC,THP-1 ISRE-Luc2,,TIB-202-ISRE-LUC2,1Y,Male,Japanese,Cancer cell line,,,,,UBERON_0000178,NCIt; C9163; Childhood acute monocytic leukemia," Gene fusion; HGNC; 2457; CSNK2A1 + HGNC; 13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line)., Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).",
CVCL_A4CE,THP-1 NF-kB-Luc2,,TIB-202-NFkB-LUC2,1Y,Male,Japanese,Cancer cell line,,,,,UBERON_0000178,NCIt; C9163; Childhood acute monocytic leukemia," Gene fusion; HGNC; 2457; CSNK2A1 + HGNC; 13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line)., Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).",
CVCL_B5NS,THP-1 NFAT-Luc2,,TIB-202-NFAT-LUC2,1Y,Male,Japanese,Cancer cell line,,,,,UBERON_0000178,NCIt; C9163; Childhood acute monocytic leukemia," Gene fusion; HGNC; 2457; CSNK2A1 + HGNC; 13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line)., Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).",
CVCL_L177,TLBR-1,,CRL-3027,42Y,Female,,Cancer cell line,,,,T-cell,UBERON_0000310,"NCIt; C37194; Anaplastic large cell lymphoma, ALK-negative", Mutation; HGNC; 11364; STAT3; Simple; p.Ser614Arg (c.1842C>G); Zygosity=Unspecified (PubMed=28356514).,
CVCL_N528,TO 165.T,,CRL-7775,21Y,Female,,Cancer cell line,,,,,,NCIt; C3043; Fibrosarcoma,,
CVCL_N530,TO 167.T,,CRL-7777,55Y,Female,,Cancer cell line,,,,,,NCIt; C2946; Chondrosarcoma,,
CVCL_N529,TO 173.T,,CRL-7778,19Y,Female,,Cancer cell line,,,,,,NCIt; C3262; Neoplasm,,
CVCL_S257,TO 183.T,,CRL-7952,70Y,Female,,Cancer cell line,,,,,,NCIt; C3272; Neurofibroma,,
CVCL_S258,TO 184.T,,CRL-7953,11Y,Male,,Cancer cell line,,,,,,NCIt; C3194; Liposarcoma,,
CVCL_3610,TO 203.T,,CRL-7780,Age unspecified,Male,,Cancer cell line,,,,,UBERON_0002481,NCIt; C9145; Osteosarcoma,,
CVCL_3611,Toledo,,CRL-2631,Adult,Female,Caucasian,Cancer cell line,,,,B-cell,UBERON_0000178,NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type, Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (DepMap=ACH-000285).,
CVCL_3612,TOV-112D,,CRL-3593,42Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000992,NCIt; C7979; Ovarian endometrioid adenocarcinoma," Mutation; HGNC; 2514; CTNNB1; Simple; p.Ser37Ala (c.109T>G); ClinVar=VCV000376235; Zygosity=Homozygous (DepMap=ACH-000048)., Mutation; HGNC; 11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=10949993; PubMed=18507860; PubMed=20204287; PubMed=22931248; PubMed=24023729; PubMed=25230021; PubMed=33328126; DepMap=ACH-000048).",
CVCL_3613,TOV-21G,,CRL-3577,62Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000992,NCIt; C40078; Ovarian clear cell adenocarcinoma," Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Cys (c.37G>T); ClinVar=VCV000045123; Zygosity=Heterozygous (PubMed=22705003; PubMed=24224046; PubMed=25230021; PubMed=28273451; Cosmic-CLP=1240222; DepMap=ACH-000885)., Mutation; HGNC; 9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Heterozygous (PubMed=25230021; Cosmic-CLP=1240222; DepMap=ACH-000885).",
CVCL_UL07,TRNDi001-D,GM28227,,Age unspecified,Male,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,"NCIt; C126864; Niemann-Pick disease, type C1", Mutation; HGNC; 7897; NPC1; Simple; p.Ile1061Thr (c.3182T>C); ClinVar=VCV000002967; Zygosity=Homozygous (PubMed=32114296).,
CVCL_UL22,TRNDi004-I,GM28078,,1Y,Male,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,"NCIt; C126866; Niemann-Pick disease, type B", Mutation; HGNC; 11120; SMPD1; Simple; p.Leu43_Ala44del; Zygosity=Heterozygous (PubMed=31009819).,
CVCL_UL27,TRNDi007-B,GM28229,,5M,Male,African American,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C84734; Glycogen storage disease type II, Mutation; HGNC; 4065; GAA; Simple; p.Arg854Ter (c.2560C>T); ClinVar=VCV000004034; Zygosity=Homozygous (PubMed=31026687).,
CVCL_A0LK,TRNDi012-B,GM28385,,16Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002427,NCIt; C3040; Fibrodysplasia ossificans progressiva, Mutation; HGNC; 171; ACVR1; Simple; p.Arg206His (c.617G>A); ClinVar=VCV000018309; Zygosity=Heterozygous (PubMed=34139597).,
CVCL_A8NS,TRNDi029-A,GM28558,,3M,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002067,NCIt; C35139; Alagille syndrome, Mutation; HGNC; 6188; JAG1; Simple; p.Arg465Arg (c.1395G>T) (chr20:g.10629709C>A); Zygosity=Heterozygous; Note=Splice site mutation (PubMed=34087995).,
CVCL_A8PE,TRNDi031-A,GM28559,,17Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C35139; Alagille syndrome, Mutation; HGNC; 6188; JAG1; Simple; p.Cys312Ter (c.936T>A); ClinVar=VCV001358138; Zygosity=Heterozygous (PubMed=34198154).,
CVCL_1774,TT,,CRL-1803,77Y,Female,Caucasian,Cancer cell line,,,,Parafollicular cell,UBERON_0002046,"NCIt; C46099; Hereditary thyroid gland medullary carcinoma,ORDO; Orphanet_99361; Familial medullary thyroid carcinoma", Mutation; HGNC; 9967; RET; Simple; p.Cys634Trp (c.1902C>G); ClinVar=VCV000013918; Zygosity=Heterozygous (PubMed=7736432; PubMed=30737244; Cosmic-CLP=930299; DepMap=ACH-001321).,
CVCL_1775,TUR,,CRL-2367,37Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C8263; Adult acute monocytic leukemia," Gene fusion; HGNC; 16063; MLLT10 + HGNC; 15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line)., Mutation; HGNC; 9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (DepMap=ACH-002314)., Mutation; HGNC; 12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (DepMap=ACH-002314).",
CVCL_8275,TuWi,,CCL-31,30Y6M,Female,African American,Cancer cell line,333761,Human papillomavirus type 18 (HPV18).,,,UBERON_0000002,NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma,,
CVCL_0633,U-118MG,,CRL-7712,47Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000955,NCIt; C60781; Astrocytoma," Mutation; HGNC; 5382; IDH1; None_reported; -; Zygosity=- (PubMed=19435942)., Mutation; HGNC; 11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (PubMed=10416987; Cosmic-CLP=687588).",
CVCL_0020,U-138MG,,HTB-16,47Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000955,NCIt; C60781; Astrocytoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (PubMed=9842975)., Mutation; HGNC; 9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (DepMap=ACH-001214).",
CVCL_A4CF,U-2 OS-Luc2,,HTB-96-LUC2,15Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000979,NCIt; C9145; Osteosarcoma, Mutation; HGNC; 9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).,
CVCL_2219,U-373MG ATCC,,HTB-17,75Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001872,NCIt; C60781; Astrocytoma," Mutation; HGNC; 9588; PTEN; Simple; p.Glu242Valfs*15 (c.723_724dupTG); ClinVar=VCV000536553; Zygosity=Unspecified (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (PubMed=10416987; PubMed=14614447).",
CVCL_UR33,U-87 MG-Luc2,,HTB-14-LUC2,Age unspecified,Male,Caucasian,Cancer cell line,,,,,,NCIt; C3058; Glioblastoma," Mutation; HGNC; 7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).",
CVCL_0022,U-87MG ATCC,,HTB-14,Age unspecified,Male,Caucasian,Cancer cell line,,,,,,NCIt; C3058; Glioblastoma," Mutation; HGNC; 5382; IDH1; None_reported; -; Zygosity=- (PubMed=19435942)., Mutation; HGNC; 9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=9090379; Cosmic-CLP=687590; DepMap=ACH-000075)., Mutation; HGNC; 11998; TP53; None_reported; -; Zygosity=- (Cosmic-CLP=687590; DepMap=ACH-000075).",
CVCL_UE09,U-87MG ATCC IDH1 p.R132H,,HTB-14IG,Age unspecified,Male,Caucasian,Cancer cell line,,,,,,NCIt; C3058; Glioblastoma," Mutation; HGNC; 5382; IDH1; Simple_edited; p.Arg132His (c.395G>A); ClinVar=VCV000156444; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (ATCC=HTB-14IG)., Mutation; HGNC; 9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).",
CVCL_UR35,U-87MG ATCC IDH1 p.R132H-Luc2,,HTB-14IG-LUC2,Age unspecified,Male,Caucasian,Cancer cell line,,,,,,NCIt; C3058; Glioblastoma," Mutation; HGNC; 5382; IDH1; Simple_edited; p.Arg132His (c.395G>A); ClinVar=VCV000156444; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (ATCC=HTB-14IG-LUC2)., Mutation; HGNC; 9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).",
CVCL_0007,U-937,,CRL-1593,37Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C8263; Adult acute monocytic leukemia," Gene fusion; HGNC; 16063; MLLT10 + HGNC; 15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (PubMed=8643484; PubMed=25485619)., Mutation; HGNC; 9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (DepMap=ACH-000406)., Mutation; HGNC; 12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (DepMap=ACH-000406).",
CVCL_4988,U-CH1,,CRL-3217,56Y,Male,,Cancer cell line,,,,,UBERON_0003690,NCIt; C129927; Sacral chordoma, Mutation; HGNC; 11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Unspecified (PubMed=28515451).,
CVCL_1D67,U-CH11,,CRL-3302,71Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0003690,NCIt; C129927; Sacral chordoma, Mutation; HGNC; 11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Unspecified (PubMed=28515451).,
CVCL_VR46,U-CH11R,,CRL-3399,75Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0003690,NCIt; C129927; Sacral chordoma,,
CVCL_IR27,U-CH12,,CRL-3326,83Y,Male,,Cancer cell line,,,,,UBERON_0003690,NCIt; C129927; Sacral chordoma, Mutation; HGNC; 11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Unspecified (PubMed=28515451).,
CVCL_VR43,U-CH17M,,CRL-3402,38Y,Male,,Cancer cell line,,,,,UBERON_0034929,NCIt; C129927; Sacral chordoma, Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Heterozygous or homozygous (PubMed=29148152).,
CVCL_VR45,U-CH17S,,CRL-3401,38Y,Male,,Cancer cell line,,,,,UBERON_0002097,NCIt; C129927; Sacral chordoma, Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Heterozygous or homozygous (PubMed=29148152).,
CVCL_A5IF,U-CH19,,CRL-3516,77Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0003690,NCIt; C129927; Sacral chordoma,,
CVCL_4989,U-CH2,,CRL-3218,72Y,Female,Caucasian,Cancer cell line,,,,,,NCIt; C129927; Sacral chordoma,,
CVCL_IR23,U-CH7,,CRL-3404,67Y,Male,,Cancer cell line,,,,,UBERON_0003690,NCIt; C129927; Sacral chordoma,,
CVCL_A5IH,U-CHCF359B,,CRL-3517,<20Y,Female,,Cancer cell line,,,,,UBERON_0001905,NCIt; C5412; Clivus chordoma,,
CVCL_A5II,U-CHCF365,,CRL-3518,11Y,Male,,Cancer cell line,,,,,UBERON_0000403,NCIt; C5412; Clivus chordoma,,
CVCL_0566,U266B1,,TIB-196,53Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000178,NCIt; C3242; Plasma cell myeloma," Mutation; HGNC; 1097; BRAF; Simple; p.Lys601Asn (c.1803A>T); ClinVar=VCV000376285; Zygosity=Heterozygous (Cosmic-CLP=753615; DepMap=ACH-000626)., Mutation; HGNC; 11998; TP53; Simple; p.Ala161Thr (c.481G>A); ClinVar=VCV000161518; Zygosity=Homozygous (PubMed=1373872; PubMed=21173094; Cosmic-CLP=753615; DepMap=ACH-000626).",
CVCL_0042,U2OS,,HTB-96,15Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000979,NCIt; C9145; Osteosarcoma, Mutation; HGNC; 9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (PubMed=23649806; DepMap=ACH-000364).,
CVCL_B0A7,U2OS DR-GFP,,CRL-3455,15Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000979,NCIt; C9145; Osteosarcoma, Mutation; HGNC; 9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).,
CVCL_2Z95,U937-DC-SIGN,,CRL-3253,37Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C8263; Adult acute monocytic leukemia," Gene fusion; HGNC; 16063; MLLT10 + HGNC; 15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line)., Mutation; HGNC; 9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line).",
CVCL_4036,UACC-1179,,CRL-3127,61Y,Female,,Cancer cell line,,,,,UBERON_0000175,NCIt; C4194; Invasive breast carcinoma of no special type, Mutation; HGNC; 11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Unspecified (ATCC=CRL-3127).,
CVCL_4040,UACC-1598,,CRL-3128,78Y,Female,,Cancer cell line,,,,,UBERON_0000992,NCIt; C7978; Ovarian serous cystadenocarcinoma,,
CVCL_4041,UACC-2087,,CRL-3180,51Y,Female,,Cancer cell line,,,,,UBERON_0000175,NCIt; C5214; Breast adenocarcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Val216Met (c.646G>A); ClinVar=VCV000182965; Zygosity=Unspecified (ATCC=CRL-3180).,
CVCL_W021,UACC-2648,,CRL-3121,69Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C4194; Invasive breast carcinoma of no special type,,
CVCL_ZE36,UACC-2715,,CRL-3190,,Female,,Cancer cell line,,,,,,NCIt; C4872; Breast carcinoma,,
CVCL_W092,UACC-2996,,CRL-3123,,Female,,Cancer cell line,,,,,,NCIt; C7550; Ovarian serous adenocarcinoma,,
CVCL_B221,UACC-3133,,CRL-2988,52Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C7950; Invasive breast lobular carcinoma,,
CVCL_4042,UACC-3199,,CRL-2983,58Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0001097,NCIt; C4194; Invasive breast carcinoma of no special type,,
CVCL_W091,UACC-3247,,CRL-3124,56Y,Female,,Cancer cell line,,,,,,NCIt; C4908; Ovarian carcinoma,,
CVCL_4047,UACC-462,,CRL-2989,41Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002358,NCIt; C3850; Pancreatic carcinoma,,
CVCL_4050,UACC-732,,CRL-3166,33Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C4872; Breast carcinoma,,
CVCL_1781,UACC-812,,CRL-1897,43Y,Female,,Cancer cell line,,,,,UBERON_0000310,NCIt; C4194; Invasive breast carcinoma of no special type, Mutation; HGNC; 1100; BRCA1; Simple; p.Ser1140Gly (c.3418A>G); ClinVar=VCV000041817; Zygosity=Homozygous (PubMed=19593635).,
CVCL_1782,UACC-893,,CRL-1902,57Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000310,NCIt; C4194; Invasive breast carcinoma of no special type," Mutation; HGNC; 1748; CDH1; Simple; p.His233Gln (c.699C>G); ClinVar=VCV000233773; Zygosity=Homozygous (PubMed=19593635)., Mutation; HGNC; 11998; TP53; Simple; p.Arg342Ter (c.1024C>T); ClinVar=VCV000182970; Zygosity=Homozygous (PubMed=16541312; ATCC=CRL-1902).",
CVCL_1N91,UCSD233i-SAD2-2,GM24666,,83Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C2866; Alzheimer's disease,,
CVCL_1N92,UCSD241i-APP2-3,GM24675,,60Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,"NCIt; C146894; Familial Alzheimer's disease, type 1",,
CVCL_JE76,UCSF-OT-1109,,CRL-3442,44Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0001723,NCIt; C4648; Tongue squamous cell carcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=28559012).,
CVCL_0104,UKE-1,GM23245,,59Y,Female,,Cancer cell line,,,,,UBERON_0000178,NCIt; C3407; Essential thrombocythemia, Mutation; HGNC; 6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Homozygous (PubMed=16408098).,
CVCL_1D68,UM-Chor1,,CRL-3270,64Y,Male,,Cancer cell line,,,,,UBERON_0004108,NCIt; C5412; Clivus chordoma,,
CVCL_UZ98,UM-Chor5,,CRL-3428,16Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0004108,NCIt; C5412; Clivus chordoma,,
CVCL_A5IC,UM-Chor5C,,CRL-3512,16-20Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001831,NCIt; C5412; Clivus chordoma,,
CVCL_A5ID,UM-Chor5D,,CRL-3513,16-20Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0004108,NCIt; C5412; Clivus chordoma,,
CVCL_1783,UM-UC-3,,CRL-1749,Age unspecified,Male,Caucasian,Cancer cell line,,,,,UBERON_0001255,NCIt; C4912; Bladder carcinoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (PubMed=9850064)., Mutation; HGNC; 795; ATM; Simple; p.Gln2800fs*6 (c.8400delG); Zygosity=Heterozygous (Cosmic-CLP=724838; DepMap=ACH-000522)., Mutation; HGNC; 14446; PARD3B; Unexplicit; Ex9-18del; Zygosity=Homozygous (PubMed=20215515)., Mutation; HGNC; 11998; TP53; Simple; p.Phe113Cys (c.338T>G); ClinVar=VCV000634690; Zygosity=Homozygous (PubMed=7787250; PubMed=9850064; Cosmic-CLP=724838; DepMap=ACH-000522).",
CVCL_1784,UMC-11,,CRL-5975,Age unspecified,Male,Caucasian,Cancer cell line,,,,,,NCIt; C4038; Lung carcinoid tumor, Mutation; HGNC; 6770; SMAD4; Simple; p.Leu536fs*14 (c.1606_1612delCTAGACG); Zygosity=Heterozygous (Cosmic-CLP=909779; DepMap=ACH-001417).,
CVCL_1899,UPCI-SCC-090,,CRL-3239,46Y,Male,Caucasian,Cancer cell line,333760,Human papillomavirus type 16 (HPV16).,,,UBERON_0001723,NCIt; C4648; Tongue squamous cell carcinoma,,
CVCL_C058,UPCI-SCC-152,,CRL-3240,47Y,Male,Caucasian,Cancer cell line,333760,Human papillomavirus type 16 (HPV16).,,,UBERON_0001051,NCIt; C4043; Hypopharyngeal squamous cell carcinoma,,
CVCL_2230,UPCI-SCC-154,,CRL-3241,54Y,Male,Caucasian,Cancer cell line,333760,Human papillomavirus type 16 (HPV16).,,,UBERON_0001723,NCIt; C4648; Tongue squamous cell carcinoma,,
CVCL_D656,USC-HN1,,CRL-3026,,Female,,Cancer cell line,,,,,,NCIt; C6064; Maxillary sinus squamous cell carcinoma,,
CVCL_B079,UWB1.289,,CRL-2945,56Y,Female,Caucasian,Cancer cell line,,,,,,NCIt; C36100; BRCA1-associated hereditary breast and ovarian cancer syndrome, Gene deletion; HGNC; 1100; BRCA1; Zygosity=Heterozygous (PubMed=17259345).,
CVCL_B078,UWB1.289+BRCA1,,CRL-2946,56Y,Female,Caucasian,Cancer cell line,,,,,,NCIt; C36100; BRCA1-associated hereditary breast and ovarian cancer syndrome, Gene deletion; HGNC; 1100; BRCA1; Zygosity=Heterozygous (PubMed=17259345).,
CVCL_1785,VA-ES-BJ,,CRL-2138,41Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002371,NCIt; C3714; Epithelioid sarcoma, Mutation; HGNC; 7773; NF2; Simple; p.Ser87Ter (c.260C>A); Zygosity=Homozygous (Cosmic-CLP=688121; DepMap=ACH-001702).,
CVCL_2235,VCaP,,CRL-2876,59Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002412,NCIt; C4863; Prostate carcinoma," Gene fusion; HGNC; 3446; ERG + HGNC; 11876; TMPRSS2; Name(s)=TMPRSS2-ERG (PubMed=23447416; PubMed=23615946)., Mutation; HGNC; 11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (PubMed=14518029; PubMed=23615946; Cosmic-CLP=1299075; DepMap=ACH-000115).",
CVCL_9830,VM-CUB-3,,HTB-6,Age unspecified,,,Cancer cell line,,,,,UBERON_0001255,NCIt; C4912; Bladder carcinoma, Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680).,
CVCL_A732,VMM1,,CRL-3225,62Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000955,NCIt; C3224; Melanoma,,
CVCL_A736,VMM15,,CRL-3227,39Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C3224; Melanoma, Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=26405815).,
CVCL_S581,VMM17,,CRL-3228,64Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C3224; Melanoma, Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=26405815).,
CVCL_A737,VMM18,,CRL-3229,45Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C3224; Melanoma, Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=26405815).,
CVCL_A739,VMM39,,CRL-3230,71Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C3224; Melanoma,,
CVCL_4D07,VMM425,,CRL-3231,60Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002355+UBERON_0002072,NCIt; C3224; Melanoma,,
CVCL_A740,VMM5A,,CRL-3226,81Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C3224; Melanoma, Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=26405815).,
CVCL_4D09,VMM917,,CRL-3232,57Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0036014+UBERON_0002072,NCIt; C3224; Melanoma,,
CVCL_1792,WERI-Rb-1,,HTB-169,1Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0010230,NCIt; C7541; Retinoblastoma, Gene deletion; HGNC; 9884; RB1; Zygosity=Homozygous (PubMed=25326674).,
CVCL_2760,WiDr,,CCL-218,44Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4349; Colon adenocarcinoma," Mutation; HGNC; 583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=20570890; PubMed=24042735; PubMed=28683746)., Mutation; HGNC; 6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).",
CVCL_B481,WILTU-1,,HTB-50,Age unspecified,Sex unspecified,,Cancer cell line,,,,,UBERON_0002113,NCIt; C40407; Kidney Wilms tumor,,
CVCL_1909,WISH,,CCL-25,30Y6M,Female,African American,Cancer cell line,333761,Human papillomavirus type 18 (HPV18).,,,UBERON_0000002,NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma,,
CVCL_6785,WM1158,WC00046,,Age unspecified,Male,,Cancer cell line,,,,,UBERON_0000027,NCIt; C3224; Melanoma, Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=15009714; Wistar).,
CVCL_6786,WM1232,WC00084,,Age unspecified,Female,,Cancer cell line,,,,,,NCIt; C3224; Melanoma, Gene deletion; HGNC; 9588; PTEN; Zygosity=Hemizygous (Wistar).,
CVCL_6787,WM1341D,WC00096,,Age unspecified,Male,,Cancer cell line,,,,,UBERON_0002097,NCIt; C3510; Cutaneous melanoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (Wistar)., Mutation; HGNC; 1097; BRAF; Simple; p.Val600Arg (c.1798_1799delGTinsAG); ClinVar=VCV000375940; Zygosity=Heterozygous (Wistar).",
CVCL_W886,WM1346,WC00121,,,Female,,Cancer cell line,,,,,,NCIt; C3224; Melanoma,,
CVCL_6788,WM1361A,WC00075,,Age unspecified,Male,,Cancer cell line,,,,,,NCIt; C3510; Cutaneous melanoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (PubMed=17260012; Wistar)., Gene deletion; HGNC; 9588; PTEN; Zygosity=Hemizygous (Wistar)., Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Homozygous (PubMed=17260012; PubMed=23851445; Wistar).",
CVCL_6789,WM1366,WC00078,,79Y,Male,,Cancer cell line,,,,,UBERON_0003399,NCIt; C3510; Cutaneous melanoma," Mutation; HGNC; 1097; BRAF; None_reported; -; Zygosity=- (Wistar)., Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (PubMed=17260012; PubMed=23851445; PubMed=25645078; PubMed=25728708; Wistar).",
CVCL_6790,WM1382,WC00055,,,Female,,Cancer cell line,,,,,UBERON_0001097,NCIt; C3224; Melanoma, Mutation; HGNC; 6342; KIT; Simple; p.Asn822Lys (c.2466T>A) (N818K); ClinVar=VCV000375931; Zygosity=Unspecified (PubMed=24576830).,
CVCL_6472,WM1552C,,CRL-2808,72Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002072,NCIt; C3510; Cutaneous melanoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (PubMed=17260012; Wistar)., Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=17260012; PubMed=23851445; Cosmic-CLP=1299078; DepMap=ACH-002205; Wistar)., Mutation; HGNC; 11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (PubMed=17260012; PubMed=23851445; Cosmic-CLP=1299078; DepMap=ACH-002205).",
CVCL_6791,WM1617,WC00076,,62Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0001097,NCIt; C3510; Cutaneous melanoma, Gene deletion; HGNC; 9588; PTEN; Zygosity=Hemizygous (from autologous cell line WM278).,
CVCL_D555,WM1650,,CRL-2810,30Y,Male,,Cancer cell line,,,,,UBERON_0002097,NCIt; C3224; Melanoma,,
CVCL_6792,WM1789,WC00080,,58Y,Male,,Cancer cell line,,,,,UBERON_0002097,NCIt; C3224; Melanoma," Gene deletion; HGNC; 9588; PTEN; Zygosity=Hemizygous (Wistar)., Mutation; HGNC; 1097; BRAF; Simple; p.Lys601Glu (c.1801A>G); ClinVar=VCV000013966; Zygosity=Homozygous (Wistar).",
CVCL_6793,WM1791C,WC00086,,Age unspecified,Male,,Cancer cell line,,,,,,NCIt; C3510; Cutaneous melanoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (Wistar)., Mutation; HGNC; 1097; BRAF; None_reported; -; Zygosity=- (Wistar)., Mutation; HGNC; 6407; KRAS; Simple; p.Thr50Ile (c.149_150delinsTT); Zygosity=Unspecified (Wistar).",
CVCL_6794,WM1922,WC00093,,,Male,,Cancer cell line,,,,,,NCIt; C3224; Melanoma,,
CVCL_6795,WM239A,WC00044,,55Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C3224; Melanoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (Wistar)., Gene deletion; HGNC; 9588; PTEN; Zygosity=Hemizygous (Wistar).",
CVCL_6796,WM3060,WC00126,,55Y,Male,,Cancer cell line,,,,,UBERON_0001097,NCIt; C3224; Melanoma," Mutation; HGNC; 1097; BRAF; None_reported; -; Zygosity=- (Wistar)., Mutation; HGNC; 9801; RAC1; Simple; p.Pro29Ser (c.85C>T); ClinVar=VCV000376362; Zygosity=Heterozygous (PubMed=25056119).",
CVCL_6797,WM3211,WC00045,,34Y,Female,,Cancer cell line,,,,,UBERON_0000027,NCIt; C4022; Acral lentiginous melanoma," Mutation; HGNC; 1097; BRAF; None_reported; -; Zygosity=- (Wistar)., Mutation; HGNC; 6342; KIT; Simple; p.Leu576Pro (c.1727T>C); ClinVar=VCV000375919; Zygosity=Unspecified (PubMed=23851445; PubMed=24576830; Wistar).",
CVCL_6798,WM3248,WC00081,,Age unspecified,Male,,Cancer cell line,,,,,,NCIt; C3510; Cutaneous melanoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (Wistar)., Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (Wistar).",
CVCL_C275,WM3629,WC00117,,Age unspecified,Sex unspecified,,Cancer cell line,,,,,UBERON_0000027,NCIt; C3224; Melanoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (Wistar)., Mutation; HGNC; 1097; BRAF; Simple; p.Asp594Gly (c.1781A>G); ClinVar=VCV000013972; Zygosity=Heterozygous (Wistar).",
CVCL_6799,WM3670,WC00119,,Age unspecified,Sex unspecified,,Cancer cell line,,,,,UBERON_0000027,NCIt; C3224; Melanoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (Wistar)., Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Unspecified (Wistar).",
CVCL_6800,WM3734,WC00090,,24Y,Female,,Cancer cell line,,,,,UBERON_0000955,NCIt; C3224; Melanoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (Wistar)., Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (Wistar).",
CVCL_6801,WM3854,WC00125,,64Y,Male,,Cancer cell line,,,,,UBERON_0000027,NCIt; C3224; Melanoma, Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Unspecified (Wistar).,
CVCL_6802,WM3928,WC00115,,Age unspecified,Male,,Cancer cell line,,,,,UBERON_0001542,NCIt; C3224; Melanoma, Gene deletion; HGNC; 1788; CDKN2B; Zygosity=Homozygous (Wistar).,
CVCL_6803,WM46,WC00069,,43Y,Female,,Cancer cell line,,,,,UBERON_0001416,NCIt; C3224; Melanoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (Wistar)., Gene deletion; HGNC; 9588; PTEN; Zygosity=Hemizygous (Wistar)., Mutation; HGNC; 1773; CDK4; Simple; p.Arg24Cys (c.70C>T); ClinVar=VCV000016928; Zygosity=Unspecified (Wistar).",
CVCL_6995,WM51,WC00122,,Age unspecified,Male,,Cancer cell line,,,,,,NCIt; C3224; Melanoma, Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (Wistar).,
CVCL_6804,WM852,WC00065,,63Y,Male,,Cancer cell line,,,,,UBERON_0001416,NCIt; C3510; Cutaneous melanoma," Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (PubMed=17260012)., Mutation; HGNC; 1097; BRAF; None_reported; -; Zygosity=- (Wistar)., Mutation; HGNC; 11998; TP53; Simple; p.Ser241Phe (c.722C>T); ClinVar=VCV000012359; Zygosity=Unspecified (PubMed=17260012; PubMed=23851445).",
CVCL_6805,WM88,WC00123,,Age unspecified,Male,Caucasian,Cancer cell line,,,,,,NCIt; C3224; Melanoma, Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=24576830; DepMap=ACH-000899; Wistar).,
CVCL_6806,WM9,WC00056,,Age unspecified,Male,,Cancer cell line,,,,,UBERON_0001097,NCIt; C3224; Melanoma, Gene deletion; HGNC; 9588; PTEN; Zygosity=Hemizygous (Wistar).,
CVCL_6807,WM902B,WC00083,,Age unspecified,Male,,Cancer cell line,,,,,UBERON_0002097,NCIt; C3510; Cutaneous melanoma," Gene deletion; HGNC; 9588; PTEN; Zygosity=Hemizygous (Wistar)., Mutation; HGNC; 1773; CDK4; Simple; p.Arg24Leu (c.71G>T); ClinVar=VCV000376377; Zygosity=Unspecified (PubMed=21156289; PubMed=23851445; Wistar).",
CVCL_6808,WM983A,WC00048,,54Y,Male,Caucasian,Cancer cell line,,,,,,NCIt; C3224; Melanoma, Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=16827748; PubMed=18632627; Wistar).,
CVCL_6809,WM983B,WC00066,,54Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001542,NCIt; C3224; Melanoma, Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=16827748; PubMed=18632627; PubMed=21156289; DepMap=ACH-000765; Wistar).,
CVCL_0581,WRL 68,,CL-48,30Y6M,Female,African American,Cancer cell line,333761,Human papillomavirus type 18 (HPV18).,,,UBERON_0000002,NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma,,
CVCL_WM16,WTC dual tagged FBL-mEGFP/NPM1-mTagRFPT-cl18,AICS-0084-018,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_UK02,WTC dual tagged SEC61B-mEGFP/LMNB1-mTagRFPT-cl36,AICS-0059-036,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_A8RS,WTC dual tagged TOMM20-mEGFP/mTagRFPT-TUBA1B-cl79,AICS-0078-079,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_IR30,WTC EGFP-PXN-cl50,AICS-0005,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_YU29,WTC FBL-mEGFP/NPM1-mTagRFPT/CLYBL-dCas9-TagBFP-KRAB-cl61,AICS-0089-061,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_ZX20,WTC FBL-mEGFP/NPM1-mTagRFP-T/UBTF-HaloTag-cl147,AICS-0086-147,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_A5ET,WTC-CLYBL-dCas9-TagBFP-KRAB-cl391,AICS-0090-391,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_A5ES,WTC-DMD-mEGFP-cl96,AICS-0063-096,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_JM16,WTC-mEGFP-ACTB-cl184,AICS-0016,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_WM14,WTC-mEGFP-ACTN2-cl85,AICS-0075-085,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_UD14,WTC-mEGFP-ATP2A2-cl51,AICS-0046-051,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_D0N2,WTC-mEGFP-CDH1-cl32,AICS-0014-032,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_D0N3,WTC-mEGFP-CDH1-cl35,AICS-0014-035,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_A8SR,WTC-mEGFP-CTCF-cl20,AICS-0099-020,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_VK86,WTC-mEGFP-CTNNB1-cl67,AICS-0058-067,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_C6T4,WTC-mEGFP-DCP1A-cl124,AICS-0083-124,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_C6T3,WTC-mEGFP-DCP1A-cl5,AICS-0083-005,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_IR31,WTC-mEGFP-DSP-cl65,AICS-0017,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_A6XI,WTC-mEGFP-EZH2-cl18,AICS-0095-018,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_JM17,WTC-mEGFP-FBL-cl6,AICS-0014,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_UK05,WTC-mEGFP-FUS-cl69,AICS-0080-069,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_B6E3,WTC-mEGFP-G3BP1-cl1,AICS-0082-001,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_VK83,WTC-mEGFP-GJA1-cl16,AICS-0053-016,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_UD17,WTC-mEGFP-HIST1H2BJ-cl36,AICS-0061-036,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_LK42,WTC-mEGFP-LAMP1-cl37,AICS-0022-037,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_IR32,WTC-mEGFP-LMNB1-cl210,AICS-0013,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_VK78,WTC-mEGFP-MAP1LC3B-cl22,AICS-0030-022,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_JM15,WTC-mEGFP-MYH10-cl80,AICS-0024,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_UK03,WTC-mEGFP-MYL2-cl27,AICS-0060-027,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_UD15,WTC-mEGFP-MYL7-cl3,AICS-0052-003,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_VK85,WTC-mEGFP-NPM1-cl50,AICS-0057-050,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_UD18,WTC-mEGFP-NUP153-cl88,AICS-0069-088,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_A8RT,WTC-mEGFP-PCNA-cl83,AICS-0088-083,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_A6XH,WTC-mEGFP-POLR2A-cl74,AICS-0096-074,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_VK81,WTC-mEGFP-RAB5A-cl13,AICS-0040-013,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_VK82,WTC-mEGFP-RAB5A-cl35,AICS-0040-035,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_WM17,WTC-mEGFP-Safe harbor locus (AAVS1)-cl28,AICS-0036-028,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_JM19,WTC-mEGFP-Safe harbor locus (AAVS1)-cl6,AICS-0036-006,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_JM14,WTC-mEGFP-SEC61B-cl55,AICS-0010,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_VK79,WTC-mEGFP-SLC25A17-cl115,AICS-0033-115,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_UK04,WTC-mEGFP-SMC1A-cl9,AICS-0068-009,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_YU30,WTC-mEGFP-SON-cl24,AICS-0094-024,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_WM15,WTC-mEGFP-SOX2-cl26,AICS-0074-026,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_LK46,WTC-mEGFP-ST6GAL1-cl1,AICS-0025-001,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_LK43,WTC-mEGFP-ST6GAL1-cl44,AICS-0025-044,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_A7MD,WTC-mEGFP-TERF2-cl25,AICS-0093-025,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_JM18,WTC-mEGFP-TJP1-cl20,AICS-0023,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_VK80,WTC-mEGFP-TNNI1-cl172,AICS-0037-172,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_IR33,WTC-mEGFP-TOMM20-cl27,AICS-0011,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_UD16,WTC-mEGFP-TTN-cl39,AICS-0048-039,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_IR34,WTC-mEGFP-TUBA1B-cl105,AICS-0012,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_VK84,WTC-mTagRFPT-CAAX-Safe harbor locus (AAVS1)-cl91,AICS-0054-091,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_LK45,WTC-mTagRFPT-CETN2-cl19,AICS-0032-019,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_ZX21,WTC-mTagRFPT-LMNB1-cl62,AICS-0034-062,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_LK44,WTC-mTagRFPT-TUBA1B-cl35,AICS-0031-035,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_ZX22,WTC-TFAM-mEGFP-cl31,AICS-0087-031,,30Y,Male,Japanese,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001511,,,
CVCL_D3AN,XP10CA iPSC,AG29051,,19Y,Female,Egyptian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002427,NCIt; C141367; Xeroderma pigmentosum variant type,,
CVCL_C7PD,XP23BE iPSC,AG28409,,21Y4M,Male,Native North American,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002427,"NCIt; C114770; Xeroderma pigmentosum, complementation group C", Mutation; HGNC; 12816; XPC; Simple; c.622-2A>C (IVS5.1-2A>C); ClinVar=VCV000190209; Zygosity=Homozygous; Note=Splice acceptor mutation (from parent cell line).,
CVCL_8013,XP44RO(Mel),GM13030,,31Y,Male,,Cancer cell line,,,,,UBERON_0000473,"NCIt; C3224; Melanoma,ORDO; Orphanet_910; Xeroderma pigmentosum",,
CVCL_IU88,Z-119,,CRL-3394,25Y,Female,Latino,Cancer cell line,,,,,UBERON_0002371,NCIt; C114819; Adult B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1," Gene fusion; HGNC; 76; ABL1 + HGNC; 1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 1 fused to ABL1 exon 2 (e1a2 transcript) (PubMed=8600166; PubMed=10071072; PubMed=10576511).",
CVCL_B077,Z-138,,CRL-3001,70Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0002371,NCIt; C4337; Mantle cell lymphoma, Mutation; HGNC; 12032; TRAF2; Simple; p.Trp114Ter (c.341G>A); Zygosity=Unspecified (PubMed=24362935).,
CVCL_IU89,Z-181,,CRL-3395,33Y,Male,Mexican-American,Cancer cell line,,,,,UBERON_0002371,NCIt; C114819; Adult B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1," Gene fusion; HGNC; 76; ABL1 + HGNC; 1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 1 fused to ABL1 exon 2 (e1a2 transcript) (PubMed=8600166; PubMed=10071072; PubMed=10576511).",
CVCL_4796,Z-33,,CRL-3393,53Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0002371,NCIt; C114819; Adult B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1," Gene fusion; HGNC; 76; ABL1 + HGNC; 1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 1 fused to ABL1 exon 2 (e1a2 transcript) (PubMed=8751477; PubMed=10071072; PubMed=10576511).",
CVCL_0588,ZR-75-1,,CRL-1500,63Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0007795,NCIt; C4194; Invasive breast carcinoma of no special type, Mutation; HGNC; 5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (DepMap=ACH-000097).,
CVCL_A4AL,ZR-75-1 Tam1,,CRL-3438,63Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0007795,NCIt; C4194; Invasive breast carcinoma of no special type, Mutation; HGNC; 5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).,
CVCL_A4AM,ZR-75-1 Tam2,,CRL-3439,63Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0007795,NCIt; C4194; Invasive breast carcinoma of no special type, Mutation; HGNC; 5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).,
CVCL_1661,ZR-75-30,,CRL-1504,47Y,Female,African American,Cancer cell line,,,,,UBERON_0007795,NCIt; C4194; Invasive breast carcinoma of no special type," Gene fusion; HGNC; 622; APPBP2 + HGNC; 24280; PHF20L1; Name(s)=APPBP2-PHF20L1; Note=In frame (PubMed=23260012)., Gene fusion; HGNC; 2191; COL14A1 + HGNC; 15605; SKAP1; Name(s)=COL14A1-SKAP1; Note=In frame (PubMed=23260012)., Gene fusion; HGNC; 14347; BCAS3 + HGNC; 3430; ERBB2; Name(s)=ERBB2-BCAS3; Note=Out of frame (PubMed=23260012)., Gene fusion; HGNC; 12929; PCGF2 + HGNC; 29259; TAOK1; Name(s)=TAOK1-PCGF2; Note=In frame (PubMed=23260012)., Gene fusion; HGNC; 17399; ARHGAP32 + HGNC; 17312; TIMM23; Name(s)=TIMM23-ARHGAP32; Note=Out of frame (PubMed=23260012)., Gene fusion; HGNC; 25989; CWC25 + HGNC; 19143; USP32; Name(s)=USP32-CWC25, USP32-CCDC49; Note=Out of frame (PubMed=23260012)., Mutation; HGNC; 1097; BRAF; Simple; p.Ile326Thr (c.977T>C); ClinVar=VCV000424419; Zygosity=Heterozygous (PubMed=19593635).",
CVCL_D101,AG-F,,CRL-2530,3Y11M,Female,Caucasian,Cancer cell line,,,,T-cell,UBERON_0000178,NCIt; C7953; Childhood T acute lymphoblastic leukemia," Gene fusion; HGNC; 13222; BCL11B + HGNC; 2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line)., Mutation; HGNC; 3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).",
CVCL_LE07,AG25367,AG25367,,30Y6M,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002427,NCIt; C123412; Alzheimer's disease 3, Mutation; HGNC; 9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Unspecified (Coriell=AG25367).,
CVCL_LE08,AG25370,AG25370,,81Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002427,NCIt; C123413; Alzheimer's disease 4, Mutation; HGNC; 9509; PSEN2; Simple; p.Asn141Ile (c.422A>T); ClinVar=VCV000008845; Zygosity=Heterozygous (Coriell=AG25370).,
CVCL_UX47,AG27221,AG27221,,13Y10M,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001868,NCIt; C34951; Progeria, Mutation; HGNC; 6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (Coriell=AG27221).,
CVCL_WT86,AG27415,AG27415,,14FW,Male,,Induced pluripotent stem cell,,,,Fibroblast of lung,UBERON_0005597,,,
CVCL_WU12,AG27427,AG27427,,13Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002427,NCIt; C3447; Werner syndrome, Mutation; HGNC; 6636; LMNA; Simple; p.Glu578Val (c.1733A>T); ClinVar=VCV000066863; Zygosity=Heterozygous (Coriell=AG27427).,
CVCL_YM60,AG27590,AG27590,,10Y8M,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001554,NCIt; C34951; Progeria, Mutation; HGNC; 6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (Coriell=AG27590).,
CVCL_A9ZQ,AG27602,AG27602,,72Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002427,,,
CVCL_A9ZR,AG27605,AG27605,,72Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002427,NCIt; C2866; Alzheimer's disease, Mutation; HGNC; 613; APOE; Simple; p.Arg130Cys (c.388C>T); Zygosity=Homozygous; Note=ApoE3 allele (PubMed=30699343).,
CVCL_B5PP,AG27606,AG27606,,60Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002427,NCIt; C2866; Alzheimer's disease, Mutation; HGNC; 613; APOE; Simple; p.Arg130Cys (c.388C>T); Zygosity=Homozygous; Note=ApoE3 allele (PubMed=30699343).,
CVCL_YN67,AG27607,AG27607,,69Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C2866; Alzheimer's disease, Mutation; HGNC; 613; APOE; Simple; p.Arg176Cys (c.526C>T); ClinVar=VCV000017848; Zygosity=Heterozygous; Note=ApoE2 allele (Coriell=AG27607).,
CVCL_B5PQ,AG27608,AG27608,,72Y10M,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002427,, Mutation; HGNC; 613; APOE; Simple; p.Arg130Cys (c.388C>T); Zygosity=Homozygous; Note=ApoE3 allele (PubMed=30699343).,
CVCL_B5PR,AG27609,AG27609,,87Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0004262,NCIt; C2866; Alzheimer's disease, Mutation; HGNC; 613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (PubMed=30699343).,
CVCL_B5PS,AG27611,AG27611,,75Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002427,,,
CVCL_B5PT,AG27703,AG27703,,20Y4M,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002427,NCIt; C2993; Down syndrome,,
CVCL_YX72,AG27711,AG27711,,90Y11M,Male,African American,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C2866; Alzheimer's disease,,
CVCL_B5PU,AG27875,AG27875,,29Y,Male,African American,Induced pluripotent stem cell,,,,Fibroblast of foreskin,UBERON_0001471,,,
CVCL_B5PG,AG28041,AG28041,,55Y,Female,African American,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002427,,,
CVCL_B5PH,AG28049,AG28049,,84Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002427,,,
CVCL_B5PI,AG28057,AG28057,,81Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002427,,,
CVCL_B5PJ,AG28205,AG28205,,64Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002427,,,
CVCL_B5PK,AG28262,AG28262,,67Y,Female,Southeast Asian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002427,,,
CVCL_B5PL,AG28269,AG28269,,69Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002427,,,
CVCL_B5PM,AG28278,AG28278,,1Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001868,NCIt; C2993; Down syndrome,,
CVCL_C7PA,AG28336,AG28336,,57Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C26845; Parkinson's disease,,
CVCL_B5PN,AG28340,AG28340,,14Y,Male,African American,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0004262,NCIt; C34951; Progeria, Mutation; HGNC; 6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (Coriell=AG28340).,
CVCL_C7PB,AG28346,AG28346,,67Y,Male,African American,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001415,,,
CVCL_C7PC,AG28369,AG28369,,54Y,Male,African American,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001415,,,
CVCL_C7PE,AG28462,AG28462,,12Y,Male,Mexican,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C3335; Rothmund-Thomson syndrome, Mutation; HGNC; 9949; RECQL4; Simple; c.1483+27_1483+37del (c.1483+25del11) (g.2746del11); ClinVar=VCV002431799; Zygosity=Homozygous (Coriell=AG28462).,
CVCL_C7PF,AG28585,AG28585,,8Y9M,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002427,NCIt; C135725; Cockayne syndrome type A,,
CVCL_C7PG,AG28599,AG28599,,85Y9M,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001416,NCIt; C26845; Parkinson's disease,,
CVCL_C7PH,AG28801,AG28801,,1Y8M,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001868,NCIt; C2993; Down syndrome,,
CVCL_C7PI,AG28851,AG28851,,49Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0001416,,,
CVCL_C7PJ,AG28869,AG28869,,21Y,Female,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0003530,,,
CVCL_D3AR,AG28929,AG28929,,35Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_D3AM,AG29046,AG29046,,44Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C26747; Type 2 diabetes mellitus,,
CVCL_D3AP,AG29054,AG29054,,31Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002427,,,
CVCL_D3AQ,AG29059,AG29059,,58Y,Female,African American,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002427,,,
CVCL_0139,AGS,,CRL-1739,54Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000945,NCIt; C4004; Gastric adenocarcinoma," Mutation; HGNC; 2514; CTNNB1; Simple; p.Gly34Glu (c.101G>A); ClinVar=VCV000017584; Zygosity=Heterozygous (ATCC=CRL-1739; Cosmic-CLP=906790; DepMap=ACH-000880)., Mutation; HGNC; 8975; PIK3CA; Simple; p.Glu453Lys (c.1357G>A); ClinVar=VCV000376470; Zygosity=Heterozygous (Cosmic-CLP=906790; DepMap=ACH-000880)., Mutation; HGNC; 11998; TP53; None_reported; -; Zygosity=- (PubMed=1370612).",
CVCL_A4BR,AGS-Luc2,,CRL-1739-LUC2,54Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000945,NCIt; C4004; Gastric adenocarcinoma," Mutation; HGNC; 2514; CTNNB1; Simple; p.Gly34Glu (c.101G>A); ClinVar=VCV000017584; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 8975; PIK3CA; Simple; p.Glu453Lys (c.1357G>A); ClinVar=VCV000376470; Zygosity=Heterozygous (from parent cell line).",
CVCL_U957,AlAb,,CRL-7715,54Y,Female,,Cancer cell line,,,,,UBERON_0002048,NCIt; C5214; Breast adenocarcinoma,,
CVCL_1071,AML-193,,CRL-9589,13Y,Female,African American and Caucasian,Cancer cell line,,,,,UBERON_0000178,NCIt; C9160; Childhood acute myeloid leukemia," Mutation; HGNC; 25657; BCORL1; Simple; p.Arg784Ter (c.2350C>T); Zygosity=Unspecified (PubMed=21989985; DepMap=ACH-000557)., Mutation; HGNC; 11998; TP53; Simple; c.993+2T>G (IVS9+2T>G); ClinVar=VCV000635384; Zygosity=Unspecified; Note=Splice donor mutation (DepMap=ACH-000557).",
CVCL_6337,AML14.3D10/CCCKR3 Clone 16,,CRL-12079,68Y,Male,,Cancer cell line,,,,,UBERON_0000178,NCIt; C9154; Adult acute myeloid leukemia,,
CVCL_B386,Amsalem,,CRL-2628,12Y,Female,,Cancer cell line,,,,T-cell,UBERON_0000178,NCIt; C7953; Childhood T acute lymphoblastic leukemia,,
CVCL_0028,AN3-CA,,HTB-111,55Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000027,NCIt; C26687; Acanthosis nigricans," Mutation; HGNC; 6877; MAPK3; Simple; p.Pro373Ser (c.1117C>T); Zygosity=Heterozygous (ATCC=HTB-111)., Mutation; HGNC; 9588; PTEN; Simple; p.Arg130Glnfs*4 (c.389delG); ClinVar=VCV000192224; Zygosity=Homozygous (PubMed=20944090; ATCC=HTB-111).",
CVCL_DP56,AR230-r,,CRL-3346,52Y,Female,Japanese,Cancer cell line,,,,,UBERON_0000178,"NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive"," Gene fusion; HGNC; 76; ABL1 + HGNC; 1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=Mu-BCR transcript (from parent cell line).",
CVCL_UC13,AR230-s,,CRL-3345,52Y,Female,Japanese,Cancer cell line,,,,,UBERON_0000178,"NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive"," Gene fusion; HGNC; 76; ABL1 + HGNC; 1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=Mu-BCR transcript (from parent cell line).",
CVCL_B0CC,ART [Human OVCAR-8 contaminated cell line],,CRL-3468,64Y,Female,Caucasian,Cancer cell line,,,,,,NCIt; C105555; High grade ovarian serous adenocarcinoma," Mutation; HGNC; 2514; CTNNB1; Simple; p.Gln26Arg (c.77A>G); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6407; KRAS; Simple; p.Pro121His (c.362C>A); Zygosity=Heterozygous (from parent cell line).",
CVCL_0152,AsPC-1,,CRL-1682,62Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0007795,NCIt; C9120; Pancreatic ductal adenocarcinoma," Gene deletion; HGNC; 6844; MAP2K4; Zygosity=Homozygous (PubMed=9331070)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Homozygous (PubMed=8026879; PubMed=11115575; PubMed=11169959; PubMed=11787853; PubMed=15367885; PubMed=21607521; Cosmic-CLP=910702; DepMap=ACH-000222)., Mutation; HGNC; 11998; TP53; Simple; p.Cys135Alafs*35 (c.403delT); ClinVar=VCV001069265; Zygosity=Heterozygous (PubMed=8026879; PubMed=11169959; PubMed=11787853; PubMed=15367885; PubMed=21607521; Cosmic-CLP=910702; DepMap=ACH-000222).",
CVCL_X497,ATCC-BXS0114,,ACS-1028,31Y,Female,African American,Induced pluripotent stem cell,,,,,UBERON_0002371,,,
CVCL_0A06,ATCC-BXS0115,,ACS-1029,24Y,Female,Hispanic,Induced pluripotent stem cell,,,,,UBERON_0002371,,,
CVCL_0A07,ATCC-BXS0116,,ACS-1030,31Y,Female,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0002371,,,
CVCL_0A08,ATCC-BXS0117,,ACS-1031,27Y,Female,Asian,Induced pluripotent stem cell,,,,,UBERON_0002371,,,
CVCL_X496,ATCC-BYS0110,,ACS-1024,33Y,Male,African American,Induced pluripotent stem cell,,,,,UBERON_0002371,,,
CVCL_0A04,ATCC-BYS0111,,ACS-1025,24Y,Male,Hispanic,Induced pluripotent stem cell,,,,,UBERON_0002371,,,
CVCL_0A05,ATCC-BYS0112,,ACS-1026,31Y,Male,Caucasian,Induced pluripotent stem cell,,,,,UBERON_0002371,,,
CVCL_0A03,ATCC-BYS0113,,ACS-1027,45Y,Male,Asian,Induced pluripotent stem cell,,,,,UBERON_0002371,,,
CVCL_X498,ATCC-CYS0105,,ACS-1021,72Y,Male,,Induced pluripotent stem cell,,,,Fibroblast of heart,UBERON_0000948,,,
CVCL_C250,ATCC-DYP0250,,ACS-1004,16Y,Male,,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002097,NCIt; C2975; Cystic fibrosis, Mutation; HGNC; 1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (ATCC=ACS-1004).,
CVCL_C251,ATCC-DYP0530,,ACS-1014,63Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002067,NCIt; C26845; Parkinson's disease,,
CVCL_C252,ATCC-DYP0730,,ACS-1003,2M,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of foreskin,UBERON_0001471,NCIt; C2993; Down syndrome,,
CVCL_C253,ATCC-DYR0100,,ACS-1011,<1M,Male,,Induced pluripotent stem cell,,,,Fibroblast of foreskin,UBERON_0001471,,,
CVCL_C254,ATCC-DYR0530,,ACS-1012,63Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002067,NCIt; C26845; Parkinson's disease,,
CVCL_X499,ATCC-DYS0100,,ACS-1019,<1M,Male,,Induced pluripotent stem cell,,,,Fibroblast of foreskin,UBERON_0001471,,,
CVCL_C255,ATCC-DYS0530,,ACS-1013,63Y,Male,Caucasian,Induced pluripotent stem cell,,,,Fibroblast of skin,UBERON_0002067,NCIt; C26845; Parkinson's disease,,
CVCL_C256,ATCC-HYR0103,,ACS-1007,31Y,Male,Hispanic,Induced pluripotent stem cell,,,,Fibroblast,UBERON_0002107,,,
CVCL_X500,ATCC-HYS0103,,ACS-1020,31Y,Male,Hispanic,Induced pluripotent stem cell,,,,Fibroblast,UBERON_0002107,,,
CVCL_2299,ATRFLOX,,CRL-2780,48Y,Male,Caucasian,Cancer cell line,,,,,UBERON_0001155,NCIt; C4910; Colon carcinoma," Mutation; HGNC; 173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line)., Mutation; HGNC; 1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line)., Mutation; HGNC; 9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).",Homologous recombination; HGNC; 882; ATR (Note=1 of 2 alleles).
CVCL_1074,AU565,,CRL-2351,43Y,Female,Caucasian,Cancer cell line,,,,,UBERON_0000175,NCIt; C5214; Breast adenocarcinoma, Mutation; HGNC; 11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (ATCC=CRL-2351).,
CVCL_1904,AV3,,CCL-21,30Y6M,Female,African American,Cancer cell line,333761,Human papillomavirus type 18 (HPV18).,,,UBERON_0000002,NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma,,